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Literature Review: Biomimetic Strategies in Total 
Synthesis 
Introduction 
Synthetic realization of biogenetic pathways in total synthesis of naturally occurring 
compounds is one of the most impressive parts of organic chemistry. This discipline is 
strongly intersected with biochemistry because essentially all biological processes in living 
nature are based on organic reactions. Very complicated transformations of substances, like 
photosynthesis or the preparation of milk from grass, are not reproduced in laboratory. But 
many simple processes, like synthesis of peptides, DNA and, of cause, biologically active 
compounds, could be repeated in vitro. Thus, organic chemistry is firmly connected to 
biochemistry as well as to pharmacology and medicine. And the overall goal of all these 
disciplines is the preparation of biologically active compounds in the laboratory or factory. 
Understanding of biogenetic pathways helps chemists to achieve the total synthesis of natural 
compounds in a very elegant manner. The successful synthesis of many natural products often 
follows routes analogous to processes that occur in the living cell with less enzyme 
participation.  
The theory of minimum enzyme participation in the biosynthesis of complex natural 
compounds originates from the fact that plants and bacteria produce an enormous amount of 
bioactive metabolites. The role of these secondary metabolites is not yet fully studied as well 
as their biosynthesis, and this theory says that most of these compounds are formed in living 
cells as side products of their metabolism. 1 Some typical functions of that metabolites include 
defence against other species or communication between species (ct. pheromones). 
Another theory considers that the huge structural diversity of biological metabolites 
produced by nature was formed during the evolution of enzymes, and that all metabolites play 
a certain role in the internal economy of the producing organism. D. Williams in his article 
"Why are secondary metabolites (natural products) biosynthesized?"2 wrote: “We propose that 
all such structures serve the producing organisms by improving their survival fitness. We 
argue that this conclusion is necessitated by the fact that natural products are normally 
complex structures, whose biosynthesis is programmed by many kilobases of DNA. If it were 
2  Literature Review 
otherwise, the pressures of Darwinian natural selection would have precluded the expenditure 
of so much metabolic energy in their construction and the development of such complexity.”  
Vedic knowledge about nature tells us that all living organisms were created according 
to the plan of supreme intelligence, and all plants play a certain role in the interactions 
between organisms. Bioactive chemical substances, respectively, also have influence on 
certain functions of human organism and mind and these compounds are synthesized by the 
aid of plants specially for utilizing them in medicine and nourishment. Vedic scriptures say 
that all plants were applied in people’s everyday life, but in the age of Kali-yuga this science 
was forgotten, and some traces of that knowledge still remain in some countries as folk 
medicine. The folk medicine often helps modern scientists to find bioactive compounds in 
plants, and to synthesize their analogs with a view towards development of new drugs. 
Perhaps the most appealing facet of a biomimetic strategy is that it pursues the 
development of synthetic methodology inspired by biogenesis, even if the mimicked 
biogenetic route is only hypothetical. The importance of biomimetic synthesis can be 
emphasized by words of Skyler and Heathcock who have written that “a truly biomimetic total 
synthesis represents a general solution not to the preparation of a compound but to the 
preparation of all similarly derived natural products (discovered and undiscovered).”3 
We can determine biomimetic total synthesis as a straightforward and efficient 
preparation of complex natural products and their analogs from simple natural compounds or 
their derivatives using typical biogenetic reactions. Biogenetic reactions we can determine as 
reactions involved in the conversion of metabolites, catalyzed with enzymes or uncatalyzed, 
which take place in living cells, or similar to them. We should note that some enzyme 
catalyzed reactions could be mimicked in the laboratory by using appropriate catalysts, 
activation by light or by improving of basic conditions like reagents, solvent, temperature, 
pressure or concentration. Those reactions we should determine as biomimetic. The scope of 
biomimetic reactions consists of few types of simple transformations like aldol, Michael or 
Diels-Alder reactions. Sometimes one simple reaction initiates a cascade of reactions leading 
to selective formation of products containing complex polycyclic skeletons and several new 
stereocenters. Skeletal rearrangement of metabolites, catalysed with enzymes, could be 
mimicked by analogues transformations of carbocations or radicals. This review is an attempt 
to summarize and classify the knowledge about biomimetic total synthesis.  
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All the scope of biomimetic syntheses we divided by its key reactions. This division is 
not very punctual, because some syntheses coud include several different types of key 
reactions, but such classification of literature reported syntheses could simplify the 
information and make the studying and reviewing of it more clearly. Thus, the review would 
consist of following parts:  
1) Biomimetic Mannich, Michael and aldol reactions. 
2) Biomimetic cyclization of polyketides, which both could be related to a polyketide 
biosynthetic pathway. 
3) Cation- cyclizations. 
4) Radical- cyclizations, which both relate to the terpene cyclization pathway. 
5) Synthesis of polyethers, which could reflect the biogenetic formation of C-O bonds, 
especially in tetrahydrofurans and other oxa-cycles. 
6) Oxidative aromatic coupling and dimerizations, which usually followes the biogenetic 
pathway of formation C-C bonds between aromatic units. 
7) Pericyclic reactions, which is the most common biogenetic pathway for the synthesis 
of complex polycyclic natural products. 
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Biomimetic Mannich, Michael and aldol reactions 
The history of biomimetic total synthesis began in 1917 with Robinson’s famous three 
component synthesis of tropinone (9) from succinaldehyde (1), methylamine (2) and 
acetonedicarboxylic acid (3).4 Condensation of methylamine with succindialdehyde formed a 
five-membered heterocycle which participated in sequential inter- and intramolecular Mannich 
reactions with calcium acetonedicarboxylate. Double decarboxylation of 8 provided tropinone 
(9) in 43 % yield by a remarkable one-pot reaction. Robinson’s recognition of tropinone’s 
symmetry led to a brilliant, direct synthesis from readily available starting materials. 
 
Scheme 1. Robinson’s total synthesis of tropinone (9) 
For comparing with the biomimetic Robinson’s synthesis a modern one pot synthesis of 
tropinone (9) from cycloheptanol (10) using hypervalent iodine(V) oxidant IBX was recently 
achieved by K.C. Nicolaou and coworkers in 2002 (Scheme 2).5 He developed a facile 
conversion of alcohols to -unsaturated ketones with IBX (2-iodoxybenzoic acid) through a 
ketone intermediate, which is oxidized to an enone by single electron transfer (SET) 
mechanism. Double aza-Michael reaction of cyclohepta-2,6-diene-1-one (12) with methyl 
amine allowed to prepare tropinone from cycloheptanol (10) or cycloheptanone (11) in one pot 
and good yield (58 %). 
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Scheme 2. Nicolaou’s total synthesis of tropinone (9) 
Another interesting biomimetic transformation is the one-step biomimetic synthesis of 
styelsamine B (14), containing a polyaromatic structure of zoochromes isolated from marine 
invertebrates, which was developed by Skyler and Heathcock.3 This synthesis includes 
Michael addition of kynuramine (15) to o-quinone (17), which is obtained by oxidation of N-
acetyl dopamine (16) with Ag2O. Subsequent oxidation of the resulting catechol 18 initiated 
an aldol condensation/ cyclization/ aromatization cascade to give styelsamine B (14). 
 
Scheme 3. Total synthesis of styelsamine B (14) by Skyler and Heathcock 
A stereoelectronically controlled Mannich cyclization is responsible for the 
diastereoselective construction of the tetracycle in Corey’s synthesis of the porantherin 
alkaloid (19).6 Starting from the symmetrical starting material 20, a cyclic enamine 21 is 
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initially formed, with the help of acid. This enamine then yields the bicyclic compound 22 by 
means of a Mannich cyclization. The subsequent preparation of the iminium species 23 and 
cyclization to 24, starting from the initially formed enamine, is achieved with catalytic 
quantities of acid. The complete reaction sequence from 20 to 24 (cleavage of the acetal 
protecting group, Mannich cyclization) is carried out sequentially, in order to guarantee water-
free conditions for the Mannich reaction. 
 
Scheme 4. Corey’s synthesis of porantherin (19) 
Another synthesis of porantherin was demonstrated by R. Stevens et al. in 1987.7 
Treatment of compound 25 with acid resulted in ketoenamine 26 after neutralization. By 
heating it in presence of vinyl acetate and p-toluenesulfonic acid ketone 26 was converted into 
enol acetate and the enamine isomerized into an imine. Intramolecular Mannich reaction of 
this intermediate 27 gave aminoketone 28 in good yield. Oxidation of amine 28 with mercuric 
acetate initiated a second Mannich reaction to obtain tetracyclic ketone 29, which was 
converted to porantherin (19) in two steps by heating of 29 with phenylsulfonyl hydrazide and 
treatment of the hydrazone with tert-BuLi. 
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Scheme 5. Total synthesis of porantherin (19) by R. Stevens 
Similar to Robinson’s synthesis of tropinone, total synthesis of coccinelline (30) by R. 
Stevens and Li published in 1979 is based on a Robinson-Schöpf condensation of an amine 
dialdehyde equivalent and acetone dicarboxylic ester 31.8 Treatment of diacetal 32 with acid 
gave iminium salt 33, which was condensed with acetone dicarboxylic ester 31 after pH was 
adjusted to 5.5. The origin of stereoselectivity could be explained by transition state 34 at the 
Scheme 6. After decarboxylation, ketone 35 was obtained in 56 % yield. 
 
Scheme 6. Total synthesis of coccinelline (30) by R. Stevens and Li 
Such domino sequences can also be applied intramolecularly, as the synthesis of the 
alkaloid karachin (36) proves (Scheme 7). In this impressive example, a domino reaction takes 
place as follows: a vinylogous Mannich reaction (to 38) is succeeded by a Michael reaction (to 
39) and then another Mannich reaction (to 36). Three C−C bonds are formed sequentially by 
Domino Mannich + Michael + Mannich cyclization yielding karachin (36). When berberin 37 
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was treated with 20 equivalents of the diene 40 for 18 h at 100 °C, the yield of 36 in this 
sequence was 66%.9 
 
Scheme 7. Total synthesis of karachin (36) by R. Stevens 
Another example of a biomimetic Michael reaction was published by H. Takayama and 
coworkers. This was a key reaction in the total synthesis of pandamarilactonine A and B (41) 
(Scheme 8).10 These naturally occurring compounds were prepared in few steps using 
Mukaiyama aldol reaction of symmetrical aldehyde 42 with 2-trimethylsilyloxy-3-methyl 
furan (43) to give -lactone 44. Dehydration and deprotection of 44 gave amine 45, which 
underwent a vinylogous aza-Michael reaction to afford a mixture of stereoisomers of 
pandamarilactonine (41) in 18 % yield. 
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Scheme 8. Total synthesis of pandamarilactonine A and B (41) 
Intramolecular cascade aldol reactions might be used for the synthesis of iridodial type 
natural products. For example, biosynthesis of iridodial (46) involves coenzyme reduction of 
unsaturated aldehyde 48, which is formed by intramolecular aldol reaction of 10-oxocitral 
(47). A biomimetic synthesis of iridodial (46) was reported by Japanese authors in 1987.11 
Treatment of 10-oxocitral (47) with formic acid afforded dehydroiridodial (49) in 30 % yield. 
Addition of coenzyme model 50 resulted in hydrogenation, giving 5 % of iridodial (Scheme 
9). 
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Scheme 9. Biosynthesis and total synthesis of iridodial (46) 
A modern synthesis of iridodial-type compounds was reported by D. MacMillan in 
2005.12 Intramolecular Michael reaction of dialdehyde 51 has been done under L-proline 
catalyzed conditions to give the iridodial core of (-)-brasoside (52) in good yield and 
diastereoselectivity. Another compound (-)-littoralisone (53), containing the same iridodial 
core structure, was synthesized by photochemical [2+2] cycloaddition (Scheme 10). 
 
Scheme 10. Synthesis of (-)-brasoside (52) and (-)-littoralisone (53) by D. MacMillan 
A great example of using biomimetic Mannich and Michael reactions in the total 
synthesis of monoterpenoid indole alkaloids (+)-geissoschizine (54) and (+)-N-
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methylvellosimine (55) was shown by S.F. Martin and coworkers (Scheme 11).13 The key 
steps of the synthesis of these compounds are a vinylogous Mannich reaction of 
dihydrocarboline 56 with silyl ketene acetal 57, and an intramolecular Michael reaction of a 
dicarbonyl compound, generated by acylation of 58 with diketene, to provide compound 59. 
Stereochemistry of these reactions is matched to that of authentic products. The alkaloid 55 
was also prepared in a concise biomimetic manner by intramolecular Mukaiyama-Mannich 
reaction of intermediate 60, to give a mixture of aldehydes 55. Epimerization of isomers with 
NaOH gave the thermodynamically more stable compound 55, which is the same as the 
naturally occurring product. 
 
 
Scheme 11. Total syntheses of (+)-geissoschizine (54) and (+)-N-methylvellosimine (55) by 
S.F. Martin. 
A total synthesis of coronatine (61), published by A. Ichihara, is based on an 
intramolecular vinylogous Michael reaction of cyclopentanone 62.14 Obtained bicyclic core 
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structure 63 of coronatine was formed in good yield and stereoselectivity to give only cis-
bicyclononane core structure (63) of mentioned natural product. 
 
Scheme 12. Total synthesis of coronatine (61) by A. Ichihara 
The biogenetic pathway toward the ervatamine alkaloids probably involves a cationic 
key intermediate 64, formed from a vobasine N-oxide equivalent 65 as illustrated in Scheme 
13, which would be transformed into 19,20-dehydroervatamine (66) by closure of the C ring 
via cyclization of the enamine moiety upon the 3-methyleneindoleninium cation 64.15 
 
Scheme 13. Biogenetic pathway of ervatamine alkaloids 
Total synthesis of ervatamine alkaloids, reported by M. Bennasar and J. Bosch, realized 
this biomimetic approach. Heating of compound 67 with MeI in DMSO afforded the 
tetracyclic skeleton of ervatamine alkaloids 68.16 
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Scheme 14. Total synthesis of 19,20-dehydroervatamine (66) by M. Bennasar and J. Bosch 
Total synthesis of indole alkaloid ervistine (69) was accomplished by M. Bennasar and 
coworkers in concise biomimetic manner.17 Alkylation of indolacetone 70 with pyridinium salt 
71 gave enamine 72, which was dimethylaminomethylated to afford iminium salt 73, which 
underwent cyclization resulting in tetracyclic compound 74. This intermediate was converted 
to ervistine (69) in two steps. 
 
Scheme 15. Total synthesis of ervistine (69) was accomplished by M. Bennasar 
Recently, the Nicolaou group has published syntheses of rugulosin (75, Scheme 16) and 
several other family members, featuring an impressive biomimetic dimerization/cascade 
sequence.18 Addition of MnO2 and Et3N to anthradihydroquinone 76 led to the formation of 
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cage structure (78), through a radical dimerization of quinone 77 followed by a series of 
intramolecular Michael reactions, in 50% overall yield. 
 
Scheme 16. Nicolaou’s syntheses of rugulosin (75) 
A biomimetic approach to the discorhabdin alkaloids, elaborated by C. Heathcock, 
involves intramolecular cyclization of tyramine-substituted indoloquinonimines under 
oxidative conditions to construct the characteristic spirodienone structure of the discorhabdin 
alkaloids.19 Compound 79 was prepared from tryptamine and tyramine derivatives. Treatment 
of 79 with Cu(II) chloride under oxygen afforded discorhabdin C in good yield after 
deprotection. Hydrogenation of unbrominated spiroketone 80 and bromination of -position 
gave bromoenones which underwent smooth conversion to dethiadiscorhabdin D (81) upon 
treatment with basic alumina. 
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Scheme 17. Total synthesis of dethiadiscorhabdin D (81) by C. Heathcock 
One of the most fascinating and educational accounts of a tandem biomimetic reaction 
sequence is Clayton Heathcock’s 1996 paper on the Daphniphyllum alkaloids.20 Following 
several years study of these molecules, it was found that squalene derivative 82 could be 
converted to pentacyclic amine 83 simply by sequential treatment with methylamine and warm 
acetic acid. A methylamine-induced Michael reaction and condensation gave rise to 
dihydropyridinium intermediate 84 which was poised for an intramolecular Diels-Alder 
reaction. The resultant tetracyclic iminium ion 85 was then attacked by a pendant alkene to 
give tertiary carbocation 86. A 1,5-hydride shift followed by iminium ion hydrolysis provided 
compound 87, a postulated biogenetic precursor of several Daphniphyllum alkaloids, in an 
amazing 65% yield from dialdehyde 82. This remarkable sequence forms five rings and eight 
stereocenters with complete diastereo- and regiocontrol from the linear dialdehyde 82. 
Heathcock’s beautiful work on this and related compounds is a tribute to his genius and can be 
considered a chemical masterpiece. 
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Scheme 18. Heathcock’s biomimetic approach to Daphniphyllum alkaloids 
A recent contribution to the area of tandem biomimetic reactions is the synthesis of 
trichodimerol (88) by the Corey21 and Nicolaou22 laboratories. Both groups took advantage of 
the C2-symmetry in 88 to design in situ dimerizations of acetate 89. Deacetylation of 89 with 
sodium methoxide (Corey) or cesium hydroxide (Nicolaou) triggered the formation of 
trichodimerol 88 in a modest 10% (Corey) or 16% (Nicolaou) yield. Compound 90 may 
represent an actual intermediate in this remarkable pathway, or the formation of 88 may occur 
by way of another degenerate pathway (e.g., a different order of events or a photochemical 
[4+4] cycloaddition). 
 
Scheme 19. Nicolaou’s and Corey’s total syntheses of (-)-trichodimerol (88) 
89 90 88
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A total synthesis of sesquiterpenes called litseaverticillols 91 using a biomimetic aldol 
condensation of ketoaldehyde 92 as a key reaction was accomplished by Greek authors in 
2004.23 Furan 93 underwent a Diels-Alder reaction with singlet oxygen, solvolysis of 
compound 94 gave hydroperoxide 95. Reduction of hydroperoxide 95 with dimethyl sulfide 
gave ketoaldehyde 92, which underwent aldol condensation in situ by treatment with Hünig’s 
base in 51% yield. Prepared liseaverticillol B (91) was obtained along with it’s diastereomeric 
product.  
 
Scheme 20 Biomimetic total synthesis of litseaverticillol B (91) 
Coleophomone D (96) exists in nature as a mixture of atropisomers D2,4 and 
diastereomers D1,3 due to very facile aldol/retroaldol equilibrium of these unusual metabolites 
(Scheme 21). In Nicolaou’s24 studies of the synthesis of different coleophomones the facile 
condensation of diketone 97 and cyanoketone 98 afforded benzyl alcohol 99. Oxidation of 99 
with MnO2 gave all coleophomones D as a mixture of all the postulated isomers (D1-D4) in 
83% yield. 
18  Literature Review 
 
Scheme 21. Nicolaou’s synthesis of coleophomones (96) 
An original total synthesis of pentalenene (100) by means of the squarate ester cascade 
was recently reported by L. Paquette.25 Starting from diisopropyl squarate (101), the tricyclic 
core of pentalenene (100) was furnished in one-pot and 76% yield. The mechanism of this 
cascade reaction includes 4 and 8 cyclizations of dialcoholate 102 prepared by double 
alkylation of diisopropyl squarate (101). On the last step of the domino sequence intermediate 
102 undergoes transannular aldol reaction to form tricyclic pentalene architecture 104. 
 
Scheme 22. Total synthesis of pentalenene (100) by L. Paquette 
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A biomimetic total synthesis of (-)-erinacine E (105) was reported by Japanese authors.26 
Swern oxidation of allylic alcohol 106 led to a subsequent intramolecular Michael cyclization 
of intermediate ketoaldehyde, and in-situ elimination, giving aldehyde 107 in 93% yield. 
Treatment of this ketoaldehyde with DBU provided the product of an intramolecular aldol 
reaction with concomitant migration of the benzoyl group 108 in good yield, which was 
converted to the natural product (-)-erinacine E (105) in 3 steps. 
 
Scheme 23 Biomimetic total synthesis of (-)-erinacine E 
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Biomimetic cyclization of polyketides 
The polyketide pathway is one of the most common in the biosynthesis of natural 
compounds. In Nicolaou’s synthesis of azaspiracid the ABCD rings of intermediate 109 were 
constructed by acidic treatment of protected ketone 110 which underwent thermodynamically 
controlled cyclization.27 Although the produced isomer has wrong stereochemistry at C-13, it 
could be epimerized into the correct structure in the next steps. 
 
Scheme 24. Nicolaou’s synthesis the ABCD ring system of azaspiracid 
Recently a concise approach to the pentacyclic structure of ptilomycalin A and the total 
synthesis of crambescidin 359 (110) were reported.28 The authors proposed that this polycyclic 
unit of requisite molecule might be synthesized by a biomimetic strategy from linear diketone 
111. Thus treatment of diketone 111 with guanidine, followed by cleavage of the  silyl groups 
afforded the desired crambescidin 359 (110) in 18% overall yield. 
 
Scheme 25. Total synthesis of crambescidin 359 (110) 
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Many alkaloids contain a pyrrole moiety or another heterocyclic fragment. For example, 
polycitrin A (112) consist of a maleimide moiety, which biogenetically could be formed by 
oxidative dimerization of the two corresponding arylpyruvic acids and consecutive closure of 
the pyrrole ring with ammonia. In the total synthesis of polycitrin A (112) by W. Steglich et 
al. that biogenetic approach was successfully applied.29 Treatment of the dianion derived from 
3-(4-methoxyphenyl)pyruvic acid (113) and nBuLi with iodine followed by reaction of the 
resulting solution with ammonia and TiCl4 at room temperature afforded 3,4-bis-(4-
methoxyphenyl)pyrrole-2.5-dicarboxylic acid (114) in 72% yield. Oxidation with an aqueous 
sodium hypochlorite solution afforded 95% of maleimide 115, which was converted to 
polycitrin A (112) in a few steps. 
 
Scheme 26 Total synthesis of polycitrin A (112) 
The total synthesis of lamellarin L (116), achieved by W. Steglich and coworkers, 
appears to be an elegant example for the biomimetic formation of pyrrole containing 
alkaloids.30 Coupling of two different arylpyruvate units 117 and 118 gave diketone 119, 
which was converted into pyrrole 121 by heating with amine 120. Pyrrole 121 was converted 
to lamellarin L (116) in few steps with 38% overall yield. 
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Scheme 27. Total synthesis of lamellarin L (116) by W. Steglich 
Recently a concise synthesis of S-(-)-zearalenone (122) using an efficient late stage 
aromatization of polyketone 123 has been published.31 Heating of alcohol 124 together with 
ester 125 afforded via a transesterification reaction formation of tetraketone 123. Obtained 
ketone underwent aromatization under basic conditions to give resorcinol 126 in 82%. Finally, 
treatment with Hoveyda-Grubbs catalyst (127) completed the total synthesis of S-(-)-
zearalenone (122) in a very efficient manner. 
 
Scheme 28. Total synthesis of S-(-)-zearalenone (122) 
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A possible precursor of the potent antibiotic landomycinone (128), tetracyclic compound 
129 was synthesized following a biomimetic formation of the resorcylate ring by cylization of 
triketone 130.32 The dimethoxy naphthalene derivative 130 with two vicinal side chains was 
prepared by reaction of the dibromide 131 with silyl ether 132 ([Bu4N][Ph3SnF2]-catalysis) 
followed by Stille reaction of 133 with stannane 134. Acidic hydrolysis gave the triketo ester 
130 that cyclized in a biomimetic-type reaction to the highly substituted dihydro 
benz[a]anthracene 129. 
 
Scheme 29. A biomimetic approach to landomycinone (128) 
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Cascade cation­ cyclizations 
Fifty-three years ago, Gilbert Stork and Albert Eschenmoser independently proposed 
that the steroid ring system could be formed by tandem cation-π cyclizations of a polyene in 
an ordered transition state.33 A non-enzymatic version of this reaction type was demonstrated 
in W. S. Johnson’s classic synthesis of progesterone (135) in 1971 (Scheme 30).34 Treatment 
of trienyne 136 with trifluoroacetic acid gave rise to cation 137 which cyclized cleanly to 
ketone 138 in excellent yield after hydrolysis of intermediate 139. Unlike the enzymatic 
cation-π cyclizations used to form steroids in nature, Johnson’s procedure produces 
progesterone as a racemate. Nevertheless, the striking cation-π cyclization strategy has proven 
to be very general for steroid synthesis and many other (racemic and enantioselective) variants 
have been developed by Johnson and others. 
 
Scheme 30. Johnson’s classic synthesis of progesterone (135) 
For example, in the synthesis of 4-androstene-3,17-dione (140), published in 1980, 
Johnson et al. developed an improved cation--cyclization of propargyl silane functionalized 
polyene 141.35 The role of the propargyl silane function is to terminate the cation--cyclization 
by elimination of trimethylsilyl cation as shown in Scheme 31. Ozonolysis of obtained allene 
142 afforded the desired 4-androstene-3,17-dione (140). 
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Scheme 31. Johnson’s synthesis of 4-androstene-3,17-dione (140). 
Cationic cyclization can be used for the synthesis of prostaglandins as well. The total 
synthesis of PGE1 (143), published in 1982 by Japanese authors, involves a stereocontrolled 
bromomercuration cyclization of polyene 144.36 Although the wrong stereochemistry at C-11 
was obtained, it was inverted under Mitsunobu conditions to reach the structure of PGE1. 
 
Scheme 32. Cationic cyclization applied to the synthesis of prostaglandins 
A stereospecific iminium ion – vinylsilane cyclization was applied as a key reaction in 
Overman’s synthesis of indoloquinolizidine alkaloid dl-deplancheine (145) in 1982.37 
Subjecting tryptamine hydrochloride in a Pictet-Spengler reaction with aldehyde 146 afforded 
vinylsilane 147. Heating of 147 with paraformaldehyde and camphorsulphonic acid gave the 
indoloquinolizidine structure of alkaloid deplancheine 145 with complete retention of 
stereochemistry at the exocyclic double bond. 
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Scheme 33. Overman’s synthesis of deplancheine (145) 
The total synthesis of humulene (148) by Corey and coworkers is an interesting example 
for the formation of a macrocycle by cation olefin cyclization of mesylate 150 (Scheme 9).38 
Stannane 150, prepared in few steps from E,E-farnesol (149), was treated with 
dimethylaluminium chloride to get humulene (148). 
 
Scheme 34. Total synthesis of humulene (148) by Corey 
A number of marine natural products could be prepared by bromonium ion-initiated 
cyclizations of sesquiterpenes. Biomimetic studies toward the synthesis of (-)-aplysistatin, 
published in 1982, showed that treatment of lactone 151 with 2,4,4,6-tetrabromocyclohexa-
2,5-dienone (TBCD) in dry nitromethane afforded cyclization to form, however, mostly the 
wrong diastereomer of dihydroaplysistatin 152.39 The ratio of products was 19:81 of 7,8-
dihydroaplysistatin and the corresponding 12-epi isomer. An improved synthesis of (-)-
aplysistatin was reported in 1984 by Japanese authors who performed a mercuric ion-induced 
brominative cyclization of 151 to obtain a 2:1 ratio of products.40 
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Scheme 35. Synthesis of (+)-12-epiaplysistatin (152) by bromonium ion-initiated cyclization 
Another type of cascade cation-π cyclization for the synthesis of tricyclic sesquiterpene 
junicedran-11-ol (154) was published by Indian authors in 1997.41 The synthesis involved a 
biogenetically patterned carbenium ion mediated cyclization of sesquiterpene 155 with 
subsequent rearrangement of carbocation 156 to spiro intermediate 157 which underwent final 
cationic cyclization to form ketone 158, and then junicedran-11-ol (154) after reduction with 
lithium in liquid ammonia in a good yield.· 
 
Scheme 36. Total synthesis of tricyclic sesquiterpene junicedran-11-ol (154) 
The trans-decaline core can be found in many types of natural products. In the total 
synthesis of (±)-balanitol (159), published by Li et al., a characteristic eudesmane decalin ring 
system was constructed on the basis of an intramolecular electrophilic cation-olefin 
cyclization.42 Formolysis of compound 160 in 88% fomic acid at 20 °C for 1.5 h afforded the 
corresponding decalin 161 in a stereoselective manner. 
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Scheme 37. Total synthesis of (±)-balanitol (159) 
The autors of a very efficient synthesis of liphagal (162) proved the biogenetic pathway 
to this marine sponge metabolite by it’s total synthesis applying a cascade cation-π cyclization 
for construction of the tetracyclic core of 162 (Scheme 8).43 Treatment of benzofuran 163 with 
chlorosulfonic acid resulted in a region- and stereoselective cyclization to provide tetracyclic 
compound 164, which is the direct precursor of liphagal (162). 
 
Scheme 38. Total synthesis of liphagal (162) 
In 1999, Yamamoto developed the first enantioselective biomimetic cyclization of a 
polyprenoid using a Lewis acid-assisted chiral Brønsted acid (LBA) as an artificial cyclase and 
used it to synthesize (-)-ambrox (165).44 In this synthesis binaphtol based LBA 166 was used 
for cyclization of trienol 167, which proceeded with good diastereoselectivity but moderate ee 
value (Scheme 39). 
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Scheme 39. Enantioselective total synthesis of (-)-ambrox (165). 
(S)-2,3-Epoxysqualene (168) is cyclized in some plants primarily to dammarenediol 
(169). The first total synthesis of this tetracycle using a polyolefin cascade cyclization 
designed to mirror the biosynthetic transformation was reported by Corey in 1996.45 In 
contrast to Johnson’s use of fluorine to control the regioselectivity of C-ring formation (to 
cyclohexane instead of cyclopentane), a strategy later used in his own synthesis of 
dammarenediol,46 Corey’s strategy used an enolsilane 170 to direct C-ring formation during a 
biomimetic tricyclization (Scheme 40). 
 
Scheme 40 Corey’s synthesis of dammarenediol (169) 
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Biomimetic total synthesis of (+)-pyripyropene (171) was accomplished by A. Smith et 
al. 47 Epoxide 172 was treated with boron trifluoride diethyletherate to induce the formation of 
two C-C and one C-O bonds in a highly stereoselective manner. Base-catalyzed cyclization of 
173 was achieved with DBU. A subsequent acylation gave pyripyropene E (171) in 24% 
overall yield. 
 
Scheme 41. Total synthesis of (+)-pyripyropene (171) by A. Smith 
An asymmetric cascade cation-π cyclization in the total synthesis of antiochic acid (174) 
was recently published by Chinese authors.48 The key reaction of polyene 175 with chiral 
acetal 176 under Lewis acid conditions proceeds with good diastereo- and enantioselectivity 
(Scheme 42). The origin of enantioselectivity could be explained by formation of a chiral 
carbonium cation as shown in the Scheme. 
 
Scheme 42. Total synthesis of antiochic acid (174) 
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The Takasago corporation developed a highly practical and economically feasible 
commercial process for the production of (-)-menthol (179) based on a catalytic asymmetric 
biomimetic synthesis.49 This synthesis begins with the termal cracking of -pinene (180), 
which gives myrcene (181). Treatment of 181 with diethylamine and a catalytic amount of 
butyllithium afforded diethyl geranylamine (182). Amine 182 underwent a very efficient 
asymmetric isomerization with a rhodium binaphthyl catalyst to give enamine 183 with TON 
> 400,000, a quantitative yield and 98 % ee. Cleavage of enamine 183 was achieved with 
diluted sulfuric acid. The obtained citronellal (184) was treated with zinc bromide giving 
isopulegone (185). Hydrogenation of 185 in presence of a nickel catalyst afforded (-)-menthol 
(179).  
 
Scheme 43. Commercial asymmetric synthesis of (-)-mentol (179) 
Many types of terpenoid indole alkaloids are formed by electrophilic cyclization. For 
example, debromoflustramine B (186) consists of a hexahydropyrrolo[2,3-b]indoline ring 
system, which is present in numerous alkaloid natural products. Biogenetically, it can be 
perceived to arise via electrophilic attack on a tryptophan or tryptamine unit at the indole C-3 
position, followed by capture of the resulting C-2 iminium ion by the side-chain nitrogen. The 
authors of a short and efficient synthesis of debromoflustramine B (186) (three steps from 
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tryptamine, 57% overall), showed that the hexahydropyrrolo[2,3-b]indoline ring system (187) 
can be prepared by zinc triflate-mediated alkylation of tryptamine derivative 188.50 
 
Scheme 44. Total synthesis of debromoflustramine B (186) 
A total synthesis of indole monoterpene alkaloid (-)-hobartine (189) was published in 
1984 by Borschberg and coworkers.51 Condensation of indole-2-acetaldehyde (190) with 
chiral amine 191, prepared from -terpineol in few steps, gave imine 192. Treatment of imine 
192 with formic acid resulted in cationic cyclizations to give (-)-hobartine (189) as a single 
product in 64% yield. 
 
Scheme 45. Total synthesis of indole monoterpene alkaloid (-)-hobartine (189) 
Metal-catalyzed reactions could mimic biogenetic cationic cyclization pathways. For 
example, B. Trost’s synthesis of indole alkaloid ibogamine (193) is based on Pd-catalyzed 
reactions.52 Condensation of aldehyde 194 with tryptamine and reduction of the obtained 
imine with NaBH4 afforded amine 195. A further metal catalyzed transformation of 195 with 
3-6% of Pd(PPh3)4 gave quinuclidine 196 in 45% yield. Treatment of obtained compound with 
PdCl2(MeCN)2 and AgBF4 followed by reduction of Pd-intermediates with NaBH4 gave 
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racemic ibogamine (193) in 40-45 % yield. The asymmetric synthesis of this alkaloid is also 
reported in the same article. 
 
Scheme 46. B. Trost’s synthesis of ibogamine (193) 
The total synthesis of hapalindole U (197) and ambiguine H (198) was recently reported 
by P. Baran.53 Welwitindolinone A (199), and fischerindole (200) were also synthesized using 
similar strategy. Oxidative coupling of 4-bromoindole (201) and ketone 202 gave compound 
203. Reductive intramolecular Heck reaction in a Pd/sodium formiate system afforded 
tetracyclic compound 204, which was converted to isonitrile (-)-hapalindole 197 in one pot 
and 60 % yield.  
 
Scheme 47. Total synthesis of hapalindole U (197) and ambiguine H (198) by P. Baran 
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Ergot alkaloids represent a significant interest due to their unprecedented biological 
activity. A general strategy for the synthesis of some Ergot alkaloids could be a vinylogous 
Mannich reaction of tryptiminium salt 205 and substituted furan 206 (Scheme 48). Concise 
total synthesis of rugulovasines A and B (207) was performed in seven chemical operations 
from commercially available matherials.54 Condensation of the indol-2-acetaldehyde 208 with 
N-benzyl-N-methylamine followed by reaction of the iminium salt 205, produced in situ, with 
the furan 206 gave butenolide 209 as a mixture of diastereomers. Cyclization of 209 via an 
SRN1-reaction then provided the tetracyclic core structure, which was further deprotected to 
give a mixture (1:2) of rugulovasines. 
 
Scheme 48. S. F. Martin’s total synthesis of rugulovasines A and B (207) 
An improved approach to Ergot alkaloids is based on an intramolecular vinylogous 
Mannich reaction, which provides quick access to ruguvolasines A and B (207) and also 
setoclavine (210) (Scheme 49).55 Stille coupling of bromoindol 211 and furan 212 gave adduct 
213 which was reduced with diisobuthylaluminium hydride. Obtained iminium salt underwent 
spontaneous cyclization to afford spirocyclic butenolides 214. Reduction of 214 with DIBAL-
H provided an intermediate amino lactol which underwent facile isomerization and 
dehydration to generate a mixture of epimeric dihydropyridines 215. This mixture of isomers 
was treated with acid to furnish 64% of racemic setoclavine (210) after deprotection. 
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Scheme 49. An improved approach to Ergot alkaloids by S. F. Martin 
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Radical mediated biomimetic coupling, cyclizations and 
rearrangements 
Some biogenetic enzyme catalyzed processes transformation of molecules can be 
mimicked by radical mediated cyclizations or rearrangement reactions. For the synthesis of 
steroid structures radical-π cyclization cascade can be used, and it can provide a high level of 
diastereoselection. For example, the reaction of acyl selenide 216 and Bu3SnH-AIBN effects a 
tetracyclization to give ketone 217.56 
 
Scheme 50. An example of a radical-π cyclization cascade for synthesis of steroids 
This strategy was more recently elaborated to a short biomimetic synthesis of a steroidal 
skeleton.57 (-)-Menthone was used as a remote chiral auxiliary on a terminus of the polyalkene 
(218). Photoinduced electron transfer then initiated the polycyclization by formation of radical 
cation 219. From the ensuing cascade, eight stereogenic centers were created to form only two 
of the greater than 200 possible isomers (Scheme 51). The resulting ketal 220 is formed in 
10% yield as a 7:1 diastereomeric mixture and >99% ee, showcasing a remarkable example of 
remote asymmetric induction. 
 
Scheme 51. Enantioselective steroid synthesis by radical-π cyclization cascade 
Literature Review   37 
A general approach to the aplysin group of natural products was developed by P. Howes 
et al.58 Irradiation of a mixture of diene 221 and (t-BuS)2 at 15 °C provided the product of a 
radical addition-cyclization 222 with 61% yield and 98% diastereoselectivity. Reductive 
desulfation with Raney nickel followed by bromination gave racemic aplysin (223). Exposure 
of diene 221 to standard conditions (AIBN, Bu3SnH, heat) or just heating of compound 221 
gave debromoisolaurinterol (224) as a 5:1 or 7:1 mixture of diastereomers, respectively. This 
compound underwent very facile cyclization under acid catalysis to give debromoaplysin in 
quantitative yield. 
 
Scheme 52. Radical-π cyclization in the synthesis of aplysin (223) 
Radical cyclization reactions have been used for construction of prostaglandin-type of 
products. For example, radical-mediated cyclization of linear polyene 225 resulted in the 
formation of cis-cyclopentadienyl structure of the isoprostane series. The key step includes the 
cyclization reaction of iodo-precursor 225 under radical conditions (Bu3SnH, BEt3) under a 
stream of dry argon followed by injection of dry air and, finally, addition of Ph3P as reducing 
agent. Cleavage of silyl protecting groups of 226 gave 15-(RS)-5,6-dehydro-8-epi-PGF2a 
methyl ester (227) in good yield. 
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Scheme 53. Radical mediated synthesis of prostaglandin-type compounds 
A biomimetic reaction, the rearrangement of [3.2.1]bicycle 229 into the corresponding 
[2.2.2]bicyclooctane structure has been accomplished by M. Toyota and coworkers in the last 
step of a synthesis of (±)-methyl atis-16-en-19-oate (228) (Scheme 11).59 Preparation of 
imidazolyl thiocarbonates from a diastereomeric mixture of alcohols 229, followed by radical 
hydrogenation resulted in deoxygenation and skeletal rearrangement of radical intermediate 
230 with stereoselective formation of the more stable [2.2.2]bicyclooctane molecule 228. 
 
Scheme 54. Biomimetic total synthesis of (±)-methyl atis-16-en-19-oate (228) 
The [2.2.2]bicyclooctane moiety of platencin might be biogenetically produced by 
enzyme catalyzed rearrangement of [3.2.1]bicyclooctane terpenes. This reaction could be 
mimicked by applying radical conditions. This strategy was successfully applied in Nicolaou’s 
first synthesis of platencin (231).60 This transformation and conditions are similar to that in the 
previous synthesis of methyl atis-16-en-19-oate (228) reported by M. Toyota. 
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Scheme 55. Key step in Nicolaou’s total synthesis of platencin (231) 
Homolytic coupling is widely used for preparation of dimeric natural products. For 
example, a very efficient synthesis of dl-chimonanthine (232), was reported by A. Scott in 
1964.61 Treatment from N-methyltryptamine (233) with MeMgI followed by addition of ferric 
chloride induced formation of dimerized product 234 which was further cyclized to give dl-
chimonanthine (232). 
 
Scheme 56. Synthesis of dl-chimonanthine (232) by A. Scott 
The traditional Chinesee herbal medicine, Stellera chamaejasmae L., has yielded an 
unusual biflavanone, chamaejasmine (235, Scheme 57). Li and coworkers found that metallic 
lanthanum in refluxing THF reductively homocoupled the requisite alkyl iodide (236) in a 
highly stereoselective radical mediated process, to form chamaejasmine (235) in 10–20% 
yield, after global deprotection.62 The authors believe that π–π stacking interactions of radical 
intermediates 237 might be responsible for directing the predominate Re–Re facial selective 
dimerization of 236. 
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Scheme 57. Radical dimerization in the synthesis of chamaejasmine (235) 
In 2008 bispyrrolidinoindoline diketopiperazine alkaloids WIN 64745 and 64821 (238) 
were synthesized by Co-catalyzed radical coupling of 239 which was prepared in few steps 
from commercially available amino acids.63 Bromination of tryptophan derivative 240 resulted 
in cyclization providing bromoindoline 239, which was smoothly converted to a 
bispyrrolidinoindoline 241, using CoCl(PPh3) in acetone. This might be a general route to such 
type of indole alkaloids. 
 
Scheme 58. Radical dimerization in the synthesis of WIN 64745 and 64821 (238) 
(-)-Siccanine (242), isolated in 1962, possesses an unusual cis,syn,cis-fused alicyclic 
ring system and also interesting biologic activity. The proposed biosynthesis of this substance 
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includes epoxyolefin cyclization of siccanochromene B (243). The biomimetic synthesis of (-
)-siccanin (242) reported by B. Trost is based on a radical mediated cyclization of epoxide 244 
which proceeded with good yield and stereoselectivity (Scheme 59).64 
 
Scheme 59. B. Trost’s synthesis of (-)-siccanin (242) 
A biomimetic transannular radical cyclization for the total synthesis of epi-illudol (245) 
was successfully realized in 1997 by M. Malacria and coworkers.65 In nature this tricyclic 
compound is produced from humulene (148) (Scheme 60). Heating of bromomethyl silane 
246 with tributyltin hydride resulted in a radical cyclization cascade reaction to produce the 
core structure of illudol 247 in 47 % yield. Oxidation and deprotection of compound 247 
afforded epi-illudol (245). 
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Scheme 60. Biomimetic transannular radical cyclization in the synthesis of epi-illudol (148) 
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Biomimetic oxydative cyclization of polyenes (synthesis of polyethers)  
In 1986 authors were able to prove the hypothesis of a two step biogenetic synthesis of 
polyethers through polyepoxyde intermediates, by producing polyether 249 in good yield and 
stereoselectivity.66 Epoxydation of triene lactone 250 with m-CPBA, and basic hydrolysis of 
triepoxide 248 followed by acidic lactonization resulted in the diastereoselective formation of 
polyether 249 (Scheme 61). 
 
Scheme 61. Stereoselective synthesis of polyether 249 through polyepoxide cyclization 
Another hypothesis involving metal-mediated hydroxylation of polyenes could not be 
proven in an attempt to synthesize goniocin (251) by rhenium mediated hydroxylation of 
252.67 The obtained polyether 253 displayed wrong stereochemistry 
(trans,threo,cis,threo,cis,threo) instead of the desired (trans,threo,trans,threo,trans,threo) 
configuration (Scheme 62). 
 
Scheme 62. Rhenium mediated hydroxylation of polyene 252 
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The successful approach to goniocin (251) defined the correct stereochemistry on the 
first THF ring by treatment of diene 254 with CF3CO2ReO3 in TFA to yield tetrahydrofuranyl 
compound 255 (Scheme 63).68 Compound 255 was converted into tris-tetrahydrofuranyl 256 
by asymmetric dihydroxylation of 255 and ring closure of bismesylate 257. 
 
Scheme 63. Total synthesis of goniocin (251) 
Some tetrahydrofuran-containing natural products can be synthesized by 
bromoetherification cyclization of unsaturated linear molecules. For example trans-(+)-
deacetylkumausyne (258) was prepared by mild bromination of compound 259 with 2,4,4,6-
tetrabromo-2,5-cyclohexadienone (TBCD) as source of Br+.69 After cleavage of the THP-
group, the desired tetrahydrofuran 260 was obtained stereoselectively in good yield. 
 
Scheme 64. Synthesis of trans-(+)-deacetylkumausyne (258) by bromoetherification 
Biomimetic asymmetric total synthesis of (-)-laurefucin (261) via an organoselenium-
mediated intramolecular hydroxyetherification was recently reported by Korean authors.70 The 
treating of oxacycle 262 with N-phenylselenophthalimide (N-PSP) in the presence of pTSA 
generated an -selenonium ion, which was converted via intramolecular cyclization to 
selenoether 263. Subsequent activation of the phenylselenyl group of this compound by 
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exposure to an excess of N-PSP, followed by transannular cyclization of 264 through 
intramolecular attack by the oxocane oxygen atom produced the pivotal dioxatricyclic 
oxonium intermediate 265, which led to hydroxyether 266 by reaction with water with an 
overall double inversion. This very efficient and stereospecific transformation goes with 
quantitative yield, allowing to produce the natural product (-)-laurefucin (261) in few steps. 
 
Scheme 65. Total synthesis of (-)-laurefucin (261) 
An epoxide opening cyclization strategy was applied toward the synthesis of (±)-
heliannuol D (267) and its epimer.71 The benzoxepane moiety of the title compound, a 
common structural feature of the heliannuol family of natural products, was prepared by 
intramolecular opening of epoxide 269 with phenol under basic conditions. Cleavage of 
aromatic methoxy function afforded corresponding natural product (±)-heliannuol D (267) in 
good yield. 
 
Scheme 66. Synthesis of (±)-heliannuol D (267) 
The total synthesis of triterpene natural product abudinol B (270) was recently published 
by F. McDonald et al.72 This synthesis closely mimics the proposed biosynthetic pathway, 
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which involves cyclization of squalene-like linear precursor 271. First, tricyclization of 
diepoxide 271 was achieved with trimethylsilyl triflate with 50 % yield. In this reaction two C-
C bonds and one C-O bond were formed with high stereoselectivity to get 50 % yield of 
compound 272. A second bicyclization of diepoxide 273 with formation of one C-C and one 
C-O bonds gave 15 % of ent-abudinol B (270) along with unreacted intermediates and 
isomers.  
 
Scheme 67. Total synthesis of ent-abudinol B (270) 
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Oxidative aromatic coupling 
As far as poppy produces papaverine (274) along with morphine and codeine, it was 
proposed that isoquinolines could be biosynthetic precursors for morphine related alkaloids. 
Later it was found that morphine (275) and related alkaloids are formed in P. somniferum 
through a series of benzylisoquinoline intermediates which culminate in (R)-reticuline (276).73 
Oxydative phenol coupling could be a good alternative to biosynthesis of opium alkaloids. 
 
Scheme 68. Biogenetic precursors of morphine (275) 
In 1983 the opium alkaloid (-)-codeine (277) was synthesized in eight steps from bromo 
(±)-N-norreticuline (278). The key step was oxidative phenol coupling mediated by 
bis(trifluoroacetoxyiodobenzene), which afforded tetracyclic compound 279, which then was 
converted to codeine (277).74 
 
Scheme 69. Biomimetic total synthesis of (-)-codein (277) in 1983 
A biomimetic total synthesis of neoisostegane (280), published in 1986, is based on an 
intramolecular oxidative biaryl coupling of dibenzylbutanolide 281 with a ruthenium (IV) 
catalyst.75 Compound 281 was prepared by alkylation of benzylbutanolide 282 with benzyl 
bromide 283 in 74% yield. Oxidative intramolecular coupling, achieved with ruthenium (IV) 
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tetrakis(trifluoroacetate), proceeded very efficiently in almost quantitative yield to give 
neoisostegane (280). 
 
Scheme 70. Biomimetic total synthesis of neoisostegane (280). 
A remarkable intramolecular phenol coupling in the total synthesis of (-)-galanthamine 
(284) has been published in 2001 (Scheme 10).76 (-)-Galanthamine (284) is considered to be 
synthesized biologically by the phenolic oxidative coupling of norbelladine (289) (Scheme 
71). The aromatic rings of norbelladine-like derivative 285 were coupled by using 
phenyliodine(III) bis(trifluoroacetate) (PIFA, 286) to give the coupled product 287 in 82% 
yield, debenzylation of which provided the core structure of (-)-galanthamine 288. The 
analogous coupling with hypervalent iodine (in this case, the reagent of choice was PhI(OAc)2 
was used to prepare a library of galanthamine-like molecules through biomimetic diversity-
oriented synthesis.77 
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Scheme 71. Total synthesis of (-)-galanthamine (284) 
Intermolecular oxidative coupling of aromatic compounds was used in total synthesis of 
the core structure of popolohuanone.78 This tricyclic structure was synthesized by non-
phenolic coupling of compound 291 with Tl(III) as an oxidant. After demethylation and 
oxidation quinone compound 293 underwent base-induced biquinone rearrangement reaction 
to form the tricyclic core structure of popolohuanone E (294) in good yield.· 
 
Scheme 72. Synthesis of core structure of popolohuanone (294) 
Oxidative C-C coupling of the biaryl moiety was proposed as the last step in the 
biosynthesis of vancomycine aglycon, which was studied by Evans et al.79 A fragment of 
vancomycine macrolactam 295 was prepared from 296 using vanadium (V) reagents in good 
yield. 
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Scheme 73. Oxydative biaryl coupling in the synthesis of vancomycine 
Another example relates to the remarkable observation that the formation of the very 
characteristic tropolone ring during the biosynthesis of colchicines employs a cyclopropane 
intermediate (Scheme 74).80 Carrying a hydroxy group in the α-position this substructure can 
enter into a regioselective fragmentation and ring expansion process finally generating 
colchicines. Lead tetraacetate oxidation of the phenol ring of 297 gave rise to the semi-
protected o-quinone 298 in a regioselective manner, which cleanly underwent the cyclization 
process to form the coupling product 299. A second oxidation again provided an o-quinone 
derivative (300) which on subsequent treatment with dimethylsulfoxonium methylide ran 
through a highly regioselective and also diastereoselective nucleophilic cyclopropanation to 
generate a single tetracyclic alcohol (301) in respectable 75% yield. Mild acid treatment 
converted it directly to 7-hydroxydesacetamidocolchicine 302. 
 
Scheme 74. A biomimetic approach to colchicines 
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The total syntheses of the potent protein kinase C inhibitor calphostin was reported by 
Craig A. Merlic et al.81 Oxidative coupling of diketone 303, accomplished in O2/TFA-system 
probably proceeds by free radical mechanism. It should be noted, that in this reaction a wrong 
diastereomer 304 of calphostin structure was formed. Heating of 304, however, affected 
epimerization to give the correct stereochemistry for the core structure 305 of calphostin C 
(306). 
 
Scheme 75. Synthesis of of calphostin C (306) by oxidative aromatic coupling 
Oxidative spirocyclization of a phenol was used for the total synthesis of (±)-geodin 
(307), the spirocoumaranone subunit of Sch 202596. The key step was oxidation of phenol 
308 with DDQ, which afforded the desired product in 57% yield. 
 
Scheme 76. Synthesis of (±)-geodin (307) by oxidative phenolic spirocyclization 
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Pericyclic reactions 
Pericyclic reactions of polyenes represent a very attractive field of organic chemistry 
considering the biomimetic total synthesis of natural molecules. The most common are termal 
6-electron cyclizations. Photochemical 4 and termal 8 cyclizations are less common. In 
Figure 1 the most common patterns of biomimetic electrocyclization reactions are shown. 
 
Figure 1. Common pericyclic reactions, related to the biosynthesis and chemical synthesis of 
natural products 
 
Biomimetic [2+2] cycloaddition reactions 
[2+2] Cycloaddition is an obvious method for construction of cyclobutane rings. For 
example, an intermolecular photochemical [2+2]-cycloaddition of diene 309 and alkene 310 
was successfully used for the synthesis of biyouyanagin A (311) and analogues.82 Irradiation 
with UV-light afforded the [2+2] cycloaddition product in 54 % yield. 
 
Scheme 77. Biomimetic synthesis of biyouyanagin A (311) by [2+2] cycloaddition 
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Hsung has achieved an expedient biomimetic synthesis of the rhododaurichromanic 
acids (Scheme 78).83 Condensation of dione 312 with farnesal (313) and concomitant oxa-6 
electrocyclization gave (2H)-pyran 314. Acylation and oxidation of 314 provided 315, the 
methyl ester of daurichromenic acid. Irradiation of this material provided 
rhododaurichromanic methyl esters 316 and 317 as a 1:1 mixture, whose saponification gave 
the natural products. 
 
Scheme 78. [2+2]-Cycloaddition in the synthesis of rhododaurichromanic acids 
The ketene-olefin cycloaddition has been utilized in Corey’s synthesis of β-trans 
bergamotene (318) in 1985.84 The acid chloride 319 was synthesized from geranyl acetone in 
three steps. Slow addition of Hünig’s base to acyl chloride 319 generated ketene 320, which 
underwent [2+2]-cycloaddition to give bicyclo[3.1.1]heptane 321 isolated in 43% yield. 
Reduction of ketone 321 with hydrazine afforded the natural product β-trans bergamotene 
(318) in 69% yield (Scheme 79). 
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Scheme 79. Corey’s synthesis of β-trans bergamotene (318) 
 
Biomimetic [4+2] cycloaddition reactions 
Chapman’s synthesis of carpanone (322) is a striking example illustrating the power of 
biomimetic strategies.85 Palladium-catalyzed phenolic coupling of alcohol 323 generated the 
highly-reactive bis(orthoquinomethane) 324 which then readily participated in an 
intramolecular hetero Diels-Alder reaction to give carpanone directly from 323 in a single 
laboratory operation. Clearly, Chapman’s synthesis was guided by an appreciation for the 
latent symmetry in carpanone (322) which is readily apparent in intermediate 325 and derives 
from oxidative dimerization of alcohol 323. The fact that carpanone (322) and two minor 
stereoisomers are found as racemates in nature suggests a non-enzymatic dimerization in the 
biosynthesis of these compounds. Simple starting materials and a concise strategy 
distinguishes Chapman’s synthesis of carpanone as truly practical. 
 
Scheme 80. Chapman’s synthesis of carpanone (322) 
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A total synthesis of (±)-panepophenanthrin (326) by Diels-Alder reaction of hemiketal 
327 was published by J. Baldwin.86 Later an asymmetric synthesis of this natural product was 
published by J. Porco and coworkers.87 The key step involves ketalization of ketone 328 by 
heating it with acid to form reactive intermediate 327, which undergoes Diels-Alder 
cycloaddition. This cyclization is very efficient and proceeds with high stereoselectivity and 
provides 85% yield of the natural product 326 after deprotection. 
 
Scheme 81. Total synthesis of (±)-panepophenanthrin (326) 
A remarkable example of a biomimetic Diels-Alder dimerization was shown by J. Porco 
et al. in the total synthesis of torreyanic acid (331).88 The key intermediate 332 was 
synthesized by tartrate-mediated nucleophilic epoxidation involving hydroxyl group direction, 
which facilitated the asymmetric synthesis of a key chiral quinone monoepoxide intermediate. 
The cascade reaction sequence was initiated by oxidation of alcohol 333, to give aldehyde 
intermediate 332, which underwent a facile electrocyclization followed by a Diels-Alder 
dimerization resulting in 335. Very efficient regio- and stereoselective Diels-Alder 
dimerization reaction gave torreyanic acid in 80% yield after deprotection. 
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Scheme 82. J. Porco’s total synthesis of torreyanic acid (331). 
Firstly, bisorbicillinol (336) and bisorbibutenolide (337) were synthesized in Nicolaou 
and Corey groups.89 The synthesis is based on biomimetic [4+2]-dimerization of the requisite 
quinol 339 which functioned as both diene and dienophile after deprotection. Later highly 
efficient enantioselective total syntheses of bisorbicillinolide (338), bisorbicillinol (336), and 
bisorbibutenolide (337) were accomplished in 2005 by Li Deng et al.90 Treatment of PMB-
protected sorbicillinol 339 with trifluoroacetic acid (TFA) accomplished the removal of the 
PMB group and the [4+2] dimerization of the resulting sorbicillinol in one pot to afford (+)-
bisorbicillinol (336). This product could be converted into bisorbibutenolide (337) by anionic 
rearrangement with potassium bis-trimethylsilyl amide, or into bisorbicillinolide (338) by 
standing in methanol.  
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Scheme 83. Syntheses of bisorbicillinols (336-338) 
Plagiosporolides represent a wide class of biochemical Diels-Alder products, suggested 
to be biosynthesized from eudesmanolide sesquiterpenoids 340 and a fusicoccane diterpenic 
hydrocarbon 341 in a formal sense. This intermolecular Diels-Alder reaction was successfully 
accomplished by Japanese authors in the biomimetic synthesis of plagiosporolides A (342) and 
B.91 This cycloaddition proceeds with high stereoselectivity and good yield. 
 
Scheme 84. Biomimetic synthesis of plagiosporolides A (342) 
Quideau et al., however, focused on an in situ dearomatization reaction to arise at the 
necessary quinol, and was able to subject hydroxycuparene (343), to their biomimetic 
dearomatizing ortho-selective hydroxylation conditions utilizing the hypervalent iodine 
oxidant SIBX (stabilized o-iodoxybenzoic acid), generating quinol 344. This underwent the 
endo- and site selective [4+2] cycloaddition to form naturally occurring (+)-aquaticol (345), in 
24% yield, along with (–)-aquaticol, and an overoxidized dihydroxycuparene.92 Aquaticol is a 
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bissesquiterpene that has been isolated from a plant used in traditional Chinese medicine, 
Veronica anagallis-aquatica.93 
 
Scheme 85. Synthesis of (+)-aquaticol (345) 
Synthesis of (+)-absinthin (346), a biologically active compound from the herb 
Artemisia absinthium L., used in traditional Chinese medicine, was published by Zhai et al.94 
Diene 347, underwent biomimetic Diels-Alder dimerization with formation of 348, in a regio 
and stereospecific manner, when stored neat under a nitrogen atmosphere at room temperature. 
The two identical Diels-Alder partners approached each other from their least hindered faces, 
adopting a head-to-head orientation with regard to the lactone carbonyl groups, thus 
minimizing steric interactions. A five step stereochemical inversion of the highly sterically 
congested teriary center provided (+)-absinthin (346) in 18.6% overall yield from readily 
available materials. 
 
Scheme 86. Total synthesis of (+)-absinthin (346) 
The total synthesis of elisabethine A (349) by intramolecular Diels-Alder reaction under 
biomimetic conditions was published by J. Mulzer (Scheme 87).95 Independently V. Rawal 
and coworkers reported a similar synthesis of 349 and biomimetic synthesis of elisapterosin B 
(350) by oxidative cyclization of elisabethin analogs.96 In Mulzer’s synthesis of elisabethine A 
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(349), ether cleavage and oxidation of compound 351 gave quinone intermediate 352, which 
underwent intramolecular Diels-Alder reaction to give the tricyclic skeleton of natural product 
353. Elisapterosine B (350) was obtained biomimetically by V. Rawal et al. using oxidation of 
elisabethine A (349) with cerium-ammonium nitrate in high yield. 
 
Scheme 87. Total synthesis of elisabethine A (349) and elisapterosine B (350) 
An efficient stereoselective synthesis of the fusarium toxin equisetin (354), was reported 
by J. Dixon and S. Ley in 2000.97 The key step is a stereoselective lithium perchlorate 
mediated intramolecular Diels-Alder reaction of a fully conjugated E,E,E-triene 355 with a 
trisubstituted ,-unsaturated -ketothioester. The Diels-Alder intermediate 356 was 
synthesized from commercially avaible (R)-citronellol (357) in 9 steps and 22 % yield and the 
cyclized product 356 was converted into the natural compound in three steps. That allowed to 
prepare (-)-equisetin only in 13 steps from citronellol. 
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Scheme 88. Total synthesis of equisetin (354) 
D. Trauner recently reported the total synthesis of rubiomcolin B (358).98 The key 
reaction of this biomimetic synthesis is a tautomerization/Diels-Alder reaction of compound 
359. Ether cleavage of TBS protected phenol with TASF (tris[dimethylamino]sulfonium 
difluorotrimethyl silicate), and oxidation with PhI(OAc)2 gave quinone intermediate 360, 
which spontaneously underwent intramolecular Diels-Alder reaction in 60 % yield. The furan 
intermediate furomollugin (361) was obtained from the natural compound mollugin (362). 
Oxidation of mollugin (362) with CAN (cerium ammonium nitrate) gave para-quinone 363, 
which which was converted to furomollugin (361) with loss of acetone under basic conditions. 
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Scheme 89. Total synthesis of rubiomcolin B (358) by D. Trauner 
(+)-Himbacine (364) was synthesized by J. E. Baldwin and coworkers by biomimetic 
intramolecular Diels-Alder cycloaddition of activated iminium ion derived from 366 (Scheme 
90).99 On treatment with trifluoroacetic acid butenolide 366 underwent N-Boc deprotection 
and condensation followed by an iminium ion activated intramolecular Diels-Alder 
cycloaddition to give the (+)-himbacine precursor 365 on reductive work up. Compound 365 
was converted into (+)-himbacine in four synthetic steps. 
 
Scheme 90. Total synthesis of (+)-himbacine (364) by J. E. Baldwin 
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M. Kuehne in 1983 published the biomimetic Diels-Alder cyclization of 19-oxosecodine 
(367) into 19-oxovincadifformine (368), which proceeds with good yield in refluxing 
xylene.100 N. Langlois showed that under acidic conditions 368 reacted to another alkaloid 19-
oxoaspidofractinine (369) by intramolecular Michael reaction.101 M. Kuehne and Y.-L. Li in 
1999 achieved a formal total synthesis of alkaloid pauciflorine A (368).102 In that synthesis 19-
oxoaspidofractinine (369) was converted in three steps into tosylate 370, which underwent 
nucleophile induced fragmentation to give nitrile 371, a pauciflorine A precursor. 
 
Scheme 91. Biomimetic synthesis of pauciflorine A (368) 
Efficient total syntheses of (±)-vincadifformine (372) and (-)-tabersonine (373) were 
achieved by T. Fukuyama et al.103 Deprotection of aminoaldehyde 374 gave enamine 
intermediate 375, which underwent intramolecular Diels-Alder reaction to form (±)-
vincadifformine (372) in 67 % yield. Similarly, heating of chiral hydroxyaldehyde 376 with 
pyrrolidine afforded (-)-tabersonine (373) after dehydratation with Ph3P/CCl3 in 73% yield. 
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Scheme 92. Total syntheses of (±)-vincadifformine (372) and (-)-tabersonine (373) 
The chemistry of indole alkaloids might sometimes appear weird and unexpected. The 
fact, however, that borreverine (378) co-occurred with its corresponding “monomer” borrerine 
(379) inspired M. Koch104 and his collaborators to treat this simple alkaloid with acid, an 
operation that led to a mixture of borreverine (378) and isoborreverine in a yield of about 
80%.105 This biomimetic sequence passes through the ring opened material which as the 
iminium salt 380 offers an electron poor 2π-system which readily combines with the electron 
rich 4π-system of 381. A subsequent Mannich cyclization (Scheme 93) finally generates the 
carbon framework of borreverine 382, which picks up the methylamino group of the side-
chain in a nucleophilic attack to the 3H-indole formed in the cyclization process.  
 
Scheme 93. Biomimetic synthesis of borreverine (378) 
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In that particular case (Scheme 93) biomimetic synthesis not only chemically links up 
two completely different looking molecules, but also makes a complex natural product like 
378 look much less frightening to the synthetic chemist’s eye. A very similar situation exists 
with yuehchuken (383) which again may be viewed as a Diels–Alder dimer, in this case 
resulting from the β-prenyl derivative 384 (electron rich) and the corresponding iminium salt 
385. β-Prenylation of indole to provide diene 384 was achieved by various groups106 and 
dimerization as expected led to natural product yuehchuken (383) via Diels-Alder intermediate 
386. 
 
Scheme 94. Total synthesis of yuehchuken (383) 
A highly effective bicycloannulation methodology for the synthesis of berban and 
yohimban alkaloid systems was described by Japanese authors in 1993.107 For example, in the 
total synthesis of nitraraine (387), a three-component coupling reaction of 2,4-pentadienyltin 
reagent 388 with the C=N bond of 389 and with -unsaturated acyl chloride 390 furnished 
bicycloannulated products in a one-pot operation. The key cyclization of 391 took place in a 
highly stereoselective manner and allowed to prepare (±)-nitraraine (387) in 57% overall yield. 
 
Scheme 95. Total synthesis (±)-nitraraine (387) 
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Studies using the Corynanthe alkaloid geissoschizine (392) showed that it is a 
biosynthetic precursor of strychnine108 (393) and akuammicine (394) (Figure 2).109  
 
Figure 2. Structures of geissoschizine (392) strychnine (393) and akuammicine (394) 
S. Martin and coworkers reported an efficient biomimetic total synthesis of (±)-
akuammicine (394).110 Biomimetic geissoschizine-type precursor 395 was quickly assembled 
by exploiting a vinylogous Mannich and intramolecular hetero Diels-Alder reaction of 396 as 
key steps. The subsequent elaboration of 397 into 394 was effected by a biomimetically 
patterned transformation that involved sequential oxidation and base-induced skeletal 
reorganization. Formal synthesis of strychnine was also reported by the same authors. 
 
Scheme 96. Biomimetic total synthesis of (±)-akuammicine (394) 
Sideroxylonal B (399) is a racemic flavonoid metabolite from extracts of Eucalyptus 
sideroxylon, which shows multiple biological activities. Biogenetically, this compound 
apparently is formed from isopentenyl phloroglucinol precursors by a hetero-Diels-Alder 
coupling process. Thus, treatment of alcohol 400 with EtMgBr afforded the o-quinone methide 
401 and the isopentenyl derivative 402 in situ. Heating of this mixture for 30 min resulted in 
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hetero Diels-Alder cycloaddition to provide compound 403, which possesses wrong 
stereochemistry at C-2. Additional heating for 29 h afforded complete thermodynamic 
epimerization of the 2,3-trans isomer 403 to the 2,3-cis isomer 404 through a pyran ring-
opening and -closing process.111 
 
Scheme 97. Total synthesis of sideroxylonal B (399) 
A total synthesis of deoxypenostatin A (404), reported by B. Snider,112 is based on 
hetero Diels-Alder reaction of ketoaldehyde 405 under Yb(OTf)3 catalysis. Then, lactone 406 
was converted to unsaturated ketone 407 by intramolecular HWE (Horner-Wadsworth-
Emmons) followed by oxidation of 408 and subsequent intramolecular aldolization reaction. 
Although, the obtained molecule possessed wrong stereochemistry at the -ketone atom, it 
could be epimerized into correct deoxypenostatin A (404) with potassium carbonate in 
methanol (Scheme 98). 
Literature Review   67 
 
Scheme 98. Total synthesis of deoxypenostatin A (404) by B. Snider 
Prenylated indole alkaloids like stephacidin A (409) and notoamide B (410) have potent 
cytotoxic properties and challenging polycyclic structures. Like stephacidins A and B, the 
notoamides possess a sensitive indolopyran ring system and a tryptophane/proline-derived 
bicyclo[2.2.2]diazaoctane embedded in their core. As a result of their inherent biological 
activity and structurally diverse ring systems, this family of prenylated indole alkaloids has 
become the subject of intense synthetic endeavors, including the first total synthesis of 
stephacidin B by Myers and Herzon,113 and more recently stephacidin A (409) and stephacidin 
B by Baran and co-workers.114 In the total synthesis of stephacidin A (409), reported by R. 
Williams, the [2.2.2]-fragment of the desired molecule 414 was constructed by intramolecular 
hetero Diels-Alder cycloaddition of enamide 411, which was formed by tautomerization of 
compound 412, which is biosynthetically formed from proline and tryptamine. 115 Notoamide 
B (410) was prepared from stephacidin A by oxidation of the sensitive indole moiety followed 
by rearrangement of 413, which mimics its biogenetic pathway. 
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The galbulimima alkaloids, isolated from the bark of Galbulimima belgraVeana, have 
an interesting structure and biological activity. The biosynthetically inspired total synthesis of 
galbulimima alkaloid 13 (415) was based on a proposed polyketide biosynthetic pathway.116 
The decalene core 416 of this molecule was synthesized by Diels-Alder cycloaddition via 
heating of aldehyde 417 in toluene. Next ring was constructed by a Mukaiyama-Michael type 
vinyl radical cyclization. Subsequentally a tetracyclic structure was generated by aldol type 
condensation of enamine 419. Remarkably, formation of the C8 stereocenter during the radical 
cyclization as well as the introduction of the three other stereocenters in the conversion of silyl 
enol ether 419 to pentacyclic amine 415 occured with a high level of diastereoselectivity. 
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Scheme 99. Biomimetic total synthesis of galbulimima alkaloid 13 (415) 
A transannular Diels-Alder reaction was successfully applied by T. Takahashi in 1988 
for the synthesis of 6,(5b)-androstene-3,17-dione (420).117 Macrocyclic ketone 421 was 
prepared by intramolecular alkylation of cyanhydrin 422 and subsequent hydrolysis. Heating 
of 421 cleanly afforded 6,(5b)-androstene-3,17-dione stereoselectively (Scheme 100). 
 
Scheme 100. Synthesis of 6,(5b)-androstene-3,17-dione (420) by transannular Diels-Alder 
reaction 
A biomimetic asymmetric total synthesis of (+)-chatancin (423) has been reported by P. 
Deslongchamps and coworkers.118 This synthesis is based on transannular Diels-Alder reaction 
(TADA) of pyranophane 424, which was prepared by heating of sulfoxide 425. The TADA 
reaction is high yielding and diastereoselective. 
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Scheme 101. A biomimetic total synthesis of (+)-chatancin (423) 
Recently the total synthesis of (±)-11-O-debenzoyltashironin (426) by Danishefsky et al. 
was published.119 The key transformation in this sequence involved a remarkable cascade of 
oxidative dearomatization of 427 and transannular Diels-Alder reaction of 428, which allowed 
for the rapid assembly of the tetracyclic carbon skeleton 429 of the natural product. 
 
Scheme 102. Total synthesis of (±)-11-O-debenzoyltashironin (426) by Danishefsky 
An interesting example of a biomimetic IMDA reaction was reported in 1989 by E. 
Thomas et al. (Scheme 103).120 Cyclization of the long chain 3-(1-oxotrienyl)pyrrol-2(5H)-
one (429) afforded the 13-membered ring system of proxiphomin (430). Although the 
stereoselectivity of cycloaddition was low, the desired endo-diastereomer of 431 could be 
separated from the exo-adduct with around 25% yield. Oxidation of the selenoketone and 
deprotection of the amide function gave natural product proxiphomin (430). 
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Scheme 103. Synthesis of proxiphomin (430) by biomimetic IMDA reaction 
A transannular Diels-Alder reaction was used for the total synthesis of macquarimicins 
A (432), B (433) and C (434).121 Heating of macrocycle 435 in toluene afforded Diels-Alder 
adduct 436 with 80% yield and as one diastereomer. This compound was converted to 
macquarimicin A (432) in four steps (Scheme 104). Accordingly, a biomimetic hetero Diels-
Alder reaction of 432 with 2-methoxyprop-1-ene (437) led to macquarimicin B (433) in 83% 
yield. Treatment of 433 with acid promoted transannular alkylation to provide another 
metabolite, macquarimicin C (434) in quantitative yield. 
 
Scheme 104. Total syntheses of macquarimicins A (432), B (433) and C (434) 
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Malerich and Trauner achieved a biomimetic synthesis of pinnatal (438) and 
sterekunthal A (439).122 Knoevenagel condensation of dihydroxy naphthoquinone 440 with 
unsaturated aldehyde 441 gave (2H)-pyran 442 (Scheme 105). Deprotection, followed by 
oxidation, then afforded the suspected biosynthetic intermediate 443, which underwent 
intramolecular Diels-Alder reaction at room temperature to yield pinnatal (438). Heating of 
pinnatal in benzene solution effected retro-Diels-Alder reaction to give sterekunthal A (439). 
 
Scheme 105. Biomimetic synthesis of of pinnatal (438) and sterekunthal A (439) 
Total synthesis of (-)-spinosyn A (444) was reported in 2004 by W. Roush.123 Key 
features of the synthesis include a transannular Diels–Alder reaction of macrocyclic pentaene 
obtained from 445 and the transannular Morita–Baylis–Hillman cyclization of 446 that 
generates tetracycle 447. The authors have found that intramolecular Horner-Wadswort-
Emmons olefination of linear compound 445 led to a spontaneous transannular Diels-Alder 
cycloaddition, which proceeds stereoselectively to form the desired isomer. Treatment of 
dienone 446 with Me3P resulted in transannular Morita–Baylis–Hillman reaction in 
quantitative yield (Scheme 106). 
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Scheme 106. Total synthesis of (-)-spinosyn A (444) 
At the present moment salvinorin A (448) is the most potent hallucinogen found 
naturally occurring. The biosynthetic pathway of salvinorin A (448) was proposed to consist 
of a sequence of a transannular Michael reaction cascade of bisenone macrocycle 449, which 
could be mimicked by a transannular Diels-Alder reaction. D. Evans et al., recently reported 
an elegant asymmetric synthesis of salvinorin A (448) applying this biomimetic strategy.124 
Treatment of triketone 449 with a week base like TBAF generated a diene by enolization of 
the ketoester function, which underwent an endo-Diels-Alder reaction to provide the desired 
product 450 in quantitative yield. 
 
Scheme 107. Total synthesis of salvinorin A (448) by D. Evans 
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An organocatalytic biomimetic intramolecular Dies-Alder reaction for the synthesis of 
the decalene core of solanapyrone D (451) was recently reported by MacMillan et al.125 Using 
20 mol% of organic catalyst 452, allowed for an enantioselective intramolecular cycloaddition 
of aldehyde 453 with good yield and 90 % ee. Obtained aldehyde 454 was elongated by 
Mukaiyama-aldol reaction, and the natural product solanapyrone D (451) was prepared in a 
few further steps. 
 
Scheme 108. Organocatalytic IMDA reaction in the synthesis of solanapyrone D (451) 
A catalytic transannular asymmetric Diels-Alder (TADA) reaction was reported recently 
by E. Jacobsen.126 He found, that silicon-containing macrocyclic ketones undergo catalytic 
TADA reaction in the presence of chiral Lewis acid catalyst (460) with good endo-selectivity 
and enantiomeric excess. This method could be applied for a number of terpenoid natural 
products, containing a trans-octalene core. He has shown the usability of this catalytic TADA 
reaction for the synthesis of sesquiterpene 11,12-diacetoxydrimane (456). Ring closing 
metathesis of linear compound 457 gave macrocycle 458, which was subjected to the TADA 
reaction and after cleavage gave the desired product 459 with 83 % ee and a diastereomeric 
ratio of more than 20:1 (Scheme 109).  
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Scheme 109. Catalytic TADA reaction for the synthesis of 11,12-diacetoxydrimane (456) 
In a recent total synthesis of (-)-FR182877 (462) by Japanese authors a tandem 
biomimetic IMDA-IMHDA (intramolecular Diels-Alder - hetero Diels-Alder reaction) has 
been applied (Scheme 110).127 Deprotection of the alcohol function of linear polyene 462, and 
oxidation with MnO2 resulted in the diastereoselective formation of tetracyclic compound 464, 
which was further converted to (-)-FR182877 (462) in several steps. The first approaches to 
this molecule were reported by E. Sorensen in 2002128 and D. Evans in 2003.129 
 
Scheme 110. Total synthesis of (-)-FR182877 (462) by a tandem IMDA-IMHDA reaction 
One more interesting example for a biomimetic Diels-Alder reaction is shown with the 
total synthesis of (±)-pallavicinolide A (465), reported by Chinese authors (Scheme 111).130 
Diketone 466 was treated with IBX (2-iodoxybenzoic acid) and the in situ formed unsaturated 
diketone 467 underwent intramolecular Diels-Alder cyclization with diastereoselective 
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formation of fused tetracycle 468, which was converted to (±)-pallavicinolide A (465) via 
modification of the side chain in four steps. 
 
Scheme 111. Total synthesis of (±)-pallavicinolide A (465) 
Since the Diels-Alder reaction is one of the most commonly used key transformation in 
the total synthesis of natural products, the number of its applications is too huge to show all of 
them in this modest review. 
6­Electrocyclization reactions 
Baldwin131 and Trauner132 independently reported biomimetic syntheses of 
deoxytridachione (471). These syntheses follow the proposed biogenetic pathway, involving 
6-electrocyclization of tetraene 472. In Trauner’s synthesis tetraene 472 was prepared by Pd-
catalyzed coupling of vinyl iodide 473 and boronate 474. This intermediate spontaneously 
underwent 6-cyclization to give 31 % of deoxytridachinone (471) and 15 % of ocellapyrone 
A (475), which was formed by an 8-6 electrocyclization sequence. 
Literature Review   77 
 
Scheme 112. Synthesis deoxytridachinone (471) by D. Trauner 
Synthetic approaches toward sesquiterpene lactone xanthipungolide (476), isolated from 
the Egyptian weed Xanthium pungens, along with xanthatin (477) has been reported.133 
Xanthipungolide (476) was proposed to arise from xanthatin (477) via Z,E-isomerization (478) 
followed by oxa-6 electrocyclization to afford (2H)-pyran 479, which then undergoes 
intramolecular Diels-Alder reaction (Scheme 113). Indeed, irradiation of 477 afforded 476 in 
25% yield. Presumably, the oxa-6 electrocyclization step is not highly diastereoselective, yet 
it is reversible. As the two possible diastereomers rapidly interconvert, only one of the 
diastereomers of 479 can effectively undergo the intramolecular cycloaddition. 
 
Scheme 113. Biomimetic synthesis of xanthipungolide (476) 
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Biomimetic total synthesis of smenochromene D (480) was recently reported by D. 
Trauner (Scheme 114).134 Heating of aldehyde 481 with phenylboronic acid affected 
macrocyclization (intramolecular Fridel-Crafts alkylation) to afford the natural product. This 
reaction presumably proceeds through the intermediacy of cyclic borate 483 and vinyl ortho-
quinone methide 484, whose oxa-6 electrocyclization installs the chromene system of 480. 
 
Scheme 114. Biomimetic synthesis of smenochromene D (480) by D. Trauner 
 
Biomimetic Cope rearrangement 
The total synthesis of 1-O-methyllateriflorone (486) was described by K. C. Nicolaou 
(Scheme 115).135 The construction of the cage-like domain of the molecule involved a 
biomimetic Claisen/Diels-Alder cascade of compound 487 to form Diels-Alder adduct 489 in 
47 % yield. The spiroxalactone framework of lateriflorone (491) was generated by an 
intramolecular Michael reaction within precursor 490 involving the carboxylate residue as the 
nucleophile. This finding might bear on the biosynthetic pathway by which nature forms 
lateriflorone.  
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Scheme 115. Total synthesis of 1-O-methyllateriflorone (486) Nicolaou. 
Synthesis of forbesione (491) and desoxymorellin (492) published by E. Theodorakis et 
al. is based on tandem Claisen/Diels-Alder/Claisen rearrangement (Scheme 116).136 Heating 
of acid 493 and resorcinol 494 with ZnCl2 and POCl3 gave xanthone 495 in 46% yield. 
Alkylation with propionyl cloride 496 and hydrogenation gave compound 497, which 
underwent a Claisen/Diels-Alder cascade to form regioselectively compound 498 which is 
converted to forbesione after solvolysis. Next, alkyne Claisen rearrangement afforded 
desoxymorellin (492) from 499 in 91 % yield. Nicolaou et al. has also published the total 
synthesis of methyl forbesione using a similar biomimetic strategy.137 
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Scheme 116. Synthesis of forbesione (491) and desoxymorellin (492) by E. Theodorakis 
Claisen rearrangement was also used in the synthesis of (±)-heliannuol C (500) and E 
(501).138 Treatment of diene 502 with mild Lewis acid provided diene 503 by regioselective 
Claisen rearrangement in good yield. Epoxidation with mCPBA gave epoxide 504, which 
could be converted to the benzoxepane ring of heliannuol C by acid-mediated cyclization, or 
to heliannuol E by base-mediated cyclization followed by deoxygenation. 
 
Scheme 117. Claisen rearrangement in the synthesis of (±)-heliannuol C (500) and E (501) 
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A concise biomimetic approach toward transtaganolides C and D (506) involving an 
Ireland-Claisen rearrangement/intramolecular Diels-Alder reaction sequence suggesting the 
involvement of pericyclic reactions in the biosynthesis of these biologically active plant 
metabolites was recently reported (Scheme 120).139 Heating of 2-pyranon allylic ester 507 in a 
microwave reactor with N,O-bistrimethylsilylacetamide (BTMSA) and triethylamine resulted 
in Ireland-Claisen reaction to give acid 508 in good yield as a 2:1 mixture of diastereomers. 
Mild heating of this product under basic conditions, to prevent decarboxylation, gave the 
tricyclic product of an intramolecular Diels-Alder reaction, polycycle 509, which could lead to 
natural products transtaganolides C and D. The authors of this synthesis highlight the 
possibility of the existence of a rare Ireland-Claisen-type rearrangement in the biosynthesis of 
these compounds. 
 
Scheme 118. A biomimetic approach toward transtaganolides C and D 
 
8­Electrocyclization reactions 
In 1980, Black proposed that the endiandric acids could arise biosynthetically from 
linear polyenes.140 In 1982, K. C. Nicolaou gave chemical support to Black’s hypothesis by 
chemically synthesizing endiandric acids A-G.141 An example of the biomimetic approach to 
endiandric acids A-G is shown below (Scheme 119, 120). 
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Scheme 119. Synthesis of endiandric acids A and B 
Hydrogenation of diendiyne 511 to tetraene 512 triggered a pair of spontaneous 8 
conrotatoryand 6 disrotatory electrocyclizations to give bicyclic compound 513 which 
corresponds to the core structure of endiandric acids D, E, F and G. After some 
functionalization, tetraene 514 was heated to undergo intramolecular Diels-Alder 
cycloaddition to provide after cleavage of the silyl protecting group and oxidation of the 
resulting alcohol tetracyclic endiandric acid A (516). Endiandric acid C (518) was prepared 
from aldehyde 519. HWE reaction of this aldehyde gave methyl ester 520, which was heated 
to undergo intramolecular Diels-Alder cycloaddition to get fused tetracyclic compound 521, 
which was later converted to endiandric acid C (518) in 6 steps. 
 
Scheme 120. Synthesis of endiandric acid C (518) 
Baldwin and co-workers have also synthesized the SNF4435 core (522).142 They chose 
to use a late stage introduction of the C4-C5 and C6-C7 Z-olefins using Pd(II) chemistry, 
which is known to promote olefin isomerization. It is notable that without the introduction of 
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palladium to the reaction conditions, the all E-olefin isomer 523 does not undergo the requisite 
electrocyclizations to form bicyclo[4.2.0]octadiene 524. It is also notable that the 
isomerization was specific for the C4-C5 and C6-C7 double bonds evident by the 
stereochemistry of the product 522. 
 
Scheme 121. Synthesis of SNF4435 core (522) by Baldwin 
 
Unusual electrocyclization reactions. 
Baldwin and Trauner have also, independently, used acyclic polyunsaturated compounds 
similar to 523 for their syntheses of the bicyclo[3.1.0]hexene core of the crispatene family of 
compounds. Trauner has shown that upon exposure to Lewis acids triene 525 undergoes an 
unusual stereospecific electrocyclization to provide bicyclo[3.1.0]hexene compound 526.143 
Mechanism of this reaction could be identified as [4s + 2a] Diels-Alder reaction, which is 
also shown in Scheme 123. In the absence of a Lewis acid, a 6-disrotatory electrocyclization 
occurs to give compound 527.  
 
Scheme 122. Novel electrobicyclization reaction of triene 525 
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Baldwin and co-workers used photochemical activation of a polyene for the synthesis of 
the core structure of crispatene type of compounds.144 Irradiation of compound 528 resulted in 
the formation of the bicyclo[3.1.0]hexene arrangement 529. Mechanistically, this is expected 
to occur via E-Z double bond isomerization of the C6-C7 and C8-C9 bonds of (E,E,E,E) 
tetraene 528 to (Z,Z,E,E) tetraene 530, which undergoes an intramolecular photochemical [4s 
+2a] Diels-Alder reaction to form bicyclo[3.1.0]hexane 529 (Scheme 123). 
 
Scheme 123. Photochemical activation of polyene 528 for synthesis of core of the crispatene 
type of compounds 529 
Biomimetic [5+2] cycloaddition could be a possible biosynthetic key step of descurainin 
(531) and cartorimine (532), which was shown by B. Snider by the total synthesis of these 
products.145 Reaction of bisacetoxy pyranone 533 with Et3N gave 3-oxidopyrylium ylide 534, 
which underwent a stereo- and regiospecific [5+2] cycloaddition with styrene 535 in 31% 
yield to afford descurainin after hydrolysis (Scheme 132). 
 
Scheme 124. Biomimetic [5+2] cycloaddition in the synthesis of descurainin (531) 
A biomimetic two-step synthesis of the core structure of (±)-polygalolides A, B using 
the same [5+2] cycloaddition was also reported by B. Snider et al. (Scheme 125).146 Treatment 
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of bisacetoxy pyranone 533 with Et3N and -methylenebutyrolactone (537) afforded 
spirobicyclic product 538. Treatment of 538 with cesium carbonate resulted in acetate 
hydrolysis, the translactonization and the conjugate addition of the hydroxyethyl group to the 
enone. Lactonization on acidification afforded the core structure of polygalolides A and B 
(539). 
 
Scheme 125. Biomimetic synthesis of the core structure of (±)-polygalolides A, B 
An asymmetric synthesis of (+)-intricarene (540), found in gorgonian corals, was 
described by G. Pattenden in 2006147 and D. Trauner in 2007.148 Treatment of (-)-bipinnatin J 
(541) with VO(acac)2-tBuOOH in Pattenden’s synthesis or with m-CPBA in Trauner’s 
synthesis, followed by acetylation, gave an acetoxypyranone, which underwent a transannular 
oxidopyrylium-alkene [5+2] cycloaddition of 542 by heating in the presence of 2,2,6,6-
tetramethylpiperidine (TMP), producing the polycyclic diterpene (+)-intricarene (540). The 
total synthesis of intricarene 540 mimics most likely its biosynthesis via oxidation of 
bipinnatin J (541) in vivo. 
 
Scheme 126. Biomimetic synthesis of the (+)-intricarene (540) 
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Conclusion and the goal of research 
As the review shows, biomimetic strategies including domino sequences enable a rapid 
and efficient entry to polycyclic structures commonly found in natural products. Even though 
it is not in all cases clear whether all the reactions in fact do occur in nature and whether 
enzyme catalysis is involved. The goal of this thesis included the application of biomimetic 
transformations to the synthesis of various structures that are related to natural products. Thus, 
one project aimed at the synthesis of spirocyclic alkaloid structures via a rearrangement and 
reductive amination. Such polyfunctionalized structures should be of interest as scaffolds. 
Another project dealt with the synthesis of symbioimine and neosymbioimine, which contain a 
decalin core via an intramolecular Diels-Alder strategy. Finally, novel routes towards the 
polycyclic antibiotics platensimycin and platencin were investigated. 
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Results and Discussion 
1. Synthesis of spirocyclic scaffolds 
The goal of this project was a synthesis of para- and meta-substitued spirocyclic 
cyclohexanones 1-1 and 1-2. To elaborate a convenient method for the synthesis of such 
compounds we took 1,3-cyclohexandione (1-3) and 1,4-cyclohexanedione (1-4) as starting 
materials (eq. 1). 
 
First of all we had to protect one carbonyl function, and functionalize the other one. 
Starting 1,3-cyclohexandione (1-3) could be protected by refluxing it with one equiv. of 
ethylene glycol and catalytic amounts of p-toluenesulphonic acid in toluene with a Dean-
Stark apparatus for 2 h followed by work up and fractional distillation of the mono 
protected 1,3-cyclohexandione 1-5 (Scheme 1).149 Horner Wadsworth Emmons reaction of 
1-5 with triethyl phosphonoacetate gave ester 1-6 (1:1 mixture of diastereomers), which 
was reduced with DIBAL-H to give allylic alcohol 1-7 in good yield. 
 
Scheme 1. Synthesis of allylic alcohol 1-7 
Attempts to create a quaternary spiro center by Michael addition to unsaturated ester 
1-6 were unsuccessful. Thus, we decided to make it by Claisen rearrangement. However, 
the Ireland-Claisen rearrangement150 of the corresponding acetate of 1-7 was unsuccessful. 
Then we found that heating of allylic alcohol 1-7 with triethyl orthoacetate in toluene with 
a catalytic amount of propionic acid (Johnson-Claisen rearrangement)151 for 24 hours gave 
51 % of the desired product of the rearrangement 1-8 (Scheme 2). This reaction is 
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reversible and starting material 1-7 could be recycled and introduced into the same reaction 
to give additional 16 % of ester 1-8. The the yield of the product 1-7 could be increased to 
75 %. The obtained ester 1-8 was reduced with DIBAL-H, and allylic alcohol 1-9 was 
hydroborated and oxidized under standard conditions to provide mixture of diols 1-10 and 
1-11. These diols could be separated by flash chromatography to obtain pure 1-10 in 62 % 
yield as colorless crystals. Mesylation of both alcohol functions of 1-10 gave bis-mesylate 
1-12 in high yield. 
 
Scheme 2 Johnson-Claisen rearrangement of 7 and conversion to bis-mesilate 1-12 
Mesylate 1-12 could be cyclized to amine 1-13 by refluxing with excess of benzyl 
amine in acetonitrile for 3 days (Scheme 3). Deprotection of compound 1-13 under acidic 
conditions gave ketone 1-14, which was converted to alcohol 1-15 by the reaction with m-
methoxyphenylmagnesium bromide in good yield. The benzyl group was cleaved by Pd/C-
catalyzed hydrogenation and the obtained secondary amine 1-16 was converted to 
carbamate 1-17 by the reaction with phenyl isocyanate. Thus, fully functionalized 
spirocyclic scaffold 1-17 was prepared in 12 steps from inexpensive starting material 1,3-
cyclohexanedione. 
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Scheme 3. Synthesis of spirocyclic carbamide 1-17 
The corresponding para-substituted spirocyclic compounds were prepared by 
analogous way with minor change in the conditions (Scheme 4). 1,4-Cyclohexanedione (1-
4) was selectively converted to ketoester 1-18 by the Horner-Wadsworth-Emmons reaction 
with triethylphosponoacetate with high yield. Obtained ketoester 1-18 was reduced to 
allylic alcohol 1-19, which was converted to ester 1-20 by Johnson-Claisen rearrangement 
by heating of alcohol 1-19 with triethylorthoacetate as in the previous synthesis. Reduction 
of ester 1-21 with LiAlH4 followed by hydroboration of the double bond gave diol 1-22, 
which was cyclized with catalytic amounts (5 mol%) of bis-pentamethyl cyclopentadienyl 
iridium trichloride [Cp'·IrCl2]2152 with good yield. This efficient cyclization goes through 
the oxidation of alcohol to the aldehyde, formation of imine and reduction of the imine to 
the amine function with the iridium catalyst.153 The obtained benzylamine was converted to 
aminoalcohol 1-23 by cleavage of ketal, addition of arylmagneium bromide to ketone and 
hydrogenative deprotection of benzylamine. 
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Scheme 4. Synthesis of p-substituted spiro-scaffolds 
In conclusion, we have elaborated an efficient new synthesis of meta- and para-spiro 
scaffolds 1-17 and 1-23. The Johnson-Claisen rearrangement was a key reaction for 
construction of the quaternary center in the described syntheses of the spirocyclic 
compounds. 
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2. A novel reaction for the synthesis of 7­aryltetralones 
The palladium-catalyzed arylation of ketones and ester derivatives has greatly 
expanded the repertoire of useful methods in organic chemistry.154 Key parameters for this 
transformation include the use of sterically hindered and electron-rich phosphine ligands 
and a suitable solvent. Important recent discoveries in this regard were made by the 
Buchwald155 and Hartwig groups.156 The arylation can be run with the carbonyl compound 
directly in the presence of a base. Alternatively, preformed enolates such as trialkylsilyl 
enol ethers can be arylated in the presence of ZnF2 or Zn(OtBu)2 as addititives.156 Thus, the 
potential applications seem countless. 
 
Figure 1. Issues of regio- and stereochemistry in the potential palladium-catalyzed 
arylation of 3,4,4a,5,6,7-hexahydro-1(2H)-naphthalenone derivatives A 
In the context of the synthesis of functionalized decalin derivatives for the synthesis 
of the symbioimine molecule,167 we became interested in the arylation of enone systems of 
type A (Figure 1).1 Besides possible regioisomers, for each pathway stereoisomers 
(cis/trans) might form. The parent substrate, enone 2-4, was prepared essentially according 
to the literature by the copper-catalyzed 1,4-addition of 2-(3-bromopropyl)-1,3-
dioxolane157 (2-2) followed by acid-induced deprotection-cyclization of the ketoacetal 2-3 
(Scheme 1).158 
 
Scheme 1. Synthesis of enone 2-4 
                                                 
1 In each chapter, the numbering of Figures and Schemes start with 1. 
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Initially, we examined the regioselective formation of the two possible 
triisopropylsilyl dienol ethers. Although the selective formation of the unwanted isomer 2-
6 is possible under various conditions, the best ratio in favor of the dienol derivative 2-5 
was 68:32. The enone 2-4 was also subjected to modified Kharasch conditions [(a) 
MeMgBr, FeCl3; (b) TMSCl, Et3N, HMPA, 23 °C, 2 h] resulting in the exclusive 
formation of the trimethylsilyl dienol ether corresponding to 2-6. These conditions are 
known to produce the thermodynamic dienol ether from a cyclic enone.159 However, the 
trimethylsilyl derivative was not obtained very pure and proved to be somewhat unstable. 
Although the mixture of the two dienol ethers 2-5 and 2-6 could not be separated by 
chromatography, their structures could be assigned by comparison of the chemical shifts of 
the vinylic protons with corresponding signals of similar compounds.160 Thus, the vinylic 
protons of 2-6 appear at  = 4.92 and 5.96 ppm, whereas the two vinylic protons of 2-5 
resonate at d = 5.53 and 6.50 ppm. The latter is a doublet (J = 9.8 Hz), which clearly 
supports the assignment. 
Table 1 Regioselectivity in the formation of the silyl dienol ethers 5 and 6 
 
entry conditions Ratio 2-5: 2-6a
Yield of 2-5 + 2-6 
(%) 
1 2,6-lutidine, CH2Cl2, -20 °C, 1 h 0:100 95 
2 2,6-diisopropyl-N,N-dimethylaniline, CH2Cl2, -20 °C, 24 h 
0:100 96 
3 Cy2NEt, CH2Cl2, -78 °C, 2 h 30:70 89 
4 KN(SiMe3)2, THF/DMF (1:1), -78 °C, 24 h 50:50 82 
5 i-Pr2EtN, CH2Cl2, -20 °C, 24 h 58:42 95 
6 i-Pr2EtN, CH2Cl2, -78 °C, 24 h 68:32 98 
a The ratio 2-5/2-6 was determined by 1H NMR spectroscopy. 
We then asked ourselves whether the regiochemistry of the dienol ethers would be 
transformed to the corresponding arylated derivatives in a Buchwald-Hartwig arylation. 
Thus, dienol 2-6 ether was subjected to a palladium-catalyzed arylation reaction with 
bromobenzene in the presence of Pd(OAc)2, Ph3P, and Cs2CO3 as additive (Scheme 2). 
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Suprisingly, the only product that we could isolate was the 7-phenyltetralone 2-7a. There 
were no Heck-type products161 and no -arylated products detectable in the reaction 
mixture. If the reaction was run on a mixture of 2-5 and 2-6 (2-5:2-6 = 68:32), the same 
compound 2-7a was isolated as the only product. 
 
Scheme 2 Arylation of silyl dienol ether 6 and a mixture of 5 and 6 
Since it was described earlier that ,-unsaturated ketones could be directly arylated 
in the -position with bromoarenes and Pd(OAc)2/PPh3 in DMF/Cs2CO3 at 60-120 °C,162 
we applied these conditions directly to enone 2-4. Treatment of enone 2-4 with 
bromobenzene under these conditions afforded as well the unexpected biaryl derivative 2-
2-7a in 32-45% yield (eq 1). The normal -arylation product could not be detected by LC-
MS after reaction workup. 
 
Next, we tried to optimize this reaction by varying additives, solvent, and phosphine 
ligands. As described in the literature, certain tetraalkylammonium salts can positively 
affect palladium-catalyzed Heck-type reactions.163 It was found that addition of 1 equiv.of 
tetrabutylammonium bromide (TBAB) to the reaction mixture dramatically increased the 
yield of the reaction, resulting in 71% yield of 7-phenyltetralone 2-7a (Table 2, entry 3). In 
addition, heating of the mixture was not necessary. These optimization studies were 
followed by LC-MS using 10 mol % of biphenyl as an internal standard. Regarding the 
solvent, DMF gave the best yield (entry 3), followed by NMP (70%, entry 6). Among 
various ligands that were tried, triphenylphosphine was found to be the best one (entry 3). 
In the absence of a phosphine ligand the reaction does not take place at all. 
Electrondonating and hindered phosphines (t-Bu3P, entry 8, furyl3P, entry 10) seemingly 
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decrease the rate of the aromatization step. With these ligands, mixtures of bi- and 
triarylated products were detected by LC-MS.  
Again, the reaction is highly -selective, and no -arylated products were detected. 
Actually, the putative product of the normal -arylation was detected by LC-MS {[M]+(2-
7a) +4} at the beginning of the reaction. Furthermore, in some cases intermediates with 
{[M]+(2-7a) + 2} were detected. The rate of the dehydrogenation-aromatization is very 
high, and only the aromatic product was detected at the end of the reaction. With 1 equiv.of 
bromobenzene, the reaction does give 2-7a as well, but conversion and yield were lower. 
Table 2. Effect of trialkylammonium salts, solvents, and phosphine ligands on the reaction 
of enone 2-4 with bromobenzene 
entry Key variables Yield of 2-7a (%) 
entry Key variables Yield of 2-7a (%) 
1a no PTC, 120 °C 45 6b NMP 70 
2a Bu4NBr, 60 °C 20 7b dimethylacetamide 67 
3a Bu4NBr, 23 °C 71 8c tBu3P trace 
4a Bu4NOAc, 23 °C 7 9c (o-tolyl)3P 27 
5a Bu4NClO4, 23 °C 
48 10c furyl3P 
0 
a Reaction conditions: DMF, Pd(OAc)2 (5 mol %), PPh3 (10 mol %), PhBr (5 equiv), 
Cs2CO3 (2.5 equiv), additive (1 equiv). b Reaction conditions: solvent, Pd(OAc)2 (5 mol 
%), PPh3 (10 mol %), PhBr (5 equiv), Cs2CO3 (2.5 equiv), TBAB (1 equiv), 3 d, 23 °C. c 
Reaction conditions: DMF, Pd(OAc)2 (5 mol %), phosphine (10 mol %), PhBr (5 equiv), 
Cs2CO3 (2.5 equiv), TBAB (1 equiv), 3 d, 23 °C. 
We assume that the reaction proceeds via -arylation of the dienolate anion, followed 
by a fast dehydrogenation/aromatization of the intermediate in a tandem process. Most 
likely the aromatization is initiated by insertion of a PdL2 species into an activated C-H 
bond, followed by the elimination of PdL2H2. In essence, a reversal of classical 
hydrogenation steps must take place. Addition of some electron donors or hydrogen donors 
(HCO2H, cyclohexadiene, CuBr) that could be sacrificed did not allow us to isolate 
nonaromatized intermediates. Addition of other reagents (styrene, methyl acrylate, 
benzoquinone) that might speed the aromatization step only decreased the yield of 2-7a. In 
the absence of bromobenzene or in the presence of chlorobenzene only products of self-
condensation of enone 2-4 were detected. 
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Using the optimized conditions we coupled a number of haloarenes with the enone 2-
4. As it turned out, the reaction has broad scope, at least for enone 2-4, and both aryl 
bromides and iodides could be coupled in moderate to good yields (Table 3). The 7-
aryltetralones show a characteristic peak in the 1H NMR spectrum in the range between  = 
8.16- 8.33 ppm, which can be attributed to the isolated proton at C-8.  
7-Aryltetralones have been used, for example, in the synthesis of CCR5 antagonists 
as anti-HIV-1 agents.164 These aryltetralones were prepared in a multistep sequence 
consisting of an intramolecular Friedel-Crafts cyclization of the corresponding 
phenylbutyric acids followed by palladium-catalyzed Suzuki coupling with arylboronic 
acids. As a whole only a few examples of 7-aryltetralones 2-7 are described in the 
literature.165 
Table 3. Synthesis of 7-aryltetralones 2-7a-g 
 
entry Ar-X product Isolated yield [%] 
1 
 
2-7a 71 
2 
 
2-7a 68 
3 2-7ba 51 
4 2-7b 54 
5 2-7c 62 
6 2-7c 55 
7 2-7d 59 
8 2-7e 47 
9 2-7f 48 
10 2-7g 50 
a Reaction conditions: DMF, Pd(OAc)2 (5 mol %), PPh3 (10 mol %), PhBr (5 equiv), 
Cs2CO3 (2.5 equiv), TBAB (1 equiv), 23 °C. 
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In a control experiment we applied the optimized conditions to the coupling of 1-
cyclohexene-1-carbaldehyde 2-8 and 1-bromo-4-tert-butylbenzene 2-9 (eq 2). Somewhat 
surprisingly, we isolated not the expected biphenyl-3-carbaldehyde but rather the normal -
arylation product 2-10 (41% yield). Characteristic for this compound is a signal at  = 6.79 
ppm for the terminal enal H. The -H resonates at  = 3.62 ppm. Related compounds are 
prepared by multistep sequences.166 
 
In summary, we developed a new convenient synthesis of 7-aryltetralones by a novel 
room-temperature palladium-catalyzed arylation dehydroaromatization sequence. This 
strategy of applying the arylation/aromatization to a cyclic precursor containing one double 
bond and an electronwithdrawing group might be a valuable option for accessing certain 
biaryl compounds.  
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3. Total synthesis of (±)­symbioimine and analogs 
Symbioimine (3-1) is a novel tricyclic iminium alkaloid which recently was isolated 
from the symbiotic marine dinoflagellate Symbiodinium sp.167 This rather unusual 
compound occurs in nature as an inner salt of an imine and an aryl sulphuric acid (Figure 
1). Such zitterionic compounds are very rare,168 and the total synthesis of 3-1 certainly 
poses a challenging task. A related compound is the amphoteric neosymbioimine (3-2).169 
Besides the unique structural features, the biological activity of symbioimine (3-1) is 
noteworthy as well. Thus, it inhibits the differentiation of progenitor cells (RAW264) into 
mature osteoclasts with an EC50 = 44 g mL-1. Therefore, 3-1 has potential as a drug for 
the treatment of osteoporosis. In addition, symbioimine significantly reduces 
cyclooxygenase-2 (COX-2) activity at 10 M.169 
 
Figure 1. Alkaloids symbioimine (3-1) and neosymbioimine (3-2) 
The biosynthesis of 3-1 might involve intramolecular Diels-Alder (IMDA) reactions, 
either of a trienone via an exo transition state of type A followed by cyclization to an imine 
(Scheme 1). Alternatively, an endo-IMDA of a dihydropyridinium cation (cf. transition 
state C) followed by epimerization of the cycloadduct via an enamine might be 
operative.169 There is support for the latter mode from a model study of Snider et al.170 who 
prepared deoxysymbioimine via an IMDA of a 2,3-dihydropyridinium cation C (Z = Troc, 
Ar = Ph).  
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Scheme 1. Possible biosynthetic key steps for symbioimine (3-1) 
In preliminary studies we found that trienone 3-A (Scheme 2) did not undergo any 
Diels-Alder reaction, even after heating the substrate in a sealed tube (xylene, 180 °C) for 
24 h. We considered that the orbital overlap is not ideal since large and small coefficients 
at the termini do not really match. This compound 3-A was obtained by HWE reaction of 
ketophosphonate 4-41 and chiral aldehyde 3-42, which was obtained according to the 
literature procedure.171 Phosphonate 4-41 was obtained from ester 3-40, and diene mojety 
was constructed by oxygen-promoted Heck-type reaction of boronate 3-39 and 3,5-
dimethoxystyrene (3-6).173 
 
Scheme 2. An attempt of using exo-IMDA reaction of trienone 3-A for synthesis of 3-1 
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We reasoned that positioning an electron withdrawing group on the other side of the 
double bond should allow for a more facile IMDA (Scheme 3). Some literature precedence 
indicates that this approach should be feasible.172 However, a solution for extension of the 
aldehyde function in the cycloadduct E combined with a diastereoselective introduction of 
the methyl group would have to be found. 
 
Scheme 3. Retrosynthetic plan for the synthesis of symbioimine (3-1) 
As an initial milestone we targeted an efficient and large scale synthesis of (E,E,E)-
undeca-2,8,10-trienals 3-12 (structure F). A key step of this synthesis is the preparation of 
the 1-aryl-1,3-(E,E)-diene moiety which might be accessible via a palladium-catalyzed 
Stille or Suzuki coupling. For both methods E-vinyl halide building blocks are required. 
However, all attempts to prepare suitable Stille or Suzuki precursors were more or less 
unsuccessful. Therefore, we turned to the palladium-catalyzed oxygen-promoted Heck-
type coupling of alkenes with vinyl boronates.173 Accordingly, the vinyl boronate174 3-4 
and the styrene175 3-6 were prepared by standard procedures (Scheme 4).  
 
Scheme 4. Synthesis of starting matherials 3-4 and 3-6 
The Heck coupling of boronate 3-4 and styrene 3-6 under reported reaction 
conditions (5 mol% Pd(OAc)2, DMA, 23 °C, slow addition of boronate 3-4), led only to 
30% of the coupling product (Scheme 5). We significantly improved the yield for this 
reaction by using 2 equiv. of styrene 3-6 and 10 mol% of Pd(OAc)2 in DMF at 60 °C. The 
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unreacted styrene was easily recovered by flash chromatography after acidic cleavage of 
the TBS-group to provide the dienol 3-7 in 68% yield, based on the recovered styrene, and 
59% based on 3-4. This reaction is highly regio- and stereoselective, and only E,E-diene 
was found to be produced in more than 99% diastereomeric purity.  
 
Scheme 5. Optimization of the Heck reaction of 3-4 and 3-6 
Continuing with the synthesis, alcohol 3-7 was converted to the iodide 3-8 in two 
steps by mesylation (98%) and SN2-substitution using NaI in acetone (93%) (Scheme 6). 
Transmetalation of iodide 3-8 with t-BuLi at -80 °C followed by trapping of the 
organolithium intermediate with the known (2E)-4,4-dimethoxybut-2-enal176 3-9, 
successfully afforded aldehydes 3-12 after protection of the hydroxyl group with a silicon 
protecting group followed by hydrolysis of the acetal 3-11. Thus, syntheses of all-E-
undeca-2,8,10-trienals 3-12 bearing TBDPS, TIPS and TBS protective groups were 
possible. The synthesis of 3-12c was performed on a gram scale. 
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Scheme 6. Synthesis of the Diels-Alder substrates 3-12 
With substrates 3-12 in hand the Lewis acid catalyzed IMDA was investigated 
(Scheme 7).177 Using MeAlCl2 (1 equiv.) as Lewis acid in CH2Cl2 at –80 °C, a fast 
reaction of 3-12a was observed. However, the reaction did not stop at the stage of the 
Diels-Alder product. Rather, a subsequent intramolecular Friedel-Crafts reaction of the 
aldehyde function with the electron rich aryl ring took place, leading to the tetracyclic 
compound 3-13 (50% yield). The reaction of 3-12a with 1 equiv. of the weaker Lewis acid 
Me2AlCl at -80 °C led to around 60% conversion of 3-12a within 24 h to give 50% of 
isolated 3-14a as a single diastereomer and no Friedel-Crafts adducts were observed.  
 
Scheme 7. Lewis acid induced IMDA of trienals 3-12a-c 
The configuration of 3-14a could be secured by x-ray analysis (Scheme 8). It is 
interesting to note, that both bulky substituents (Ar and OSiR3) are axially oriented relative 
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to the decalin ring. The silicon protecting groups do not affect significantly the outcome of 
the IMDA reaction. Also, the TIPS- and TBS-protected aldehydes 3-12b and 3-12c gave 
around 50% of the corresponding cycloadducts under these conditions. A higher yield 
could be realized by using 1.6 equiv. of Me2AlCl yielding, for example, 3-14c in 85% yield 
on a gram scale. The cycloadducts already contain four of the five required stereocenters 
with the correct relative configuration. 
 
Scheme 8. IMDA reaction of 3-12c and X-Ray structure of 3-14c 
For conversion of the aldehyde function to the aminopropyl appendage, several 
options were considered. In a first attempt 3-14c was subjected to a Henry condensation178 
with nitromethane followed by a Michael addition of the resulting nitroalkene with 
MeMgBr at -80 °C. These transformations proceeded smoothly in good yields and were 
highly stereoselective producing the nitro compound 3-15 (Scheme 9). Attempts to cleave 
the silyl ether of 3-15 with TBAF surprisingly gave the corresponding lactol which was 
oxidized to lactone 3-16 with PDC in 65% isolated yield.  
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Scheme 9. Epimerization at -pozition of nitroalkene 3-16a, synthesis of lactone 3-16 
The x-ray structure of lactone 3-16 (Figure 2) showed that two stereocenters were 
not correct. Most likely, the condition of the Henry reaction caused a base-catalyzed 
epimerization at the -atom of the nitroalkene 3-16a to give the thermodynamically favored 
trans-1,2-substituted cyclohexane compound 3-16c. 
 
Figure 2. X-ray structure of lactone 3-16 
The stereochemistry of lactone 3-16 was also evident from NOESY data. In order to 
probe the formation of the tetrahydropyridine ring, the nitro group of 3-15 was reduced 
with LiAlH4, the amino group protected with Boc anhydride, and the TBS-group cleaved 
with TBAF to give alcohol 3-17 (Scheme 10). Oxidation of 3-17 followed by acid-induced 
Boc cleavage gave indeed the imine 3-18 which might be called epi-dimethyl-
symbioimine. 
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Scheme 10. Synthesis of epi-dimethyl-symbioimine 3-18 
The next plan called for a C1 extension with methoxymethylphosphorane followed 
by alkylation of the enamine of the homologated aldehyde. As expected, the mixture of 
cis/trans enol ethers 3-19 was obtained in good yield (Scheme 11). However, the acid-
induced cleavage of 3-19 afforded the tetracyclic compound 3-20. Again, the Friedel-
Crafts cyclization was so fast, that the desired homologated aldehyde could never be 
detected in the LC-MS of the reaction mixture. Even hydrolysis of the hydroxyl derivative 
3-21, which should have given a more stable cyclic hemiacetal led to the tetracyclic 
compound 3-22. 
 
Scheme 11. Attempt to homologate aldehyde 3-14c with methoxymethylphosphorane 
Finally, a practical solution was found starting with a three-step sequence involving 
NaBH4 reduction of aldehyde 3-14c, conversion of the alcohol to the corresponding 
mesylate and nucleophilic substitution of the mesylate with cyanide in DMSO leading to 
nitrile 3-23 in more than 90% yield from 3-14c (Scheme 12). Removal of the TBS-group 
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with TBAF in THF followed by nitrile saponification allowed for the formation of lactone 
3-25. While monomethylation of lactone 3-25 was possible, careful NMR analysis of the 
major diastereomer showed that methylation had taken place from the wrong side of the 
enolate.  
 
Scheme 12. Synthesis and methylation of lactone 3-25. 
Next, methylation of the nitrile 3-23 was investigated. Deprotonation of 3-23 with 
LDA (2 equiv.), followed by addition of MeI gave a single isomer, tentatively assigned 
structure 3-27 in 92% isolated yield. Indeed, conversion of 3-27 to the corresponding 
lactone allowed for determination of the stereochemistry from the NOESY data (Scheme 
13).  
 
Scheme 13. Diastereoselective methylation of nitrile 3-23 
After having solved the diastereoselective introduction of the methyl group, a method 
was sought that would avoid protection of the amino group en route to the 
tetrahydropyridine. This was initially investigated using hydroxy nitrile 3-24 (Scheme 14). 
Dess-Martin oxidation of 3-24 afforded the ketone 3-29 quantitatively. Ketone 3-29 was 
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protected with ethylene glycol in toluene, to give 68% of the expected dioxolane 3-30 and 
20% of the polycycle 3-31 resulting from attack of the aromatic ring to the keto function. 
The nitrile group of 3-30 was then reduced to the amine with LiAlH4. Cleavage of the aryl 
methyl ethers, the 1,3-dioxolane, and cyclization to the imine could be achieved in one step 
using BBr3 in CH2Cl2. The imine 3-33 is a close analog of symbioimine.  
 
Scheme 14. Synthesis of nor-methyl symbioimine 3-33 
For the synthesis of symbioimine (3-1) hydroxy nitrile 3-28 served as starting 
material. As before, oxidation to the ketone 3-34 and protection of the keto function as 1,3-
dioxolane led to nitrile 3-35 (Scheme 15). After reduction of the nitrile to the primary 
amine, treatment of 3-36 with BBr3 generated imine 3-37.  
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Scheme 15. Synthesis of imine 3-37 
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The sulfatation of the resorcinol posed a real challenge since it was not known 
whether the imine or iminium function would be compatible with the reaction conditions. 
In addition, sulfonation of the aryl ring might take place with SO3 or related agents. While 
sulfate monoesters are less common in nature as compared to phosphate monoesters, 
sulfated biomolecules do have a certain role in cellular events. Typical sulfated 
biomolecules are carbohydrates, proteins (tyrosines), and steroids.179 The transfer of sulfate 
groups to OH functions is catalyzed by sulfotransferases which use 3’-phosphoadenosine 
5’-phosphosulfate as sulfate source. In a laboratory setting, the attachment of the sulfate is 
preferentially done at the end of the synthesis, since the resulting products are very polar 
and the sulfate group is somewhat acid labile. Common methods for the preparation of aryl 
sulfates include the use of SO3/amine complexes180 (amine = pyridine, Et3N) or 
tetrabutylammonium hydrogen sulfate (Bu4N+ HSO4-) in presence of DCC.181  
In the case at hand, treatment of imine 3-37 with SO3/Py complex (10 equiv) in 
pyridine for 6 h at 70 °C afforded about 20% of the symbioimine inner salt and 70% of a 
compound, which was characterized as a bisulfate derivative of 3-1 (Scheme 16). The 
bisulfate is a water soluble analog of symbioimine, which might also be biologically active. 
We found that the bisulfate could easily be converted to symbioimine (3-1) with pTsOH in 
a water-dioxane system at room temperature. Under these conditions one sulphate group is 
selectively hydrolyzed to give additional 3-1 (54%) and about 10% of 3-37 which could be 
recovered. The NMR spectra of 3-1 were found to be identical to the spectra from the 
isolated natural product.  
 
Scheme 16. Completing of total synthesis of (±)-symbiomine (3-1). 
In summary, we developed an efficient synthesis of (±)-symbioimine (3-1), a novel 
tricyclic iminium alkaloid. The total synthesis of 3-1 was accomplished in 22 steps from 
3,5-dihydroxy benzoic acid (3-5) in more than 5% total yield, which corresponds to an 
average yield of 88% per step. Our approach features a Lewis acid induced endo-IMDA 
reaction of 2,8,10-(E,E,E)-trienal 3-12 and a diastereoselective alkylation of nitrile 3-23 as 
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key steps. This route opens the way to other symbioimine-type compounds. This study also 
emphasizes the high reactivity of the electron rich aryl ring if it comes close to another 
electrophilic group yielding interesting polycyclic structures. 
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4. Total synthesis of (+)­neosymbioimine 
After our publication of the synthesis of (±)-symbioimine,182 three other approaches 
to symbioimine appeared. Meanwhile, a synthesis of the octalene core of symbioimine, 
using a related endo-IMDA reaction of an (E,E,E)-undeca-2,8,10-trien-1-amide, was 
reported by D. Uemura.183 Another approach to the synthesis of 4-1 was realized by Snider 
et al., who prepared (±)-symbioimine through an IMDA reaction of a 2,3-
dihydropyridinium cation.170,184 Later, the enantioselective synthesis of symbioimine was 
reported in 2007 by R. Thomson, which is based on a similar biomimetic exo-IMDA 
reaction.185 
Neosymbioimine (4-1) is a minor amphoteric metabolite of the symbiotic marine 
dinoflagellate Symbiodinium sp.167,169 Like symbioimine (3-1) this alkaloid is composed of 
a tricyclic iminium core with an attached resorcinol monosulfate unit, which causes these 
molecules to occur as inner salts (Scheme 1).167,168,169 We proposed, that neosymbioimine 
(4-1) could be synthesized by the intramolecular Diels-Alder reaction of trienone 4-4, and 
subsequent homologization and imine ring formation like in our previous synthesis of 
symbioimine. For the enantioselective synthesis of 4-1 we could use the chiral source (-)-
(S)-citronellol (4-5), which is the main component of rose oil. Due to the trisubstituted 
diene unit and the nature of starting material we preferred Wittig reactions over cross-
coupling reactions for construction of the triene 4-4. 
 
Scheme 1. Retrosynthetic analysis of neosymbioimine (4-1) 
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Initially, the alcohol function of (-)-(S)-citronellol (4-5) was protected as TBS ether 
and the double bond cleaved by ozonolysis to obtain aldehyde 4-6 (Scheme 2). Aldehyde 
4-6 was converted to 4-hydroxy-8-silyloxy-enoate 4-7 by a one-pot MacMillan procedure, 
including -hydroxylation followed by Horner-Wadsworth-Emmons (HWE) reaction and 
cleavage of the N-O bond in 55% yield (Scheme 3).186  
 
Scheme 2. Organocatalytic -hydroxylation of aldehyde 4-6 
 
 
Scheme 3. Mechanism of proline catalyzed -hydroxylation of aldehyde 4-6 
The secondary alcohol of enoate 4-7 was protected with a TBS-group, followed by 
selective liberation of the primary alcohol and its oxidation to provide aldehyde 4-8. Wittig 
reaction of 4-8 with 2-(triphenylphosphoranylidene)propanal187 (4-9) gave only the E-
isomer of aldehyde 4-10 in 88% yield (Scheme 4). 
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Scheme 4. Synthesis of aldehyde 4-10 
In the subsequent condensation of 4-10 with diethyl 3,5-
dimethoxybenzylphosphonate188 (4-11), we isolated approximately a 1:1 mixture of triene 
4-12 and cyclized product 4-13 (Scheme 5). Heating of this mixture in chloroform for 2 h 
at 60 °C, induced conversion of trienoate 4-12 to 4-13 to about 95% (by NMR). The 
conversion did not increase even after 12 h. We assume that only the desired diastereomer 
of 4-12 cyclizes under these conditions. The diastereomeric impurity in substrate 4-12 most 
likely originates from the minor enantiomer contained in the commercial (-)-(S)-citronellol 
(92% ee).189 In fact, around 5% of impurity can be seen in the 1H NMR spectra of 
compounds 4-7 − 4-13. The diastereomer of 4-12 does not cyclizes due to the steric 
hinderence in the transition state (Scheme 6). 
 
Scheme 5. Spontaneous IMDA reaction of 4-12 
After reduction of ester 4-13, the target alcohol could be easily obtained in pure 
form. This crucial effect of the methyl group on the IMDA of 4-12, allowed us to produce 
enantio- and diastereomerically pure products from enantio impure starting compound 
citronellol. 
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Scheme 6. Selectivity of IMDA reaction of 4-12 
Mesylation of the primary alcohol derived from cycloadduct 4-13 followed by SN2 
reaction with sodium cyanide gave nitrile 4-14 in exellent yield (Scheme 7). Methylation 
of acetonitrile derivative 4-14 proceeded very cleanly and efficiently, using 2 equiv.of 
LDA and 2 equiv.of MeI in THF at –80 °C. Despite the fact, that a small amount (10%) of 
the undesired diastereomer was also formed, pure 4-3 was isolated in 87% yield on a gram 
scale experiment. The stereochemistry of methylation is caused probably by the steric 
hindrance in the transition state of anion 4-14. It attacks methyl iodide from the side, 
opposite to the aromatic ring. 
 
Scheme 7. Synthesis of nitrile 4-3 
The structure of nitrile 4-3, featuring all stereocenters of the natural product, was 
confirmed by single crystal x-ray analysis (Scheme 7). In this molecule the methyl and 
propanenitrile groups occupy equatorial positions, whereas the bulky units (Ar, OTBS) are 
oriented axially. In the 1H NMR spectra of nitrile 4-15 the signal of the -methyl group is 
shifted towards high field (H 0.6 ppm) due to the shielding by the aromatic ring current. 
Nitrile 4-3 was treated with TBAF to remove the TBS group. The obtained alcohol was 
oxidized to the corresponding ketone which was protected as 1,3-dioxolane 4-15 in 
exellent yield. Reduction of the nitrile to the amine with LiAlH4 followed by acid-
catalyzed imine formation gave imine 4-16 (Scheme 8).  
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Scheme 8. Synthesis of imine 4-16 
Finally, the aryl ether functions were cleaved with BBr3 providing resorcinol 4-17 in 
84% yield (Scheme 9). As a final challenge, efficient monosulfation of resorcinol 
remained. In our previous synthesis of (±)-symbioimine (4-1), the monosulfatation of the 
resorcinol was achieved via the bis-sulfate, generated by reaction of the resorcinol with an 
excess of SO3/pyridine complex followed by controlled hydrolysis of one of the sulfate 
groups. Another approach is based on sulfation with i-Bu-OSO2Cl (isobutyl chlorosulfate) 
and nP-OSO2Cl (neopentyl chlorosulfate), following by dealkylation with nucleophiles 
(NaI, NaN3, NaSCN).179 While the usability of this method for the preparation of sulfates 
of complex molecules, like steroids, carbohydrates, and proteins (tyrosines) could be 
shown, sulfation of polyfunctional substrates was not described. Initially, we tried to apply 
this method for the sulfation of resorcinol 4-17. In our hands, the reaction of neoPentyl-
OSO2Cl with 4-17 and NaHMDS (1 equiv) gave an unseparable mixture of chlorinated 
aromatic derivatives along with sulfated products in low conversion. In the case of 
resorcinols, we found that aromatic electrophilic substitution is predominant, and 
sulfochlorides seem too electrophilic. Therefore, optimisation of our earlier procedure was 
tried.  
 
Scheme 9. Synthesis of (+)-neosymbioimine (4-1) 
Excessive sulfation of 4-17 with SO3·py (5 equiv) in pyridine gave bisulfate 4-18. As 
expected, one sulfate group in 4-18 is more sensitive to hydrolysis (Scheme 9). Thus, 
keeping a solution of 4-18 in aqueous methanol at 35 °C for 18 h, led to complete 
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monohydrolysis of 4-18 (70% of 4-1 was isolated). At the same time, neosymbioimine (4-
1) was not hydrolyzed significantly (10% of 4-17 was recovered). Thus, the formation of 
the inner salt contributes to the stability of the sulfate group. The product was purified by 
routine flash chromatography, on silica gel using MeOH/CHCl3 as eluent. Synthetic 
neosymbioimine was identical by NMR to the natural compound. The optical rotation of 
synthetic neosymbioimine ([]23D +172, c 0.1, MeOH) corrlelates well with the authentic 
one ([]25D +149). Thus, the absolute stereochemistry of (+)-neosymbioimine was 
assigned. 
In summary, we developed an efficient route to the natural alkaloid (+)-
neosymbioimine, starting from readily available (-)-(S)-citronellol. The synthetic strategy 
is based on the extremely facile tandem HWE-IMDA reaction for construction of the 
neosymbioimine core, which allows for the preparation of significant amounts of (+)-
neosymbioimine (4-1) in 10% total yield over 18 steps. So far this is the only total 
synthesis of neosymbioimine reported in the literature.  
We also studied the inhibition of COX-2 (cyclooxygenase-2) activity of the synthetic 
neosymbioimine in the group of Prof. Dr. Laufer. Although for the related alkaloid 
symbioimine (3-1), the reported concentration, when the COX-2 activity is significantly 
reduced, is 10 M, for neosymbioimine (4-1) we did not find any inhibition of COX-2 
inside the range of concentrations of 4-1 from 0.1 to 10 M, and very small (15%) 
inhibition at 0.01 M. These results show that neosymbioimine (4-1) is rather inactive 
against COX-2. 
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5. Attempts toward the synthesis of platensimycin 
Platensimycin (5-1) is a novel antibiotic, which was recently isolated from several 
strains of Streptomyces platensis.190 It imparts a potent Gram-positive antibacterial activity 
including that against drug-resistant organisms (e.g., MRSA, VRE) by uniquely inhibiting 
acyl enzyme intermediates of the condensing enzymes FabF and FabF/FabH, respectively, 
vital for fatty acid biosynthesis. This natural product is interesting not only due it’s potent 
antibiotic activity, but also due to the novel structure, which could be a good challenge for 
total synthesis. 
 
Scheme 1. Retrosynthetic strategy for synthesis of platensimycin 5-1 
Initial our strategy was to construct the [3.2.1]bicyclooctane carbon core fragment of 
platencimycin 5-2 by the rearrangement of [2.2.2]bicyclooctane mesylate 3, which can be 
prepared according to a known literature method (Scheme 1).191 Heating of commercially 
available 1-methoxycyclohexa-1,4-diene (5-4), the product of the Birch reduction of 
anisole,192 with 2-chloroacrylonitrile (5-5) in benzene afforded the Diels-Alder adduct, 
which was distilled using a kugelrohr apparatus to yield 76 % of methoxybicyclooctene 5-6 
as a mixture of diastereomers (Scheme 2). 
 
Scheme 2. Synthesis of [3.2.1]bicyclooctane 11 
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Hydrolysis of product 5-6 by heating it with sodium sulphide in a water/ethanol 
mixture afforded ketone 7 in 57 % yield.191 The moderate yield of this reaction is caused 
by the side reaction involving the addition of sulfide ion to the nitrile function to produce 
thioamide 5-8 which could be isolated and characterized. Addition of Grignard reagent 5-9 
to ketone 5-7 afforded a mixture of two diastereomeric alcohols 5-10 which could be 
separated by flash chromatography. For the subsequent rearrangement only one 
diastereomer of 5-10 could be used as it evident by looking at the mechanism of this 
reaction (Scheme 3). The desired alcohol 5-10 was isolated in pure form with 46 % yield. 
The cleavage with sodium iodide of the mesylate, obtained by mesylation of the 
corresponding alocohol, by the literature procedure191 gave a poor yield of desired product 
5-11. However, we discovered that mild heating of alcohol 5-10 with 1.1 equiv. of 
camphorsulphonic acid in 1,3-propanediol surprisely gave a quantitative yield of the 
desired ketone 5-11, which could be prepared in laboratory on a multigram scale. 
 
Scheme 3. Mechanism of acid-induced rearrangement of 5-10 
Reduction of ketone 5-11 with sodium borohydride, followed by protection with 
trimethyl chlorsilane afforded TMS-ether 5-12 in high yield as a 3.5/1 mixture of 
diastereomers (Scheme 4). We have found that the double bond of 5-12 could be 
selectively hydroborated, and after oxidation with Dess-Martin periodinane (DMP) we 
obtained ketone 5-13 in good yield. Methylation of that ketone could be done in a 
diastereoselective fashion with methyllithium in diethyl ether. Cleavage of the 
trimethylsilyl function with TBAF, followed by oxidation with DMP afforded ketone 5-14. 
Several methods for installation of a hydroxyl group next to ketone 5-13 were tested, and 
we found that treatment of ketone 5-13 with potassium bis-trimethylsilylamide and Davis 
oxaziridine193 5-15 afforded 30 % of a single diastereomer of 5-16. The low yield might be 
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explained by the negative influence of the free tertiary hydroxyl function. The yield might 
be improved by protection of that function before the anionic reaction with potassium bis-
trimethylsilylamide. 
 
Scheme 4. Conversion of bicyclic ketone 5-11 to hydroxyketone 5-16 
Treatment of diol 5-16 with tosyl chloride and pyridine allowed us to perform a 
selective tosylation of the secondary alcohol function in the presence of the tertiary alcohol 
providing a good yield of tosylate 5-17. We found that treatment of 5-17 with sodium bis-
trimethylsilylamide afforded smooth cyclization to furnish tricyclic product 5-18, which 
represents a key fragment of the core structure of platencimycin 5-19 (Scheme 5). 
 
Scheme 5. Cyclization of tosylate 5-17 
At this point we decided to cancel further research on the platensimycin synthesis 
progress, because several more efficient syntheses appeared in the literature. Instead we 
focused our efforts to synthesize another new natural product, platencin, which was 
discovered by the same scientists from the Merck company in 2007.196 
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6. Formal total synthesis of platencin 
The increasing appearance of bacterial resistance stimulated a resumption of the 
search for novel antibiotics. In this regard not only various depsipeptides but also 
structurally novel polycyclic polyketide or terpene derivatives were discovered.194,195 Thus, 
the two closely related antibiotics platencin196 and platensimycin197 were described by an 
industrial research group (Figure 1). The newest of these compounds, platencin (6-1) was 
isolated from a strain of streptomyces platensis MA 7339. Like platensimycin (5-1), 
platencin (6-1) shows potent antimicrobial activity against a broad spectrum of Gram-
positive bacteria. In particular it inhibits key antibiotic resistant pathogens such as 
methicillin-resistant staphylococus aureus, vancomycin-resistant enterococci and 
streptococcus pneumoniae. 
O
N
O
H
O
OH
CO2HHplatencin (6-1)
O
O
H
O
N
Ar
H
platensimycin (5-1)  
Figure 1. Structures of platencin (6-1) and platensimycin (5-1) 
As the screening assay was targeted against the bacterial fatty acid biosynthesis both 
6-1 and 5-1 inhibit this machinery.198 In contrast to 5-1, platencin (6-1) blocks two 
condensing enzymes namely keto acyl synthase (KAS) II and III. Both compounds contain 
a highly substituted 3-amino-2,4-dihydroxy benzoic acid and a rather hydrophobic 
polycyclic enone acid sector. Biosynthetic studies revealed that the terpene part originates 
from the non-mevalonate MEP pathway (Figure 2).199,200 The two natural products might 
originate from copalyl pyrophosphate (A) and pass through the beyeran-16-yl cation C as a 
common intermediate (Figure 2).201 A Wagner-Meerwein rearrangement and proton loss 
would lead to ent-kaurene (E), the likely precursor of platensimycin. The ent-atiserene (I) 
structure with the [2.2.2]bicyclooctane subunit can be reached by a 1,3-hydride shift to G 
prior to the final Wagner-Meerwein shift leading to carbenium ion H followed by 
deprotonation. Alternatively, a late stage interconversion of the two ring systems could be 
possible as shown with the carbenium ion structures K and L.196b 
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Figure 2. Possible key intermediates in the biosynthesis of platencin (6-1) and 
platensimycin (5-1) 
The potent in vivo activities and the novel intriguing structures prompted a range of 
synthetic efforts. Thus, since the first disclosure of platensimycin in 2006 ten total or 
formal total synthesis were reported.202,203 The year 2008 saw the publication of seven 
platencin synthesis.204 We also became interested in the synthesis of platencin and 
conceived a unique route to the advanced intermediate 6-3 (Figure 3). Our design was 
inspired by the [3.2.1]- to [2.2.2]bicyclooctane interconversion that is evident from the two 
natural products. In the literature two prominent methods are known to achieve such 
transformations. Thus, Pinacol rearrangement of Diels-Alder derived bicyclo[2.2.2]octane 
systems offers an entry to [3.2.1] systems.205,206 On the other hand, the homoallyl 
homoallyl radical rearrangement which might proceed through a cyclopropylcarbinyl 
radical was used by the group of Ihara to convert a [3.2.1] to a [2.2.2] system.207,208 In fact, 
this skeleton interconversion strategy has also been used by Nicolaou and Lee in their 
syntheses of platencin. We also conceived independently a related strategy (Figure 3) but 
observed problems with the rearrangement of N to M.209 According to this plan, compound 
120  Results and Discussion 
O might be synthesized by the conjugate addition to bicyclic enone P, which could be 
prepared, according to the work of Toyota207,210 by palladium-catalyzed oxidative 
cyclization of allylcyclohexenone Q. This substrate, in turn, could be made by alkylation 
and reduction of an 3-alkoxycyclohex-2-en-1-one like compound 6-4.  
 
Figure 3. Synthetic plan for the platencin core structure 6-3 
Initially we performed some model studies on the Pd(II)-calalyzed cycloalkenylation 
reaction of silyl enol ether 6-7 (Scheme 1). The original plan was to convert the desired 
bicyclic product to decalin derivative 6-11 and then perform the key skeletal rearrangement 
on a tricyclic system derived 6-11. However, with our model system 6-6, which was 
derived via the Stork alkylation strategy211 from 3-isobutoxy-cyclohex-2-en-1-one212 (6-4), 
the conditions reported by Fukumoto et al.210 resulted in the formation of a mixture of three 
products (Scheme 1, Table 1). 3-Isobutoxy-cyclohex-2-en-1-one (6-4) was alkylated under 
LDA conditions with allyl bromide the isolated product was deprotonated again with LDA 
and coupled with methyl vinyl ketone as a Michael acceptor. Obtained ketone 6-5 was 
protected with ethylene glycol under standard conditions (PPTS, Dean Stark, benzene, 
reflux) and the vinylogous carbonyl function was reduced with DIBAL-H. Acidic 
hydrolysis of the crude product afforded cyclohex-2-en-1-one 6-6, whic was converted into 
silyl dienol ether and subjected to testing in the Pd(II)-catalyzed cycloalkenylation reaction 
(Scheme 1). 
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Scheme 1. Oxidative Pd-catalyzed conversion of silyl enol ether 6-7; R3Si = Me3Si, 
(iPr)3Si, or tBuMe2Si. Ketoenone 6-10 was used crude. 
Varying the trialkylsilyl group at the silyl enol ether 6-7 from Me3Si to tBuMe2Si 
reduced the amount of the desilylated cyclohexenone 6-6 but did not diminish formation of 
cyclohexadienone 6-9, resulting from oxidative desilylation.213 Finally, a solution was 
found with the slow addition of the catalyst to the reaction mixture (Table 1, entry 6) Thus, 
addition of the catalyst solution over 4 h to a 0.05 m solution of silyl enol ether 6-7 (R= 
tBuMe2Si) in DMSO resulted in a clean formation of the desired bicyclic product 6-8 in 
85% yield. Enone 6-8 was then converted to tricyclic diketone 6-11 in two steps (Scheme 
1). Unfortunately, the radical rearrangement on tricyclic derivatives derived from 6-11 did 
not give the desired products.214 
Table 1. Optimization of the Pd-catalyzed alkene-silyl enol ether cyclization. 
Entry[a] R3Si T Conc. Pd [mol%] Ratio 6-8: 6-9: 6-6[b] 
1 TMS r.t. 0.05 M 10 40:50:trace 
2 TMS 45 °C 0.2 M 10 33:17:50 
3 TIPS 45 °C 0.3 M 1 38:trace:60 
4 TBS r.t. 0.1 M 10 80:20:trace 
5 TBS 45 °C 0.1 M 10 80:20:3 
6 TBS 45 °C 0.05 M 5 [c] >95 %:trace:trace 
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[a] All reactions were run at 0.5 mmol scale in DMSO under 1 atmosphere of oxygen for 
24-48 h; [b] ratio determined by 1H NMR; [c] slow (within 4 h) addition of catalyst. 
After optimization of this cycloalkenylation reaction we focused on the synthesis of a 
functionalized 7-methylenebicyclo[3.2.1]octan-2-one such as 6-18 which would allow to 
form the cyclohexenone ring of platencin after the rearrangement of the biyclic 
substructure. The racemic synthesis began with vinylogous ester 6-4212 (Scheme 2). Thus, 
formylation of 6-4 with isobutyl formate followed by addition of allyl chloroformate gave 
an E/Z mixture of enol carbonates which upon flash chromatography isomerized to form 
mostly the Z-isomer 6-13, assigned by NMR, in 89% yield. This enol carbonate underwent 
a rapid decarboxylative allylation215,216 with formation of a quaternary center under 
Pd(OAc)2/PPh3 catalysis resulting in high yield of 2-oxocyclohex-3-ene carbaldehyde 6-
14. The next step using NaBH4 and CeCl3 in MeOH served to reduce the enone as well as 
the aldehyde function to give cyclohexenone 6-15. Surprisingly, the vinylogous ester 
function was reduced as well under these conditions. This avoided the use of expensive 
reducing agents like DIBAL-H. The crude hydroxyketone 6-15 was then subjected to 
pivaloylation affording pivalate 6-16 in 94% yield from aldehyde 6-14. 
 
Scheme 2. Synthesis of cyclohexenone 6-16 
Enone 6-16 was converted to silyl enol ether 6-17 which could be cyclized using our 
optimized conditions to 7-methylenebicyclo[3.2.1]oct-3-en-2-one 6-18 (Scheme 3). A 
subsequent Mukaiyama-type Michael addition217 of enone 6-18 with silyl ketene acetal218 
6-19 promoted by TiCl4 (1.2 equiv) gave only the desired diastereomer 6-20. Thus, the 
nucleophile attacks the enone syn to the one carbon methylene bridge.  
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Scheme 3. Synthesis of bicyclic keto ester 6-20 
In preparation for the intended skeletal rearrangement, the keto function of 6-20 was 
reduced under various conditions (Scheme 4). However, using sodium borohydride, zinc 
borohydride or MVP conditions (aluminium isopropoxide/isopropanol) always gave a 
mixture of alcohols, at best in a 3:1 ratio. Finally, we discovered that reaction of 6-20 with 
Et3SiH and TiCl4 proceeds with the exclusive formation of only one diastereomeric alcohol 
6-21. The configuration of the OH bearing stereocenter could be determined from NOESY 
experiments. Alcohol 6-21 was then converted to xanthogenate 6-22. However, radical 
rearrangement of xanthate ester 6-22 under the conditions reported in Nicolaou’s first total 
synthesis204a,219 of platencin (AIBN, Bu3SnH, toluene, 100 °C) did not work for our 
substrate with no conversion of 6-22. With methoxymethyl and acetyl protecting groups 
instead of the pivaloate this reaction gave a very poor yield of the desired rearrangement 
product together with large amounts of byproducts.214 Better results were obtained using 
conditions reported by a Korean group, namely the combination of tetrabutyl ammonium 
peroxydisulfate and sodium formate.220 This reaction, performed in DMSO gave a 38% 
yield of a mixture of the rearranged product 6-23 and the simple deoxygenation product 6-
24 in a ratio of 82:18. In DMF, this reaction afforded the same product mixture in 25% 
yield. 
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Scheme 4. Rearrangement reactions on xanthogenate 6-22 
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Looking for conditions that would provide a better yield and selectivity in the key 
radical rearrangement towards the[2.2.2]bicyclooctane core, we eventually found that 
heating a solution of hydrazone 6-25 in methanol in presence of NaCNBH3 and ZnCl2 
resulted in the desired deoxygenative rearrangement to form the methylene-
bicyclo[2.2.2]octane 6-23 in 60% yield (Scheme 5).207b While product 6-23 is still 
contaminated with 8 mol% of byproduct 6-24, this impurity could be removed by flash 
chromatography of the derived diol 6-28 (vide infra). This diol was obtained in pure form 
via a very efficient three step sequence from 6-23. Thus, conversion of ester 6-23 to 
Weinreb amide 6-26, treatment of 6-26 with MeLi (6 equiv) and reduction of hemiketal 6-
27 with LiAlH4 furnished diol 6-28 in 85% yield from ester 6-23. Oxidation of hemiketal 
6-27 with TPAP/NMO by the literature procedure204a afforded a poor yield (< 25%) of the 
desired ketoaldehyde 6-29. On the other hand, Swern oxidation of diol 6-28 led to 
ketoaldehyde 6-29 in good yield. A final aldol condensation on 6-29 with NaOH in EtOH 
gave the advanced intermediate 6-3 in 87% yield. The total yield of the platencin tricyclic 
core structure 6-3 from commercially available starting material 6-4 was 17.5% for 13 
steps. 
 
Scheme 4. Efficient conversion of keto ester 6-20 to the bicyclo[2.2.2]system 6-23 and its 
transformation to the core structure 6-3 of platencin 
We also studied an enantioselective approach to 6-3 via the above sequence. This 
could involve an enantioselective Pd-catalyzed decarboxylative allylation216 of allyl enol 
carbonate 6-13 with a chiral phosphine ligand (Scheme 6). According to the work of B. M. 
Trost the (S,S)-ligand 6-29 should result in (S)-6-14.221,222 Indeed, this decarboxylative 
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allylation, performed in presence of ligand 6-29 at 0 °C in THF, resulted in an 
enantiomeric excess of 78% for (+)-6-14. Lowering the temperature to –20 °C gave an 
improved ee of 87% (Figure 4). Accordingly optically active 6-14 should lead to the 
optically enriched platencin core structure 6-3.  
 
Scheme 6. Asymmetric approach to platencin (6-1) 
 
 
Figure 4. GS analysis of chiral aldehyde 6-14 
 
126  Results and Discussion 
In summary, we have developed an efficient formal synthesis of platencin. The 
tricyclic advanced intermediate 6-3 was prepared in 13 steps and 17.5% overall yield from 
commercially available starting material 6-4. Our approach is based on originally 
developed key reactions, namely the asymmetric decarboxylative allylation of allyl enol 
carbonate 6-13, the optimized Pd-catalyzed cycloalkenylation of 6-7, a highly 
diastereoselective Mukaiyama Michael addition of silyl ketene acetal 6-19 to bicyclic 
enone 6-18, and a radical-mediated reductive rearrangement of tosyl hydrazone 6-25 for 
construction of the [2.2.2]bicyclooctane core of platencin. 
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7. Conclusion 
In summary, we have completed several research projects. Synthesis of the 
spirocyclic scaffold 1-1 and 1-2, containing both meta- and para-functionalized ring 
systems, was accomplished via Johnson-Claisen rearrangement reaction of allylic alcohols 
1-7 and 1-20 as a key step. Hydroboration of the terminal alkene bond, reduction of the 
carbethoxy function and cyclization of diols 1-10 and 1-22 into piperidines opened a 
convenient route to functionalized spirocyclic scaffolds 1-1 and 1-2, where R and R1 could 
be varied as follows from our synthesis (Scheme 1). 
 
Scheme 1. Approach to spirocyclic scaffolds 1-1 and 1-2 
Another project was devoted to a new reaction of synthesis 7-aryl tetralones 2-7a-g 
with palladium catalysis. This unusual reaction we discovered during the study of the Pd-
catalyzed arylation of decalenone 2-4. Initially, the yield of this reaction was low, but we 
found that addition of tetrabutylammonium bromide (TBAB) improved the yield of the 
palladium-catalyzed arylation dehydroaromatization reaction, which provides different 7-
aryl tetralones 2-7a-g which could not be synthesized by other methods in a such simple 
and straightforward manner (Scheme 2). 
 
Scheme 2. Synthesis 7-aryl tetralones 2-7a-g 
The total synthesis of (±)-symbioimine (3-1), a novel tricyclic iminium alkaloid, we 
accomplished, using a Lewis acid induced endo-IMDA reaction as a key step (Scheme 3). 
The Diels-Alder adduct 3-14 was synthesized from trienone 3-12 by treatment with the 
mild Lewis acid Me2AlCl. The corresponding trienone was prepared by the alkylation of 
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aldehyde 3-9, and 1,3-diene 3-8 was synthesized by the Pd-catalyzed oxygen-promoted 
coupling of 3,5-dimethoxystyrene 3-6 and the related vinyl boronate ester 3-4. This 
synthesis was accomplished in 22 steps in >5% total yield, which corresponds to an 
average yield of 88% per step. Some analogs of this natural product were also synthesized 
using our original strategy. 
 
Scheme 3. Total synthesis of (±)-symbioimine (3-1) 
Thereafter, a total synthesis of the related alkaloid neosymbioimine (4-2) was 
developed in enantioselective fashion from (-)-(S)-citronellol (4-5). Aldehyde 4-6, prepared 
from (-)-(S)-citronellol in few steps, was further functionalized with organocatalytic -
hydroxylation and HWE reactions, prepared in one pot manner. Then, a HWE reaction of 
the aldehyde function of 4-10 with benzyl phosphonate 4-11 resulted in a spontaneous 
endo-IMDA reaction to produce the bicyclic decaline core of neosymbioimine (4-2). 
Elongation of the obtained aldehyde to the nitrile 4-14, and alkylation with methyl iodide 
allowed us to introduce the methyl group with good diastereoselectivity. The aromatic 
sulfate function at the end of the synthesis was also prepared with a good yield and 
selectivity, which allowed us to produce significant amounts of (+)-neosymbioimine (4-1) 
in 10% total yield over 18 steps (Scheme 4). 
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Scheme 4. Total synthesis of (+)-neosymbioimine 
A possible original route to platensimycin (5-1) was also shown (Scheme 5). The key 
step of this strategy is the construction of the [3.2.1]bicyclooctane moiety of platensimycin 
by the rearrangement of the corresponding [2.2.2]bicyclooctane 5-10, which was prepared 
by Grignard addition to the known ketone 5-7. Ketone 5-11 was further functionalized by 
selective hydroboration of the double bond and -hydroxylation of the carbon near the 
ketone function, providing after tosylation compound 5-17. Tricyclic oxa-nonanone 5-18 
was prepared by intramolecular SN2 reaction with a strong base. This product 5-18 might 
serve as a plausible precursor for platensimycin (5-1). 
 
Scheme 5. A route to platensimycin (5-1) 
Finally, a concise formal total synthesis of platencin (6-1) was developed (Scheme 
6). This approach is based on an efficient oxygen-mediated palladium-catalyzed 
cycloalkenylation reaction for the synthesis of [3.2.1]bicyclooctane 6-18 and a 
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deoxygenative radical-mediated biomimetic rearrangement reaction of derived tosyl 
hydrazone for construction of [2.2.2]bicyclooctane 6-23. A catalytic asymmetric allylation 
reaction of enolcarbonate 6-13 for the construction of the quaternary carbon center of 
aldehyde 6-14 allowed for an enantioselective route to the natural product. The total yield 
of advanced intermediate 6-3 was 17.5% for 13 steps from commercially available 
compound 6-4. 
 
Scheme 6. Formal total synthesis of platencin (6-1) 
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Experimental Section 
Chemicals and working techniques 
The chemicals were purchased from the firms Acros, Aldrich, Fluka, Lancaster, 
Avocado and Merck. All reagents were obtained from commercial suppliers, and were used 
without further purification unless otherwise stated. All solvents were distilled and/or dried 
prior to use by standard methodology except for those, which were reagent grades. The 
applied petroleum ether fraction had a boiling point of 40–60 °C. Anhydrous solvents were 
obtained as follows: THF, diethyl ether and toluene by distillation from sodium and 
benzophenone; dichloromethane and chloroform by distillation from calcium hydride; acetone 
by distillation from phosphorous pentoxide. Absolute triethylamine and pyridine and 
diisopropylethylamine were distilled over calcium hydride prior to use. Unless and otherwise 
mentioned, all the reactions were carried out under a nitrogen atmosphere and the reaction 
flasks were pre-dried by heat gun under high vacuum. All the chemicals, which were air or 
water sensitive, were stored under inert atmosphere. Compounds that are not described in the 
experimental part were synthesized according to the literature. 
 
NMR-spectroscopy 
All the spectra were measured on a Bruker Advance 400 spectrometer, which operated 
at 400 MHz for 1H and 100 MHz for 13C nuclei, respectively. 1H (400 MHz) and 13C NMR 
(100 MHz): spectra were recorded at 295 K either in CDCl3, CD3OD or [D6]DMSO; chemical 
shifts are calibrated to the residual proton and carbon resonance of the solvent: CDCl3 (H = 
7.25 ppm, C = 77.0 ppm), CD3OD (H 3.31, residual CD2HOD; C 49.0 ppm). [D6]DMSO 
(H = 2.49 ppm, C = 39.5 ppm). Data are reported as follows: chemical shift (multiplicity: s 
= singlet, d = doublet, t = triplet, q = quadruplet, m = multiplet, br = broadened, ddd = doublet 
of doublet of doublet, dt = doublet of triplet, td = triplet of doublet and so forth, J = coupling 
constant (Hz), integration, peak assignment in italic form). 
 
Mass Spectrometry 
Mass spectra were recorded on a Finnigan Triple-Stage-Quadrupol Spectrometer (TSQ-
70) from Finnigan-Mat. High-resolution mass spectra were measured on a modified AMD 
Intectra MAT 711 A from the same company. The used mass spectrometric ionization 
methods were electron-impact (EI), fast-atom bombardment (FAB) or field desorption (FD). 
FT-ICR-mass spectrometry and HR-FT-ICR mass spectra were measured on an APEX 2 
spectrometer from Bruker Daltonic with electrospray ionization method (ESI). Some of the 
mass spectra were also measured on an Agilent 1100 series LC-MSD. Analytical HPLC-MS: 
HP 1100 Series connected with an ESI MS detector Agilent G1946C, positive mode with 
fragmentor voltage of 40 eV, column: Nucleosil 100–5, C-18 HD, 5 mm, 70  3 mm Machery 
Nagel, eluent: NaCl solution (5 mM)/acetonitrile, gradient: 0/10/15/17/20 min with 
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20/80/80/99/99% acetonitrile, flow: 0.6 mL min–1. High resolution mass (HRMS) are reported 
as follows: (ESI): calcd mass for the related compound followed by found mass. 
 
Polarimetry 
Optical rotations were measured on a JASCO Polarimeter P-1020 or a Perkin Elmer 
Polarimeter 341. They are reported as follows: [α]temperatureD (concentration, solvent). The unit 
of c is g/100 mL. Anhydrous CH2Cl2, CHCl3 or MeOH was used as a solvent. For the 
measurement the sodium D line = 589 nm was used. 
 
Melting Points 
Melting points were determined with a Büchi Melting point B-540 apparatus and were 
not corrected. 
 
Chromatographic Methods 
Flash column chromatography was performed using flash silica gel (40-63 m, 230-400 
mesh ASTM) from Macherey-Nagel. 
For GC-MS coupled chromatography, a GC-system series 6890 with an injector series 
7683 and MS-detector series 5973 from Hewlett Packard was used, with EI method, and 
carrier gas He. Analytical HPLC was performed on a Hewlett Packard HP 1100 system.  
Analytical thin layer chromatography (TLC) was performed on precoated with silica gel 
60 F254 plates (Merck) or Polygram Sil G/UV254 (Macherey Nagel). The compounds were 
visualized by UV254 light and the chromatography plates were developed with an aqueous 
solution of molybdophosphorous acid (Hanessian’s stain: 20 g ammonium molybdate 
[(NH4)6Mo7O24·4H2O] and 0.4 g Ce(SO4)2·4H2O were dissolved in 400 mL of 10% H2SO4, 
heating with the heat gun) or an aqueous solution of potassium permanganate (10% of 
KMnO4 in 0.5% H2SO4, after expousing in permanganate plates were washed with water). 
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1. Synthesis of spirocyclic scaffolds 
 
1,4-Dioxaspiro[4.5]decan-7-one (1-5): 1,3-Cyclohexanedione was disoolved in 
benzene or toluene. Ethylene glycol (1 equiv.) and p-TSA (5 mol%) were added, and the 
mixture was refluxed with azeotropic water removal until 1 equiv. of water was collected. 
Then the mixture (room temperature) was washed successively with water, NaHCO3 and 
saturated NaCl, dried over Na2SO4, evaporated and distilled carefully in vacuum with a 
Vigreux column, providing 30-50 % of pure compound. Further distillation afforded a 
mixture of mono- and di-protected cyclohexanediones which also could be used in the next 
step. 
 
Ethyl (2E)-1,4-dioxaspiro[4.5]dec-7-ylideneacetate (1-6): To a suspension of NaH 
(60 % in mineral oil, 0.1 mol, 4.0 g) in dry DMF (100 mL) triethylphosphonoacetate (1 
equiv., 20 mL) was added dropwise at 20 °C (external water bath). The mixture was stirred 
for 30 min at rt under inert atmosphere before 1,4-dioxaspiro[4.5]decan-7-one (1-5) (1 equiv) 
was added dropwise at 0-20 °C. The mixture was stirred for 1 h at rt and poured into 0.5 L of 
ice-cold water. The enoate was extracted with petroleum ether, dried, evaporated and 
chromatographed using 7.5:1 petroleum/EtOAc as an eluent (Rf = 0.25). Yield: 80 % as a 
colorless oil. 
 
(2E)-2-(1,4-Dioxaspiro[4.5]dec-7-ylidene)ethanol (1-7): To a stirred solution of ethyl 
(2E)-1,4-dioxaspiro[4.5]dec-7-ylideneacetate (1-6) (6.55 g, 28.5 mmol) in CH2Cl2 (100 mL), 
DIBAL-H (2.5-3 equiv) has been added dropwise at -70 °C under N2. Then the mixture was 
warmed to rt within 1 h, and stirred for 2 h at rt. Obtained mixture was transferred into a 
solution of 80 g of Rochelle salt (sodium-potassium tartrate) in 300 mL of water and stirred 
vigorously overnight. Then the organic layer was separated, water phase was extracted with 
Et2O (2×100 mL). The combined organic extracts were washed with saturated NH4Cl and 
NaCl solutions, dried, evaporated and chromatograhed in 1:2 petroleum/EtOAc (Rf = 0.5, 
EtOAc). Yield: 4.05g, 78 % as a colorless oil. 
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Ethyl (7-vinyl-1,4-dioxaspiro[4.5]dec-7-yl)acetate (1-8): (2E)-2-(1,4-
Dioxaspiro[4.5]dec-7-ylidene)ethanol (1-7) (4.0 g, 21.7 mmol), CH3C(OEt)3 (36.5 g, 220 
mmol, 10 equiv.) and EtCO2H (0.1 mL) were stirred at 110 °C in toluene for 24 h under N2. 
Then toluene and triethyl ortoacetate were evaporated in vacuum and the residue was 
chromatographed eluating with petroleum ether:EtOAc 8:1 (Rf = 0.25) to get 2.78 g (51 %) of 
the target product. The more polar fractions were washed with pure EtOAc and evaporated to 
get 2.03 g of residue which contains starting material and intermediates. This residue was 
refluxed with the recovered toluene, triethyl ortoacetate and EtCO2H (0.05 mL) for 24 h under 
N2. Evaporation and chromatography afforded additional 860 mg (16 %) of product. Repeated 
eluation with EtOAc and cooking with the recoverd recovered toluene and triethyl ortoacetate 
and EtCO2H (0.03 mL) afforded additional 425 mg (8 %) of product. Combined yield of 
compound 1-8 was 75 % as colorless oil. 
 
2-(7-Vinyl-1,4-dioxaspiro[4.5]dec-7-yl)ethanol (1-9): To a stirred solution of ethyl (7-
vinyl-1,4-dioxaspiro[4.5]dec-7-yl)acetate (1-8) (3.64 g, 14.3 mmol) in CH2Cl2 (50 mL), 
DIBAL (min. 2 equiv) was added dropwise at -78 °C under N2. Then the mixture was warmed 
to rt within 1 h, and stirred for 3 h at rt. Obtained mixture was transferred into a solution of 50 
g of Rochelle salt (sodium-potassium tartrate) in 200 mL of water and stirred vigorously 
overnight. Then the organic layer was separated and the water phase was extracted with Et2O 
(2*100 mL). Combined extracts were washed with saturated NH4Cl and NaCl solutions, 
dried, evaporated and chromatograhed in 2:1 petroleum/EtOAc (Rf = 0.25). Yield of 1-9: 2.38 
g, 78 % as colorless oil. 1H NMR (400 MHz, CDCl3): [ppm] = 1.40-1.50 (m, 3H, CH2), 
1.57-1.75 (m, 6H, CH2), 1.86-1.97 (m, 2H, CH2), 3.61 (br s, 2H, CH2OH), 3.87-3.98 (m, 4H, 
(CH2O)2), 4.95 (d, 1H, J = 17.7 Hz, CH=CH2), 5.00 (d, 1H, J = 10.9 Hz, CH=CH2), 5.77 (dd, 
J = 17.7, 10.9 Hz, CH=CH2). 
 
2-(1,4-Dioxaspiro[4.5]dec-7-yl)di-ethanol (1-10): BH3·Me2S (94 %, 1 equiv., 1.1 mL) 
was added dropwise to a stirred solution of 2-(7-vinyl-1,4-dioxaspiro[4.5]dec-7-yl)ethanol (1-
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9) (2.3 g, 10.85 mmol) in dry THF (50 mL) at 0 °C. The mixture was stirred at 0 °C for 30 
min, warmed gradually to rt and stirred at rt for 3 h. Then it was cooled to 0 °C and 3N 
solution of NaOH (7.2 mL) and 30% H2O2 (2.3 mL) were added dropwise. The mixture was 
warmed gradually to rt and stirred at rt for 1.5 h. Then the mixture was diluted with Et2O (200 
mL), washed with water and brine, dried over Na2SO4, evaporated and chromatographed, 
eluating with pure EtOAc. The fraction with Rf = 0.4 is the regioisomer 1-11, 400 mg, 16 %, 
colorless oil. Fraction with Rf = 0.2 is the target product 1-10, 1.55 g, 62 %, colorless crystals, 
m.p. 64-65 °C. 1H NMR (400 MHz, CDCl3): [ppm] = 1.30-1.35 (m, 2H, CH2), 1.50-1.66 
(m, 8H, CH2), 1.75-1.84 (m, 2H, CH2), 2.56 (s, 2H, OH), 3.65-3.71 (m, 4H, CH2), 3.87-
3.91(m, 4H, CH2). 
 
2-(1,4-Dioxaspiro[4.5]dec-7-yl)di-(ethyl methanesulfonate) (1-12): To a solution of 
diol 1-10 from the previous reaction (230 mg, 1 mmol) and Et3N (1.4 mL, 10 mmol) in 
CH2Cl2 (10 mL) under N2 MsCl (0.31 mL, 4 mmol) was added dropwise at -50 °C. Then the 
mixture was gradually warmed to rt within 1 h and diluted with Et2O (50 mL), washed with 
water, NaHCO3 and saturated NaCl, dried over Na2SO4 and evaporated. Product 1-12 was 
purified by flash chromatography with petrol ether:EtOAc 1:1 (Rf = 0.2). Yield: 370 mg, 96 
%, Rf 0.7 (EtOAc), colorless oil. 
 
10-Benzyl-1,4-dioxa-10-azadispiro[4.1.5.3]pentadecane (1-13): To the corresponding 
dimesylate 1-12 from the previous reaction (320 mg, 0.83 mmol) in CH3CN (10 mL) BnNH2 
(~4 equiv, 0.36 mL) and Et3N (0.4 mL) were added. The mixture was refluxed under inert 
atmosphere for 3 days. After that, all volatiles were evaporated under vacuum, and Et2O (15 
mL) was added. A crystalline precipitate (probably Et3N·MeSO3H) was filtered off and 
washed twice with 10 mL of Et2O. Et2O was removed under vacuum and the residue 
chromatographed on deactivated (with Et3N) silica gel using petroleum ether:EtOAc 2:1 to 
1:1 (Rf = 0.2-0.3). Isolated yield was 220 mg (88 %) of 1-13 as a colorless oil. 1H NMR (400 
MHz, CDCl3): [ppm] = 1.32-1.39 (m, 2H, CH2), 1.48-1.57 (m, 4H, CH2), 1.58-1.67 (m, 6H, 
CH2), 2.40 (br s, 4H, NCH2), 3.51 (s, 2H, PhCH2), 3.92 (br s, 4H, (CH2O)2), 7.23-734 (m, 5H, 
C6H5). 
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3-Benzyl-8-(3-methoxyphenyl)-3-azaspiro[5.5]undecan-8-ol (1-15): The product 1-13 
from the previous step (200 mg, 0.66 mmol) was dissolved in dioxane (5 mL). HCl (6N, 5 
mL) was added at rt (water bath) and the resulted mixture stirred at rt for 24 h to result in full 
deprotection (by LC/MS) of starting material. Then the mixture was diluted with Et2O (50-80 
mL) and washed with 2M NaOH, saturated NaHCO3 and NaCl, dried over Na2SO4 and 
evaporated to dryness. 
To a Grignard reagent, prepared from 3-bromoanisole (561 mg, 3 mmol) and Mg (80 
mg, 3.3 mmol) in Et2O (6 mL), crude ketone 1-14 in Et2O (2 mL) was added dropwise at 0 
°C. The mixture was allowed to warm to rt within 0.5 h and quenched (ice water bath) with 
half-saturated NH4Cl solution (20 mL). The product was extracted with Et2O, washed with 
NaHCO3 and NaCl, dried over Na2SO4, evaporated and chromatographed on deactivated 
(with Et3N) silica gel using petroleum ether/EtOAc 1:1 (Rf = 0.2-0.3). Yield: 220 mg, 91 % of 
a colorless oil. 
 
8-(3-Methoxyphenyl)-3-azaspiro[5.5]undecan-8-ol (1-16): The benzyl amine 1-15 
from the previous step (180 mg, 0.49 mmol), Pd/C (20 % Pd, 50 mg, 0.094 mmol, ~ 0.2 
equiv.) and ammonium formate (276 mg, 4.37 mmol, ~ 9 equiv.) were refluxed in dry MeOH 
(10 mL) for 1.5 h, then filtered, evaporated and chromatographed, using gradient elution with 
CH2Cl2:MeOH:AcOH 100:10:5 to 100:20:5. The fractions with Rf = 0.5 
(CH2Cl2:MeOH:AcOH 100:20:5) were evaporated and shaken with Et2O and 2N NaOH. The 
organic phase was separated, dried over Na2SO4 and evaporated to obtain the free base of the 
target product 1-16. Yield: 121 mg (90%), colorless oil. 1H NMR (400 MHz, CDCl3): [ppm] 
= 1.02-1.11 (m, 1H, CH2), 1.14-1.28 (m, 2H, CH2), 1.70-1.93 (m, 9H, CH2), 2.68-2.80 (m, 
4H, CH2N), 3.78 (s, OCH3), 6.72-6.77 (m, 1H, Ar), 7.01-7.08 (m, 2H, Ar), 7.23 (br t, 1H, J = 
7.7 Hz, 5-PhH). 
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8-Hydroxy-8-(3-methoxyphenyl)-N-phenyl-3-azaspiro[5.5]undecane-3-
carboxamide (1-17): Et2O (5 mL) was added to 54 mg of the amine 1-16 from the previous 
step followed by addition of PhNCO (0.1 mL, ~ 5 equiv.). The mixture was stirred at rt for 10 
min, during this time all solid was dissolved. The obtained clear solution was concentrated in 
vacuum and chromatographed, eluating with petroleum ether/EtOAc 1:1 (Rf = 0.4). Yield: 75 
mg, (97 %) of the carbamate 1-17 as colorless crystals (m.p. 71-72 °C). 1H NMR (400 MHz, 
CDCl3): [ppm] = 1.14-1.28 (m, 1H, CH2), 1.31-1.41 (m, 2H, CH2), 1.48-1.67 (m, 2H, CH2), 
1.70 (s, OH), 1.78-2.08 (m, 7H, CH2), 3.35-3.55 (m, 4H, CH2N), 3.83 (s, OCH3), 6.48 (s, 2-
PhH), 6.82 (br d, 1H, J = 7.6 Hz, Ar), 6.98-7.12 (m, 3H, Ar), 7.24-7.38 (m, 5H, Ar). 
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2. Synthesis of 7­aryltetralones 
Br O
O
 
2-(3-Bromopropyl)-1,3-dioxolane (2-2):223 DIBAL-H (100 mL of 1 M solution in 
hexane) was added dropwise to to a solution of ethyl 4-bromobutanoate (19.5 g, 0.1 mol) in 
CH2Cl2 (180 mL) under N2 at -70 °C. After stirring for 1 h at –65 to –70 °C the reaction 
mixture was poured into an ice-cold 10 % HCl solution, and the mixture stirred at 0 °C for 1 
h. After separation of the organic layer, the aqueous phase was extracted with CH2Cl2 (2 × 50 
mL). The combined organic phases were washed with water, brine, dried with sodium 
sulphate, filtered, and concentrated in vacuo. The residue (16 g) was dissolved in benzene 
(350 mL), then ethylene glycol (46 g, 0.75 mol) and p-TsOH (0.68 g, 4 mmol) were added, 
followed by refluxing of the mixture with a Dean-Stark trap. After 3 h, the mixture was 
allowed to cool, and NaHCO3 (3 g) were added. After stirring for 10 min, the contents were 
washed with saturated NaHCO3 solution, dried with K2CO3, and filtered. The solvent was 
evaporated and the residue distilled resulting in 17.2 g (88%) of 2-(3-bromopropyl)-1,3-
dioxolane (2-2), b.p. 87-88 °C (10 torr). 1H NMR (400 MHz, CDCl3): [ppm] = 1.72-1.81 
(m, 2H, CH2), 1.90-2.01 (m, 2H, CH2), 3.39 (t, J = 6.7 Hz, 2H, CH2Br), 3.79 (bt, J = 6.8 Hz, 
2H, CH2O), 3.90 (bt, J = 6.8 Hz, 2H, CH2O), 4.83 (t, J = 4.6 Hz, 1H, CH); 13C NMR (100 
MHz, CDCl3): [ppm] = 27.6 (C2), 32.7 (C1), 34.0 (C3), 65.3 (CH2O), 104.1 (CH). 
O
O
O
 
3-[3-(1,3-Dioxolan-2-yl)propyl]cyclohexanone (2-3):224 This compound was prepared 
by CuI-catalyzed conjugate addition of the Grignard reagent derived from 2.225 To Mg 
turnings (0.62 g, 25.4 mmol) in 10 mL THF was added 2-(3-bromopropyl)-1,3-dioxolane 
(2.67 g, 12.6 mmol) at 22-24 °C over a period of 15 min. After being stirred for 1 h, the 
mixture was cooled to –30 °C and CuI (0.2 g, 1.05 mmol) was added at once. The mixtue was 
stirred for 15 min and cooled to –78 °C. Then, a solution of cyclohex-2-en-1-one (0.6 g, 6.24 
mmol) in THF (5 mL) was added dropwise. The mixture was warmed to 0 °C within 1 h and 
quenched with saturated NH4Cl solution (adj pH 8). After stirring for 30 min, the mixture was 
extracted with CH2Cl2, dried, filtered (MgSO4), and concentrated in vacuo. Purification of the 
residue by flash chromatography (hexane/EtOAc, 5:1) afforded 1.22 g (92%) of ketone 2-3 as 
a colorless oil. TLC (hexane/EtOAc, 5.1): Rf 0.2; 1H NMR (400 MHz, CDCl3): [ppm] = 
1.16-2.41 (m, 15H), 3.75-3.92 (m, 4H, CH2O), 4.77 (t, J = 4.8 Hz, 1H, CH); 13C NMR (100 
MHz, CDCl3): [ppm] = 21.5 (CH2), 25.7 (CH2), 31.5 (CH2), 34.3 (CH2), 36.8 (CH2), 39.4 
(CH), 41.9 (-CH2), 48.5 (-CH2), 65.3 (CH2O), 104.8 (CH-O), 212.4 (C=O). 
O
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3,4,4a,5,6,7-Hexahydronaphthalen-1(2H)-one (2-4):224 3-[3-(1,3-Dioxolan-2-
yl)propyl]cyclohexanone (2-3) (1.2 g, 5.66 mmol) was slowly refluxed 3-4 h with 1 N HCl 
(15 mL) and THF (15 mL) (TLC monitoring). After cooling, the solution was neutralized with 
a saturated solution of NaHCO3 solution, and extracted trice with CH2Cl2. The organic layers 
were dried (MgSO4), filtered and concentrated in vacuo. Purification of the residue by flash 
chromatography (hexane/EtOAc, 10:1) furnished the enone 2-4 (721 mg, 85%) as a colorless 
oil. TLC (hexane/EtOAc, 5:1): Rf 0.5; 1H NMR (400 MHz, CDCl3): [ppm] = 1.44-2.54 (m, 
13H), 6.63-6.68 (m, 1H, CH). 13C NMR (100 MHz, CDCl3): [ppm] = 21.8 (CH2), 23.0 
(CH2), 26.6 (CH2), 30.7 (CH2), 32.0 (CH2), 38.2 (CH), 40.6 (CH2), 136.2 (CH=C), 140.3 
(CH=C), 201.5 (C=O). 
O
2-4 2-6
+
(iPr)3SiO(iPr)3SiO
2-5
base
(iPr)3SiOTf1
8
4a
3
5
7
 
General procedure for the synthesis of 2-5 and 2-6: To the solution of enone 2-4 (30 
mg, 0.2 mmol) and amine (0.25 mmol) in dry CH2Cl2 (5 mL) TIPSOTf (69 mg, 0.21 mmol) 
was added dropwise, and the reaction stirred at N2 under the conditions shown in Table 1. 
After completion of the reaction (by TLC), the mixture was diluted with 10% NaHCO3 
solution, extracted with hexane, dried with Na2SO4, filtered, concentrated. The residue was 
purified by filtration through a pad (length 2 cm) of silica gel (1% Et3N in hexane). The yield 
of 2-5 + 2-6 was 80-95 %. However, the isomers could not be separated by column 
chromatography. The ratio of 2-5 and 2-6 was determined by 1H NMR. The assigments of the 
isomers 2-5 and 2-6 was done by comparison of the 1H NMR shifts of the vinylic hydrogens 
with that of similar compounds.226 
tri-Isopropylsilyl 2,3,4,4a,5,6-hexahydro-1-naphthalenyl ether (2-5): colorless oil. 
TLC (hexane): Rf 0.7; 1H NMR (400 MHz, CDCl3): [ppm] = 1.02 (d, J = 6.8 Hz, 18H, 
CH3), 1.07-1.21 (m, 5H), 1.37-1.51 (m, 1H), 1.62-1.79 (m, 3H), 1.96-2.18 (m, 5 H), 5.50-5.56 
(m, 1H, 7-H), 6.50 (d, J = 9.8 Hz, 1H, 8-H); 13C NMR (100 MHz, CDCl3): [ppm] = 13.2 
(CH-Si), 18.1 (d, J = 2.9 Hz, CH-Si), 22.6 (CH2), 25.9 (CH2), 30.6 (CH2), 30.7 (CH2), 30.9 
(CH2), 35.2 (C-4’), 106.2 (C-7), 123.1 (C-8), 135.0 (C’-8), 144.2 (C-1). 
tri-Isopropylsilyl 3,4,4a,5,6,7-hexahydro-1-naphthalenyl ether (2-6): colorless oil. 
TLC (hexane): Rf 0.7. 1H NMR (400 MHz, CDCl3): [ppm] = 1.02 (d, J = 6.8 Hz, 18H, 
CH3), 1.07-1.21 (m, 5H), 1.37-1.51 (m, 1H), 1.62-1.79 (m, 3H), 1.96-2.18 (m, 5H), 4.92 (bd, 
J = 5.1 Hz, 1H, 2-H), 5.96 (bs, 1H, 8-H); 13C NMR (100 MHz, CDCl3): [ppm] = 12.9 (CH-
Si), 18.1 (CH3), 18.2 (CH3), 22.3 (CH2), 24.1 (CH2), 25.7 (CH2), 30.7 (CH2), 30.8 (CH2), 36.3 
(C-4’), 105.8 (C-2), 120.1 (C-8), 135.0 (C’-8), 148.3 (C-1); HRMS (EI): [M]+ calcd for 
C19H34OSi 306.23789, found 306.23548. 
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O
2-7a2-6
+
OTIPSOTIPS
2-5
PhBr, Cs2CO3
Pd(OAc)2, Ph3P
DMF, 100 °C, 12 h
2-5 : 2-6 yield of 2-7a [%]
0 : 100 42
68 : 32 45  
Arylation of 2-5 and 2-6: A flask containing Cs2CO3 (165 mg, 0.5 mmol), and PPh3 
(5.3 mg, 0.02 mmol) was evacuated and flushed with nitrogen for 3 times. Then a solution of 
2-5 + 2-6 (60 mg, 0.2 mmol), PhBr (150 mg, 1.0 mmol) and Pd(OAc)2 (2.23 mg, 0.01 mmol) 
in absolute DMF (1.5 mL) was injected and the mixture stirred at 100 °C for 12 h. After 
completion of the reaction (disappearance of 2-5 + 2-6, TLC-monitoring), the mixture was 
poured onto water, extracted with CH2Cl2, dried (MgSO4), filtered, and concentrated in vacuo. 
The residue was purified by flash chromatography.  
O
ArX, DMF
Pd(OAc)2, PPh3,
Cs2CO3, TBAB, rt
O
Ar
2-4 2-7a-g
1
8
64a
 
General procedure for palladium-catalyzed arylation of 8,9-octal-1-one (2-4): A 
flask containing Cs2CO3 (340 mg, 1.0 mmol), TBAB (128 mg, 0.4 mmol) and PPh3 (10.5 mg, 
0.04 mmol) was evacuated and flushed with nitrogen for 3 times. Then, a solution of enone 2-
4 (60 mg, 0.4 mmol), aryl halide (2.0 mmol) and Pd(OAc)2 (4.45 mg, 0.02 mmol) in degassed 
DMF (2.5 mL) was injected by syringe and the mixture stirred at rt for 3-5 days. After 
completion of the reaction (TLC-monitoring), the mixture was poured onto water and 
extracted with CH2Cl2. The organic layer was dried (MgSO4), filtered, and concentrated in 
vacuo. The residue was purified by flash chromatography. During the optimization studies 
biphenyl (10 mol% based on 2-4) was added as internal standard. 
O
 
7-Phenyl-3,4-dihydronaphthalen-1(2H)-one (2-7a):227 yield 63 mg (71%), colorless 
oil. TLC (hexane/EtOAc, 4:1): Rf 0.55; 1H NMR (400 MHz, CDCl3): [ppm] = 2.06-2.16 (m, 
2H, 3-H), 2.62 (t, J = 6.3 Hz, 2H, 4-H), 2.93 (t, J = 6.1 Hz, 2H, 2-H), 7.24-7.30 (m, 2H, 5-H 
and 4’-H), 7.37 (t, J = 7.6 Hz, 2H, 3’-H), 7.54 (d, J = 7.6 Hz, 2H, 2’-H), 7.64 (dd, J = 7.8, 1.8 
Hz, 1H, 6-H), 8.22 (d, J = 1.8 Hz, 1H, 8-H); 13C NMR (100 MHz, CDCl3): [ppm] = 23.2 (C-
3), 29.4 (C-4), 39.2 (C-2), 125.5, 127.0, 127.5, 128.8, 129.4, 131.9, 132.9, 139.6, 140.0, 
143.4, 198.4 (C-1). 
O
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7-(4-Methylphenyl)-3,4-dihydronaphthalen-1(2H)-one (2-7b):227 yield 48 mg (51%), 
colorless crystals, m.p. 76-77 °C. TLC (hexane/EtOAc, 4:1): Rf 0.6; 1H NMR (400 MHz, 
CDCl3): [ppm] = 2.09 (tt, 2H, J = 6.3 Hz, J = 6.1 Hz, 3-H), 2.32 (s, 3H, CH3), 2.61 (t, 2H, J 
= 6.3 Hz, 4-H), 2.92 (t, 2H, J = 6.1 Hz, 2-H), 7.17 (d, 2H, J = 7.9 Hz, 3´-H), 7.24 (d, 1H, J = 
7.8 Hz, 5-H), 7.45 (d, 2H, J = 7.9 Hz, 2´-H), 7.64 (dd, 1H, J = 7.8, J = 1.8 Hz, 6-H), 8.20 (d, 
1H, J = 1.8 Hz, 8-H); 13C NMR (100 MHz, CDCl3): [ppm] = 21.1 (CH3), 23.3 (C-3), 29.4 
(C-4), 39.2 (C-2), 125.2, 126.8, 129.3, 129.5, 131.7, 132.8, 137.1, 137.4, 139.5, 143.1, 198.4 
(C-1). 
O
OMe
 
7-(4-Methoxyphenyl)-3,4-dihydronaphthalen-1(2H)-one (2-7c):228 yield 62 mg 
(62%), colorless crystals, m.p. 120-121 °C. TLC (hexane/EtOAc, 4:1): Rf 0.3. 1H NMR (400 
MHz, CDCl3): [ppm] = 2.08 (tt, J = 6.3, 6.1 Hz, 2H, 3-H), 2.61 (t, J = 6.3 Hz, 2H, 4-H), 2.91 
(t, J = 6.1 Hz, 2H, 2-H), 3.77 (s, 3H, OCH3), 6.90 (d, J = 8.3 Hz, 2H, 3’-H), 7.23 (d, J = 7.8 
Hz, 1H, 5-H), 7.48 (d, J = 8.3 Hz, 2H, 2’-H), 7.60 (dd, J = 7.8, 1.5 Hz, 1H, 6-H), 8.16 (d, J = 
1.5 Hz, 1H, 8-H); 13C NMR (100 MHz, CDCl3): [ppm] = 23.3 (C-3), 29.4 (C-4), 39.2 (C-2), 
55.3 (OCH3), 114.2, 124.9, 128.0, 129.3, 131.5, 132.5, 132.8, 139.2, 142.7, 159.3 (C-4’), 
198.5 (C-1). 
O
 
7-(4-tert-Butylphenyl)-3,4-dihydronaphthalen-1(2H)-one (2-7d): yield 65 mg (59%), 
colorless oil. TLC (hexane/EtOAc, 4:1): Rf 0.7. 1H NMR (400 MHz, CDCl3): [ppm] = 1.28 
(s, 9H, CH3), 2.09 (tt, J = 6.3, 6.1 Hz, 2H, 3-H), 2.61 (t, J = 6.3 Hz, 2H, 4-H), 2.92 (t, J = 6.1 
Hz, 2H, 2-H), 7.24 (d, J = 7.8 Hz, 1H, 5-H), 7.39 (d, J = 8.6 Hz, 2H, 3’-H), 7.50 (d, J = 8.6 
Hz, 2H, 2’-H), 7.64 (dd, J = 7.8, 1.8 Hz, 1H, 6-H), 8.21 (d, J = 1.8 Hz, 1H, 8-H); 13C NMR 
(100 MHz, CDCl3): [ppm] = 23.3 (C-3), 29.4 (C-4), 31.3 (CH3), 34.5 (CMe3), 39.2 (C-2), 
125.2, 125.8, 126.6, 129.3, 131.8, 132.8, 137.0, 139.4, 143.1, 150.6, 198.4 (C-1); HRMS 
(EI): [M]+ calcd for C20H22O 278.16706, found 278.16580. 
O
NMe2
 
7-[4-(Dimethylamino)phenyl]-3,4-dihydronaphthalen-1(2H)-one (2-7e): yield 50 mg 
(47%), yellowish crystals, m.p. 110-111 °C. TLC (hexane/EtOAc, 4:1): Rf 0.35. 1H NMR 
(400 MHz, CDCl3): [ppm] = 2.07 (tt, J = 6.3, 6.1 Hz, 2H, 3-H), 2.59 (t, J = 6.3 Hz, 2H, 4-H), 
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2.89 (t, J = 6.1 Hz, 2H, 2-H), 2.91 (s, 6H, CH3), 6.71 (d, J = 8.3 Hz, 2H, 3’-H), 7.19 (d, J = 
7.8 Hz, 1H, 5-H), 7.45 (d, J = 8.3 Hz, 2H, 2’-H), 7.60 (dd, J = 7.8, 2.2 Hz, 1H, 6-H), 8.17 (d, 
J = 2.2 Hz, 1H, 8-H); 13C NMR (100 MHz, CDCl3): [ppm] = 23.3 (C-3), 29.3 (C-4), 39.2 
(C-2), 40.5 (CH3), 112.6, 124.2, 127.5, 127.8, 129.2, 131.1, 132.7, 139.6, 142.0, 150.1, 198.6 
(C-1); HRMS (EI): [M]+ calcd for C18H19NO 265.14665, found 265.14554. 
O
CO2Et
 
Ethyl 4-(8-oxo-5,6,7,8-tetrahydronaphthalen-2-yl)benzoate (2-7f): yield 56 mg 
(48%), colorless crystals, m.p. 79-80 °C. TLC (hexane/EtOAc, 4:1): Rf 0.35. 1H NMR (400 
MHz, CDCl3): [ppm] = 1.34 (t, J = 7.1 Hz, 3H, CH3), 2.10 (tt, J = 6.3, 6.1 Hz, 2H, 3-H), 
2.63 (t, J = 6.3 Hz, 2H, 4-H), 2.94 (t, J = 6.1 Hz, 2H, 2-H), 4.31 (q, J = 6.1 Hz, 2H, OCH2), 
7.29 (d, J = 7.8 Hz, 1H, 5-H), 7.61 (d, J = 8.3 Hz, 2H, 2’-H), 7.67 (dd, J = 7.8, 1.8 Hz, 1H, 6-
H), 8.04 (d, J = 8.3 Hz, 2H, 3´-H), 8.24 (d, J = 1.8 Hz, 1H, 8-H); 13C NMR (100 MHz, 
CDCl3): [ppm] = 14.3 (CH3), 23.1 (C-3), 29.4 (C-4), 39.1 (C-2), 61.0 (CH2O), 125.7, 126.8, 
129.5, 129.5, 130.1, 131.9, 132.9, 138.4, 144.3, 166.4 (CO2Et), 198.2 (C-1); HRMS (EI): 
[M]+ calcd for C19H18O3 294.12558, found 294.12690. 
O
 
6,7-Dihydro-2,2'-binaphthalen-8(5H)-one (2-7g): yield 54 mg (50%), colorless 
crystals, m.p. 152 °C. TLC (hexane/EtOAc, 4:): Rf 0.6. 1H NMR (400 MHz, CDCl3): [ppm] 
= 2.08 (tt, J = 6.3, 6.1 Hz, 2H, 3-H), 2.61 (t, J = 6.3 Hz, 2H, 4-H), 2.91 (t, J = 6.1 Hz, 2H, 2-
H), 7.26 (d, J = 7.8 Hz, 1H, 5-H), 7.35-7.45 (m, 2H), 7.67 (dd, J = 7.8, 1.5 Hz, 1H, 6-H), 
7.73-7.85 (m, 4H), 7.98 (s, 1H), 8.33 (d, J = 1.5 Hz, 1H, 8-H); 13C NMR (100 MHz, CDCl3): 
[ppm] = 23.2 (C-3), 29.4 (C-4), 39.2 (C-2), 125.1, 125.6, 125.7, 126.1, 126.3, 127.6, 128.2, 
129.4, 132.1, 133.7, 132.7, 132.9, 133.6, 137.2, 139.4, 143.5, 198.4 (C-1); HRMS (EI): [M]+ 
calcd for C20H16O 272.12011, found 272.1161. 
CHO Br CHO
2-92-8  
3-(4-tert-Butylphenyl)cyclohex-1-ene-1-carbaldehyde (2-9): This compound was 
prepared by the general procedure on a 1 mmol scale, yield 97 mg, 41%, pale yellow oil. TLC 
(hexane/EtOAc, 4:1): Rf 0.6. 1H NMR (400 MHz, CDCl3): [ppm] = 1.32 (s, 9H, (CH3)3), 
1.59-1.69 (m, 2H, CH2), 1.81-1.90 (m, 1H, CH2), 2.05-2.43 (m, 3H, CH2), 3.62 (br s, 1H, C-
3), 6.79 (br s, 1H, 2-H), 7.11 (d, J = 8.2 Hz, 2H, Ar), 7.35 (d, J = 8.2 Hz, 2H, Ar), 9.48 (s, 1H, 
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CHO). 13C NMR (100 MHz, CDCl3): [ppm] = 20.5 (CH2), 21.3 (CH2), 31.3 (CH3), 31.9 
(CH2), 34.4 (C(CH3)3), 42.7 (C-3), 125.6 (Ar), 127.4 (Ar), 140.8, 141.8, 149.7, 153.4 (C-2), 
194.6 (CHO); HRMS (EI): [M]+ calcd for C17H22O 242.1728, found 242.1671. 
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3. Total synthesis of (±)­symbioimine and analogs 
CO2Me
MeO OMe  
Methyl 3,5-dimethoxybenzoate:175 To a mechanically stirred suspension of 3,5-
dihydroxybenzoic acid (100 g, 0.65 mol) and K2CO3 (360 g, 2.6 mol, 4 equiv) in acetone (1 
L) was added dimethyl sulphate (217 mL, 2.3 mol, 3.5 equiv) at room temperature. The 
reaction mixture was vigorously stirred at reflux for 4 h, then cooled to room temperature and 
filtered. The filter solid was rinsed with acetone (2 × 100 mL) and most of the acetone was 
removed with a rotary evaporator. The residue was diluted with 5% NH4OH solution (500 
mL), stirred 5 min, and extracted with Et2O (500 + 2 × 100 mL). The Et2O solution was 
washed with 5% HCl, then with saturated NaHCO3 solution, dried with Na2SO4, filtered and 
evaporated to dryness (10 mbar) at the rotary evaporator. The crude product was dissolved in 
hot MeOH (200 mL), and the solution allowed to cool to 23 °C, followed by slow dropwise 
addition of deionized water (100 mL) inducing crystallization. The crystals were filtered 
through a sintered frit, rinsed on the filter with a cooled (4 °C) mixture of deionized 
water/methanol (1/2), (2 × 100 mL), then dried under vacuum to remove all water; yield 122 g 
(0.624 mol, 96%) as a white powder, m.p. 42 °C. 
MeO OMe
OH
 
(3,5-Dimethoxyphenyl)methanol:175 NaBH4 (26.5 g, 0.70 mol, 5 equiv) was added to a 
solution of methyl 3,5-dimethoxybenzoate (27.46 g, 0.140 mol) in dimethoxyethane (250 
mL). The mixture was heated to reflux and MeOH (125 mL) was slowly added within 2 h 
while keeping the inner temperature above 70 °C. The mixture was refluxed for an additional 
1 h, and then most of the solvent was evaporated. The residue was diluted with Et2O (200 mL) 
and quenched with water (100 mL). The layers were separated and the aqueous layer 
extracted with Et2O. The combined organic layers were washed with water and brine, dried 
with Na2SO4, filtered, and concentrated in vacuo to give pure (by NMR) (3,5-
dimethoxyphenyl)methanol as a colorless oil, which crystallized when stored, yield 23.28 g 
(138.5 mmol, 99%), m.p. 47-47.5 °C. 
MeO OMe
OH
 
3,5-Dimethoxybenzaldehyde:175 To a stirred suspension of pyridinium dichromate 
(45.1 g, 1.2 equiv) in CH2Cl2 (100 mL) was added a solution of (3,5-
dimethoxyphenyl)methanol (16.8 g, 0.1 mol) in CH2Cl2 (50 mL) dropwise at room 
temperature. The mixture was stirred at room temperature for 24 h, and then filtered through a 
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pad of celite. The filter pad was washed with CH2Cl2 (2 × 30 mL). Most of the CH2Cl2 was 
removed under reduced pressure, and the residue was diluted with Et2O (100 mL). The ether 
solution was washed two times with 5% NaOH, then with 5% HCl, saturated NaHCO3 
solution, and finally with brine, followed by drying with Na2SO4 and concentration in vacuo. 
The crude product was dissolved in a minimum amount of hot MeOH, and recrystallized by 
slow addition of deionized water. The crystals were filtered, rinsed with a cold MeOH/H2O 
(1:1) mixture, and then dried under vacuum to remove all water; yield 13.5 g (81 mmol, 81%) 
as colorless crystals, m.p. 46-47 °C. 
MeO OMe
 
1,3-Dimethoxy-5-vinylbenzene (3-4):175 This reaction was performed under an inert 
atmosphere. To a suspension of methyl triphenylphosphonium bromide (23.2 g, 65 mmol, 1.2 
equiv) in dry THF (100 mL), KOtBu (8.5 g, 76 mmol, 1.4 equiv.) was added in one portion. 
The mixture was stirred for 2 h at room temperature, then cooled to -70 to -80 °C followed by 
the dropwise addition of a solution of 3,5-dimethoxybenzaldehyde (9.0 g, 54.2 mmol) in dry 
THF (50 mL) at -70 to -65 °C. Then the cooling bath was removed, and the mixture allowed 
to warm to room temperature. Now, the reaction was quenched with dry MeOH (10 mL). The 
solvents were evaporated under reduced pressure and the residue passed through a short pad 
(4 cm) of silica gel using petroleum ether/ethyl acetate, 15:1 as eluent, to give 8.54 g (52.0 
mmol, 96%) of 3,5-dimethoxystyrene 3-4 as a colorless oil. Rf = 0.45 (petroleum ether/ethyl 
acetate, 10:1). 
 
Methyl (5E)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hex-5-enoate (3-39): 
Catechol borane (13.09 g, 11.64 mL, 110 mmol) was slowly added via syringe to neat 3-38 
(12.6 g, 100 mmol) under inert atmosphere at rt (water bath) with stirring, and stirred at 70 °C 
for 3 h (controlled by TLC, Rf of catechol boronate is 0.5, Hexane/EtOAc 1:1). The resulting 
mixture was cooled to rt, and pinacol (14.16 g, 120 mmol) was added, and the mixture was 
stirred for 3 h at rt. Obtained product was purified by passing through silica gel using 
Hexane/EtOAc 6:1 as eluant (Rf = 0.25). Yield 16.5 g (64.9 mmol, 65%). 
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Methyl (5E,7E)-8-(3,5-dimethoxyphenyl)octa-5,7-dienoate (3-40): To a stirred 
mixture of styrene 3-6 (3.98 g, 24.2 mmol), Pd(OAc)2 (150 mg, 8 mol%) and Na2CO3 (1.92 g, 
17 mmol) in DMF (32 mL) at 45 °C a solution of boronate 3-39 (2.05 g, 8.12 mmol) in DMF 
(8 mL) was added via syringe pump during 24 h, and further stirred for 3 h at this 
temperature. Obtained mixture was cooled to 0 °C, and diluted with ethyl acetate (200 mL), 
washed with water (2×50 mL), dried with Na2SO4, filtered and concentrated. The crude 
product was purified by flash chromatography (Rf 0.3, Hexane/EtOAc, 5:1). Yield of diene 3-
40 was 1.08 g (3.72 mmol, 46%) as colorless crystals (mp. 34-35 °C), or 61% based on 
recovered styrene 3-6. 
 
Dimethyl [(6E,8E)-9-(3,5-dimethoxyphenyl)-2-oxonona-6,8-dien-1-yl]phosphonate 
(3-41): To a solution of MeP(O)(OMe)2 (0.816 mL, 7.6 mmol) in THF (7.5 mL) nBuLi in 
hexane (7.25 mmol, 3 mL of a 2.5M solution) was added dropwise at -78 °C. After the 
mixture was stirred at -78 °C for 1 h, a solution of ester 3-40 (550 mg, 1.896 mmol) in THF (2 
mL) was added dropwise. After 15 min of stirring at -78 °C the reaction was quenched with 
NH4Cl (30 mL of saturated solution) and allowed to warm to rt. The product was extracted 
with EtOAc (3×35 mL), washed with 30 mL of sat. NaCl, dried with Na2SO4 and evaporated. 
Product was purified by flash chromatography through a short column with EtOAc as an 
eluent (Rf 0.35) to provide 695 mg (96%) of ketophosphonate 3-41 as a yellowish oil. 
 
tert-Butyl [(2R,4E,10E,12E)-13-(3,5-dimethoxyphenyl)-2-methyl-6-oxotrideca-
4,10,12-trien-1-yl]carbamate (3A): A mixture of 3-41 (380 mg, 1 mmol) and Ba(OH)2·H2O 
(150 mg, 0.8 mmol) in THF/ H2O (10 mL/0.25 mL) was stirred at rt for 0.5 h. Aldehyde 3-42 
(205 mg, 1.1 mmol) was added dropwise and the resulting mixture was stirred overnight, then 
treated with NH4Cl (20 mL of saturated solution). The product was extracted with EtOAc 
(3×30 mL), washed with 30 mL of sat. NaCl, dried with Na2SO4 and evaporated. Product was 
purified by flash chromatography (Rf = 0.3, Hexane/EtOAc, 2:1) to provide 300 mg (68%) of 
enone 3-17 as a colorless oil. 
OTBS 
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tert-Butyl(dimethyl)(pent-4-ynyloxy)silane (3-5): A solution of TBSCl (59.0 g, 0.394 
mol, 1.1 equiv) in dry DMF (200 mL) was added dropwise to a mixture of pentyn-5-ol (30.0 
g, 0.357 mol) and imidazole (60.4 g, 0.89 mol, 2.5 equiv) at 0 °C. The mixture was stirred at 
room temperature for 12 h, then diluted with water (1 L) and extracted with petroleum ether 
(3 × 200 mL). The extracts were washed with water and brine, dried with Na2SO4, filtered, 
and evaporated in vacuo. The crude silyl ether was distilled at around 65 °C (10 mbar) to 
provide 64 g (90%) of product. Alternatively, it can be passed through a short pad of silica gel 
to yield 70 g (99%) of tert-butyl(dimethyl)(pent-4-ynyloxy)silane 3-5 as a colorless oil. Rf = 
0.85 (petroleum ether/ethyl acetate, 10:1); 1H NMR (400 MHz, CDCl3): [ppm] = 0.04 (s, 
6H, CH3Si), 0.88 (s, 9H, (CH3)3CSi), 1.71 (tt, J = 7.1, 6.1 Hz, 2H, CH2CH2O), 1.91 (t, J = 2.8 
Hz, 1H, HC≡C), 2.26 (td, J = 7.1, 2.8 Hz, 2H, CH2C≡), 3.68 (t, J = 6.1 Hz, 2H, CH2O); 13C 
NMR (100 MHz, CDCl3): [ppm] = -5.4 (CH3Si), 14.8 (CH2C≡), 18.3 ((CH3)3CSi), 25.9 
((CH3)3CSi), 31.5 (CH2CH2O), 61.4 (CH2O), 68.2 (HC≡C-), 84.2 (HC≡C-). 
B OTBS
O
O
1
3 1' 5'  
tert-Butyl(dimethyl){[(4E)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-
enyl]oxy}silane (3-6): To a stirred solution of tert-butyl(dimethyl)(pent-4-ynyloxy)silane (3-
5) (30 g, 0.152 mol) was added dropwise at room temperature catecholborane (19.4 mL, 0.182 
mol, 1.2 equiv) within 1 h under an inert atmosphere. After complete addition, the mixture 
was stirred at 70 °C for 12 h, then cooled to 23 °C, followed by the addition of pinacol (25.0 
g, 0.212 mol, 1.4 equiv). The mixture was stirred for 3 h at room temperature before it was 
diluted with petroleum ether (400 mL) and stirred for 10 min. The precipitate was filtered off 
and the filtrate washed with 5% NaOH (5 × 100 mL) and once with brine. The organic layer 
was dried with Na2SO4, filtered, and evaporated in vacuo. The residue was distilled at 108-
110 °C (0.4 mbar) to give 42 g (85%) of the vinyl boronate 3-6 as a colorless oil. 1H NMR 
(400 MHz, CDCl3): [ppm] = 0.02 (s, 6H, CH3Si), 0.87 (s, 9H, (CH3)3CSi), 1.24 (s, 12H, 
((CH3)2CO)2B-), 1.62 (tt, J = 7.1, 6.3 Hz, 2H, -CH2CH2O-), 2.19 (td, J = 7.1, 6.3 Hz, 2H, -
CH2CH=), 3.59 (t, J = 6.3 Hz, 2H, -CH2O-), 5.43 (d, J = 17.9 Hz, 1H, -CH=CBH), 6.63 (dt, J 
= 17.9, 6.3 Hz, 1H, -CH=CHBpin2); 13C NMR (100 MHz, CDCl3): [ppm] = -5.3 (CH3Si), 
18.3 ((CH3)3CSi), 24.8 (((CH3)2CO)2B-), 25.9 ((CH3)3CSi), 31.3 (CH2), 32.1 (CH2), 62.6 (-
CH2O-), 83.0 (((CH3)2CO)2B-), 118.9 (-HC=CHB-), 154.2 (-HC=CHB-); HRMS (ESI): calcd 
for C17H35BO3Si [M+H]+ 326.25576, found 326.25579. 
OH
OMe
OMe1 4
6
2'
4'
 
(4E,6E)-7-(3,5-Dimethoxyphenyl)hepta-4,6-dien-1-ol (3-7): Solid Na2CO3 (21.2 g, 
0.2 mol) was added in one portion to a stirred solution of 3,5-dimethoxystyrene (3-4) (32.0 g, 
0.195 mol) and Pd(OAc)2 (2.24 g, 10 mmol) in dry DMF (300 mL). Then oxygen was 
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bubbled through the mixture for 10 min. The flask was connected to an oxygen filled rubber 
balloon and the mixture heated to 60 °C. Then, a solution of boronate 6 (32.6 g, 0.1 mol) in 
DMF (50 mL) was added via syringe pump over 12 h while keeping the temperature of the 
flask at 60 °C and the mixture under a positive oxygen pressure. After complete addition, the 
mixture was stirred for an additional 2 h at 60 °C before it was cooled to room temperature. 
The mixture was diluted with EtOAc (500 mL) and poured into ice-cold water (1.5 L). The 
layers were separated, and the aqueous layer was extracted with EtOAc (2 × 200 mL). The 
combined organic extracts were washed with brine, dried over anhydrous Na2SO4, filtered, 
and evaporated in vacuo. The crude diene was filtered through a short pad of silica gel (5% of 
EtOAc in hexane, Rf = 0.4), giving a mixture of unreacted styrene 3-4 together with the TBS-
protected dienol. The solvents were evaporated, and the residue dissolved in MeOH (300 
mL). A solution of concentrated HCl (10 mL), dissolved in MeOH (50 mL) was added 
dropwise to this solution at room temperature. The mixture was stirred for 30 min, then 
MeOH was evaporated in vacuo at room temperature, and EtOAc (100 mL) and water (500 
mL) were added to the residue. The layers were separated and the aqueous phase extracted 
with EtOAc (2 × 100 mL). The combined EtOAc extracts were washed with 5% NaHCO3 and 
with brine, dried over anhydrous Na2SO4, filtered, and evaporated. Flash chromatography of 
the residue (hexane/EtOAc, 2:1) afforded 17.75 g of styrene 3-4 (Rf = 0.7-0.8) and 14.6 g 
(68% based on the recovered styrene 3-4, or 59% based on the reacted boronate 3-6) of 
alcohol 3-7. Rf = 0.2 (hexane/ethyl acetate, 2:1); 1H NMR (400 MHz, CDCl3): [ppm] = 1.69 
(tt, J = 7.1, 6.5 Hz, 2H, 2-H), 2.23 (td, J = 7.3, 7.1 Hz, 2H, -CH2CH=), 3.66 (t, J = 6.5 Hz, 2H, 
-CH2O-), 3.78 (s, 6H, OCH3), 5.82 (dt, J = 15.2, 7.3 Hz, 1H, 4-H), 6.20 (dd, J = 15.2, 10.6 
Hz, 1H, 5-H), 6.33 (t, J = 2.3 Hz, 1H, 4’-H), 6.37 (d, J = 15.7 Hz, 1H, 7-H), 6.52 (d, J = 2.3 
Hz, 2H, 2’-H), 6.72 (dd, J = 15.7, 10.6 Hz, 1H, 6-H); 13C NMR (100 MHz, CDCl3): [ppm] = 
29.1 (CH2), 32.1 (CH2), 55.2 (OCH3), 62.2 (OCH2), 99.5 (C-4’), 104.1 (C-2’), 129.6, 130.3, 
130.8, 135.1, 139.5 (C-1’), 160.8 (C-3’). 
OSO2Me
OMe
OMe1 4
6
2'
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(4E,6E)-7-(3,5-Dimethoxyphenyl)hepta-4,6-dienyl methanesulfonate: MsCl (5.86 
mL, 75 mmol, 1.3 equiv) was added dropwise at -30 °C to a stirred solution of alcohol 3-7 
(14.4 g, 58 mmol) and NEt3 (16.2 mL, 116 mmol, 2 equiv) in dry CH2Cl2 (300 mL) under 
inert atmosphere. The reaction was stirred 1 h at -30 °C, then allowed to warm to room 
temperature and quenched with water (300 mL). After separation of the layers, the aqueous 
phase was extracted with CH2Cl2 (2 × 100 mL). The combined CH2Cl2 extracts were washed 
with brine (2 × 50 mL), dried over anhydrous Na2SO4, filtered, and evaporated. The residue 
was chromatographed through a short pad of silica gel (hexane/EtOAc, 2:1, Rf = 0.25), to 
provide 18.6 g (57 mmol, 98%) of the mesylate. 1H NMR (400 MHz, CDCl3): [ppm] = 1.86 
(tt, J = 7.3, 6.8 Hz, 2H, 2-H), 2.25 (td, J = 7.3, 7.1 Hz, 2H, -CH2CH=), 2.98 (s, 3H, 
OSO2CH3), 3.78 (s, 6H, OCH3), 4.22 (t, J = 6.5 Hz, 2H, 1-H), 5.76 (dt, J = 15.2, 7.3 Hz, 1H, 
4-H), 6.22 (dd, J = 15.2, 10.3 Hz, 1H, 5-H), 6.33 (t, J = 2.3 Hz, 1H, 4’-H), 6.38 (d, J = 15.4 
Hz, 1H, 7-H), 6.52 (d, J = 2.3 Hz, 2H, 2’-H), 6.70 (dd, J = 15.4, 10.3 Hz, 1H, 6-H). 13C NMR 
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(100 MHz, CDCl3): [ppm] = 28.5 (CH2), 28.5 (CH2), 37.2 (OSO2CH3), 55.2 (OCH3), 69.2 
(OCH2), 99.6 (C-4’), 104.1 (C-2’), 129.2, 130.9, 131.7, 133.1, 139.3 (C-1’), 160.8 (C-3’); 
HRMS (ESI): calcd for C16H22O5S [M+H]+ 327.12606, found 327.12610. 
I
OMe
OMe7 4
2
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1-[(1E,3E)-7-Iodohepta-1,3-dienyl]-3,5-dimethoxybenzene (3-8): NaI (45 g, 0.3 mol, 
5.2 equiv) was added in one portion to a stirred solution of the foregoing mesylate (18.6 g, 57 
mmol) in dry acetone (200 mL) under inert atmosphere. The mixture was stirred in the dark 
for 24 h, then diluted with petroleum ether (100 mL) and water (200 mL). The layers were 
separated and the aqueous phase extracted with petroleum ether (100 mL). The combined 
organic layers were washed with brine (2 × 50 mL), dried over Na2SO4, filtered, and 
concentrated in vacuo. The residue was chromatographed through a short pad of silica gel 
(hexane/EtOAc, 10:1, Rf = 0.4), to yield 19.1 g (53.3 mmol, 93%) of the iodide 3-8 as a 
colorless oil. 1H NMR (400 MHz, CDCl3): [ppm] = 1.94 (tt, J = 7.1, 6.8 Hz, 2H, 6’-H), 2.26 
(td, J = 7.1, 6.8 Hz, 2H, 5’-H), 3.20 (t, J = 6.8 Hz, 2H, 7’-H), 3.79 (s, 6H, OCH3), 5.75 (dt, J = 
15.2, 7.1 Hz, 1H, 4’-H), 6.25 (dd, J = 15.2, 10.4 Hz, 1H, 3’-H), 6.34 (t, J = 2.3 Hz, 1H, 4-H), 
6.40 (d, J = 15.7, 1H, 1’-H), 6.53 (d, J = 2.3 Hz, 2H, 2,6-H), 6.71 (dd, J = 15.7, 10.4 Hz, 1H, 
2’-H); 13C NMR (100 MHz, CDCl3): [ppm] = 6.3 (C-7’), 32.7 (CH2), 33.3 (CH2), 55.3 
(OCH3), 99.6 (C-4), 104.2 (C-2,6), 129.4 (=CH-), 130.8 (=CH-), 131.7 (=CH-), 133.2 (=CH-), 
139.4 (C-1), 160.8 (C-3); HRMS (ESI): calcd for C15H19IO2 [M+H]+ 359.05025, found 
359.05007. 
OH
OMeMeO
OMe
OMe
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4
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(2E,8E,10E)-11-(3,5-Dimethoxyphenyl)-1,1-dimethoxyundeca-2,8,10-trien-4-ol (3-
10): To a solution of iodide 3-8 (1.5 g, 4.19 mmol) in dry Et2O (20 mL), prepared under inert 
atmosphere, was added t-BuLi (1.5 M in hexane, 7 mL, 10.5 mmol, 2.5 equiv) in a dropwise 
fashion at -80 °C over 15 min. The mixture was stirred at -80 °C for 0.5 h, then 
fumaraldehyde monodimethyl acetal 3-9176 (0.65 g, 5.0 mmol, 1.2 equiv) in Et2O (5 mL) was 
added dropwise. The mixture was stirred for 15 min at -80 °C, then quenched with half-
saturated NH4Cl solution, and allowed to warm to room temperature. After separation of the 
layers, the water phase was extracted with Et2O (2 × 20 mL). The combined organic layers 
were washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. The residue 
was chromatographed quickly through silica gel (hexane/EtOAc/NEt3, 100:100:1, Rf = 0.35) 
to yield the acetal 3-10 (0.91 g, 3.3 mmol, 60%) as a colorless oil. 1H NMR (400 MHz, 
CDCl3): [ppm] = 1.44-1.68 (m, 2H, H-5,6), 2.15 (q, J = 6.7 Hz, 1H, 7-H), 3.31 (s, 6H, acetal 
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OCH3), 3.78 (s, 6H, OCH3), 4.16 (br s, 1H, 4-H), 4.78 (d, J = 4.8 Hz, 1H, 1-H), 5.65 (ddd, J = 
15.9, 4.8, 1.0 Hz, 1H, 2-H), 5.79 (dt, J = 15.2, 7.1 Hz, 1H, 8-H), 5.88 (dd, J = 15.2, 6.1 Hz, 
1H, 3-H), 6.18 (dd, J = 15.2, 10.4 Hz, 1H, 9-H), 6.33 (t, J = 2.3 Hz, 1H, 4’-H), 6.36 (d, J = 
15.7, 1H, 1’-H), 6.52 (d, J = 2.3 Hz, 2H, 2’,6’-H), 6.70 (dd, J = 15.7, 10.4 Hz, 1H, 10-H); 13C 
NMR (100 MHz, CDCl3): [ppm] = 25.7 (C-6), 32.6 (C-7), 36.5 (C-5), 52.7 (acetal OCH3), 
52.7 (acetal OCH3), 55.3 (OCH3), 71.8 (C-4), 99.6 (C-4’), 102.4 (C-1), 104.2 (C-2’,6’), 126.7 
(C-2), 129.8 (C-10), 130.2 (C-11), 130.8 (C-9), 135.5 (C-8), 137.5 (C-3), 139.6 (C-1’), 160.8 
(C-3’,5’). 
General procedure for silylation and acetal cleavage of 3-10: A solution of TBSCl 
(4.05 g, 27 mmol, 2 equiv) in anhydrous CH2Cl2 (10 mL) was added to a stirred solution of 
alcohol 3-10 (4.89 g, 13.5 mmol) and imidazole (4.66 g, 67.5 mmol, 5 equiv) in CH2Cl2 (40 
mL) under an inert atmosphere within 15 min at 0 °C. The mixture was allowed to reach room 
temperature overnight, then diluted with petroleum ether (150 mL) and washed with 5% 
NaHCO3 and with brine. The organic layer was dried over Na2SO4, filtered, and concentrated 
in vacuo. The residue was dissolved in acetone (300 mL) and Amberlyst-15 (1.5 g) was added 
in one portion. The mixture was stirred at 23 °C for 40 min, then filtered through a pad of 
Na2CO3, and the filtrate was evaporated. The residue was purified by flash chromatography 
(hexane/EtOAc, 10:1, Rf = 0.25) to give 4.8 g (11.16 mmol, 83%) of 3-12c as a colorless oil. 
The corresponding TBDPS and TIPS protected aldehydes 3-12a and 3-12b were prepared by 
the same procedure giving 80% of 3-12a and 75% of 3-12b. 
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(2E,8E,10E)-4-{[tert-Butyl(diphenyl)silyl]oxy}-11-(3,5-dimethoxyphenyl)undeca-
2,8,10-trienal (3-12a): 0.45 mmol scale, yield 203 mg (80%). Rf = 0.2 (hexane/EtOAc, 10:1). 
1H NMR (400 MHz, CDCl3): [ppm] = 1.08 (s, 9H, (CH3)3CSi), 1.24-1.60 (m, 6H, CH2), 
3.80 (s, 6H, OCH3), 4.48 (q, J = 5.1 Hz, 1H, 4-H), 5.67 (dt, J = 15.2, 7.1 Hz, 1H, 8-H), 6.10 
(dd, J = 15.2, 10.6 Hz, 1H, 9-H), 6.25 (ddd, 1H, J = 15.7, 8.1 Hz, J = 1.3 Hz, 1H, 2-H), 6.34 
(t, 1H, J = 2.3 Hz, 1H, 4’-H), 6.35 (d, 1H, J = 15.7, 1H, 11-H), 6.53 (d, 2H, J = 2.3 Hz, 2H, 
2’,6’-H), 6.64-6.70 (m, 2H, 3,10-H), 7.32-7.47 (m, 6H, m,p-PhSi), 7.60 (br d, J = 6.8 Hz, 2H, 
o-PhSi), 7.60 (br d, 2H, J = 6.8 Hz, o-PhSi), 9.45 (d, 1H, J = 8.1 Hz, 1-H); 13C NMR (100 
MHz, CDCl3): [ppm] = 19.3 ((CH3)3CSi), 23.6 (CH2), 27.0 ((CH3)3CSi), 32.5 (CH2), 36.1 
(CH2), 55.3 (OCH3), 72.3 (C-4), 99.6 (C-4’), 104.2 (C-2’), 127.7, 127.7, 129.7, 129.9, 130.3, 
130.8, 131.0, 133.2, 133.5, 135.1, 135.8, 139.6 (C-1’), 159.0 (C-3), 160.9 (C-3’), 193.5 (C-1). 
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(2E,8E,10E)-11-(3,5-Dimethoxyphenyl)-4-[(triisopropylsilyl)oxy]undeca-2,8,10-
trienal (3-12b): 0.105 mmol scale, yield 40 mg (75%). Rf = 0.25 (hexane/EtOAc, 20:1). 1H 
NMR (400 MHz, CDCl3): [ppm] = 1.05 (br s, 21H, iPrSi), 1.34-1.58 (m, 2H, CH2), 1.65-
1.72 (m, 2H, CH2), 2.15 (q, J = 7.1 Hz, 2H, 7-H), 3.78 (s, 6H, OCH3), 4.59 (q, J = 5.1 Hz, 1H, 
4-H), 5.77 (dt, J = 14.9, 7.1 Hz, 1H, 8-H), 6.17 (dd, J = 14.9, 10.6 Hz, 1H, 9-H), 6.28 (dd, J = 
15.6, 7.8 Hz, 1H, 2-H), 6.33 (t, J = 2.3 Hz, 1H, H-4’), 6.37 (d, J = 15.4 Hz, 1H, 11-H), 6.52 
(d, J = 2.3 Hz, 2H, 2’,6’-H), 6.70 (dd, J = 15.4, 10.6 Hz, 1H, 10-H), 6.79 (dd, J = 15.6, 5.1 
Hz, 1H, 3-H), 9.58 (d, J = 7.8 Hz, 1H, 1-H); 13C NMR (100 MHz, CDCl3): [ppm] = 12.3 
((CH3)2CHSi), 18.0 ((CH3)2CHSi), 23.6 (CH2), 32.7 (CH2), 36.8 (CH2), 55.3 (OCH3), 71.6 
(C-4), 99.6 (C-4’), 104.2 (C-2’), 129.6, 130.3, 130.9, 131.0, 135.1, 139.5 (C-1’), 160.0 (C-3), 
160.8 (C-3’,5’), 193.6 (C-1); HRMS (ESI) calcd for C28H44O4Si [M+H]+ 473.30816, found 
473.30817. 
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(2E,8E,10E)-4-{[tert-Butyl(dimethyl)silyl]oxy}-11-(3,5-dimethoxyphenyl)undeca-
2,8,10-trienal (3-12c): 1H NMR (400 MHz, CDCl3): [ppm] = 0.02 (s, 3H, (CH3)2Si), 0.06 
(s, 3H, (CH3)2Si), 0.91 (s, 9H, (CH3)3CSi), 1.43-1.53 (m, 1H, 6-H), 1.56-1.66 (m, 1H, 5-H), 
2.15 (q, 1H, J = 7.1 Hz, 1H, 7-H), 3.78 (s, 6H, OCH3), 4.42 (ddd, J = 5.8, 4.6, 1.5 Hz, 1H, 4-
H), 5.78 (dt, J = 15.2, 7.1 Hz, 1H, 8-H), 6.17 (dd, J = 15.2, 10.6 Hz, 1H, 9-H), 6.25 (ddd, J = 
15.6, 8.1, 1.5 Hz, 1H, 2-H), 6.33 (t, J = 2.3 Hz, 1H, 4’-H), 6.37 (d, J = 15.6, 1H, 11-H), 6.52 
(d, J = 2.3 Hz, 2H, 2’,6’-H), 6.71 (dd, J = 15.6, 10.6 Hz, 1H, 10-H), 6.78 (dd, J = 15.6, 4.6 
Hz, 1H, 3-H), 9.56 (d, J = 8.1 Hz, 1H, 1-H); 13C NMR (100 MHz, CDCl3): [ppm] = -4.9 
((CH3)2Si), -4.7 ((CH3)2Si), 18.1 ((CH3)3CSi), 24.4 (C-6), 25.7 ((CH3)3CSi), 32.6 (C-7), 36.5 
(C-5), 55.3 (OCH3). 71.4 (C-4), 99.6 (C-4’), 104.2 (C-2’,6’), 129.6 (C-10), 130.3 (C-11), 
130.7 (C-2), 130.9 (C-9), 135.2 (C-8), 139.5 (C-1’), 160.0 (C-3), 160.8 (C-3’,5’), 193.6 (C-1). 
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1-(2,2-Dimethyl-1,1-diphenylpropoxy)-8,10-dimethoxy-2,3,4,4a,6a,11,11a,11b-
octahydro-1H-benzo[a]fluoren-11-ol (3-13): To a solution of trienal 3-12a (50 mg, 0.09 
mmol) in dry CH2Cl2 (5 mL) was added MeAlCl2 (1 M in CH2Cl2, 0.1 mL, 1.1 equiv) 
dropwise at -80 °C under inert atmosphere. The mixture was stirred at -80 °C for 3 h, 
quenched with water (20 mL) and allowed to warm to room temperature. The resulting 
mixture was extracted with CH2Cl2 (2 × 20 mL). The combined extracts were washed with 
saturated NaHCO3 solution, dried over over Na2SO4, filtered, and evaporated. The residue 
was purified by flash chromatography (hexane/EtOAc, 4:1, Rf = 0.35) to provide tetracycle 3-
13 (25 mg, 50%) as a colorless oil. 1H NMR (400 MHz, CDCl3): [ppm] = 0.66 (t, J = 11.2 
Hz, 1H, CH), 0.88 (m, 1H, CH2), 1.14 (s, 9H, (CH3)3CSi), 1.24-1.40 (m, 3H), 1.66-1.93 (m, 
3H), 2.55 (br t, J = 11.2 Hz, 1H, 4a-H), 2.63 (dd, J = 12.1, 6.8 Hz, 1H, 11a-H), 3.75 (s, 1H, 
OCH3), 3.77 (s, 1H, OCH3), 3.96 (br s, 1H, 6a-H), 4.35 (s, 1H, 1-H), 4.78 (s, 1H, 11-H), 5.61 
(br d, J = 9.9 Hz, 1H, 5-H), 6.02 (ddd, J = 9.9, 3.8, 3.0 Hz, 1H, 6-H), 6.21 (s, 1H, 9-H), 6.30 
(s, 1H, 7-H), 7.35-7.50 (m, 6H, m-,p-PhSi), 7.75 (br d, J = 6.8 Hz, 2H, o-PhSi), 7.82 (br d, J = 
6.8 Hz, 2H, o-PhSi); 13C NMR (100 MHz, CDCl3): [ppm] = 19.6 ((CH3)3CSi), 20.3 (CH2), 
27.3 ((CH3)3CSi), 33.0 (CH), 33.3 (CH2), 33.5 (CH2), 43.2 (CH), 44.0 (CH), 48.1 (CH), 55.2 
(OCH3), 55.4 (OCH3), 68.4 (C-11), 73.6 (C-1), 96.7 (C-9), 99.6 (C-7), 124.7 (C-6), 127.5, 
127.7, 129.7, 129.9, 133.8 (C-5), 136.2, 136.3, 150.0 (C-6b), 157.5 (C-10), 162.3 (C-8).  
General procedure for the Me2AlCl mediated IMDA reaction: To a stirred solution 
of trienal 3-12c (650 mg, 1.5 mmol) in dry CH2Cl2 (30 mL) at -80 °C was added via syringe 
Me2AlCl (1 M in CH2Cl2, 2.4 mL, 2.4 mmol, 1.6 equiv) within 0.5 h under an inert 
atmosphere. The mixture was stirred for 2.5 h at -80 °C, then treated with MeOH (5 mL) and 
5% NaHCO3 solution (10 mL) at this temperature, followed by warming to room temperature. 
The mixture was diluted with 5% NaHCO3 solution (100 mL) and extracted with Et2O (3 × 50 
mL). The organic extracts were washed with brine, dried over Na2SO4 and concentrated in 
vacuo. The residue was purified by flash chromatography (hexane/EtOAc, 10:1, Rf = 0.25) to 
yield 0.553 g (1.275 mmol, 85%) of cycloadduct 3-14c as colorless crystals. The TIPS- and 
TBDPS-protected IMDA adducts were prepared in a similar fashion.  
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8-{[tert-Butyl(dimethyl)silyl]oxy}-2-(3,5-dimethoxyphenyl)-1,2,4a,5,6,7,8,8a-
octahydronaphthalene-1-carbaldehyde (3-14c): m.p. 65 °C; 1H NMR (400 MHz, CDCl3): 
[ppm] = -0.08 (s, 3H, (CH3)2Si), -0.02 (s, 3H, (CH3)2Si), 0.87 (s, 9H, (CH3)3CSi), 1.20 (qd, J 
= 12.6, 3.8 Hz, 1H, CH2), 1.43 (br t, J = 13.6 Hz, 1H, CH2), 1.54 (br d, J = 13.6 Hz, 1H, CH2), 
1.70-1.90 (m, 3H, CH2), 1.85 (dd, J = 11.6, 10.4 Hz, 1H, 8a-H), 2.43 (br t, J = 10.4 Hz, 1H, 
4a-H), 2.79 (ddd, J = 11.6, 6.8, 4.3 Hz, 1H, 1-H), 3.74 (s, 6H, OCH3), 3.75 (br s, 1H, 2-H), 
3.95 (br s, 1H, 8-H), 5.54 (ddd, J = 9.9, 4.3, 2.8 Hz, 1H, 3-H), 5.74 (br d, J = 9.9 Hz, 1H, 4-
H), 6.29 (d, J = 2.3 Hz, 2H, 2’,6’-H), 6.31 (t, J = 2.3 Hz, 1H, 4’-H), 9.16 (d, J = 4.3 Hz, 1H, 
CHO); 13C NMR (100 MHz, CDCl3): [ppm] = -5.2 (CH3)2Si), -4.2 (CH3)2Si), 18.1 
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((CH3)3CSi), 20.5 (C-6), 25.9 ((CH3)3CSi), 33.1 (C-5), 33.2 (C-4a), 33.9 (C-7), 40.1 (C-8a), 
43.2 (C-2), 51.4 (C-1), 55.2 (OCH3), 67.1 (C-8), 98.7 (C-4’), 108.1 (C-2’,6’), 125.9 (C-4), 
133.9 (C-3), 141.7 (C-1’), 160.6 (C-3’,5’), 205.9 (CHO); HRMS (ESI): calcd for C25H38O4Si 
[M+Na]+ 453.24316, found 453.24298. 
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8-{[tert-Butyl(diphenyl)silyl]oxy}-2-(3,5-dimethoxyphenyl)-1,2,4a,5,6,7,8,8a-
octahydronaphthalene-1-carbaldehyde (3-14a): m.p. 109 °C; 1H NMR (400 MHz, CDCl3): 
[ppm] = 1.06 (s, 9H, (CH3)3CSi), 1.14-1.30 (m, 2H, CH2), 1.47 (br d, J = 13.1 Hz, 1H, CH2), 
1.64 (br d, J = 13.9 Hz, 1H, CH2), 1.80 (t, J = 10.9 Hz, 1H, 8a-H), 1.83-1.94 (m, 2H, CH2), 
2.61 (br dd, J = 12.4, 10.9 Hz, 1H, 4a-H), 2.95 (ddd, J = 11.4, 6.6, 3.6 Hz, 1H, 1-H), 3.70 (s, 
6H, OCH3), 3.77 (br s, 1H, 2-H), 4.07 (br s, 1H, 8-H), 5.57 (ddd, J = 9.9, 4.3, 2.8 Hz, 1H, 3-
H), 5.77 (br d, J = 9.9 Hz, 1H, 4-H), 6.22 (d, J = 2.3 Hz, 2H, 2’,6’-H), 6.26 (t, J = 2.3 Hz, 1H, 
4’-H), 7.30-7.42 (m, 6H, m-,p-PhSi), 7.57-7.64 (m, 4H, o-PhSi), 8.88 (d, J = 3.6 Hz, 1H, 
CHO); 13C NMR (100 MHz, CDCl3): [ppm] = 19.5 ((CH3)3CSi), 20.8 (CH2), 27.2 
((CH3)3CSi), 33.2 (CH2), 33.3 (CH2), 33.4 (C-4a), 40.3 (C-8a), 43.2 (C-2), 51.1 (C-1), 55.2 
(OCH3), 68.6 (C-8), 98.6 (C-4’), 108.2 (C-2’,6’), 126.1 (C-3), 127.3, 127.4, 129.5, 129.7, 
133.3, 133.7 (C-4), 134.6, 136.0, 136.13, 141.6 (C-1’), 160.5 (C-3’,5’), 204.7 (CHO). 
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2-(3,5-Dimethoxyphenyl)-8-[(triisopropylsilyl)oxy]-1,2,4a,5,6,7,8,8a-octahydro-
naphthalene-1-carbaldehyde (3-14b): colorless oil; 1H NMR (400 MHz, CDCl3): [ppm] = 
1.02 (br s, 21H, iPr3Si), 1.22 (qd, J = 12.6, 3.8 Hz, 1H, CH2), 1.43-1.59 (m, 2H, CH2), 1.78-
1.92 (m, 4H), 2.47 (br dd, J = 12.4, 10.6 Hz, 1H, 4a-H), 2.89 (ddd, J = 11.4, 6.6, 4.1 Hz, 1H, 
1-H), 3.74 (s, 6H, OCH3), 3.77 (m, 2-H), 4.16 (s, 1H, 8-H), 5.56 (ddd, J = 9.9, 4.6, 2.8 Hz, 
1H, 3-H), 5.75 (br d, J = 9.9 Hz, 1H, 4-H), 6.29 (d, J = 2.3 Hz, 2H, 2’,6’-H), 6.31 (t, J = 2.3 
Hz, 1H, 4’-H), 9.25 (d, J = 4.1 Hz, 1H, CHO); 13C NMR (100 MHz, CDCl3): [ppm] = 12.9 
((CH3)2CHSi), 18.3 ((CH3)2CHSi), 20.9 (CH2), 32.9 (C-4a), 33.2 (CH2), 34.2 (CH2), 40.6 (C-
8a), 43.3 (C-2), 51.3 (C-1), 55.2 (OCH3), 67.6 (C-8), 98.8 (C-4’), 108.2 (C-2’,6’), 125.8 (C-
3), 133.9 (C-4), 141.6 (C-1’), 160.6 (C-3’,5’), 206.0 (CHO). 
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4S,4aS,5R,6S,8aR)-4-{[Tert-Butyl(dimethyl)silyl]oxy}-6-(3,5-dimethoxyphenyl)-5-
[(E)-2-nitrovinyl]-1,2,3,4,4a,5,6,8a-octahydronaphthalene: A mixture of aldehyde 3-14c 
(20 mg, 0.046 mmol) and NH4OAc (20 mg) in MeNO2 (1 mL) was stirred at 60 °C for 24 h 
under an inert atmosphere. Thereafter, excess MeNO2 was evaporated under reduced pressure 
and the residue purified by flash chromatography (hexane/EtOAc, 10:1, Rf = 0.3) to provide 
19 mg (0.04 mmol, 88%) of nitroalkene as a colorless oil. 1H NMR (400 MHz, CDCl3): 
[ppm] = -0.03 (s, 3H, (CH3)2Si), -0.03 (s, 3H, (CH3)2Si), 0.84 (s, 9H, (CH3)3CSi), 1.05-1.15 
(m, 1H, CH2), 1.24-1.61 (m, 3H, CH2), 1.70 (br d, J = 12.9 Hz, 1H, CH2), 1.77 (ddd, J = 13.1, 
3.8, 3.5 Hz, 1H, 4-H), 1.93 (br d, J = 12.9 Hz, 1H, CH2), 2.49 (dd, J = 13.1, 11.4 Hz, 1H, 9-
H), 2.55 (br d, J = 9.9 Hz, 1H, 3-H), 3.28 (d, J = 3.8 Hz, 1H, 5-H), 3.79 (br s, 7H, H-12, 
OCH3), 5.58 (ddd, J = 9.9, 4.6, 2.8 Hz, 1H, 11-H), 5.84 (br d, J = 9.9 Hz, 1H, 10-H), 6.36 (s, 
3H, 16,14-H), 7.11 (d, J = 13.6 Hz, 1H, 1-H), 7.67 (dd, J = 13.6, 9.9 Hz, 1H, 2-H); 13C NMR 
(100 MHz, CDCl3): [ppm] =-4.2 ((CH3)2Si), -4.1 ((CH3)2Si), 18.1 ((CH3)3CSi), 20.5 (CH2), 
25.9 ((CH3)3CSi), 31.0 (CH), 32.9 (CH2), 34.1 (CH2), 43.1 (CH), 45.6 (CH), 49.3 (CH), 55.4 
(OCH3), 71.1 (C-5), 98.4 (C-16), 107.1 (C-14), 124.1 (C-11), 135.0 (C-10), 139.0 (C-2), 
145.3 (C-13), 146.9 (C-1), 160.8 (C-15). 
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4-{[tert-Butyl(dimethyl)silyl]oxy}-6-(3,5-dimethoxyphenyl)-5-[(1S)-1-methyl-2-
nitroethyl]-1,2,3,4,4a,5,6,8a-octahydronaphthalene (3-15): A solution of the foregoing 
nitroalkene (180 mg, 0.38 mmol) in dry Et2O (5 mL) was slowly added to a stirred solution of 
MeMgBr (3 M in Et2O, 2 mL, 6 mmol) in Et2O (12 mL) at -80 °C under inert atmosphere. 
The reaction was stirred at -80 °C for 3 h, then quenched with a 10% solution of glacial acetic 
acid in dry Et2O (10 mL) and allowed to warm to 0 °C. Saturated NaHCO3 solution (20 mL) 
was then added, the mixture stirred for 30 min at room temperature, and then extracted with 
Et2O (3 × 20 mL). The combined organic extracts were washed with brine, dried over 
Na2SO4, filtered, and evaporated. The residue was purified by flash chromatography 
(hexane/EtOAc, 10:1, Rf = 0.35) to give 0.148 g (0.30 mmol, 80%) of the nitro compound 3-
15 as a colorless oil. 1H NMR (400 MHz, CDCl3): [ppm] = 0.08 (s, 3H, (CH3)2Si), 0.12 (s, 
3H, (CH3)2Si), 0.92 (s, 9H, (CH3)3CSi), 1.00 (d, J = 7.1 Hz, 3H, CH3), 1.01-1.07 (m, 1H, 
CH2), 1.30 (br t, J = 11.4 Hz, 1H, CH2), 1.48-1.57 (m, 2H, 3-H, CH2), 1.65 (br d, J = 3.5 Hz, 
1H, CH2), 1.75 (br d, J = 15.6 Hz, 1H, CH2), 1.83 (ddd, J = 13.1, 4.6, 3.5 Hz, 1H, 4-H), 1.90 
(br d, J = 13.9 Hz, 1H, CH2), 2.56 (br t, J = 11.4 Hz, 1H, 9-H), 3.17 (d, J = 4.6 Hz, 1H, 12-H), 
3.52 (q, J = 7.1 Hz, 1H, 2-H), 3.78 (s, 6H, OCH3), 3.90 (br s, 1H, 5-H), 4.36 (dd, J = 11.6, 7.1 
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Hz, 1H, 1-H), 4.55 (dd, J = 11.6, 8.9 Hz, 1H, 1-H), 5.60 (ddd, J = 9.9, 4.6, 2.1 Hz, 1H, 11-H), 
5.78 (br d, J = 9.9 Hz, 1H, 10-H), 6.30 (t, J = 2.3 Hz, 1H, 16-H), 6.35 (d, J = 2.3 Hz, 2H, 14-
H); 13C NMR (100 MHz, CDCl3): [ppm] = -5.0 (C-18), -3.2 (C-18), 14.6 (C-21), 18.3 (C-
19), 20.3 (CH2), 26.1 (C-20), 31.5 (CH), 32.9 (CH), 34.4 (CH2), 35.0 (CH2), 41.4 (CH), 43.0 
(CH), 46.2 (CH), 55.3 (OCH3), 72.0 (C-5), 81.8 (C-1), 98.1 (C-16), 106.6 (C-14), 126.2 (C-
11), 134.8 (C-10), 147.4 (C-13), 160.6 (C-15). 
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4-(3,5-Dimethoxyphenyl)-3-methyl-3a,4,6a,7,8,9,9a,9b-
octahydrobenzo[de]chromen-2(3H)-one (3-16): To a solution of nitro compound 3-15 (48 
mg, 0.098 mmol) in THF (1 mL) was added TBAF (1 M in THF, 1 mL), and the mixture was 
stirred for 24 h at room temperature. It was diluted with water (25 mL) and extracted with 
Et2O (3 × 15 mL). The combined organic extracts were washed with brine, dried over 
Na2SO4, filtered, and concentrated in vacuo. The crude product was dissolved in 
dichloromethane (2 mL), PDC (200 mg) was added and the mixture stirred at room 
temperature for 24 h. Then, the mixture was diluted with Et2O (30 mL), washed with water 
and brine. The organic layer was dried over Na2SO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (hexane/EtOAc, 4:1, Rf = 0.3) to provide 21 
mg (0.062 mmol, 65%) of lactone 3-16 as colorless crystals, m.p. 153-155 °C. 1H NMR (400 
MHz, CDCl3): [ppm] = 1.14 (qd, J = 12.1, 4.6 Hz, 1H, CH2), 1.52 (d, J = 7.1 Hz, 3H, CH3), 
1.46-1.72 (m, 4H), 1.79 (dd, J = 11.4, 3.0 Hz, 1H, CH), 1.89 (dd, J = 12.6, 2.0 Hz, 1H, CH2), 
2.03 (br d, J = 14.7 Hz, 1H, CH2), 2.13 (br t, J = 11.9 Hz, 1H, 9-H), 2.43 (qd, J = 7.1, 4.5 Hz, 
1H, 2-H), 3.26 (br s, 1H, 12-H), 3.79 (s, 6H, OCH3), 4.30-4.34 (br s, 1H, 5-H), 5.59 (dt, J = 
9.9, 3.0 Hz, 1H, 11-H), 5.80 (br d, J = 9.9 Hz, 1H, 10-H), 6.34 (t, J = 2.3 Hz, 1H, 16-H), 6.37 
(d, J = 2.3 Hz, 2H, 14-H); 13C NMR (100 MHz, CDCl3): [ppm] = 16.2 (C-19), 21.0 (CH2), 
30.0 (CH), 30.7 (CH2), 31.3 (CH2), 36.0 (CH), 37.1 (CH), 44.2 (CH), 46.3 (CH), 55.3 
(OCH3), 78.4 (C-5), 97.7 (C-16), 106.5 (C-14), 125.9 (C-10), 132.3 (C-11), 146.8 (C-16), 
160.9 (C-15,17), 174.9 (C-1). 
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tert-Butyl-2-[2-(3,5-dimethoxyphenyl)-8-hydroxy-1,2,4a,5,6,7,8,8a-
octahydronaphthalen-1-yl]propylcarbamate (3-17): A solution of nitro compound 3-15 
(100 mg, 0.204 mmol) in dry THF (5 mL) was added dropwise at -30 °C to a stirred mixture 
of LiAlH4 (200 mg) in THF (2 mL) under an inert atmosphere within 20 min. Subsequently, 
the mixture was stirred at room temperature for 12 h and, finally refluxed for 1 h. Then the 
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mixture was cooled to 0 °C and treated with i-PrOH (3 mL). The resulting mixture was 
diluted with Et2O and filtered through celite. The filtrate was concentrated and the crude 
amine dissolved in MeOH (10 mL). Then, NEt3 (1 mL) and Boc2O (0.7 g) were added 
sequentially at 0 °C and the mixture stirred at room temperature for 0.5 h. The MeOH was 
evaporated under reduced pressure and the residue diluted with Et2O, washed with KHSO4 (1 
M) and with brine. The organic layer was dried over Na2SO4, filtered, and concentrated in 
vacuo. The residue was purified by flash chromatography (hexane/EtOAc, 10:1, Rf = 0.35). 
The obtained carbamate was dissolved in THF (5mL) and TBAF (1 M in THF, 5 mL) was 
added dropwise. The mixture was heated to 60 °C for 48 h under an inert atmosphere, then 
diluted with water (50 mL), and extracted with Et2O (3 × 30 mL). The combined organic 
layers were washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (hexane/EtOAc, 4:1, Rf = 0.15) to give 50 mg 
(0.112 mmol, 55% from 3-15) of carbamate 3-17 as a colorless oil. 1H NMR (400 MHz, 
CDCl3): [ppm] = 0.95 (d, J = 7.1 Hz, 3H, CH3), 1.04 (qd, J = 12.4, 3.5 Hz, 1H, CH2), 1.41 
(s, 9H, t-Bu), 1.46-1.91 (m, 6H), 2.44 (br dd, J = 11.6, 11.1 Hz, 1H, 9-H), 2.65 (qd, J = 7.1, 
2.0 Hz, 1H, 2-H), 2.97-3.06 (m, 1H, 1-H), 3.20-3.30 (m, 2H, 1,3-H), 3.79 (s, 6H, OCH3), 3.85 
(br s, 1H, 12-H), 4.77 (s, 1H, 5-H), 5.60 (dt, J = 9.9, 3.0 Hz, 1H, 11-H), 5.75 (br d, J = 9.9 Hz, 
1H, 10-H), 6.29 (t, J = 2.3 Hz, 1H, 16-H), 6.37 (d, J = 2.3 Hz, 2H, 14-H); 13C NMR (100 
MHz, CDCl3): [ppm] = 15.6 (C-19), 20.2 (CH2), 28.4 (CH3)3C), 30.9 (CH), 32.7 (CH), 33.9 
(CH2), 35.6 (CH2), 42.0 (CH), 46.6 (CH), 47.7 (C-1), 55.3 (OCH3), 71.1 (C-5), 79.2 
(CH3)3C), 97.7 (C-16), 106.9 (C-14), 127.0 (C-11), 134.7 (C-10), 148.4 (C-13), 156.4 (C=O), 
160.5 (C-15). 
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Epi-symbioimine analog, 4-(3,5-dimethoxyphenyl)-3-methyl-2,3a,4,6a,7,8,9,9b-
octahydro-3H-benzo[de]quinoline (3-18): PDC (200 mg) was added to a solution of alcohol 
3-17 (50 mg, 0.112 mmol) in CH2Cl2 (5 mL) and the mixture stirred for 24 h at room 
temperature. It was diluted with Et2O and filtered through silica gel. The resulting solution 
was concentrated under reduced pressure and subjected to flash chromatography 
(hexane/EtOAc, 4:1, Rf = 0.25). The obtained ketone seems not to be all too stable, for 
example it quickly decomposes in CDCl3. For the hydrolysis of the carbamate, AcCl (3 drops) 
was added to dry MeOH (5 mL) to generate an anhydrous solution of HCl. This solution was 
added to the previously obtained ketone, and the mixture refluxed for 0.5 h. Then, NEt3 (0.2 
mL) was added and the solution concentrated under reduced pressure. The residue was 
purified by flash chromatography (EtOAc/NEt3, 100:1, Rf = 0.5 in MeOH, 0.05 in EtOAc) to 
give 27 mg (0.086 mmol, 80%) of imine 3-18 as a colorless oil. 1H NMR (400 MHz, CDCl3): 
[ppm] = 1.08 (d, J = 6.3 Hz, 3H, CH3), 1.38-1.52 (m, 1H, 8a-H), 1.59-1.69 (m, 1H, 7a-H), 
1.65 (br d, J = 13.4 Hz, 1H, 3-H), 1.68-1.82 (m, 1H, 2-H), 1.95-2.13 (m, 4H, 4,7b,8b,9-H), 
2.22 (tdd, J = 12.6, 5.3, 3.1 Hz, 1H, 6a-H), 2.35 (dd, J = 12.1, 3.8 Hz, 1H, 6b-H), 3.00 (ddd, J 
= 16.9, 10.6, 2.8 Hz, 1H, 1a-H), 3.47 (br s, 1H, 12-H), 3.72 (dd, J = 16.9, 4.5 Hz, 1H, 1b-H), 
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3.78 (s, 6H, OCH3), 5.61 (br d, J = 10.2 Hz, 1H, 11-H), 5.73 (d, J = 10.2 Hz, 1H, 10-H), 6.31 
(t, J = 2.3 Hz, 1H, 16-H), 6.36 (d, J = 2.3 Hz, 2H, 14,18-H); 13C NMR (100 MHz, CDCl3): 
[ppm] = 16.90 (CH3), 27.6 (C-2), 28.1 (C-7), 33.2 (C-8), 39.0 (C-6), 39.6 (C-4), 40.5 (C-12), 
41.7 (C-9), 44.0 (C-3), 55.3 (OCH3), 58.3 (C-1), 97.4 (C-16), 106.3 (C-14), 127.4 (C-10), 
130.6 (C-11), 148.9 (C-13), 160.8 (C-15), 175.3 (C-5). 
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4-{[tert-Butyl(dimethyl)silyl]oxy}-6-(3,5-dimethoxyphenyl)-5-[(E)-2-methoxyvinyl]-
1,2,3,4,4a,5,6,8a-octahydronaphthalene (3-19): To a stirred slurry of methoxymethyl 
triphenylphosphonium chloride (600 mg, 1.75 mmol) in dry THF (5 mL), a solution of 
NaN(SiMe3)2 (275 mg, 1.5 mmol) in THF (3 mL) was added dropwise at 0 °C under an inert 
atmosphere. The deep red solution was stirred at 0 °C for 10 min then cooled to -50 °C. At 
this point, aldehyde 3-14c (215 mg, 0.5 mmol) in THF (2 mL) was added -50 °C. Then the 
mixture was heated to 0 °C for 30 min, cooled and treated with saturated NH4Cl solution (20 
mL) and extracted with petroleum ether (3 × 25 mL). The combined organic extracts were 
washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. The residue was 
purified by flash chromatography (hexane/EtOAc, 10:1, Rf = 0.3) to give 159 mg (0.35 mmol, 
70%) of enol ether 3-19 as a 30:70 mixture of cis/trans isomers as a colorless oil. 13C NMR 
(100 MHz, CDCl3): [ppm] = -5.2, -4.0, -3.5, 18.2, 18.3, 20.6, 20.7, 25.9, 26.1, 33.5, 33.5, 
34.2, 34.3, 34.4, 34.9, 38.9, 43.7, 43.9, 45.8, 49.2, 55.2, 55.2, 55.3, 59.2, 67.3, 67.4, 97.6, 
98.1, 103.9, 107.5, 109.1, 109.2, 127.3, 127.4, 133.5, 133.8, 143.8, 144.6, 146.0, 159.6, 159.8; 
HRMS (ESI) calcd C27H42O4Si [M+H]+ 459.29251, found 459.29309. 
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4-{[tert-Butyl(dimethyl)silyl]oxy}-7,9-dimethoxy-1,2,3,4,4a,4b,10b,12a-
octahydrochrysene (3-20): To the enol ether 3-19 (142 mg, 0.31 mmol) in acetone (10 mL) 
was added Amberlyst-15 (400 mg), and the mixture stirred at room temperature for 24 h. The 
resulting solution was filtered through a pad of dry Na2CO3, and the filtrate concentrated 
under reduced pressure. The residue was subjected to flash chromatography (hexane/EtOAc, 
10:1, Rf = 0.45) to furnish tetracycle 3-20 (69 mg, 0.16 mmol, 52%) as colorless crystals, 
m.p. 138-140 °C. Further elution with hexane/EtOAc, 4:1, Rf = 0.3 gave the corresponding 
alcohol 3-22 (30 mg, 0.096 mmol, 31%) as colorless crystals, m.p. 153-155 °C. 1H NMR 
(400 MHz, CDCl3): [ppm] = 0.07 (s, 3H, (CH3)2Si), 0.12 (s, 3H, (CH3)2Si), 0.93 (s, 9H, 
(CH3)3CSi), 0.83-0.98 (m, 1H, CH2), 1.17-1.28 (m, 2H, CH, CH2), 1.35-1.45 (m, 1H, CH2), 
1.64-1.72 (m, 2H, CH2), 2.36-2.47 (m, 2H, CH), 3.53 (br t, J = 5.6 Hz, 1H, 12-H), 3.80 (s, 3H, 
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OCH3), 3.81 (s, 3H, OCH3), 4.08 (br s, 1H, 5-H), 5.68 (d, J = 9.9 Hz, 1H, 10-H), 5.96 (dd, J = 
10.1, 6.1 Hz, 1H, 2-H), 6.13 (ddd, J = 9.9, 5.6, 2.5 Hz, 1H, 11-H), 6.28 (d, J = 2.0 Hz, 1H, 16-
H), 6.45 (br s, 1H, 14-H), 6.78 (d, J = 10.1 Hz, 1H, 1-H); 13C NMR (100 MHz, CDCl3): 
[ppm] = -5.1 (CH3)2Si), -3.6 (CH3)2Si), 18.2 (CH3)3CSi), 20.5 (CH2), 25.9 (CH3)3CSi), 32.4 
(CH2), 33.7 (CH2), 34.4 (CH), 35.3 (CH), 37.8 (C-12), 43.6 (CH), 55.2 (OCH3), 55.5 (OCH3), 
67.1 (C-5), 95.4 (C-16), 104.5 (C-14), 115.0 (C-18), 120.6 (C-1), 125.1 (C-11), 127.1 (C-2), 
134.5 (C-10), 141.2 (C-13), 155.4 (C-17), 159.7 (C-15); HRMS (ESI) calcd for C26H38O3Si 
[M+H]+ 427.26630, found 427.26643. 
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7-(3,5-Dimethoxyphenyl)-8-[(E)-2-methoxyvinyl]-1,2,3,4,4a,7,8,8a-
octahydronaphthalen-1-ol (3-21): To a stirred solution of silyl ether 3-19 (70 mg, 0.15 
mmol) in THF (1 mL), TBAF (1 M in THF, 2 mL) was added dropwise, and the mixture 
heated to 50 °C for 24 h under inert atmosphere. Then the mixture was diluted with water and 
extracted with Et2O. The ether extracts were washed with brine, dried over Na2SO4, filtered, 
and concentrated in vacuo. The residue was purified by flash chromatography 
(hexane/EtOAc, 4:1, Rf = 0.2) to yield 44 mg (0.127 mmol, 85%) of alcohol 3-21 as a single 
E-isomer (enol ether double bond). 1H NMR (400 MHz, CDCl3): [ppm] = 1.06-1.17 (m, 1H, 
CH2), 1.24-1.43 (m, 2H, 4-H, CH2), 1.53-1.85 (m, 4H, CH2), 2.35 (br dd, J = 12.4, 10.9 Hz, 
1H, 9-H), 2.49 (ddd, J = 10.9, 6.4, 5.6 Hz, 1H, 3-H), 3.33 (br dd, J = 5.6, 4.6 Hz, 1H, 12-H), 
3.38 (s, 3H, OCH3), 3.76 (s, 6H, OCH3), 3.85 (br s, 1H, 5-H), 4.02 (dd, J = 12.9, 10.9 Hz, 1H, 
2-H), 5.58 (ddd, J = 9.9, 4.6, 2.8 Hz, 1H, 11-H), 5.73 (br d, J = 9.9 Hz, 1H, 10-H), 6.33 (s, 
3H, 14,16-H), 6.43 (d, J = 12.9 Hz, 1H, 1-H); 13C NMR (100 MHz, CDCl3): [ppm] = 20.6 
(CH2), 33.0 (CH2), 33.2 (CH2), 34.8 (C-9), 39.6 (C-3), 42.3 (C-4), 48.8 (C-12), 55.2 (OCH3), 
55.6 (OCH3), 66.3 (C-5), 98.2 (C-16), 103.8 (C-2), 109.0 (C-14), 127.5 (C-11), 133.6 (C-10), 
143.3 (C-13), 146.4 (C-1), 159.9 (C-15).  
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7,9-Dimethoxy-1,2,3,4,4a,4b,10b,12a-octahydrochrysen-4-ol (3-22): A mixture of the 
enol ether 3-21 (25 mg, 0.072 mmol) and Amberlyst-15 (100 mg) in acetone (2 mL) and 
water (0.07 mL) was stirred for 24 h at room temperature. The resulting mixture was worked 
up as described previously to give (18 mg, 0.058 mmol, 80%) of the tetracycle 3-22. Rf = 0.3 
(petroleum ether/ethyl acetate, 4:1), colorless crystals, m.p. 153-155 °C. 1H NMR (400 MHz, 
CDCl3): [ppm] = 0.84-0.94 (m, 1H, CH2), 1.23-1.31 (m, 2H, 4-H, CH2), 1.38-1.47 (br d, 1H, 
CH2), 1.53-1.68 (m, 3H, CH2), 2.21 (br dd, J = 11.9, 11.6 Hz, 1H, 9-H), 2.40 (ddd, J = 10.9, 
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6.8, 5.8 Hz, 1H, 3-H), 3.50 (br dd, J = 5.8, 5.6 Hz, 1H, 12-H), 3.74 (s, 6H, OCH3), 4.03 (d, J = 
2.3 Hz, 1H, 5-H), 5.65 (d, J = 9.9 Hz, 1H, 10-H), 5.94 (dd, J = 10.1, 6.3 Hz, 1H, 2-H), 6.08 
(ddd, J = 9.9, 5.6, 2.5 Hz, 1H, 11-H), 6.21 (d, J = 2.0 Hz, 1H, 16-H), 6.38 (br s, 1H, 14-H), 
6.73 (d, J = 10.1 Hz, 1H, 1-H); 13C NMR (100 MHz, CDCl3): [ppm] = 20.4 (CH2), 32.2 
(CH2), 33.5 (CH2), 34.6 (C-3), 35.4 (C-9), 37.8 (C-12), 42.5 (C-4), 55.3 (OCH3), 55.5 (C-19), 
66.3 (C-5), 95.5 (C-16), 104.5 (C-14), 114.8 (C-18), 120.8 (C-1), 125.5 (C-11), 126.4 (C-2), 
133.9 (C-10), 140.7 (C-13), 155.5 (C-17), 159.8 (C-15); HRMS (ESI) calcd for C20H24O3 
[M+H]+ 313.17982, found 313.17978. 
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[8-{[tert-Butyl(dimethyl)silyl]oxy}-2-(3,5-dimethoxyphenyl)-1,2,4a,5,6,7,8,8a-
octahydronaphthalen-1-yl]methanol: NaBH4 (74 mg, 2.0 mmol, 4 equiv) was added to a 
stirred solution of aldehyde 3-14c (215 mg, 0.5 mmol) in EtOH (2 mL) at 0 °C. The mixture 
was stirred at room temperature until the starting material had disappeared (24 h). Thereafter, 
the mixture was diluted with water (10 mL) and petroleum ether (50 mL). Then saturated 
NH4Cl (10 mL) was added dropwise to destroy the excess borohydride. The mixture was 
extracted with Et2O (3 × 25 mL). The combined organic layers were washed with brine, dried 
over Na2SO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (hexane/EtOAc, 10:1, Rf = 0.2) to provide 214 mg (0.495 mmol, 99%) of the 
primary alcohol as a colorless oil. 1H NMR (400 MHz, CDCl3): [ppm] = 0.04 (s, 3H, 
(CH3)2Si), 0.06 (s, 3H, (CH3)2Si), 0.90 (s, 9H, (CH3)3CSi), 1.09-1.19 (m, 1H, CH2), 1.37-1.53 
(m, 3H, CH2), 1.70-1.84 (m, 3H, 8a-H, CH2), 2.06-2.15 (m, 1H, 1-H), 2.46 (br dd, J = 12.4, 
10.4 Hz, 1H, 4a-H), 3.35-3.44 (m, 1H, CH2OH), 3.77 (s, 6H, OCH3), 3.79 (m, 1H, CH2OH), 
4.03 (br s, 1H, 8-H), 5.55 (ddd, J = 9.9, 4.8, 2.8 Hz, 1H, 3-H), 5.67 (br d, J = 9.9 Hz, 1H, 4-
H), 6.35 (t, J = 2.3 Hz, 1H, 4’-H), 6.50 (d, J = 2.3 Hz, 2H, 2’,6’-H); 13C NMR (100 MHz, 
CDCl3): [ppm] = -5.3 ((CH3)2Si), -3.5 ((CH3)2Si), 18.2 ((CH3)3CSi), 20.5 (CH2), 25.9 
((CH3)3CSi), 33.4 (CH2), 34.0 (CH2), 34.8 (C-4a), 41.1 (C-8a), 41.3 (C-1), 44.5 (C-2), 55.2 
(OCH3), 61.7 (CH2OH), 67.0 (C-8), 98.4 (C-4’), 108.2 (C-2’,6’), 127.3 (C-3), 133.8 (C-4), 
144.3 (C-1’), 160.6 (C-3’,5’); HRMS (ESI) calcd for C25H40O4Si [M+H]+ 433.27686, found 
427.27694. 
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[8-{[tert-Butyl(dimethyl)silyl]oxy}-2-(3,5-dimethoxyphenyl)-1,2,4a,5,6,7,8,8a-
octahydronaphthalen-1-yl]methyl methanesulfonate: MsCl (0.115 mL, 1.5 mmol, 1.7 
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equiv) was added dropwise to a stirred solution of the foregoing primary alcohol (380 mg, 
0.88 mmol) and NEt3 (0.56 mL, 4 mmol, 4.5 equiv) in dry CH2Cl2 (10 mL) at -50 °C. The 
mixture was stirred for 1 h at -30 °C, then allowed to warm to room temperature within 1 h 
and treated with a saturated NaHCO3 solution (30 mL). The resulting mixture was extracted 
with CH2Cl2 (3 × 20 mL). The combined organic extracts were washed with saturated 
NaHCO3 solution, dried over Na2SO4, filtered, and concentrated in vacuo. Flash 
chromatography of the residue (hexane/EtOAc, 10:1, Rf = 0.15-0.2) afforded 430 mg (0.84 
mmol, 96%) of the mesylate as a colorless oil. 1H NMR (400 MHz, CDCl3): [ppm] = 0.07 
(s, 6H, (CH3)2Si), 0.91 (s, 9H, (CH3)3CSi), 1.20 (qd, J = 12.9, 3.6 Hz, 1H, CH2), 1.30-1.43 
(m, 2H), 1.52 (br d, 1H, J = 13.6 Hz, CH2), 1.65-1.86 (m, 3H), 2.40 (dddd, J = 11.1, 10.8, 5.6, 
3.6 Hz, 1H, 1-H), 2.49 (br dd, J = 12.4, 10.6 Hz, 1H, 4a-H), 2.83 (s, 3H, SO2CH3), 3.62 (dd, J 
= 10.8, 8.6 Hz, 2H, CH2Oms, 2-H), 3.62 (br s, 1H, 2-H), 3.77 (s, 6H, OCH3), 3.86 (br s, 1H, 
8a-H), 4.32 (dd, J = 8.6, 3.6 Hz, 1H, CH2OMs), 5.57 (ddd, J = 9.9, 4.8, 2.8 Hz, 1H, 3-H), 5.68 
(br d, J = 9.9 Hz, 1H, 4-H), 6.34 (d, J = 2.3 Hz, 2H, 2’,6’-H), 6.44 (t, J = 2.3 Hz, 1H, 4’-H); 
13C NMR (100 MHz, CDCl3): [ppm] = -5.5 ((CH3)2Si), -3.5 ((CH3)2Si), 18.2 ((CH3)3CSi), 
20.3 (CH2), 25.8 ((CH3)3CSi), 33.1 (CH2), 33.8 (CH2), 34.8 (CH), 36.9 (CH), 38.3 (CH), 40.9 
(CH), 43.1 (CH), 55.2 (OCH3), 66.6 (C-8), 69.2 (CH2OMs), 98.5 (C-4’), 108.8 (C-2’,6’), 
126.9 (C-3), 133.2 (C-4), 142.3 (C-1’), 160.3 (C-3’,5’); HRMS (ESI) calcd for C26H42NO6SSi 
[M+H]+ 511.25441, found 511.25345. 
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[8-{[tert-Butyl(dimethyl)silyl]oxy}-2-(3,5-dimethoxyphenyl)-1,2,4a,5,6,7,8,8a-
octahydronaphthalen-1-yl]acetonitrile (3-23): A mixture of the foregoing mesylate (430 
mg, 0.84 mmol) and NaCN (490 mg, 10 mmol) in DMSO (6 mL) was stirred at 50 °C for 48 h 
under an inert atmosphere. Afterwards, the mixture was poured into water (100 mL) and 
extracted with hexane (3 × 30 mL). The combined organic extracts were washed with brine, 
dried over Na2SO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (hexane/EtOAc, 20:1, Rf = 0.25) to furnish 355 mg (0.805 mmol, 95%) of 
nitrile 3-23 as a colorless oil. 1H NMR (400 MHz, CDCl3): [ppm] = 0.04 (s, 3H, (CH3)2Si), 
0.07 (s, 3H, (CH3)2Si), 0.91 (s, 9H, (CH3)3CSi), 1.14 (qd, J = 12.9, 3.8 Hz, 1H, CH2), 1.25-
1.40 (m, 2H, CH, CH2), 1.52 (br d, J = 13.2 Hz, 1H, CH2), 1.62 (dd, J = 16.2, 11.9 Hz, 1H, 2-
H), 1.64-1.75 (m, 1H, CH2), 1.82 (m, 2H, CH2), 2.33 (dddd, J = 11.9, 9.1, 5.6, 2.8 Hz, 1H, 3-
H), 2.43 (br dd, J = 12.4, 10.6 Hz, 1H, 9-H), 2.47 (dd, J = 16.2, 2.8 Hz, 1H, 2-H), 3.69 (br t, J 
= 5.6 Hz, 1H, 12-H), 3.78 (s, 6H, OCH3), 3.82 (br s, 1H, 5-H), 5.60 (ddd, 1H, J = 9.9, 4.6, 2.8 
Hz, 11-H), 5.69 (br d, J = 9.9 Hz, 1H, H-10), 6.37 (t, J = 2.3 Hz, 1H, 16-H), 6.50 (d, J = 2.3 
Hz, 2H, H-14,18); 13C NMR (100 MHz, CDCl3): [ppm] = -5.4 (CH3)2Si), -3.5 (CH3)2Si), 
17.6 (CH2), 18.1 ((CH3)3CSi), 20.2 (CH2), 25.8 ((CH3)3CSi), 32.9 (CH2), 33.7 (CH2), 35.0 
(CH), 36.9 (CH), 42.3 (CH), 44.7 (CH), 55.3 (OCH3), 66.5 (C-5), 99.0 (C-16), 108.5 (C-14), 
119.6 (C-1), 126.7 (C-11), 133.3 (C-10), 141.8 (C-13), 160.5 (C-15); HRMS (ESI) calcd for 
C26H39NO3Si [M+H]+ 442.27720, found 442.27717. 
Experimental Section   161 
H
H
HO
CN
H
OMe
OMe
1
2
3
9
7
4 14
1
6
5
11
12
 
[2-(3,5-Dimethoxyphenyl)-8-hydroxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-
yl]acetonitrile (3-24): To a stirred solution of nitrile 3-23 (345 mg, 0.78 mmol) in THF (2 
mL) was added dropwise TBAF (1 M in THF, 5 mL) at room temperature. The mixture was 
stirred at room temperature for 2 h then diluted with EtOAc (40 mL), washed with water and 
brine. The organic layer was dried over Na2SO4, filtered, and concentrated in vacuo. Flash 
chromatography of the residue (hexane/EtOAc, 2:1, Rf = 0.25) afforded hydroxynitrile 3-24 
(250 mg, 0.76 mmol, 98%) as colorless crystals, m.p. 142-143 °C. 1H NMR (400 MHz, 
CDCl3): [ppm] = 1.14 (qd, J = 12.9, 3.8 Hz, 1H, CH2), 1.34-1.88 (m, 7H), 1.78 (dd, J = 16.2, 
11.1 Hz, 1H, 2-H), 2.30-2.44 (m, 2H, 3,9-H), 2.54 (dd, J = 16.2, 4.1 Hz, 1H, 2-H), 3.67 (br s, 
1H, 12-H), 3.78 (s, 6H, OCH3), 3.85 (br s, 1H, 5-H), 5.60 (ddd, J = 9.9, 4.6, 2.8 Hz, 1H, 11-
H), 5.69 (br d, J = 9.9 Hz, 1H, 10-H), 6.37 (t, J = 2.3 Hz, 1H, 16-H), 6.48 (d, J = 2.3 Hz, 2H, 
14,18-H); 13C NMR (100 MHz, CDCl3): [ppm] = 17.9 (CH2), 20.1 (CH2), 32.8 (CH2), 34.0 
(CH2), 35.1 (CH), 36.9 (CH), 41.3 (CH), 45.0 (CH), 55.3 (OCH3), 65.4 (C-5), 98.9 (C-16), 
108.6 (C-14), 120.0 (C-1), 127.1 (C-11), 132.9 (C-10), 141.6 (C-13), 160.5 (C-15); HRMS 
(ESI) calcd for C20H25NO3 [M+H]+ 328.19072, found 328.19057. 
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4-(3,5-Dimethoxyphenyl)-3a,4,6a,7,8,9,9a,9b-octahydrobenzo[de]chromen-2(3H)-
one (3-25): The hydroxynitrile 3-24 (40 mg, 0.12 mmol) was dissolved in EtOH (4 mL). 
KOH (50% in water 0.4 mL) was added and the mixture stirred at 80 °C for 24 h under inert 
atmosphere. Then, the mixture was cooled to room temperature, diluted with water (30 mL) 
and acidified with 5% HCl to pH 1. The mixture was extracted with EtOAc (3 × 25 mL). The 
extracts were washed with water and dried over Na2SO4, filtered and concentrated in vacuo. 
The crude hydroxy acid, obtained as a white solid, was refluxed in toluene (10 mL) together 
with pTsOH·H2O (50 mg, 0.26 mmol) for 1 h. After cooling, the toluene was evaporated 
under reduced pressure, and the residue subjected to flash chromatography (hexane/EtOAc, 
4:1, Rf = 0.25) to give lactone 3-25 (36 mg, 0.110 mmol, 90%) as colorless crystals, m.p. 
125-126 °C. 1H NMR (400 MHz, CDCl3): [ppm] = 1.11-1.22 (m, 1H, CH2), 1.42-1.52 (m, 
1H, CH2), 1.62-1.93 (m, 7H), 2.10-2.20 (m, 1H, 3-H), 2.29 (br dd, J = 14.9, 11.6 Hz, 1H, 9-
H), 2.55 (dd, J = 15.2, 2.5 Hz, 1H, 2-H), 3.56 (br dd, J = 5.1, 4.6 Hz, 1H, 12-H), 3.77 (s, 6H, 
OCH3), 4.24 (q, J = 7.5 Hz, 1H, 5-H), 5.65 (ddd, J = 9.6, 4.6, 2.8 Hz, 1H, 11-H), 5.83 (br d, J 
= 9.6 Hz, 1H, 10-H), 6.29 (d, J = 2.3 Hz, 2H, 14-H), 6.36 (t, J = 2.3 Hz, 1H, 16-H); 13C NMR 
(100 MHz, CDCl3): [ppm] = 18.2 (CH2), 26.4 (CH2), 26.8 (CH2), 35.0 (C-2), 35.6 (C-4), 
36.1 (C-9), 38.3 (C-3), 45.8 (C-12), 55.3 (OCH3), 74.6 (C-5), 98.3 (C-16), 108.2 (C-14), 
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127.9 (C-11), 134.1 (C-10), 141.3 (C-13), 160.5 (C-15), 174.5 (C-1). HRMS (ESI) calcd for 
C20H24O4 [M+H]+ 329.17474, found 329.17480. 
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epi-4-(3,5-Dimethoxyphenyl)-3-methyl-3a,4,6a,7,8,9,9a,9b-
octahydrobenzo[de]chromen-2(3H)-one, epi-3-26: nBuLi (2.5 M in hexanes, 80 L, 0.2 
mmol, 2 equiv) was added dropwise to a stirred solution of iPr2NEt (28 L, 0.2 mmol, 2 
equiv) in anhydrous THF (1 mL) at 0 °C under inert atmosphere. The solution was stirred for 
15 min at 0 °C then cooled to -80 °C. A solution of lactone 3-25 (33 mg, 0.10 mmol) in THF 
(0.5 mL) was added dropwise to the LDA solution. The mixture was stirred for 3 h at -80 °C 
followed by the addition of MeI (25 L, 0.4 mmol, 4 equiv). Stirring was continued at -80 °C 
for 0.5 h then the mixture was allowed to reach room temperature. The reaction was quenched 
by addition of water and the mixture extracted with EtOAc (3 × 20 mL). The combined 
organic layers were washed with brine, dried over anhydrous Na2SO4, filtered, and 
concentrated in vacuo. The residue was purified by flash chromatography (hexane/EtOAc, 
4:1, Rf = 0.3) to give epi-3-26 and 3-26 as a 7:1 mixture of diastereomers. It was not possible 
to separate the two diastereomers by flash chromatography. 1H NMR (400 MHz, CDCl3): 
[ppm] = 0.44 (d, J = 7.3 Hz, 3H, CH3), 1.20-1.99 (m, 7H, 4-H, CH2), 2.22 (ddd, J = 12.1, 
6.3, 2.5 Hz, 1H, 3-H), 2.36 (br dd, J = 15.2, 11.9 Hz, 1H, 9-H), 2.83 (qd, J = 7.3, 2.5 Hz, 1H, 
2-H), 3.54 (m, 1H, 12-H), 3.78 (s, 6H, OCH3), 4.53 (dt, J = 8.9, 7.1 Hz, 1H, 5-H), 5.65 (ddd, J 
= 9.6, 3.6, 3.0 Hz, 1H, 11-H), 5.73 (br d, J = 9.6 Hz, 1H, 10-H), 6.38 (s, 3H, 14,16-H); 13C 
NMR (100 MHz, CDCl3): [ppm] = 9.5 (CH3), 17.1 (CH2), 26.1 (CH2), 26.3 (CH2), 32.0 (C-
4), 34.3 (C-9), 39.6 (C-2), 40.5 (C-3), 45.9 (C-12), 55.3 (OCH3), 75.4 (C-5), 98.4 (C-14), 
108.9 (C-16), 128.3 (C-11), 133.2 (C-10), 143.3 (C-13), 160.8 (C-15), 176.1 (C-1). 
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2-[8-{[tert-Butyl(dimethyl)silyl]oxy}-2-(3,5-dimethoxyphenyl)-1,2,4a,5,6,7,8,8a-
octahydronaphthalen-1-yl]propanenitrile (3-27): nBuLi (2.5 M in hexanes, 0.8 mL, 2 
mmol, 2 equiv) was added dropwise to a stirred solution of iPr2NEt (281 L, 2 mmol, 2 
equiv) in anhydrous THF (5 mL) at 0 °C under inert atmosphere. The solution was stirred for 
15 min at 0 °C and cooled to -80 °C. A solution of nitrile 3-23 (420 mg, 0.95 mmol) in THF 
(5 mL) was added dropwise to this LDA solution. The mixture was stirred for 1 h at -80 °C 
followed by the addition of MeI (124 L, 2 mmol, 2 equiv). Stirring was continued at -80 °C 
for 0.5 h then the mixture was allowed to reach room temperature. The reaction was quenched 
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by the addition an excess of half-saturated NH4Cl solution. The product was extracted with 
petroleum ether (3 × 30 mL). The combined organic extracts were washed with brine, dried 
over Na2SO4, filtered, and evaporated. The residue was purified by flash chromatography 
(hexane/EtOAc, 20:1, Rf = 0.25) to provide 398 mg (0.874 mmol, 92%) of alkylated nitrile 3-
27 as a colorless viscous oil. 1H NMR (400 MHz, CDCl3): [ppm] = 0.05 (s, 3H, (CH3)2Si), 
0.08 (s, 3H, (CH3)2Si), 0.56 (d, 3H, J = 7.3 Hz, CH3), 0.91 (s, 9H, (CH3)3CSi), 1.17-1.28 (m, 
1H, CH2), 1.37-1.60 (m, 3H, 4-H, CH2), 1.67-1.90 (m, 3H, CH2), 2.34 (ddd, J = 10.6, 6.0, 4.5 
Hz, 1H, 3-H), 2.49 (br dd, J = 11.6, 10.8 Hz, 1H, 9-H), 2.96 (qd, J = 7.3, 4.5 Hz, 1H, 2-H), 
3.75 (br s, 1H, 12-H), 3.79 (s, 6H, OCH3), 3.89 (br s, 1H, 5-H), 5.58 (br d, J = 9.9 Hz, 1H, 11-
H), 5.64 (br d, J = 9.9 Hz, 1H, 10-H), 6.36 (s, 1H, H-16), 6.57 (s, 2H, H-14); 13C NMR (100 
MHz, CDCl3): [ppm] = -5.5 (CH3)2Si), -3.4 (CH3)2Si), 12.7 (CH3), 18.2 ((CH3)3CSi), 20.4 
(CH2), 25.1 (C-2), 25.8 ((CH3)3CSi), 33.1 (CH2), 33.9 (CH2), 34.8 (C-9), 41.01 (C-3), 41.6 
(C-4), 44.5 (C-12), 55.3 (OCH3), 67.5 (C-5), 99.0 (C-16), 108.8 (C-14), 122.9 (C-1), 127.6 
(C-11), 132.4 (C-10), 143.8 (C-13), 160.6 (C-15); HRMS (ESI) calcd for C27H41NO3Si 
[M+H]+ 456.29285, found 456.29278. 
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2-[2-(3,5-Dimethoxyphenyl)-8-hydroxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-
yl]propanenitrile (3-28): To a solution of silyl ether 3-27 (348 mg, 0.76 mmol) in THF (1.5 
mL) was added TBAF (1 M in THF, 5 mL) dropwise at 0 °C under inert atmosphere followed 
by stirring of the mixture at room temperature for 24 h. After complete deprotection (checked 
by TLC), the mixture was diluted with EtOAc. The layers were separated, and the organic 
layer washed with water and brine, dried over Na2SO4, filtered, and concentrated in vacuo. 
The residue was purified by flash chromatography (hexane/EtOAc, 2:1, Rf = 0.25) to give 240 
mg (0.704 mmol, 92%) of hydroxynitrile 3-28 as colorless crystals, m.p. 159-160 °C. 1H 
NMR (400 MHz, CDCl3): [ppm] = 0.86 (d, J = 7.3 Hz, 3H, CH3), 1.17-1.30 (m, 1H, CH2), 
1.54-1.90 (m, 6H, 4-H, CH2), 2.29-2.36 (m, 1H, 3-H), 2.40 (br dd, J = 11.6, 10.4 Hz, 1H, 9-
H), 3.06 (qd, J = 7.3, 3.0 Hz, 1H, 2-H), 3.63 (br s, 1H, 12-H), 3.78 (s, 6H, OCH3), 4.04 (br s, 
1H, 5-H), 5.56 (br d, J = 9.9 Hz, 1H, 11-H), 5.63 (br d, J = 9.9 Hz, 1H, 10-H), 6.37 (br s, 1H, 
16-H), 6.53 (br s, 2H, 14-H); 13C NMR (100 MHz, CDCl3): [ppm] = 14.9 (CH3), 20.2 
(CH2), 26.0 (C-2), 33.2 (CH2), 34.1 (CH2), 34.9 (C-9), 40.7 (C-4), 40.8 (C-3), 45.6 (C-12), 
55.3 (OCH3), 66.0 (C-5), 98.9 (C-16), 109.1 (C-14), 122.5 (C-1), 127.7 (C-11), 131.9 (C-10), 
142.9 (C-13), 160.6 (C-15); HRMS (ESI) calcd for C21H27NO3 [M+H]+ 342.20637, found 
343.20625. 
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4-(3,5-Dimethoxyphenyl)-3-methyl-3a,4,6a,7,8,9,9a,9b-
octahydrobenzo[de]chromen-2(3H)-one (3-26): TBAF (1 M in THF, 2 mL) was added to a 
solution of silyl ether 3-27 (20 mg, 44 mol) at room temperature under inert atmosphere. 
The solution was stirred for 12 h, then diluted with EtOAc (40 mL) and washed with water 
(20 mL), and brine (20 mL). The organic layer was dried over Na2SO4, filtered, and 
evaporated. The crude alcohol 3-28 (Rf = 0.6, hexane/EtOAc, 1:1) was dissolved in toluene (2 
mL). To this solution TMSCl (0.5 mL) and concentrated HCl (0.05 mL) were added and the 
mixture was stirred at 110 °C for 24 h under inert atmosphere. After cooling, the toluene was 
removed in vacuo and the residue purified by flash chromatography (hexane/EtOAc, 4:1, Rf = 
0.25) to furnish lactone 3-26 (11.2 mg, 33 mol, 75%), m.p. 117-118 °C. 1H NMR (400 
MHz, CDCl3): [ppm] = 1.13 (m, 1H), 1.39 (d, J = 6.3 Hz, 3H, CH3), 1.54-1.78 (m, 2H), 
1.73-2.03 (m, 5H), 2.22 (br t, J = 11.6 Hz, 1H, 9-H), 2.26 (dq, J = 13.4, 6.8 Hz, 1H, 2-H), 
3.65 (br s, 1H, 12-H), 3.79 (s, 6H, OCH3), 4.27 (dd, J = 5.8, 5.6 Hz, 1H, 5-H), 5.65 (ddd, J = 
9.6, 4.6, 2.8 Hz, 1H, 11-H), 5.78 (br d, J = 9.6 Hz, 1H, 10-H), 6.37 (t, J = 2.3 Hz, 1H, 16-H), 
6.47 (d, J = 2.3 Hz, 2H, 14-H); 13C NMR (100 MHz, CDCl3): [ppm] = 13.0 (CH3), 19.8 
(CH2), 27.7 (CH2), 28.3 (CH2), 36.5 (CH), 36.6 (CH), 39.2 (CH), 44.7 (CH), 45.7 (CH), 55.3 
(OCH3), 72.3 (C-5), 98.1 (C-16), 108.9 (C-14), 129.7 (C-11), 133.6 (C-10), 141.6 (C-13), 
160.5 (C-15), 177.6 (C-1); HRMS (ESI) calcd for C21H26O4 [M+H]+ 343.19039, found 
343.19018. 
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[2-(3,5-Dimethoxyphenyl)-8-oxo-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-
yl]acetonitrile (3-29): To a stirred solution of hydroxynitrile 3-24 (105 mg, 0.35 mmol) in 
dry CH2Cl2 (4 mL) was added dropwise a solution of Dess-Martin periodinane (15% in 
CH2Cl2, 1.5 mL) at 0 °C. The mixture was stirred at room temperature for 3 h, before it was 
diluted with CH2Cl2 (20 mL) and washed with saturated Na2CO3 solution of (2 × 10 mL). The 
organic layer was dried over Na2SO4, filtered, and concentrated in vacuo. The residue was 
purified by flash chromatography (hexane/EtOAc, 4:1, Rf = 0.25) to give 103 mg (0.347 
mmol, 99%) of ketone 3-29 as colorless crystals, m.p. 105 °C. 1H NMR (400 MHz, CDCl3): 
[ppm] = 1.58-1.85 (m, 3H, CH2), 2.02-2.49 (m, 7H), 3.11 (d, J = 16.2 Hz, 1H, CH2), 3.68 (br 
s, 1H, 12-H), 3.79 (s, 6H, OCH3), 5.72 (ddd, J = 10.1, 4.0, 2.0 Hz, 1H, 11-H), 5.76 (br d, J = 
10.1 Hz, 1H, 10-H), 6.38 (t, J = 2.3 Hz, 1H, 16-H), 6.48 (d, J = 2.3 Hz, 2H, 14-H); 13C NMR 
(100 MHz, CDCl3): [ppm] = 18.0 (CH2), 27.5 (CH2), 35.3 (CH2), 34.4 (CH), 42.8 (CH2), 
43.8 (C-12), 45.0 (CH), 50.4 (CH), 55.3 (OCH3), 99.1 (C-16), 108.6 (C-14), 119.4 (C-1), 
128.3 (C-11), 123.0 (C-10), 140.9 (C-13), 160.7 (C-15), 211.6 (C-5); HRMS (ESI) calcd for 
C20H23NO3 [M+Na]+ 348.15707, found 348.15690. 
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[7’-(3,5-Dimethoxyphenyl)-3’,4’,4a’,7’,8’,8a’-hexahydro-2’H-spiro[1,3-dioxolane-
2,1’-naphthalen]-8’-yl]acetonitrile (3-30): A solution of ethylene glycol (0.28 mL, 5 mmol), 
ketone 3-29 (145 mg, 0.48 mmol), and CSA (60 mg, 0.25 mmol) in toluene (20 mL) was 
refluxed for 12 h with azeotropic removal of water using a Dean-Stark apparatus. After 
cooling, the toluene was evaporated under reduced pressure and the residue subjected to flash 
chromatography (hexane/EtOAc, 4:1) yielding acetal 3-30 (111 mg, 0.326 mmol, 68%, Rf = 
0.3) as colorless crystals, m.p. 146-147 °C, and polycycle 3-31 (29 mg, 0.096 mmol, 20%, Rf 
= 0.2) as colorless crystals, m.p. 128-130 °C). 1H NMR (400 MHz, CDCl3): [ppm] = 1.15-
1.30 (m, 2H, CH2), 1.45-2.03 (m, 6H), 2.32 (br dd, J = 12.4, 10.4 Hz, 1H, 9-H), 2.38-2.47 (m, 
1H, 3-H), 2.62 (dd, J = 16.9, 4.0 Hz, 1H, CH2), 3.67 (br s, 1H, 12-H), 3.78 (s, 6H, OCH3), 
3.82-4.08 (m, 4H, acetal CH2), 5.68 (s, 2H, 10,11-H), 6.36 (br s, 1H, 16-H), 6.50 (br s, 2H, 
14-H); 13C NMR (100 MHz, CDCl3): [ppm] = 20.1 (CH2), 22.9 (CH2), 32.6 (CH2), 34.0 
(CH2), 37.1 (C-3), 40.9 (C-9), 43.3 (C-4), 45.7 (C-12), 55.3 (OCH3), 62.3 (acetal CH2), 63.4 
(acetal CH2), 98.9 (C-16), 108.5 (C-14), 110.7 (C-5), 120.7 (C-1), 127.5 (C-11), 132.4 (C-10), 
141.6 (C-13), 160.5 (C-15); HRMS (ESI) calcd for C22H27NO4 [M+Na]+ 392.18323, found 
392.18339. 
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(5,7-Dimethoxy-1,2,3,9,10,10a-hexahydro-1,9-ethenophenanthren-10-yl)acetonitrile 
(3-31): 1H NMR (400 MHz, CDCl3): [ppm] = 0.96-1.05 (m, 1H, CH2), 1.96-2.42 (m, 8H), 
2.78 (br s, 1H, CH2), 3.31 (br s, 1H, 9-H), 3.81 (s, 3H, OCH3), 3.82 (s, 3H, OCH3), 5.38 (br d, 
J = 9.6 Hz, 1H, 12-H), 5.55 (ddd, J = 9.6, 5.8, 2.5 Hz, 1H, 11-H), 6.36 (d, J = 2.3 Hz, 1H, 6-
H), 6.41 (d, J = 2.3 Hz, 1H, 8-H), 6.80-6.85 (m, 1H, 4-H); 13C NMR (100 MHz, CDCl3): 
[ppm] = 21.2 (CH2), 23.5 (CH2), 28.7 (CH2), 36.5 (CH), 36.9 (CH), 37.9 (CH), 42.3 (CH), 
55.3 (OCH3), 55.3 (OCH3), 97.7 (C-6), 104.8 (C-8), 115.9 (CN), 118.9 (C-4b), 125.1 (C-4), 
129.9 (C-11), 132.0 (C-4a), 134.1 (C-12), 137.5 (C-8a), 157.7 (C-5), 159.1 (C-7). 
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Nor-methyl-de-sulfo-symbioimine (freebase, 3-33): To a stirred solution of nitrile 3-
30 (70 mg, 205 mol) in dry Et2O (2 mL) was added dropwise a solution of LiAlH4 (1 M in 
Et2O, 1 mL, 1 mmol) at 0 °C under inert atmosphere. The reaction was stirred at room 
temperature for 12 h then quenched by dropwise addition of i-PrOH (1 mL). The mixture was 
diluted with Et2O and filtered through celite. Concentration of the filtrate under reduced 
pressure afforded 62 mg (179 mol, 87%, colorless oil) of amine 3-32 which was used in the 
next step without further purification. To a stirred solution of the amine (50 mg, 144 mol) in 
CH2Cl2 (2 mL) was added a solution of BBr3 (1 M in CH2Cl2, 1 mL, 1 mmol) dropwise at -80 
°C under inert atmosphere. The mixture was slowly warmed to room temperature and stirred 
for 10 h, then poured into a half-saturated solution of NaHCO3 (20 mL), and extracted with 
EtOAc (4 × 20 mL). The combined organic extracts were washed with brine (2 × 10 mL), 
dried over Na2SO4, filtered, and evaporated. The residue was purified by flash 
chromatography (CHCl3/MeOH/NEt3, 100:25:1, Rf = 0.3) to yield (22.5 mg , 80 mol, 55%) 
of imine 3-33 as a white powder, m.p. 248-250 °C, decomp. 1H NMR (400 MHz, CDCl3): 
[ppm] = 0.52 (qd, 1H, J = 12.4, 4.6 Hz, CH2), 1.22-1.37 (m, 1H, CH2), 1.43-1.57 (m, 1H, 
CH2), 1.73-2.11 (m, 5H), 2.08 (br dd, J = 12.9, 12.4 Hz, 1H, CH2), 2.24 (br d, J = 12.9 Hz, 
1H, CH2), 2.85 (dd, J = 7.1, 6.6 Hz, 2H, 1-H), 3.24-3.31 (m, 1H, 12-H), 3.47 (br dd, J = 17.4, 
15.9 Hz, 1H, 6-H), 5.57 (br d, J = 9.9 Hz, 1H, 11-H), 5.76 (d, J = 9.9 Hz, 1H, 10-H), 6.01 (s, 
2H, 14-H), 6.07 (br s, 1H, 16-H), 9.13 (br s, 2H, OH); 13C NMR (100 MHz, CDCl3): [ppm] 
= 25.4 (CH2), 25.8 (CH2), 31.1 (CH2), 36.7 (CH), 40.7 (CH), 41. 9 (CH), 45.0 (C-12), 45.5 
(C-1), 48.3 (C-6), 100.8 (C-16), 107.9 (C-14), 129.0 (C-11), 132.2 (C-10), 142.0 (C-13), 
157.7 (C-15), 170.8 (C-5); HRMS (ESI) calcd for C18H22NO2 [M+H]+ 284.16451, found 
284.16463. 
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2-[2-(3,5-Dimethoxyphenyl)-8-oxo-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-
yl]propanenitrile (3-34): To a stirred solution of hydroxynitrile 3-28 (235 mg, 0.69 mmol) in 
dry CH2Cl2 (8 mL) was added a solution of Dess-Martin periodinane (15% in CH2Cl2, 4 mL) 
dropwise at 0 °C. The mixture was then stirred at room temperature for 8 h. The resulting 
mixture was diluted with CH2Cl2 (30 mL) and washed with saturated Na2CO3 solution (2 × 20 
mL). The organic layer was dried over Na2SO4, filtered, and evaporated. The residue was 
subjected to flash chromatography (hexane/EtOAc, 4:1, Rf = 0.25) providing 233 mg (0.69 
mmol, 99%) of ketone 3-34 as a colorless oil. 1H NMR (400 MHz, CDCl3): [ppm] = 0.51 (d, 
J = 7.6 Hz, 3H, CH3), 1.64-1.88 (m, 2H, CH2), 2.08 (br d, 1H, CH2), 2.16-2.31 (m, 2H, 3-H, 
CH2), 2.37 (br d, J = 12.6 Hz, 1H, 6-H), 2.48 (td, J = 12.6, 6.6 Hz, 1H, 6-H), 2.60-2.67 (m, 
2H, 4,9-H), 3.58-3.65 (m, 1H, 2-H), 3.72 (br s, 1H, 12-H), 3.79 (s, 1H, OCH3), 5.73 (br d, J = 
10.1 Hz, 1H, 10-H), 5.78 (br d, J = 10.1 Hz, 1H, 11-H), 6.37 (s, 1H, 16-H), 6.59 (s, 2H, 14-
H); 13C NMR (100 MHz, CDCl3): [ppm] = 13.0 (C-20), 24.8 (C-2), 27.6 (CH2), 32.6 (CH2), 
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38.9 (C-9), 42.6 (C-6), 43.8 (C-12), 45.1 (C-3), 50.1 (C-4), 55.4 (OCH3), 99.1 (C-16), 108.7 
(C-14), 122.9 (C-1), 129.4 (C-11), 129.9 (C-10), 142.4 (C-13), 160.7 (C-15), 211.7 (C-5). 
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2-[7’-(3,5-Dimethoxyphenyl)-3’,4’,4a’,7’,8’,8a’-hexahydro-2’H-spiro[1,3-dioxolane-
2,1’-naphthalen]-8’-yl]propanenitrile (3-35): A solution of ethylene glycol (0.76 mL, 13.7 
mmol), ketone 3-34 (233 mg, 0.69 mmol), and CSA (79 mg, 0.34 mmol) in benzene (20 mL) 
was refluxed for 6 h with azeotropic removal of water using a Dean-Stark apparatus. After 
cooling, the toluene was evaporated under reduced pressure and the residue purified by flash 
chromatography (hexane/EtOAc, 4:1) to give the acetal 3-35 (260 mg, 0.68 mmol, 99%) as a 
colorless oil. Rf = 0.3 (hexane/EtOAc, 4:1); 1H NMR (400 MHz, CDCl3): [ppm] = 0.93 (d, J 
= 7.1 Hz, 3H, CH3), 1.33-1.43 (m, 2H, CH2), 1.52-1.65 (m, 1H, CH2), 1.71 (dd, J = 11.1, 5.8 
Hz, 1H, 4-H), 1.70-1.79 (m, H, CH2), 1.87-1.99 (m, 2H, CH2), 2.21 (dd, J = 5.8, 2.8 Hz, 1H, 
3-H), 2.36 (br dd, J = 11.6, 11.1 Hz, 1H, 9-H), 2.69 (qd, J = 7.1, 2.8 Hz, 1H, 2-H), 3.59 (br s, 
1H, 12-H), 3.80 (s, 6H, OCH3), 3.83-4.05 (m, 4H, acetal CH2), 5.80 (br d, J = 9.1 Hz, 1H, 10-
H), 6.06 (br d, J = 9.1 Hz, 1H, 11-H), 6.36 (s, 1H, 16-H), 6.53 (s, 2H, 14-H); 13C NMR (100 
MHz, CDCl3): [ppm] = 16.4 (CH3), 23.3 (CH2), 27.0 (C-2), 31.7 (CH2), 34.6 (CH2), 39.2 (C-
9), 43.1 (C-3), 45.2 (C-12), 46.9 (C-4), 55.3 (OCH3), 63.8 (acetal CH2), 64.0 (acetal CH2), 
98.3 (C-16), 107.4 (C-14), 110.7 (C-1), 123.6 (C-5), 128.7 (C-11), 133.5 (C-10), 144.0 (C-
13), 160.9 (C-15); HRMS (ESI) calcd for C23H29NO4 [M+H]+ 384.21693, found 384.21699. 
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De-sulfo-symbioimine (3-37): To a stirred solution of nitrile 3-35 (170 mg, 0.44 mmol) 
in anhydrous Et2O (5 mL) was added a solution of LiAlH4 (1 M in Et2O, 4 mL, 4 mmol) 
dropwise at 0 °C under inert atmosphere. The reaction was stirred at room temperature for 12 
h then quenched by the dropwise addition of iso-propanol (10 mL). The mixture was diluted 
with Et2O and filtered through celite. The filtrate was concentrated under reduced pressure to 
afford 151 mg (0.39 mmol, 89%, colorless oil) of amine 3-36 which was used in the next step 
without further purification. To a stirred solution of crude amine (151 mg, 0.39 mmol) in 
CH2Cl2 (10 mL) was added a solution of BBr3 (1 M in CH2Cl2, 5 mL, 5 mmol) dropwise at -
80 °C under inert atmosphere. The mixture was slowly warmed to room temperature while 
being stirred for 12 h, and finally poured into half-saturated NaHCO3 solution (50 mL). The 
mixture was extracted with EtOAc (3 × 50 mL). The combined organic extracts were washed 
with brine (2 × 20 mL), dried over Na2SO4, filtered, and evaporated. The residue was purified 
by flash chromatography (CHCl3/MeOH/NEt3, 240:30:5, Rf = 0.3) to give (71 mg, 242 mol, 
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55%) of imine 3-37 as a white powder (m.p. > 250 °C, decomp.). 1H NMR (400 MHz, 
CDCl3): [ppm] = 0.92 (br s, 4H, H-2,19), 1.25-1.39 (m, 1H, CH2), 1.42-1.57 (m, 2H), 1.84-
2.14 (m, 5H), 2.23 (br d, J = 13.4 Hz, 1H, CH2), 2.80-2.92 (m, 1H, 1-H), 3.38-3.50 (m, 2H, 
1,12-H), 5.57 (br dd, J = 9.6, 4.3 Hz, 1H, 11-H), 5.70 (br d, J = 9.6 Hz, 1H, 10-H), 6.05 (s, 
1H, 16-H), 6.15 (s, 2H, 14-H), 9.12 (br s, 2H, OH); 13C NMR (100 MHz, CDCl3): [ppm] = 
16.6 (CH3), 25.4 (C-7), 27.5 (C-2), 31.3 (C-8), 36.8 (C-6), 34.0 (C-9), 42.5 (C-12), 42.6 (C-
4), 43.9 (C-3), 56.2 (C-1), 100.8 (C-16), 108.5 (C-14), 129.9 (C-11), 131.4 (C-10), 141.9 (C-
13), 157.8 (C-15), 170.0 (C-5); HRMS (ESI) calcd for C19H23NO2 [M+H]+ 298.18016, found 
298.18019. 
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(±)-symbioimine (1)  
(±)-Symbioimine (3-1): To a solution of the free base 3-37 (15 mg, 50 mol) in dry 
pyridine (2 mL) was added SO3/Py complex (80 mg, 0.5 mmol) at room temperature. The 
mixture was stirred at 60-70 °C under inert atmosphere for 6 h, until the starting product had 
disappeared by TLC (Rf = 0.3-0.4 in CHCl3/MeOH, 4:1). Then the pyridine was evaporated 
under reduced pressure and the residue purified by flash chromatography (CHCl3/MeOH, 4:1, 
Rf = 0.25) affording the alkaloid 3-1 (3.8 mg, 10 mol, 20%). Further elution with 
CHCl3/MeOH/iPrOH/H2O 2:2:1:0.5, Rf = 0.2) afforded 20 mg of the bisulfate derivative of 
symbioimine. To this bisulfate in dioxane (1 mL) and water (0.5 mL) was added pTsOH·H2O 
(5 mg, 26 mol) and the mixture stirred for 6 h at room temperature, before it was neutralized 
with 1 drop of pyridine. The solvents were evaporated under reduced pressure and the residue 
subjected to flash chromatography (CHCl3/MeOH, 4:1, Rf = 0.25) to give further 
symbioimine (3-1) (10.3 mg, 27 mol, 54%) as a white powder, m.p. 228-229 °C (decomp.). 
The combined yield of 3-1 from imine 3-37 was 74%. In addition, some amount of 3-37 
(10%) was recovered from the hydrolysis experiment. HRMS (ESI) calcd for C19H23NO5S 
[M+H]+ 378.13697, found 378.13664. 
Table 1. Comparison of 13C chemical shifts of synthetic symbioimine and with that of the 
natural compound 
Atom No. Synthetic, ppm Natural, ppm , ppm. 
1 50.0 50.0 0.0 
2 26.2 26.2 0.0 
3 40.8 41.1 0.3 
4 40.3 40.1 0.2 
5 187.4 188.0 -0.6 
6 33.6 33.8 -0.2 
7 24.4 24.4 0.0 
8 29.8 29.8 0.0 
9 41.5 41.4 0.1 
10 130.5 130.4 0.1 
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11 129.6 129.5 0.1 
12 41.7 41.7 0.0 
13 139.9 139.8 0.1 
14 112.8 112.8 0.0 
15 154.1 154.1 0.0 
16 106.0 105.8 0.2 
17 157.3 157.2 0.1 
18 111.8 111.7 0.2 
19 15.6 15.6 0.0 
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4. Total synthesis of (+)­neosymbioimine 
OTBSMe
Me
Me
 
(6S)-8-[(tert-Butyldimethylsilyl)oxy]-2,6-dimethyl-2-octene (4-5a): To a solution of 
commercial (-)-(S)-citronellol 4-5 (5.0 g, 32 mmol) and imidazole (4.35 g, 64 mmol, 2 equiv) 
in dry DMF (35 mL) was added TBSCl (6.0 g, 40 mmol, 1.25 equiv) portionwise at 0 °C. The 
reaction mixture was allowed to warm to 20–25 °C and stirred for 12 h at this temperature. 
Then the mixture was poured into ice water (300 mL) and extracted with petroleum ether (3 × 
100 mL). The combined organic layers were washed once with saturated NaCl solution, dried 
over Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by 
flash chromatography (petroleum ether, Rf 0.3) using a short column, yield 8.2 g (95%) of 4-
5a, colorless oil. 1H NMR (400 MHz, CDCl3):  = 0.04 (s, 6H, SiCH3), 0.87 (d, J = 6.5 Hz, 
3H, CH3CH), 0.89 (s, 9H, SiC(CH3)3), 1.09–1.19 (m, 1H), 1.28–1.37 (m, 2H), 1.50–1.58 (m, 
2H), 1.59 (s, 3H, Z-CH=CCH3), 1.67 (s, 3H, E-CH=CCH3), 1.97 (ddd, J = 8.1, 6.8, 6.8 Hz, 
2H, CH2CH=C), 3.57–3.67 (m, 2H, CH2OSi), 5.09 (dd, J = 6.8, 6.8 Hz, 1H, CH=C). 13C 
NMR (100 MHz, CDCl3):  = –5.3 (SiCH3), 17.6 (Z-CH=CCH3), 18.3 (SiC(CH3)3), 19.6 
(CH3CH), 25.5 (CH2CH=C), 25.7 (E-CH=CCH3), 26.0 (SiC(CH3)3), 29.1 (CH3CH), 37.2 
(CH3CHCH2), 39.9 (CH3CHCH2), 61.4 (CH2O), 124.9 (CH=CMe2), 131.0 (CH=CMe2). 
[]D23 –4.5 (neat). 
OTBSMe
CHO
 
(4S)-6-{[tert-Butyl(dimethyl)silyl]oxy}-4-methylhexanal (4-6): O3 was bubbled 
through a solution of the foregoing TBS-protected citronellol (7.4 g, 27.4 mmol) in CH2Cl2 
(25 mL) and MeOH (25 mL), containing pyridine (0.5 mL) at –78 °C until a blue color 
appeared (~3 h). Excess of ozone was purged out of the flask with nitrogen before Me2S (2.34 
mL, 32 mmol) was added dropwise at –78 °C. The reaction mixture was slowly warmed to 20 
°C overnight. The mixture was concentrated under reduced pressure and the residue purified 
by flash chromatography (petroleum ether/EtOAc, 20:1), yield 6.2 g (93%), colorless oil. Rf 
0.35 (petroleum ether/EtOAc, 20:1). 1H NMR (400 MHz, CDCl3):  = 0.02 (s, 6H, SiCH3), 
0.87 (s, 9H, SiC(CH3)3), 0.88 (d, J = 6.5 Hz, 3H, CH3CH), 1.30–1.71 (m, 5H), 2.35–2.49 (m, 
2H, CH2CHO), 3.57–3.68 (m, 2H, CH2OSi), 9.75 (s, 1H, CHO). 13C NMR (100 MHz, 
CDCl3):  = –5.4 (SiCH3), 18.3 (SiC(CH3)3), 19.3 (CH3CH), 25.9 (SiC(CH3)3), 28.9 
(CH3CHCH2), 29.1 (CH3CH), 39.5 (CH3CHCH2), 41.6 (CHCHO), 61.0 (CH2O), 202.8. 
HRMS (ESI): calcd for C13H28O2Si [M+Na]+ 267.1756, found 267.1753. []D23 –0.112 
(neat). 
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Ethyl (2E,4S,6R)-8-{[tert-butyl(dimethyl)silyl]oxy}-4-hydroxy-6-methyloct-2-enoate 
(4-7): To a solution of aldehyde 4-6 (5.0 g, 20 mmol) and nitroso benzene (2.14 g, 20 mmol, 1 
equiv) in anhydrous DMSO (75 mL) was added D-proline (0.91 g, 8 mmol, 0.4 equiv) at 20 
°C. The mixture was vigorously stirred for 25 min under nitrogen (the colour of the reaction 
changed from green to yellow during this time), then cooled to 0 °C. Thereafter, a premixed 
and cooled (0 °C) solution of triethylphosphonoacetate (10 mL, 50 mmol, 2.5 equiv), DBU 
(7.5 mL, 50 mmol, 2.5 equiv) and LiCl (2.1 g, 50 mmol, 2.5 equiv) in CH3CN (75 mL) was 
added quickly (1-2 min) at 0 °C. The resulting mixture was stirred for 15 min at 0 to 10 °C 
and diluted with MeOH (380 mL). NH4Cl (2.5 g, 53 mmol) and Cu(OAc)2 (362 mg, 2 mmol) 
were added sequentially. The resulting mixture was stirred for 24 h at room temperature, then 
the MeOH was evaporated under vacum. Water (500 mL) was added and the mixture 
extracted with Et2O (3 × 100 mL). The combined organic layers were washed with water and 
saturated NaCl solution, dried over Na2SO4, filtered, and concentrated in vacuo. The residue 
was purified by flash chromatography to give 3.62 g (55%) of the enoate 4-7 as a yellowish 
oil, which is sufficiently pure for the next step. Rf 0.5 (petroleum ether/EtOAc, 4:1), 0.2 
(petroleum ether/EtOAc, 10:1). 1H NMR (400 MHz, CDCl3):  = 0.03 (s, 6H, SiCH3), 0.87 
(s, 9H, SiC(CH3)3), 0.94 (d, J = 6.5 Hz, 3H, CH3CH), 1.27 (t, J = 7.1 Hz, 3H, OCH2CH3), 
1.31–1.60 (m, 4H), 1.78-1.88 (m, 1H), 2.26 (d, J = 4.6 Hz, 1H, CHOH), 3.60–3.70 (m, 2H, 
CH2OSi), 4.17 (q, J = 7.1 Hz, 2H, OCH2CH3), 4.33–4.38 (m, 1H, CHOH), 6.02 (d, J = 15.7 
Hz, 1H, CH=CHCO2Et), 6.92 (dd, J = 15.7, 4.6 Hz, 1H, CH=CHCO2Et). 13C NMR (100 
MHz, CDCl3):  = –5.4 (SiCH3), 14.2 (OCH2CH3), 18.3 (SiC(CH3)3), 19.8 (CH3CH), 25.9 
(SiC(CH3)3), 26.6 (CH3CH), 39.8 (CH3CHCH2), 43.7 (CH3CHCH2), 60.3 (CH2O), 61.1 
(CH2O), 69.4 (CHOH), 119.7 (CH=CHCO2Et), 150.8 (CH=CHCO2Et), 166.6 (CO2Et). 
HRMS (ESI): calcd for C17H34O4Si [M+Na]+ 353.2119, found 353.2117. []D23 –5.16 (c 5.0, 
CH2Cl2). 
OTBSMe
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Ethyl (2E,4S,6R)-4,8-bis{[tert-butyl(dimethyl)silyl]oxy}-6-methyloct-2-enoate (4-
7a): To a stirred solution of the 4-hydroxy enoate 7 (630 mg, 1.9 mmol) in CH2Cl2 (10 mL), 
imidazole (646 mg, 9.5 mmol, 5 equiv) and DMAP (23 mg, 0.19 mmol, 0.1 equiv) were 
added. Then, TBSCl (573 mg, 3.8 mmol, 2 equiv) was added in one portion at 0 °C. The 
reaction mixture was allowed to warm to room temperature overnight. The mixture was 
diluted with petroleum ether (50 mL), washed with water and with saturated NaCl solution. 
After drying the organic layer over Na2SO4, filtration, and concentration in vacuo, the residue 
was purified by flash chromatography (petroleum ether/EtOAc, 25:1), yield 743 mg (88 %), 
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yellowish oil. Rf 0.3 (petroleum ether/EtOAc, 25:1). 1H NMR (400 MHz, CDCl3):  = –0.02–
0.07 (m, 12H, SiCH3), 0.87 (s, 9H, SiC(CH3)3), 0.89 (s, 9H, SiC(CH3)3), 1.28 (t, J = 7.1 Hz, 
3H, OCH2CH3), 1.21–1.36 (m, 2H), 1.49–1.58 (m, 2H), 1.72–1.82 (m, 1H), 3.58–3.65 (m, 
2H, CH2OTBS), 4.18 (q, J = 7.1 Hz, 2H, OCH2CH3), 4.30–4.37 (m, 1H, CHOTBS), 5.93 (d, J 
= 15.4 Hz, 1H, CH=CHCO2Et), 6.90 (dd, J = 15.4, 5.3 Hz, 1H, CH=CHCO2Et). 13C NMR 
(100 MHz, CDCl3):  = –5.4 (SiCH3), –5.3 (SiCH3), –4.9 (SiCH3), –4.3 (SiCH3), 14.2 
(OCH2CH3), 18.1 (SiC(CH3)3), 18.3 (SiC(CH3)3), 19.5 (CH3CH), 25.6 (CH3CH), 25.8 
(SiC(CH3)3), 26.0 (SiC(CH3)3), 40.4 (C-7), 45.2 (C-5), 60.3 (CH2O), 61.1 (CH2O), 69.8 
(CHOTBS), 119.6 (CH=CHCO2Et), 151.4 (CH=CHCO2Et), 166.7 (CO2Et). HRMS (ESI): 
calcd for C23H48O4Si2 [M+Na]+ 467.2983, found 467.2983. []D23 –8.67 (c 13.5, CH2Cl2). 
OHMe
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Ethyl (2E,4S,6R)-4-{[tert-butyl(dimethyl)silyl]oxy}-8-hydroxy-6-methyloct-2-enoate 
(4-7b): Camphor sulfonic acid (19 mg, 0.082 mmol, 0.05 equiv) was added to a solution of 
the foregoing disilyl ether 4-7a (727 mg, 1.64 mmol) in MeOH (10 mL) at 20 °C. The mixture 
was stirred for 1 h at 20 °C (TLC monitoring). After the starting material had disappeared on 
TLC, the mixture was diluted with diethyl ether and washed with saturated NaHCO3 solution 
and with saturated NaCl solution. The organic phase was dried over Na2SO4, filtered, and 
evaporated. The residue was purified by flash chromatography to provide the primary alcohol 
4-7b (470 mg, 87%) as a colorless oil. Rf 0.25 (petroleum ether/EtOAc, 4:1). 1H NMR (400 
MHz, CDCl3):  = 0.01 (s, 3H, SiCH3), 0.04 (s, 3H, SiCH3), 0.88 (s, 9H, SiC(CH3)3), 0.91 (d, 
J = 6.8 Hz, 3H, CH3CH), 1.27 (t, J = 7.1 Hz, 3H, HOCH2CH3), 1.38–1.60 (m, 4H), 1.71–1.80 
(m, 1H), 3.65 (dd, J = 6.8, 6.8 Hz, 2H, CH2OH), 4.17 (q, J = 7.1 Hz, 2H, OCH2CH3), 4.30–
4.37 (m, 1H, CHOTBS), 5.93 (d, J = 15.7 Hz, 1H, CH=CHCO2Et), 6.89 (dd, J = 15.7, 5.3 Hz, 
1H, CH=CHCO2Et). 13C NMR (100 MHz, CDCl3):  = –5.0 (SiCH3), –4.4 (SiCH3), 14.2 
(HOCH2CH3), 18.1 (SiC(CH3)3), 19.8 (CH3CH), 25.8 (CH3CH), 25.8 (SiC(CH3)3), 40.2 
(CH3CHCH2), 44.8 (CH3CHCH2), 60.3 (CH2O), 60.8 (CH2O), 69.8 (CHOH), 119.7 
(CH=CHCO2Et), 151.3 (CH=CHCO2Et), 166.7 (CO2Et). HRMS (ESI): calcd for C17H34O4Si 
[M+Na]+ 353.2119, found 353.2119. []D23 –2.23 (c 10.0, CH2Cl2). 
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Ethyl (2E,4S,6S)-4-{[tert-butyl(dimethyl)silyl]oxy}-6-methyl-8-oxo-oct-2-enoate (4-
8): To a stirred solution of the foregoing primary alcohol (417 mg, 1.26 mmol) in CH2Cl2 (6 
mL) was added dropwise a solution of Dess-Martin periodinane (3 mL of a 15 ww% solution 
in CH2Cl2, 1.2 equiv) at 0 °C. After being stirred for 2 h at 20 °C, the mixture was diluted 
with diethyl ether (60 mL) and washed with half saturated NaHCO3 solution (2  50 mL) and 
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with saturated NaCl solution (20 mL). The water phase was extracted with diethyl ether, and 
the combined organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo. 
Flash chromatography of the residue afforded 388 mg (1.18 mmol, 94%) of aldehyde 4-8 as a 
colorless oil. Rf 0.4 (petroleum ether/EtOAc, 10:1). 1H NMR (400 MHz, CDCl3):  = 0.01 (s, 
3H, SiCH3), 0.04 (s, 3H, SiCH3), 0.89 (s, 9H, SiC(CH3)3), 0.97 (d, J = 6.1 Hz, 3H, H-9), 1.27 
(t, J = 7.1 Hz, 3H, OCH2CH3), 1.35 (ddd, J = 12.6, 8.3, 4.1 Hz, 1H, H-5a), 1.55 (ddd, J = 
12.6, 8.1, 4.1 Hz, 1H, H-5b), 2.20–2.30 (m, 2H, CH-6,7a), 2.37 (ddd, J = 10.1, 8.6, 1.8 Hz, 
1H, H-7b), 4.17 (q, J = 7.1 Hz, 2H, OCH2CH3), 4.33 (dddd, J = 8.1, 5.3, 4.1, 1.3 Hz, 1H, H-
4), 5.93 (dd, J = 15.6, 1.3 Hz, 1H, H-2), 6.87 (dd, J = 15.6, 5.3 Hz, 1H, H-3), 9.70 (dd, J = 
2.0, 1.8 Hz, 1H, H-8). 13C NMR (100 MHz, CDCl3):  = –5.0 (SiCH3), –4.3 (SiCH3), 14.2 
(OCH2CH3), 18.1 (SiC(CH3)3), 19.9 (C-9), 24.4 (C-6), 25.8 (SiC(CH3)3), 44.3 (C-5), 51.4 (C-
7), 60.4 (CH2O), 69.7 (C-4), 120.1 (C-2), 150.6 (C-3), 166.4 (C-1), 202.2 (C-8). HRMS (ESI) 
calcd for C17H32O4Si [M+CH3OH+Na]+ 383.2224, found 383.2221. []D23 –31.1 (c 5.0, 
CH2Cl2). 
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Ethyl (2E,4S,6R,8Z)-4-{[tert-butyl(dimethyl)silyl]oxy}-6,9-dimethyl-10-oxodeca-
2,8-dienoate (4-10): Aldehyde 4-8 (1.84 g, 5.6 mmol) and 2-
(triphenylphosphoranylidene)propanal (4-9)187 (3.57 g, 11.2 mmol, 2 equiv) in toluene (50 
mL) were heated to 100 °C for 30 h. Thereafter, the toluene was evaporated under reduced 
pressure and the residue diluted with Et2O. The precipitate (Ph3P=O) was filtered, washed 
with a small amount of Et2O, and the filtrate was then concentrated. The resulting oil was 
purified by flash chromatography through a short column. Rf 0.4 (petroleum ether/EtOAc, 
10:1), yield 1.82 g (4.95 mmol, 88%), colorless oil. 1H NMR (400 MHz, CDCl3):  = 0.00 (s, 
3H, SiCH3), 0.03 (s, 3H, SiCH3), 0.88 (s, 9H, SiC(CH3)3), 0.95 (d, J = 6.8 Hz, 3H,H-11), 1.27 
(t, J = 7.1 Hz, 3H, OCH2CH3), 1.32 (ddd, J = 13.4, 9.1, 4.1 Hz, 1H, H-5a), 1.56 (ddd, J = 
13.4, 8.3, 4.1 Hz, 1H, H-5b), 1.70 (s, 3H, H-12), 1.85–1.95 (m, 1H, H-6), 2.18–2.35 (m, 2H, 
H-7a,b), 4.17 (q, J = 7.1 Hz, 2H, OCH2CH3), 4.33 (dddd, J = 8.1, 5.3, 4.1, 1.3 Hz, 1H, H-4), 
5.93 (dd, J = 15.6, 1.3 Hz, 1H, H-2), 6.45 (dd, J = 7.3, 7.3 Hz, 1H, H-8), 6.87 (dd, J = 15.6, 
5.3 Hz, 1H, H-3), 9.39 (s, 1H, H-10). 13C NMR (100 MHz, CDCl3): [ppm] = –5.0 (SiCH3), –
4.3 (SiCH3), 9.4 (C-12), 14.2 (OCH2CH3), 18.1 (SiC(CH3)3), 19.7 (C-11), 25.8 (SiC(CH3)3), 
29.1 (C-6), 36.7 (C-7), 44.3 (C-5), 60.4 (CH2O), 69.7 (C-4), 119.9 (C-2), 140.3 (C-9), 150.8 
(C-2), 152.9 (C-8), 166.5 (C-1), 195.1 (C-10). HRMS (ESI): calcd for C20H36O4Si [M+Na]+ 
391.2275, found 391.2272. []D23 -0.92 (c 10.0, CH2Cl2). 
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Ethyl (1S,2S,4aS,6R,8S,8aS)-8-{[tert-butyl(dimethyl)silyl]oxy}-2-(3,5-
dimethoxyphenyl)-4,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carboxylate 
(4-13): To a solution of diethyl 3,5-dimethoxybenzylphosphonate (4-11) (5.53 g, 19.2 mmol, 
4 equiv) in THF (40 mL), KOtBu (1.34 g, 12.0 mmol, 2.5 equiv) was added at 20 °C in one 
portion (water bath used). The mixture was stirred for 1 h at ambient temperature under 
nitrogen. The resulting clear solution was cooled to –78 °C, before aldehyde 4-10 (1.80 g, 
4.74 mmol) in THF (10 mL) was added dropwise between –70 and –80 °C. Then the reaction 
mixture was warmed to 0 °C for 30 min, and treated with half-saturated NH4Cl solution (50 
mL). The organic phase was extracted with petroleum ether (3  50 mL). The combined 
organic extracts were washed with water (25 mL) and saturated NaCl solution (25 mL), dried 
over Na2SO4, filtered, and evaporated under reduced pressure. The intermediate triene 4-12 
could not be obtained in pure form due to the rather facile Diels-Alder reaction, which already 
occurred at room temperature. For complete conversion, the obtained oil was dissolved in 
CHCl3 (10 mL) and the solution heated to 60 °C for 2 h. Then the solvent was evaporated and 
the residue purified by flash chromatography (Rf 0.4, petroleum ether/EtOAc, 10:1) to afford 
2.05 g (4.1 mmol, 86%) of 95% pure cycloadduct 4-13 as a colorless oil. The other 5% is the 
diastereomer of the uncyclized triene 4-12 (4% from (+)-(R)-citronellol, ~1% from proline). 
These compounds were separated in the next step after reduction of the ester group. 1H NMR 
(400 MHz, CDCl3):  = –0.09 (s, 3H, SiCH3), –0.02 (s, 3H, SiCH3), 0.71 (ddd, 1H, J = 12.4, 
12.4, 12.1 Hz, H-5a), 0.86 (s, 9H, SiC(CH3)3), 0.90 (d, J = 6.8 Hz, 3H, H-11), 1.12 (m, 1H, H-
7a), 1.13 (t, J = 7.1 Hz, 3H, OCH2CH3), 1.61 (br d, J = 11.6 Hz, 1H, H-8a), 1.70 (d, J = 13.9 
Hz, 1H, H-7b), 1.75 (s, 3H, H-10), 1.83–1.93 (m, 1H, H-6), 2.10 (d, J = 12.1 Hz, 1H, H-5b), 
2.37 (dd, J = 11.1, 11.1 Hz, 1H, H-4a), 2.94 (dd, J = 11.9, 6.6 Hz, 1H, H-1), 3.69 (br s, 1H, H-
2), 3.74 (s, 6H, OCH3), 3.82–3.94 (m, 2H, OCH2CH3), 4.17 (br s, 1H, H-8), 5.83 (br s, 1H, H-
3), 6.25 (d, J = 2.0 Hz, 2H, H-2’, 6’), 6.30 (t, J = 2.0 Hz, 1H, H-4’). 13C NMR (100 MHz, 
CDCl3):  = –5.5 (SiCH3), –4.2 (SiCH3), 14.0 (OCH2CH3), 18.1 (SiC(CH3)3), 21.2 (C-10), 
22.4 (C-11), 25.8 (SiC(CH3)3), 26.9 (C-6), 36.4 (C-4a), 38.6 (C-5), 40.2 (C-8a), 42.4 (C-7), 
44.4 (C-2), 46.8 (C-1), 55.1 (OCH3), 59.7 (OCH2CH3), 67.8 (C-8), 98.2 (C-4’), 108.0 (C-2’, 
6’), 122.0 (C-3), 138.0 (C-4), 143.7 (C-1’), 160.1 (C-3’, 5’), 172.8 (C-9). HRMS (ESI): calcd 
for C29H46O5Si [M+Na]+ 525.3008, found 525.3005. []D23 +180 (c 3.0, CH2Cl2). 
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[(1S,2S,4aS,6R,8S,8aS)-8-{[tert-Butyl(dimethyl)silyl]oxy}-2-(3,5-dimethoxyphenyl)-
4,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]methanol (4-13a): To a stirred 
solution of ester 4-13 (2.0 g, 3.98 mmol) in CH2Cl2 (30 mL), a solution of DIBAL (17 mL of 
a 0.7–1.3 M solution in CH2Cl2, 12 mmol, 3 equiv) was added dropwise at –20 °C. The 
resulting mixture was allowed to warm to room temperature and stirred for 24 h, then diluted 
with Et2O (100 mL) and poured into a cold solution of Rochelle’s salt (40 g) in water (120 
mL). The mixture was vigorously stirred for 24 h, then the organic phase was separated, and 
the water phase extracted with Et2O (2  50 mL). The combined extracts were washed with 
water and with saturated NaCl solution, dried over Na2SO4, filtered, and concentrated under 
reduced pressure. The residue was purified by flash chromatography provide 1.610 g (88%, 
3.50 mmol) of the primary alcohol 4-13a as a colorless oil. Rf 0.25 (petroleum ether/EtOAc, 
10:1). 1H NMR (400 MHz, CDCl3):  = 0.04 (s, 3H, SiCH3), 0.05 (s, 3H, SiCH3), 0.70 (ddd, J 
= 12.4, 12.4, 12.1 Hz, 1H, H-5a), 0.78 (dd, J = 8.6, 2.8 Hz, 1H, H-8a), 0.89 (s, 9H, 
SiC(CH3)3), 0.90 (d, J = 6.8 Hz, 3H, H-11), 1.04 (dd, J = 13.6, 11.1 Hz, 1H, H-7a), 1.40 (dd, J 
= 11.1, 10.6 Hz, 1H, H-7b), 1.75 (s, 3H, H-10), 1.82–1.97 (m, 1H, H-6), 2.01–2.10 (m, 1H, H-
1), 2.10 (d, J = 12.1 Hz, 1H, H-5b), 2.40 (dd, J = 12.4, 8.6 Hz, 1H, H-4a), 3.42 (dd, J = 19.2, 
8.6 Hz, 1H, H-9a), 3.52 (br s, 1H, H-2), 3.77 (s, 6H, OCH3), 3.78 (d, J = 19.2 Hz, 1H, H-9b), 
4.03 (s, 1H, H-8), 5.34 (br s, 1H, H-3), 6.34 (t, J = 2.0 Hz, 1H, H-4’), 6.48 (d, J = 2.0 Hz, 2H, 
H-2’, 6’). 13C NMR (100 MHz, CDCl3):  = –5.4 (SiCH3), –3.6 (SiCH3), 18.2 (SiC(CH3)3), 
21.2 (C-10), 22.3 (C-11), 25.9 (SiC(CH3)3), 26.8 (C-6), 37.7 (C-4a), 39.0 (C-5), 40.7 (C-8a), 
41.1 (C-1), 42.5 (C-7), 44.3 (C-2), 55.2 (OCH3), 62.0 (C-9), 67.6 (C-8), 98.1 (C-4’), 108.3 (C-
2’, 6’), 123.5 (C-3), 138.0 (C-4), 144.8 (C-1’), 160.5 (C-3’, 5’). HRMS (ESI): calcd for 
C27H44O4Si [M+Na]+ 483.2901, found 483.2896. []D23 +216 (c 2.7, CH2Cl2). 
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[(1S,2S,4aS,6R,8S,8aS)-8-{[Tert-butyl(dimethyl)silyl]oxy}-2-(3,5-dimethoxyphenyl)-
4,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]methyl methanesulfonate (4-
13b): To a stirred solution of the foregoing primary alcohol 4-13a (1.45 g, 3.15 mmol) and 
Et3N (4.3 mL, 31.5 mmol, 10 equiv) in CH2Cl2 (55 mL), MsCl (0.487 mL, 6.3 mmol, 2 equiv) 
was added dropwise at –50 °C. The reactiom mixture was warmed to 0 °C within 1 h and 
stirred for 1 h at this temperature. The mixture was then treated with half saturated NaHCO3 
solution. Extractive workup (3  40 mL of CH2Cl2) followed by flash chromatography 
afforded the mesylate (1.59 g, 2.96 mmol, 94%) as colorless crystals, mp. 129 °C). Rf 0.2 
(petroleum ether/EtOAc, 10:1). 1H NMR (400 MHz, CDCl3):  = 0.07 (s, 6H, SiCH3), 0.70 
(ddd, J = 12.4, 12.1, 11.6 Hz, 1H, H-5a), 0.90 (s, 9H, SiC(CH3)3), 0.91 (d, J = 6.8 Hz, 3H, H-
11), 1.04 (dd, J = 14.2, 12.4 Hz, 1H, H-7a), 1.41 (dd, J = 11.4, 10.4 Hz, 1H, H-8a), 1.75 (s, 
3H, H-10), 1.78 (br d, J = 12.4 Hz, 1H, H-7b), 1.81–1.94 (m, 1H, H-6), 2.10 (d, J = 12.1 Hz, 
1H, H-5b), 2.35 (dddd, J = 12.4, 10.8, 5.3, 4.1 Hz, 1H, H-1), 2.40 (dd, J = 11.6, 10.8 Hz, 1H, 
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H-4a), 2.84 (s, 3H, H-12), 3.58 (br dd, J = 5.3, 4.3 Hz, 1H, H-2), 3.65 (dd, J = 10.8, 8.6 Hz, 
1H, H-9a), 3.78 (s, 6H, OCH3), 3.83 (br s, 1H, H-8), 4.32 (dd, J = 8.6, 4.1 Hz, 1H, H-9b), 
5.37 (br d, J = 4.3 Hz, 1H, H-3), 6.33 (t, J = 2.0 Hz, 1H, H-4’), 6.42 (d, J = 2.0 Hz, 2H, H-2’, 
6’). 13C NMR (100 MHz, CDCl3):  = –5.5 (SiCH3), –3.5 (SiCH3), 18.2 (SiC(CH3)3), 21.1 
(C-10), 22.2 (C-11), 25.8 (SiC(CH3)3), 26.7 (C-6), 37.1 (C-12), 37.8 (C-4a), 38.2 (C-1), 38.8 
(C-5), 40.7 (C-8a), 42.3 (C-7), 42.8 (C-2), 55.3 (OCH3), 67.1 (C-8), 69.5 (C-9), 98.3 (C-4’), 
108.9 (C-2’, 6’), 123.1 (C-3), 137.7 (C-4), 142.9 (C-1’), 160.3 (C-3’, 5’). HRMS (ESI): calcd 
for C28H46O6SSi [M+Na]+ 561.2677, found 561.2675. []D23 +192 (c 10.0, CH2Cl2). 
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[(1S,2R,4aS,6R,8S,8aR)-8-{[tert-Butyl(dimethyl)silyl]oxy}-2-(3,5-dimethoxyphenyl)-
4,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]acetonitrile (4-14): A mixture of 
the foregoing mesylate (1.82 g, 3.38 mmol) and NaCN (1.65 g, 33.8 mmol, 10 equiv.) in dry 
DMSO (50 mL) was stirred for 3 d at 50 °C under inert atmosphere. The mixture was diluted 
with water (300 mL) and extracted with petroleum ether (3  75 mL). The combined organic 
extracts were washed with saturated NaCl solution, dried over Na2SO4, filered, and 
concentrated under reduced pressure. The residue was purified by flash chromatography to 
give 1.55 g (3.31 mmol, 98%) of nitrile 4-14 as a colorless oil. Rf 0.2 (petroleum 
ether/EtOAc, 20:1). 1H NMR (400 MHz, CDCl3):  = 0.04 (s, 3H, SiCH3), 0.06 (s, 3H, 
SiCH3), 0.68 (ddd, J = 12.6, 12.1, 12.1 Hz, 1H, H-8a), 0.90 (s, 9H, SiC(CH3)3), 0.91 (d, J = 
6.8 Hz, 3H, H-20), 1.02 (dd, J = 14.2, 12.4 Hz, 1H, H-6a), 1.30 (dd, J = 11.4, 10.4 Hz, 1H, H-
4), 1.64 (dd, J = 16.2, 12.4 Hz, 1H, H-2a), 1.75(s, 3H, H-21), 1.76 (br d, J = 12.4 Hz, 1H, H-
6b), 1.81–1.94 (m, 1H, H-7), 2.09 (br d, J = 12.1 Hz, 1H, H-8b), 2.30 (dddd, J = 12.4, 11.4, 
5.3, 2.8 Hz, 1H, H-3), 2.37 (dd, J = 11.4, 10.4 Hz, 1H, H-9), 2.47 (dd, J = 16.2, 2.8 Hz, 1H, 
H-2b), 3.65 (br dd, J = 5.3, 4.3 Hz, 1H, H-12), 3.78 (s, 6H, OCH3), 3.80 (br s, 1H, H-5), 5.41 
(d, J = 4.3 Hz, 1H, H-11), 6.36 (t, J = 2.0 Hz, 1H, H-16), 6.48 (d, J = 2.0 Hz, 2H, H-14, 18). 
13C NMR (100 MHz, CDCl3):  = –5.4 (SiCH3), –3.5 (SiCH3), 17.9 (C-2), 18.1 (SiC(CH3)3), 
21.1 (C-21), 22.1 (C-20), 25.8 (SiC(CH3)3), 26.7 (C-7), 36.8 (C-3), 38.0 (C-9), 38.6 (C-8), 
42.0 (C-4), 42.3 (C-6), 44.4 (C-12), 55.3 (OCH3), 67.1 (C-5), 98.7 (C-15), 108.6 (C-14, 18), 
119.7 (C-1), 122.9 (C-11), 137.8 (C-10), 142.4 (C-13), 160.4 (C-15, 17). HRMS (ESI): calcd 
for C28H43NO3Si [M+Na]+ 492.2904, found 492.2905. []D23 +278 (c 10.0, CH2Cl2). 
OMe
OMe
Me
Me
H
H
H
N
Me1
2
4
6
8
20
21
19
11
12
16
18
TBSO
 
Experimental Section   177 
(2R)-2-[(1R,2R,4aS,6R,8S,8aR)-8-{[tert-Butyl(dimethyl)silyl]oxy}-2-(3,5-
dimethoxyphenyl)-4,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-
yl]propanenitrile (4-3): A solution of nBuLi (2.5 M in hexane, 1.92 mL, 4.8 mmol, 2 equiv) 
was added dropwise to a solution of iPr2NH (0.702 mL, 5 mmol, 2 equiv) in THF (10 mL) at 
0 °C under N2. The LDA solution was stirred for 0.5 h at this temperature, then cooled to –85 
°C. Now, a solution of nitrile 4-14 (1.14 g, 2.4 mmol) in THF (15 mL) was added dropwise 
within 10 min. A yellowish color of the nitrile anion appeared within minutes. The mixture 
was stirred for 1 h at –80 °C before MeI (300 L, 4.8 mmol, 2 equiv) was introduced at this 
temperature. The mixture was stirred for 30 min at –80 °C. The yellowish color completely 
disappeared at this time. Then the mixture was treated with half-saturated NH4Cl solution (25 
mL) and warmed to room temperature. The mixture was extracted with petroleum ether (3  
30 mL). The combined organic extracts were washed with saturated solution of NaCl, dried 
over Na2SO4, and filtered. The petroleum ether was evaporated and the residue purified by 
flash chromatography (Rf 0.25, petroleum ether/EtOAc, 20:1) to afford diastereomerically 
pure nitrile 4-3 (1.005 g, 87%, de >99%) as colorless crystals (m.p. 124–125 °C). The other 
diastereomer (Rf 0.15) was formed in insignificant amounts (ca. 10%). 1H NMR (400 MHz, 
CDCl3):  = 0.05 (s, 3H, SiCH3), 0.08 (s, 3H, SiCH3), 0.60 (d, J = 7.4 Hz, 1H, H-19), 0.80 
(ddd, J = 12.4, 12.4, 12.1 Hz, 1H, H-8a), 0.91 (s, 9H, SiC(CH3)3), 0.92 (d, J = 6.8 Hz, 3H, H-
20), 1.10 (dd, J = 14.2, 12.4 Hz, 1H, H-6a), 1.50 (dd, J = 11.4, 10.4 Hz, 1H, H-4), 1.74 (s, 3H, 
H-21), 1.81 (br d, J = 14.2 Hz, 1H, H-6b), 1.85–1.95 (m, 1H, H-7), 2.11 (br d, J = 12.4 Hz, 
1H, H-8b), 2.27 (ddd, J = 11.4, 5.3, 4.3 Hz, 1H, H-3), 2.46 (dd, J = 12.4, 11.4 Hz, 1H, H-9), 
2.91 (qd, J = 7.1, 4.3 Hz, 1H, H-2), 3.69 (br s, 1H, H-12), 3.79 (s, 6H, OCH3), 3.80 (s, 1H, H-
5), 5.42 (br s, 1H, H-11), 6.35 (s, 1H, H-16), 6.54 (s, 2H, H-14, 18). 13C NMR (100 MHz, 
CDCl3):  = –5.4 (SiCH3), –3.4 (SiCH3), 13.1 (C-19), 18.2 (SiC(CH3)3), 20.8 (C-21), 22.2 (C-
20), 25.5 (C-2), 25.8 (SiC(CH3)3), 26.8 (C-7), 37.5 (C-9), 38.6 (C-8), 41.3 (C-3), 41.7 (C-4), 
42.4 (C-6), 44.3 (C-12), 55.3 (OCH3), 68.4 (C-5), 98.8 (C-16), 108.7 (C-14, 18), 122.9 (C-1), 
123.7 (C-11), 137.0 (C-10), 144.5 (C-13), 160.6 (C-15, 17). HRMS (ESI): calcd for 
C29H45NO3Si [M+Na]+ 506.3061, found 506.3060. []D20 +212 (c 10.0, CH2Cl2). 
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(2R)-2-[(1R,2R,4aS,6R,8S,8aR)-2-(3,5-Dimethoxyphenyl)-8-hydroxy-4,6-dimethyl-
1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]propanenitrile (4-3a): To a stirred solution of 
nitrile 4-3 (1.00 g, 2.07 mmol) in THF (2.5 mL), a 1M solution of TBAF in THF (12 mL, 12 
mmol, 6 equiv) was added dropwise at 0 °C. The mixture was gradually warmed to 23 °C and 
stirred at this temperature until the starting compound had disappeared according to TLC (~24 
h). The mixture was diluted with EtOAc (50 mL) and washed with water and saturated NaCl 
solution, dried over Na2SO4, filtered, and evaporated. Purification of the residue by flash 
chromatography afforded the hydroxy nitrile 4-3a (757 mg, 2.05 mmol, 99%) as colorless 
crystals, mp. 127–128 °C. Rf 0.2 (petroleum ether/EtOAc, 4:1). 1H NMR (400 MHz, CDCl3): 
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 = 0.80 (ddd, J = 12.4, 12.4, 12.1 Hz, 1H, H-8a), 0.87 (d, J = 7.3 Hz, 3H, H-19), 0.95 (d, J = 
6.3 Hz, 3H, H-20), 1.25 (dd, J = 14.4, 12.1 Hz, 1H, H-6a), 1.40 (d, J = 4.3 Hz, 1H, OH), 1.65 
(dd, J = 11.6, 10.4 Hz, 1H, H-4), 1.73 (s, 3H, H-21), 1.82 (br d, J = 14.4 Hz, 1H, H-6b), 1.85–
1.95 (m, 1H, H-7), 2.15 (br d, J = 12.4 Hz, 1H, H-8b), 2.27 (ddd, J = 11.6, 5.8, 3.6 Hz, 1H, H-
3), 2.36 (dd, J = 12.4, 10.4 Hz, 1H, H-9), 3.04 (qd, J = 7.3, 3.6 Hz, 1H, H-2), 3.58 (br dd, J = 
5.8, 4.3 Hz, 1H, H-12), 3.78 (s, 6H, OCH3), 4.03 (s, 1H, H-5), 5.37 (d, J = 4.3 Hz, 1H, H-11), 
6.36 (t, J = 2.0 Hz, 1H, H-16), 6.48 (d, J = 2.0 Hz, 2H, H-14, 18). 13C NMR (100 MHz, 
CDCl3):  = 15.0 (C-19), 20.9 (C-21), 22.2 (C-20), 26.2 (C-2), 26.9 (C-7), 37.7 (C-9), 38.8 
(C-8), 40.5 (C-3), 40.8 (C-4), 42.6 (C-6), 45.4 (C-12), 55.3 (OCH3), 66.7 (C-5), 98.6 (C-16), 
109.1 (C-14,18), 122.5 (C-1), 123.8 (C-11), 136.2 (C-10), 143.4 (C-13), 160.5 (C-15, 17). 
HRMS (ESI): calcd for C23H31NO3 [M+Na]+ 392.2196, found 392.2197. []D20 +286 (c 5.0, 
CH2Cl2). 
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(2R)-2-[(1R,2R,4aS,6R,8aR)-2-(3,5-Dimethoxyphenyl)-4,6-dimethyl-8-oxo-
1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]propanenitrile (4-3b): A solution of Dess-
Martin periodinane (15 wt.% in CH2Cl2, 6.4 mL, 3 mmol, 1.5 equiv) was added dropwise at 0 
°C to a stirred solution of the foregoing secondary alcohol 4-3b (738 mg, 2.0 mmol) in 
CH2Cl2 (10 mL). The reaction mixture was gradually warmed to room temperature and stirred 
until the starting material had disappeared according to TLC (~ 12 h). The mixture was 
diluted with Et2O (50 mL) and filtered. The undissolved solid was washed with Et2O. The 
filtrate was washed with saturated solutions of NaHCO3 and NaCl, dried over Na2SO4, 
filtered, and concentrated in vacuo. Purification of the residue by flash chromatography 
afforded 705 mg (1.92 mmol, 96%) of the ketone 4-b as colorless crystals, mp. 49–51 °C. Rf 
0.2 (petroleum ether/EtOAc, 8:1), 0.4 (petroleum ether/EtOAc, 4:1). 1H NMR (400 MHz, 
CDCl3):  = 0.52 (d, J = 7.3 Hz, 3H, H-19), 1.12 (d, J = 6.5 Hz, 3H, H-20), 1.34 (ddd, J = 
12.6, 12.4, 12.1 Hz, 1H, H-8a), 1.79 (s, 3H, H-21), 1.92–2.06 (m, 1H, H-7), 2.17 (br dd, J = 
12.6, 10.4 Hz, 1H, H-4), 2.21 (dd, J = 12.4, 12.1 Hz, 1H, H-6a), 2.32 (br d, J = 12.4 Hz, 1H, 
H-8b), 2.38 (dd, J = 12.4, 3.5 Hz, 1H, H-6b), 2.58 (dd, J = 10.4, 4.6 Hz, 1H, H-3), 2.63 (dd, J 
= 12.4, 10.4 Hz, 1H, H-9), 3.54 (qd, J = 7.1, 4.6 Hz, 1H, H-2), 3.67 (br s, 1H, H-12), 3.80 (s, 
6H, OCH3), 5.56 (d, J = 4.3 Hz, 1H, H-11), 6.37 (t, J = 2.0 Hz, 1H, H-16), 6.56 (d, J = 2.0 Hz, 
2H, H-14, 18). 13C NMR (100 MHz, CDCl3):  = 13.2 (C-19), 20.8 (C-21), 22.4 (C-20), 24.9 
(C-2), 35.6 (C-7), 38.5 (C-8), 38.8 (C-3), 43.6 (C-12), 46.4 (C-4), 49.9 (C-9), 50.7 (C-6), 55.4 
(OCH3), 98.2 (C-16), 108.7 (C-14, 18), 123.0 (C-1), 125.3 (C-11), 135.1 (C-10), 143.0 (C-
13), 160.7 (C-15, 17), 211.4 (C-5). HRMS (ESI): calcd for C23H29NO3 [M+Na]+ 390.2040, 
found 390.2042. []D20 +323 (c 3.55, CHCl3).  
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(2R)-2-[(3'R,4a'S,7'R,8'R,8a'R)-7'-(3,5-Dimethoxyphenyl)-3',5'-dimethyl-
3',4',4a',7',8',8a'-hexahydro-2'H-spiro[1,3-dioxolane-2,1'-naphthalen]-8'-
yl]propanenitrile (4-15): A mixture of the foregoing ketone (700 mg, 1.9 mmol), (CH2OH)2 
(2.0 mL, 20 equiv) and CSA (200 mg, 0.9 mmol, 0.5 equiv) was refluxed in benzene (20 mL) 
with azeotropic removal of water for 10 h. After cooling, the mixture was washed with 
saturated solutions of NaHCO3 and NaCl, dried over Na2SO4, filtered, and concentrated in 
vacuo. The residue was purified by flash chromatography to provide 734 mg (1.78 mmol, 
94%) of acetal 4-15 as colorless crystals, mp. 56 °C. Rf 0.25 (petroleum ether/EtOAc, 8:1). 
1H NMR (400 MHz, CDCl3):  = 0.99 (d, J = 6.3 Hz, 3H, H-20), 1.04 (d, J = 7.1 Hz, 3H, H-
19), 1.06–1.14 (m, 2H, H-6a, 8a), 1.57 (dd, J = 10.8, 3.8 Hz, 1H, H-4), 1.70–1.80 (m, 1H, H-
7), 1.82 (s, 3H, H-21), 1.90 (dd, J = 13.4, 2.8 Hz, 1H, H-6b), 2.01–2.10 (m, 2H, H-3, 8b), 2.44 
(dd, J = 12.4, 10.8 Hz, 1H, H-9), 2.56 (br q, J = 7.1 Hz, 1H, H-2), 3.47 (br s, 1H, H-12), 3.80 
(s, 6H, OCH3), 3.85–3.94 (m, 1H, H-22), 3.98–4.05 (m, 3H, H-22), 5.91 (s, 1H, H-11), 6.35 
(s, 1H, H-16), 6.49 (s, 2H, H-14, 18). 13C NMR (100 MHz, CDCl3):  = 17.5 (C-19), 19.1 (C-
21), 22.0 (C-20), 26.8 (C-2), 30.0 (C-7), 36.9 (C-8), 40.7 (C-9), 43.1 (C-6), 44.4 (C-3), 44.9 
(C-12), 48.2 (C-4), 55.3 (OCH3), 64.3 (C-22), 64.5 (C-22), 98.0 (C-16), 106.9 (C-14, 18), 
110.9 (C-5), 123.3 (C-1), 123.4 (C-11), 139.7 (C-10), 144.5 (C-13), 160.9 (C-15, 17). HRMS 
(ESI): calcd for C25H33NO4 [M+Na]+ 434.2302, found 434.2303. []D23 –28.3 (c 10.0, 
CHCl3).  
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(3R,3aR,4R,6aS,8R,9bR)-4-(3,5-Dimethoxyphenyl)-3,6,8-trimethyl-
2,3a,4,6a,7,8,9,9b-octahydro-3H-benzo[de]quinoline (4-16): LiAlH4 (290 mg, 7.65 mmol, 5 
equiv) was dissolved in dry Et2O (60 mL) at room temperature, then the solution was 
concentrated under reduced pressure to around 6 mL. To this solution nitrile 4-15 (630 mg, 
1.53 mmol) in Et2O (6 mL) was added dropwise at 0 °C. After the mixture was stirred for 24 
h at 23 °C, it was diluted with Et2O (50 mL) and quenched by dropwise addition of Rochelle’s 
salt solution (20 g in 60 mL of deionized water), then vigorously stirred for 24 h. After this 
time the organic phase was separated and the water phase extracted with Et2O (3  20 mL). 
The combined organic layes were washed with saturated NaCl solution, dried over Na2SO4, 
filtered, and evaporated to yield 625 mg (98%) of the corresponding primary amine as a 
colorless semi-solid, which was used in the next step as such. To a solution of this amine in 
THF (15 mL) was added dropwise at 20 °C aqueous HCl (3M, 10 mL). The mixture was 
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heated to 50 °C for 2 h, then cooled to 20 °C and neutralized with saturated NaHCO3 solution. 
The mixture was extracted with EtOAc. The organic extracts were washed with saturated 
NaCl solution, dried over Na2SO4, filtered, and evaporated. The residue was purified by flash 
chromatography using deactivated silica gel (to the slurry of SiO2 and solvent, about 1% of 
Et3N based on the volume of SiO2 was added; the eluent itself did not contain Et3N). Rf 0.25 
(5% MeOH in CHCl3). To remove Et3N salts from the compound, the collected fractions were 
evaporated and dissolved in EtOAc (40 mL). This solution was washed with saturated 
solution of NaHCO3 and NaCl, dried over Na2SO4, filtered, and concentrated in vacuo, yield 
of 4-16 is 490 mg (1.386 mmol, 90%) from nitrile 4-15, yellowish viscous oil. 1H NMR (400 
MHz, CDCl3):  = 0.92 (ddd, J = 12.4, 12.1, 11.8 Hz, 1H, H-8a), 0.95 (d, J = 6.3 Hz, 3H, H-
20), 0.97 (d, J = 5.8 Hz, 3H, H-19), 1.01–1.12 (m, 1H, H-2), 1.54 (ddd, J = 10.8, 10.1, 5.1 Hz, 
1H, H-3), 1.62–1.72 (m, 1H, H-7), 1.70 (s, 3H, H-21), 1.75 (br dd, J = 13.1, 11.9 Hz, 1H, H-
6a), 1.92 (dd, J = 12.4, 11.8 Hz, 1H, H-9), 1.98 (dd, J = 12.4, 10.8 Hz, 1H, H-4), 2.08 (br d, J 
= 12.1 Hz, 1H, H-8b), 2.29 (br d, J = 11.9 Hz, 1H, H-6b), 2.90 (br dd, J = 16.9, 10.6 Hz, 1H, 
H-1a), 3.52 (dd, J = 16.9, 4.3 Hz, 1H, H-1b), 3.54 (br s, 1H, H-12), 3.71 (s, 6H, OCH3), 5.88 
(d, J = 4.6 Hz, 1H, H-11), 6.27 (t, J = 2.0 Hz, 1H, H-16), 6.37 (d, J = 2.0 Hz, 2H, H-14, 18). 
13C NMR (100 MHz, CDCl3):  = 16.9 (C-19), 21.0 (C-21), 22.4 (C-20), 27.6 (C-2), 32.9 (C-
7), 37.8 (C-8), 39.7 (C-4), 43.0 (C-12), 44.6 (C-3), 45.4 (C-9), 45.9 (C-6), 55.2 (OCH3), 57.1 
(C-1), 97.6 (C-16), 109.0 (C-14, 18), 125.3 (C-11), 137.2 (C-10), 143.0 (C-13), 160.1 (C-
15,17), 171.9 (C-5). HRMS (ESI): calcd for C23H31NO2 [M+H]+ 354.2428, found 354.2425. 
[]D23 +258 (c 7, CHCl3).  
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5-[(3R,3aR,4R,6aS,8R,9bR)-3,6,8-Trimethyl-2,3a,4,6a,7,8,9,9b-octahydro-3H-
benzo[de]quinolin-4-yl]benzene-1,3-diol (4-17): To a stirred solution of imine 4-16 (176 
mg, 0.5 mmol) in CH2Cl2 (2.5 mL) was added dropwise a solution of BBr3 (1M in CH2Cl2, 
2.5 mL, 2.5 mmol, 5 equiv) at –80 °C under nitrogen. The mixture was warmed to 0 °C within 
1 h, and stirred at this temperature for 1.5 h and finally treated with excess of saturated 
NaHCO3 solution. This mixture was diluted with deionized water and extracted with EtOAc 
(3  25 mL). The combined extracts were washed with saturated solutions of NaHCO3 and 
NaCl, dried (Na2SO4), filtered and concentrated in vacuo. The residue was chromatographed 
on flash silica gel, deactivated with Et3N using 10% MeOH in CHCl3 as an eluent (Rf 0.25). 
To remove Et3N salts from the isolated compound, the collected fractions obtained after 
evaporation were diluted with EtOAc and washed with saturated NaHCO3 solutions and 
NaCl, dried over Na2SO4, filtered and evaporated to dryness, to give 137 mg (0.42 mmol, 
84%) of the free base 4-17 as a yellowish powder, mp. 280 °C, decomp. 1H NMR (400 MHz, 
DMSO):  = 0.90–1.00 (m, 2H, H-2, 8a), 0.92 (s, 3H, H-19), 0.98 (d, J = 6.1 Hz, 3H, H-20), 
1.45 (ddd, J = 10.3, 9.3, 4.8 Hz, 1H, H-3), 1.60-1.75 (m, 2H, H-7, 6a), 1.71 (s, 3H, H-21), 
1.85-2.01 (m, 2H, H-9, 4), 2.10 (br d, J = 12.1 Hz, 1H, H-8b), 2.21 (br d, J = 12.1 Hz, 1H, H-
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6b), 2.80-2.90 (m, 1H, H-1a), 3.25-3.48 (m, 2H, H-12,1b), 5.35 (d, J = 4.3 Hz, 1H, H-11), 
6.04 (s, 1H, H-16), 6.11 (s, 2H, H-14, 18), 9.13 (br s, 2H, OH). 13C NMR (100 MHz, CDCl3): 
 = 16.6 (C-19), 20.8 (C-21), 22.4 (C-20), 27.6 (C-2), 32.4 (C-7), 37.3 (C-8), 39.2 (C-4), 42.4 
(C-12), 44.1 (C-3), 44.7 (C-9), 45.4 (C-6), 56.4 (C-1), 100.7 (C-16), 108.5 (C-14, 18), 125.6 
(C-11), 136.1 (C-10), 142.3 (C-13), 157.7 (C-15, 17), 167.8 (C-5). HRMS (ESI) calcd for 
C21H27NO2 [M+H]+ 326.21146, found 326.21145. []D23 +282 (c 1.0, MeOH).  
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Neosymbioimine (4-1)  
Neosymbioimine (4-1): The cyclic imine 4-17 (202 mg, 0.62 mmol) was dissolved in 
pyridine (10 mL). SO3·Py (500 mg, 3 mmol, 5 equiv) was added under nitrogen. The mixture 
was stirred at 60 °C under nitrogen for 24 h and then treated with MeOH (10 mL). Volatiles 
were evaporated at room temperature under vacuum to dryness, and the residue was filtered 
through a flash silica gel pad (6  3 cm) using a mixture of CHCl3/nPrOH/MeOH/H2O, 
5:5:2:1 as eluent in order to remove the excess of SO3·Py. The filtered fractions mostly 
contain bis-sulfate 4-18 (Rf 0.3) along with neosymbioimine 4-1 (Rf 0.7). Bis-sulfat 4-18 is 
unstable and hydrolyses in solution itself. The filtrate fractions were evaporated and dissolved 
in MeOH (4 mL) and water (2 mL). This solution was kept at 36 °C for 18 h to achieve 
complete mono hydrolysis of the bis-sulfate. Then pyridine (0.1 mL) was added, and volatiles 
were evaporated in vacuo to dryness at room temperature. The residue was chromatographed 
on flash silica gel (10  3 cm) column using CHCl3/MeOH, 6:1 as eluent. This way, some 
starting imine 4-17 (32 mg, 0.064 mmol, 10%) (pyridinium sulfate salt) was recovered as a 
yellowish solid (Rf 0.35), followed by neosymbioimine 4-1 (177 mg, 0.44 mmol, 70%) as a 
white powder (Rf 0.25, mp. 245 °C, decomp.). Based on the recovered starting material, the 
yield of neosymbioimine is 79% from 4-17. HRMS (ESI): calcd for C21H27NO5S [M-H]– 
404.15372, found 404.15365,  0.16 ppm. []D23 +172 (c 0.1, MeOH). 
1H and 13C NMR data of natural and synthetic neosymbioimine in CD3OD.a 
Atom 
1H 
1H, 
ppm 
13C 
13C, 
ppm Natural, 800 MHz Synthetic, 400 MHz
Natural, 
150 
MHz 
Synthetic, 
100 MHz 
1a 3.14 br dd (11.2, 15.8) 
3.20 ddd (15.7, 
11.4, 3.0) -0.06 52.6 51.8 0.8 
1b 3.55 dd (3.9, 15.8) 3.56 dd (15.7, 4.6) 0.01 
2 1.33 m 1.34 dqd (11.4, 5.9, 4.6) -0.01 27.9 27.8 0.1 
3 1.77 dt (4.8, 11.1) 1.80 ddd (11.4, 11.2, 5.0 ) -0.03 43.6 43.2 0.4 
4 2.62 br dd (11.1, 12.4) 
2.65 br dd (12.4, 
11.2) -0.03 41.6 41.8 0.2 
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5    189.3 190.1 -0.8 
6a 2.25 m 2.25 m -0.01 42.8 42.3 0.5 6b 2.56 m 2.52 m 0.04 
7 1.91 m 1.94 m -0.03 34.0 34.0 0.0 
8a 1.28 q (12.4) 1.28 ddd (12.6, 12.4, 12.1) 0.00 37.5 37.4 0.1 
8b 2.25 td (3.4, 12.4) 2.26 br d (12.6) -0.01 
9 2.32 dt (3.4, 12.4) 2.39 br d (12.4, 11.9) -0.07 46.1 45.9 0.2 
10    137.6 137.6 0.0 
11 5.52 br d (4.8) 5.52 br d (4.8) 0.00 126.4 126.4 0.0 
12 3.70 t (4.8) 3.71 br dd (5.0, 4.8) -0.01 43.3 43.2 0.0 
13    142.3 142.3 0.0 
14 6.58 t (1.9) 6.60 br s -0.02 114.9 114.9 0.0 
15    158.8 158.9 -0.1 
16 6.60 t (1.9) 6.60 br s 0.00 108.5 108.5 0.0 
17    154.4 154.4 0.0 
18 6.79 t (1.9) 6.78 br s 0.01 115.7 115.6 0.1 
19 1.15 d (5.9) 3H 1.16 d (6.2) 3H -0.01 16.3 16.2 0.1 
20 1.12 d (6.5) 3H 1.13 d (6.5) 3H -0.01 22.1 22.1 0.0 
21 1.83 br s 3H 1.84 br s 3H -0.01 21.1 21.1 0.0 
(a) Kita, M.; Ohishi, N.; Washida, K.; Kondo, M.; Koyama, T.; Yamada, K.; Uemura, D. 
Bioorg. Med. Chem. 2005, 13, 5253-5258. 
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5. The attempts toward the synthesis of platensimycin 
 
1-Methoxybicyclo[2.2.2]oct-5-en-2-one (5-7): A solution of 2,5-dihydroanisole (5-4) 
(25 g, 22.7 mmol) and 2-chloroacrylonitrile (5-5) (30 g, 34 mmol) was refluxed in benzene 
(200 mL) under inert atmosphere for 20 h. After that time the solvent was evaporated and the 
residue was distilled using a Kugelrohr apparatus (T = 180 °C, at 9 mbar).191 Yield of bicyclic 
compound 5-6 is 34 g (0.172 mol, 76%).  
A solution of 33.0 g (0.165 mol) of 6-chloro-6-cyano-1-methoxybicyclo[2.2.2]oct-2-ene 
5-6 and 79.0 g (0.33 mol) of Na2S·9H2O in 250 mL of ethanol was heated under reflux for 14 
h. The solution was poured into H2O (500 mL) and extracted three times with ether (150 mL). 
The combined extracts were washed with saturated aqueous NH4C1 solution, H2O, and brine. 
The organic layer was dried (MgSO4), filtered and concentrated, and distilled under reduced 
pressure to give 12.54 g (50% yield) of 5-7, bp. 80 °C/1 mm. 
 
2-[2-(1,3-Dioxan-2-yl)ethyl]-1-methoxybicyclo[2.2.2]oct-5-en-2-ol (5-10): 2-(2-
Bromoethyl)-1,3-dioxane (5-9) (21.8 mL, 31.2 g, 160 mmol) was added dropwise to a 
solution of activated (with 2 drops of dibromoethane) Mg (4.37 g, 180 mmol) in THF (120 
mL) at 20-25 °C during 1 h, and further stirred at this temperature for 20 min. Then THF (60 
mL) was added and the mixture was cooled to -20 °C. Neat ketone 5-7 (12.2 g, 80 mmol) was 
added at -20 °C for 30 min, and the mixture was stirred at -15…-20 °C for 30 min (TLC-
monitoring). After completing of the reaction the mixture was treated with NH4Cl (100 mL of 
satd. solution) and worked up by extraction with diethyl ether. The mixture of diastereomeric 
alcohols 5-10 was separated by flash chromatography (Rf 0.3, petroleum ether/EtOAc, 2:1) to 
yield 9.86 g (46 %) of exo-alcohol 5-10 as a colorless oil. 
 
1-[2-(1,3-Dioxan-2-yl)ethyl]bicyclo[3.2.1]oct-6-en-2-one (5-11): A mixture of alcohol 
5-10 (5.95 g, 22.2 mmol) and camphorsulphonic acid (5.7 g, 24.4 mmol, 1.1 equiv) in 1,3-
propanediol (40 mL) was stirred at 75 °C for 4 h under inert atmosphere. After completing of 
the reaction (by TLC) the mixture was cooled to rt and diluted with water (200 mL). The 
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product was extracted with diethyl ether (3×150 mL), dried with Na2SO4 and concentrated. 
The crude product was purified by flash chromatography (Rf 0.25, petroleum ether/EtOAc, 
4:1) to yield 5.21 g (0.22 mol, 99 %) of ketone 5-11. 1H NMR (400 MHz, CDCl3): [ppm] = 
1.26-1.32 (m, 1H, CH2), 1.43-1.59 (m, 2H, CH2), 1.43-1.59 (m, 4H, CH2), 1.85-1.93 (m, 1H, 
CH2), 1.97-2.09 (m, 1H, CH2), 2.15-2.20 (m, 1H, CH2), 2.21-2.28 (m, 1H, H-3), 2.58-2.67 (m, 
1H, H-3), 2.82-2.88 (m, 1H, H-5), 3.67-3.76 (m, 2H, CH2O), 4.02-4.08 (m, 2H, CH2O), 4.50 
(t, J = 5.1 Hz, 1H, CHO2), 5.66 (d, J = 5.6 Hz, 1H, H-7), 6.10 (dd, J = 5.6, 2.8 Hz, 1H, H-6). 
 
({1-[2-(1,3-Dioxan-2-yl)ethyl]bicyclo[3.2.1]oct-6-en-2-yl}oxy)(trimethyl)silane (5-
12): To a solution of ketone 5-11 (1.27 g, 5.4 mmol) and CeCl3·7H2O (2.012 g, 5.4 mmol) in 
MeOH (15 mL) NaBH4 (205 mg, 5.4 mmol) was added at 0 °C. The mixture was stirred for 
10 min (ice bath) and diluted with NH4Cl (50 mL of satd. solution) and EtOAc (50 mL). After 
shaking, layers were separated and the water phase was extracted with EtOAc (2×30 mL). 
Combined extracts were dried with Na2SO4, filtered and concentrated. To a crude mixture of 
the alcohols in CH2Cl2 (20 mL), imidazole (1.36 g, 20 mmol) and TMSCl (1.26 mL, 10 
mmol) were added sequentially at 0 °C. The resulting mixture was allowed to warm to rt and 
stirred for 15 min, then quenched with NaHCO3 (30 mL) and extracted with petroleum ether 
(3×50 mL). The combined extracts were dried with Na2SO4, concentrated, and the residue 
was chromatographed (Rf 0.35, petroleum ether/EtOAc 15:1) to yield 1.6 g (5.16 mmol, 95%) 
of a 3.5:1 diastereomeric mixture of silyl ethers 5-12 as a colorless oil. 
 
1-[2-(1,3-Dioxan-2-yl)ethyl]-2-[(trimethylsilyl)oxy]bicyclo[3.2.1]octan-6-one (5-13): 
To a stirred solution of a mixture of silyl ethers 5-12 (1.57 g, 5.06 mmol) in THF (15 mL) 
BH3·THF (10 mL of 1M THF solution, 10 mmol) was added at -80 °C. The resulting mixture 
was slowly allowed to warm to 0 °C within 2 h and stirred at 0 °C for 1 h. Then a solution of 
NaOH (3N, 7.5 mL) was added dropwise at 0 °C followed by dropwise addition of 30 % 
H2O2 (2.5 mL). The mixture was warmed to rt for 1 h and worked up by extraction with 
diethyl ether, drying and concentration. Crude alcohol (1.81 g) was dissolved in 
dichloromethane (25 mL) and DMP (16 mL of 15 % CH2Cl2 solution) was added at 0 °C. The 
resulting mixture was stirred at rt overnight and diluted with with NaHCO3 (100 mL of satd. 
solution). Extractive workup with dichloromethane (3×50 mL), drying with Na2SO4 and 
concentration afforded after chromatography 1.38 g (0.42 mmol, 84%) of ketone 5-13 as a 
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colorless oil (Rf 0.3, petroleum ether/EtOAc, 15:1). 1H NMR (400 MHz, CDCl3): [ppm] = 
0.05-0.10 (m, 9H, (CH3)3Si), 1.20-2.40 (m, 15 H), 3.54-3.70 (m, 1H, H-2), 3.55-3.75 (m, 2H, 
CH2O), 4.00-4.10 (m, 2H, CH2O), 4.43-4.47 (m, 1H, CHO2). 
 
1-[2-(1,3-Dioxan-2-yl)ethyl]-6-hydroxy-6-methylbicyclo[3.2.1]octan-2-one (5-14): 
To a stirred solution of ketone 5-13 (1.35 g, 4.1 mmol) in diethyl ether (15 mL) MeLi (10 mL, 
16 mmol of 1.6M diethyl ether solution) was added at -85 °C. The mixture was slowly 
warmed to rt. The reaction was worked up by quenching with NH4Cl, extracting with diethyl 
ether, drying and concentrating. Crude ketone was dissolved in THF (10 mL) and treated with 
TBAF (10 mL of 1 M THF solution) at rt for 1 h. The resulting mixture was treated with 
water (40 mL) and extracted with diethyl ether (3×30 mL). The combined extracts were 
washed with saturated NaCl solution (20 mL), dried with Na2SO4 and concentrated. Crude 
diol was dissolved in dichloromethane and treated with DMP (15 mL of 15 % CH2Cl2 
solution) at rt overnight. The reaction was worked up as in the previous synthesis of 5-13, and 
the product was isolated by chromatography (Rf 0.2-0.3, petroleum ether/EtOAc 1:1) to yield 
769 mg (2.87 mmol, 70%) of hydroxyketone 5-14. 1H NMR (400 MHz, CDCl3): [ppm] = 
1.27-1.34 (m, 1H, CH2), 1.43 (s, 3H, CH3), 1.46-1.64 (m, 6H, CH2), 1.72-2.10 (m, 6H, CH2), 
2.17-2.24 (m, 1H, H-5), 2.22-2.28 (m, 1H, H-3), 2.76-2.86 (m, 1H, H-3), 3.68-3.78 (m, 2H, 
CH2O), 4.03-4.09 (m, 2H, CH2O), 4.48 (t, J = 4.8 Hz, 1H, CHO2). 
 
1-[2-(1,3-Dioxan-2-yl)ethyl]-3,6-dihydroxy-6-methylbicyclo[3.2.1]octan-2-one (5-
16): To a stirred solution of ketoalcohol 5-14 (310 mg, 1.15 mmol) in THF (12 mL) 
NaHMDS (2.9 mmol, 2.5 equiv, 1 M THF solution) was added dropwise at -80 °C. The 
mixture was stirred at -80 °C for 3 h followed by dropwise addition of oxaziridine 5-15 (825 
mg, 3 mmol) in THF (3 mL). The resulted mixture was stirred for 2 h at this temperature and 
quenched with NH4Cl (20 mL of saturated solution) and extracted with Et2O (3×30 mL). The 
combined extracts were washed with satd. NaCl solution (20 mL), dried with Na2SO4, filtered 
and concentrated. The crude product was purified by flash chromatography (Rf 0.15, 
petroleum ether/EtOAc 1:1) to yield 98 mg (0.345 mmol, 30%) of ketodiol 5-16 as a colorless 
oil. 
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5-[2-(1,3-Dioxan-2-yl)ethyl]-6a-methylhexahydro-2H-2,5-
methanocyclopenta[b]furan-7-one (5-18): To a stirred solution of compound 5-16 (70 mg, 
0.24 mmol) in CH2Cl2 (1 mL) and pyridine (0.24 mL, 3 mmol) p-toluenesulphonyl chloride 
(190 mg, 1 mmol) was added. The mixture was stirred at rt overnight (TLC-monitoring). The 
obtained mixture was concentrated and the crude product was chromatographed (Rf 0.25, 
petroleum ether/EtOAc 1:1) to afford 89 mg (0.204, 85%) of tosylate 5-17. 1H NMR (400 
MHz, CDCl3): [ppm] = 1.17-1.21 (m, 1H, CH2), 1.27-1.45 (m, 3H, CH2), 1.44 (s, 3H, CH3), 
1.59-2.12 (m, 9H, CH2), 2.41 (s, 1H, ArCH3), 2.59-2.70 (m, 1H, H-5), 3.44-3.49 (m, 2H, 
CH2O), 3.67-3.76 (m, 2H, CH2O), 4.46 (t, J = 5.0 Hz, 1H, CHO2), 5.52 (dd, J = 10.6, 8.6 Hz, 
H-3), 7.30 (d, J = 8.2 Hz, 2H, Ar), 7.84 (d, J = 8.2 Hz, 2H, Ar). 
The obtained tosylate 5-17 (35 mg, 0.08 mmol) was dissolved in THF (1 mL), and 
NaHMDS (0.25 mmol, 0.25 mL of 1M THF solution) was added at -50 °C. The mixture was 
warmed to rt for 1 h, quenched with NH4Cl (5 mL) and worked up by extraction with Et2O 
drying with Na2SO4, filtered and concentrated in vacuo. The crude product was purified by 
flash chromatography (Rf 0.25, petroleum ether/EtOAc 3:1) to afford 15 mg (0.56 mmol, 70 
%) of tricyclic product 5-18 as a colorless oil. 1H NMR (400 MHz, CDCl3): [ppm] = 1.27-
1.32 (m, 1H, CH2), 1.50 (s, 3H, CH3), 1.51-1.70 (m, 5H, CH2), 1.75-1.83 (m, 2H, CH2), 1.88-
1.94 (m, 1H, CH2), 1.99-2.24 (m, 3H, CH2), 2.49-2.54 (dd, J = 6.1, 6.1 Hz, 1H, H-3a), 3.70-
3.77 (m, 2H, CH2O), 4.04-4.10 (m, 2H, CH2O), 4.22 (d, J = 4.6 Hz, 1H, H-2), 4.51 (t, J = 4.8 
Hz, 1H, CHO2). 
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6. Formal total synthesis of platencin 
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6-4  
6-Allyl-3-isobutoxy-6-(3-oxobutyl)cyclohex-2-en-1-one (6-5). To a solution of iPr2NH 
(3.92 mL, 28.0 mmol) in anhydrous THF (30 mL) was added dropwise nBuLi (10 mL, 2.5 M 
solution in hexanes, 25 mmol, 1.1 equiv) at –20 °C. The mixture was stirred for 15 min and 
then cooled to –80 °C. At this point, a solution of 3-isobutoxycyclohex-2-en-1-one229 6-4 
(3.78 g, 22.5 mmol) in THF (10 mL) was added dropwise and the mixture stirred for 1 h at 
this temperature before allyl bromide (2.57 mL, 30.0 mmol, 1.33 equiv) was injected. The 
resulting mixture was allowed to warm to room temperature overnight, and then treated with a 
half saturated solution of NH4Cl (30 mL) and Et2O (50 mL). After shaking in a separatory 
funnel and separation of the layers, the water phase was extracted with Et2O (2 × 35 mL). The 
combined organic layers were washed with saturated NaCl solution (20 mL), dried with 
anhydrous Na2SO4, filtered, and evaporated. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 8:1 (Rf ~ 0.35) to provide 4.2 g (0.20 mmol, 90%) 
of 6-allyl-3-isobutoxycyclohex-2-en-1-one as colorless crystals (m.p. 36 °C).  
The allylated compound, dissolved in THF (20 mL) was added to a solution of LDA [22 
mmol, 1.1 equiv, prepared from nBuLi (8.8 mL, 2.5 M, 22.0 mmol) and iPr2NH (3.37 mL, 24 
mmol) at –20 °C for 20 min] in THF (100 mL) at –80 °C with stirring. The mixture was 
stirred for 1 h, before methyl vinyl ketone (1.68 mL, 20.0 mmol, 1 equiv) was added 
dropwise. The resulting mixture was stirred for 0.5 h at –80 °C and then treated with water 
(50 mL). Extractive work-up like in the previous step followed by flash chromatography of 
the crude product (Rf ~ 0.3, petroleum ether/EtOAc, 4:1) afforded 4.68 g (16.8 mmol, 84%) 
of 6-allyl-3-isobutoxy-6-(3-oxobutyl)cyclohex-2-en-1-one (6-5) as a colorless oil. 1H NMR 
(400 MHz, CDCl3): [ppm] = 0.95 (d, J = 6.8 Hz, 6H, (CH3)2CH), 1.68–1.91 (m, 4H), 2.00 
(qt, J = 6.8, 6.5 Hz, 1H, (CH3)2CH), 2.10 (s, 3H, COCH3), 2.15–2.22 (m, 1H), 2.30–2.52 (m, 
5H), 3.55 (d, J = 6.3 Hz, 2H, iPrCH2O), 5.02–5.08 (m, 2H, CH2CH=CH2), 5.21 (s, 1H, 2-H), 
5.63–5.74 (m, 1H, CH2CH=CH2). 13C NMR (100 MHz, CDCl3): [ppm] = 19.0 ((CH3)2CH), 
25.6 (CH2), 27.7((CH3)2CH), 28.0 (CH2), 29.9 (CH2), 30.0 (COCH3), 38.3 (CH2), 39.3 (CH2), 
45.5 (C-6), 74.8 (iPrCH2O), 101.7 (C-2), 118.3 (CH2CH=CH2), 133.8 (CH2CH=CH2), 176.2 
(C-3), 202.1 (C-1), 208.7 (COCH3). HRMS (ESI): calcd for C17H26O3 [M+Na]+ 301.17742, 
found 301.17733. 
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4-Allyl-4-[2-(2-methyl-1,3-dioxolan-2-yl)ethyl]cyclohex-2-en-1-one (6-6). 
Vinylogous ester 6-5 (2.5 g, 9.0 mmol), ethylene glycol (10.17 mL, 180.0 mmol, 20 equiv) 
and PPTS (900 mg, 3.6 mmol, 0.4 equiv) in benzene (90 mL) were refluxed with a Dean-
Stark trap for 2-12 h (TLC-monitoring, Rf 0.25, petroleum ether/EtOAc, 4:1). The mixture 
was cooled and treated with saturated NaHCO3 solution (60 mL). After separation of the 
layers, the aqueous phase was extracted with Et2O (2 × 50 mL). The combined organic layers 
were washed with saturated NaCl solution (40 mL), dried with anhydrous Na2SO4, filtered, 
and evaporated to dryness to obtain 6-allyl-3-isobutoxy-6-[2-(2-methyl-1,3-dioxolan-2-
yl)ethyl]cyclohex-2-en-1-one (quant.), which was sufficiently pure for the next step. 
The obtained dioxolane was dissolved in anhydrous THF (80 mL), and DIBAL-H (13.5 
mL, 1 M in hexane, 1.5 equiv) was added dropwise at –80 °C. The mixture was warmed to –
60 °C and kept at this temperature for 1 h before it was poured into a vigorously stirred, ice-
cold solution of Rochelle’s salt (60 g) in water (150 mL). The mixture was stirred for 2 h, 
then Et2O (50 mL) was added and the layers were separated. The aqueous phase was extracted 
with Et2O (2 × 35 mL) and the combined organic extracts were washed with saturated NaCl 
solution (40 mL), dried with anhydrous Na2SO4, filtered, and evaporated in vacuo. The 
residue was dissolved in Et2O (100 mL), water (0.9 mL) and pTsOH·H2O (72 mg, 0.375 
mmol, ~ 0.04 equiv) were added with stirring at 20 °C. The mixture was stirred for 20–30 
minutes (TLC-monitoring), then saturated NaHCO3 solution (30 mL) was added. After 
shaking in a separatory funnel and separation of the layers, the aqueous phase was reextracted 
with ether (50 mL). The combined organic extracts were washed with saturated NaCl solution 
(40 mL), dried with anhydrous Na2SO4, filtered, and concentrated in vacuo. Flash 
chromatography (Rf 0.3, petroleum ether/EtOAc, 3:1) of the residue afforded 1.80 g (7.2 
mmol, 80% from 6-5) of 4-allyl-4-[2-(2-methyl-1,3-dioxolan-2-yl)ethyl]cyclohex-2-en-1-one 
(6-6) as a colorless oil. 1H NMR (400 MHz, CDCl3): [ppm] = 1.28 (s, 3H, CH3), 1.50–1.58 
(m, 4H, CH2), 1.82–1.87 (m, 2H, CH2), 2.20 (br d, J = 7.6 Hz, 2H, CH2), 2.40–2.45 (m, 2H, 
CH2), 3.86–3.96 (m, 4H, (CH2O)2), 5.05–5.13 (m, 2H, CH=CH2), 5.70–5.80 (m, 1H, 
CH=CH2), 5.91 (d, J = 10.4 Hz, 2H, 2-H), 6.65 (d, J = 10.4 Hz, 2H, 3-H). 13C NMR (100 
MHz, CDCl3): [ppm] = 23.8 (CH3), 30.9 (CH2), 31.5 (CH2), 33.4 (CH2), 33.8 (CH2), 38.0 
(C-4), 42.4 (CH2), 64.7 ((CH2O)2C), 109.7 ((CH2O)2C), 118.7 (CH=CH2), 128.3 (C-2), 133.3 
(CH=CH2), 157.6 (C-3), 199.4 (C-1). HRMS (ESI): calcd for C15H22O3 [M+Na]+ 273.14612, 
found 273.14614. 
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Conversion of enone xx into bicyclic ketone 5-[2-(2-Methyl-1,3-dioxolan-2-
yl)ethyl]-7-methylenebicyclo[3.2.1]oct-3-en-2-one (6-8). a) Silyl dienol ether 7. To a stirred 
solution of LDA [1.5 mmol, 1.5 equiv, prepared from nBuLi (0.6 mL, 2.5 M, 1.5 mmol) and 
iPr2NH (0.22 mL, 1.56 mmol) at –20 °C for 20 min] in THF (5 mL), a solution of enone 6-6 
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(250 mg, 1.0 mmol) in THF (5 mL) was added dropwise at –80 °C. The mixture was stirred 
for 1 h at this temperature, then a solution of TBSCl (300 mg, 2.0 mmol, 2 equiv) or TMSCl 
(0.251 mL, 2.0 mmol) or TIPSCl (0.449 mL, 2.0 mmol) in THF (1.5 mL) was added dropwise 
followed by HMPA (1.5 mmol, 0.27 mL). The mixture was allowed to warm to room 
temperature within 1 h, and stirred for an additional 0.5 h at 20 °C. Then the mixture was 
diluted with water (20 mL) and petroleum ether (30 mL). After shaking in a separatory funnel, 
and separation of the layers, the aqueous layer was extracted with petroleum ether (2 × 20 
mL). The combined organic extracts were washed with saturated NaCl solution (20 mL), 
dried with anhydrous Na2SO4, filtered, and concentrated in vacuo. The residue was passed 
through a short column of silica gel [petroleum ether/EtOAc, 20:1 (Rf ~ 0.25 – 0.35)] to 
provide the silyl dienol ethers 6-7 in about 90% yield as colorless oils. 
The obtained silyl enol ether 6-7 (0.5 mmol) was dissolved in DMSO (see Table in the 
Results and Discussion) to give the indicated concentration, Pd(OAc)2 was added, and the 
resulting solution was stirred under oxygen atmosphere (ballon with O2) until TLC showed 
complete consumption of silyl enol ether 6-7 (24–48 h). The mixture was diluted with Et2O 
(30 mL) and water (30 mL). After separation of the layers, the aqueous phase was extracted 
with Et2O (2 × 20 mL). The combined organic layers were washed with saturated NaCl 
solution (20 mL), dried with anhydrous Na2SO4, filtered, and concentrated in vacuo. The 
crude mixture was analyzed by 1H NMR. The product 6-8 was also purified by flash 
chromatography (Rf ~ 0.25, petroleum ether/EtOAc, 4:1) to provide 85% yield, a colorless 
oil.  
Compound 6-8: 1H NMR (400 MHz, CDCl3): [ppm] = 1.28 (s, 3H, CH3), 1.51–1.78 
(m, 5H), 2.03 (d, J = 10.4 Hz, 1H, CH2), 2.25–2.37 (m, 2H), 3.39 (d, J = 4.8 Hz, 1H, 1-H), 
3.86–3.95 (m, 4H, (CH2O)2), 4.98 (s, 1H, 7’a-H), 4.95 (s, 1H, 7’b-H), 5.76 (dd, J = 9.6, 1.5 
Hz, 1H, 3-H), 6.95 (dd, J = 9.6, 2.0 Hz, 1H, 4-H). 13C NMR (100 MHz, CDCl3): [ppm] = 
23.8 (CH3), 31.4 (CH2), 35.1 (CH2), 42.6 (CH2), 44.6 (CH2), 46.2 (C-5), 58.6 (C-1), 64.6 
((CH2O)2C), 109.5 ((CH2O)2C), 112.0 (C-7’), 126.6 (C-3), 145.4 (C-7), 158.1 (C-4), 198.6 
(C-2). HRMS (ESI): calcd for C15H20O3 [M+Na]+ 271.13047, found 271.13072.  
Compound 6-9: 1H NMR (400 MHz, CDCl3): [ppm] = 1.22 (s, 3H, CH3), 1.39–1.45 
(m, 2H, CH2), 1.71–1.79 (m, 2H, CH2), 2.34 (d, J = 7.3 Hz, 2H, CH2), 3.83–3.92 (m, 4H, 
(CH2O)2), 4.97–5.03 (m, 2H, CH=CH2), 5.49-5.61 (m, 1H, CH=CH2), 6.30 (d, J = 10.4 Hz, 
2H, 2,6-H), 6.68 (d, J = 10.4 Hz, 2H, 3,5-H). 13C NMR (100 MHz, CDCl3): [ppm] = 23.9 
(CH3), 32.6 (CH2), 33.8 (CH2), 44.1 (CH2), 45.3 (C-4), 64.4 ((CH2O)2C), 109.4 ((CH2O)2C), 
118.8 (CH=CH2), 130.4 (C-2,6), 132.1 (CH=CH2), 154.1 (C-3,5), 186.4 (C-1). HRMS (ESI): 
calcd for C15H20O3 [M+Na]+ 271.13047, found 271.13036. 
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6-Methylenehexahydro-4a,7-methanobenzo[7]annulene-2,8(1H,5H)-dione (6-11). 
To a stirred solution of enone 6-8 (574 mg, 2.3 mmol) in acetone (27 mL) was added 
pTsOH·H2O (0.44 g, 2.3 mmol, 1 equiv) at 20 °C, and the solution was stirred for 40 min 
(TLC-monitoring, Rf ~ 0.3, petroleum ether/EtOAc, 2:1) until complete conversion. The 
resulting solution was diluted with water (20 mL), saturated NaHCO3 solution (20 mL) and 
Et2O (50 mL). After shaking in a separatory funnel and separation of the layers, the aqueous 
layer was re-extracted with Et2O (2 × 25 mL). The combined organic extracts were washed 
with saturated NaCl solution (20 mL), dried with anhydrous Na2SO4, filtered, and 
concentrated in vacuo to give pure ketonenone 6-10 in quantitative yield (470 mg), colorless 
oil. 
The obtained ketoenone 6-10 (2.3 mmol) was dissolved in THF (10 mL) and tBuOH (5 
mL). A solution of KOtBu (570 mg, ~ 5 mmol, ~ 2.2 equiv) in THF (3 mL) was added 
dropwise at –80 °C. The mixture was stirred for 2.5 h at –80 °C, then treated with half 
saturated NH4Cl solution (20 mL), and diluted with Et2O (40 mL). After shaking in a 
separatory funnel and separation of the layers, the aqueous phase was extracted with Et2O (2 
× 30 mL). The combined organic extracts were washed with saturated NaCl solution (20 mL), 
dried with anhydrous Na2SO4, filtered, and concentrated in vacuo. Flash chromatography of 
the residue (petroleum ether/EtOAc, 3:1, Rf ~ 0.3) provided tricyclic diketone 6-11 (412 mg, 
2.0 mmol, 88%) as a colorless oil. 1H NMR (400 MHz, CDCl3): [ppm] = 1.76–1.89 (m, 3H), 
1.94–2.02 (m, 1H), 2.21–2.41 (m, 6H), 2.52 (s, 1H, CH2), 2.77–2,85 (m, 1H, CH2), 3.30 (d, 
1H, J = 5.1 Hz, 7-H), 4.95 (br s, 1H, 6’a-H), 4.95 (dd, J = 2.5, 2.0 Hz, 1H, 6’b-H). 13C NMR 
(100 MHz, CDCl3): [ppm] = 35.2 (CH2), 36.4 (CH2), 39.0 (CH2), 41.1 (CH2), 42.9 (C-4’), 
43.4 (C-1’), 43.9 (CH2), 45.0 (CH2), 59.8 (C-7), 109.3 (C-6’), 147.0 (C-6), 208.0 (C=O), 
209.3 (C=O). HRMS (ESI): calcd for C13H16O2 [M+Na]+ 227.10425, found 227.10407. 
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1-Allyl-4-isobutoxy-2-oxocyclohex-3-ene-1-carbaldehyde (6-14). NaH (2.25 g, 56.25 
mmol, 1.5 equiv) and KH (100 mg) were washed with dry THF (40 mL) under inert 
atmosphere. Then dry THF (260 mL) was added followed by isobutyl formate (8.64 mL, 2 
equiv) at 0 °C. This was followed by the dropwise addition of 3-isobutoxycyclohex-2-en-1-
one229 6-4 [6.3 g, 37.5 mmol (Rf 0.25, petroleum ether/ethyl acetate, 4:1)] in THF (10–20 mL) 
was added with stirring. The mixture was stirred at 0 °C (bath temperature) for 24 h. When 
the reaction started, gas evolution was observed. If the reaction does not start (checked by 
TLC) a small amount of KH should be added. When the formylation reaction was finished 
(TLC, Rf 0.75, petroleum ether/ethyl acetate, 4:1), allylchloroformate (6.8 g, 1.5 equiv) was 
added, and the mixture stirred at 0 °C for 1 h. The reaction was quenched by addition of water 
(200 mL) and saturated NH4Cl solution (50 mL), and the mixture extracted with Et2O (3 × 
150 mL). The combined organic extracts were washed with saturated NaHCO3 solution, 
saturated NaCl solution, dried with Na2SO4, filtered. All volatiles of the filtrate were 
evaporated very well. The crude residue, which represents E/Z mixture of allyl enol 
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carbonates 6-13 (Rf 0.25 and 0.4, petroleum ether/ethyl acetate, 4:1), was dissolved in 
absolute THF (260 mL) under inert atmosphere. Ph3P (262 mg, 1 mmol, 2.67 %) and 
Pd(OAc)2 (112 mg, 0.5 mmol, 1.33 %) were added at 20 °C, followed by stirring of the 
mixture for 1 h. After TLC showed complete reaction, Me2S (0.1 mL) was added (to 
deactivate the palladium catalyst) and the solvent was evaporated. The residue was purified 
by flash chromatography (petroleum ether/ethyl acetate, 10:1, Rf 0.3) to provide aldehyde 6-
14 as a colorless oil (8.15 g, 34.5 mmol, 92%). 1H NMR (400 MHz, CDCl3): [ppm] = 0.95 
(d, J = 6.8 Hz, 6H, CH3), 1.89 (dddd, 1H, J = 14.4, 8.1, 5.6, 1.3 Hz, 1H, 6a-H), 2.00 (qt, J = 
6.8, 6.5 Hz, 1H, CH(CH3)2), 2.26 (ddd, J = 13.9, 5.8, 5.5 Hz, 1H, 5a-H), 2.37 (ddd, J = 18.2, 
5.8, 5.5 Hz, 1H, 5b-H), 2.59 (d, J = 7.3 Hz, 2H, CH2CH=CH2), 3.57 (dd, J = 6.5, 1.3 Hz, 2H, 
iPrCH2O), 5.06–5.14 (m, 2H, CH2CH=CH2), 5.34 (s, 1H, 3-H), 5.53–5.65 (m, 1H, 
CH2CH=CH2), 9.55 (d, 1H, J = 1.3 Hz, CH=O). 13C NMR (100 MHz, CDCl3): [ppm] = 19.0 
(CH3), 24.3, 25.8, 27.7, 36.2 (CH2CH=CH2), 60.2 (C-1), 75.1 ((CH3)2CH), 102.4 (C-3), 119.4 
(CH2CH=CH2), 132.0 (CH2CH=CH2), 178.1 (C-4), 195.8 (C-2), 200.7 (CH=O). HRMS 
(ESI): calcd for C14H20O3 [M+Na]+ 259.13047, found 259.13054. 
The enol carbonate 6-13 could be purified by flash chromatography (petroleum 
ether/EtOAc, 4:1, Rf 0.4). On the silica gel column, enol carbonate 6-13 isomerized to give 
mostly the Z-isomer in 89% yield as yellow crystals, m.p. 45–46 °C. 1H NMR (400 MHz, 
CDCl3): [ppm] = 0.96 (d, J = 6.6 Hz, 6H, CH3), 2.02 (m, 1H, CH(CH3)2), 2.45 (t, J = 6.8 Hz, 
2H, 5-H), 2.75 (td, J = 6.8, 1.8 Hz, 2H, 6-H), 3.61 (d, J = 6.6 Hz, 2H, iPrCH2O), 4.71 (d, J = 
7.1 Hz, 2H, OCH2CH=CH2), 5.31 (br d, J = 10.4 Hz, 1H, CH2CH=CH2), 5.39 (br d, J = 17.2 
Hz, 1H, CH2CH=CH2), 5.46 (s, 1H, 3-H), 5.88–5.99 (m, 1H, CH2CH=CH2), 7.94 (t, J = 1.8 
Hz, 1H, 1’-H). 13C NMR (100 MHz, CDCl3): [ppm] = 19.0 (CH3), 21.0 (C-5), 27.7 
(CH(CH3)2), 27.8 (C-6), 69.5 (OCH2CH=CH2), 75.0 (iPrCH2O), 103.3 (C-3), 118.7 (C-1), 
120.0 (CH2CH=CH2), 130.6 (CH2CH=CH2), 141.5 (OC(O)O), 151.9 (C-1’), 177.4 (C-4), 
188.1 (C-2). HRMS (ESI): calcd for C15H20O5 [M+Na]+ 303.12029, found 303.12007. 
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(1-Allyl-4-oxocyclohex-2-en-1-yl)methyl pivalate (6-16). To a stirred solution of 
aldehyde 6-14 (8.14 g, 34.5 mmol) and CeCl3·7H2O (0.2 equiv, 2.6 g) in MeOH (135 mL), 
was added NaBH4 (2.67 g, 70 mmol, 2 equiv) portionwise, keeping the inner temperature 
between 0–10° C, using an ice/NaCl bath for cooling. The addition time is around 30 min. 
After complete addition of NaBH4, the mixture was stirred for 0.5 h and treated with saturated 
NH4Cl solution (50 mL). It was then diluted with water and extracted with Et2O (2 × 200 mL 
+ 100 mL). To this ether solution water (4 mL) and pTsOH·H2O (0.4 g) were added and the 
mixture was stirred for 0.5 h at room temperature. After complete hydrolysis, (checked by 
TLC), the reaction was quenched with saturated NaHCO3 solution (20 mL). After separation 
of the layers, the organic phase was washed with saturated NaCl solution, dried with 
anhydrous Na2SO4, filtered, and concentrated in vacuo very well. The obtained 
192  Experimental Section 
hydroxyketone 6-15 (Rf 0.25, petroleum ether/ethyl acetate, 1:1) was pure enough for the next 
transformation. 1H NMR (400 MHz, CDCl3): [ppm] = 1.83–2.00 (m, 2H, 5-H), 2.04 (t, J = 
5.6 Hz, 1H, OH), 2.28(d, J = 7.6 Hz, 2H, CH2CH=CH2), 2.40–2.54 (m, 2H, 6-H), 3.51–3.63 
(m, 2H, CH2OH), 5.10–5.19 (m, 2H, CH2CH=CH2), 5.72–5.85 (m, 1H, CH2CH=CH2), 6.01 
(d, J = 10.4 Hz, 1H, 2-H), 6.76 (d, J = 10.4 Hz, 1H, 3-H). 13C NMR (100 MHz, CDCl3): 
[ppm] = 28.4 (C-5), 33.8 (CH2CH=CH2), 39.9 (C-6), 41.0 (C-4), 67.3 (CH2OH), 119.0 
(CH2CH=CH2), 129.8 (C-2), 133.2 (CH2CH=CH2), 154.6 (C-3), 199.5 (C-1). HRMS (ESI): 
calcd for C10H14O2 [M+Na]+ 189.08860, found 189.08872. 
Thus, the crude compound 6-15 was dissolved in dry CH2Cl2 (70 mL). Then pyridine 
(11.2 mL, 140 mmol, 4 equiv) and 4-dimethylaminopyridine (210 mg, 1.725 mmol, 0.05 
equiv) were added followed by the addition of pivaloyl chloride (8.55 mL, 70.0 mmol, 2 
equiv) at 0 °C. The mixture was stirred for 48 h at room temperature, then treated with water 
(50 mL). The layers were separated and the aqueous phase extracted with CH2Cl2 (2 × 50 
mL). The combined CH2Cl2 layers were washed with saturated NaHCO3 solution (25 mL), 
saturated NaCl solution, dried with anhydrous Na2SO4, filtered, and concentrated in vacuo. 
The residue was flash chromatographed (petroleum ether/ethyl acetate, 8:1, Rf 0.3) to provide 
pure (1-allyl-4-oxocyclohex-2-en-1-yl)methyl pivalate 6-16 (8.1 g, 32.4 mmol, 94%) as 
colorless oil. 1H NMR (400 MHz, CDCl3): [ppm] = 1.18 (s, 9H, C(CH3)3), 1.89 (br t, J = 6.8 
Hz, 2H, 5-H), 2.25 (d, J = 7.5 Hz, 2H, CH2CH=CH2), 2.44 (br t, J = 6.8 Hz, 2H, 6-H), 3.87 (d, 
J = 11.1 Hz, 1H, CH2OPiv), 4.05 (d, J = 11.1 Hz, 1H, CH2OPiv), 5.04–5.13 (m, 2H, 
CH2CH=CH2), 5.63–5.75 (m, 1H, CH2CH=CH2), 5.97 (d, J = 10.4 Hz, 1H, 2-H), 6.64 (d, J = 
10.4 Hz, 1H, 3-H). 13C NMR (100 MHz, CDCl3): [ppm] = 27.2 (C(CH3)3), 29.0 (C-5), 33.7 
(C-6), 39.0 (C(CH3)3), 39.5 (C-4), 40.2 (CH2CH=CH2), 67.7 (CH2OPiv), 119.6 
(CH2CH=CH2), 130.0 (C-2), 132.3 (CH2CH=CH2), 153.0 (C-3), 178.1 (C-C(CH3)3), 198.7 
(C-1). HRMS (ESI): calcd for C15H22O3 [M+Na]+ 273.14614, found 273.14612. 
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(1-Allyl-4-{[tert-butyl(dimethyl)silyl]oxy}cyclohexa-2,4-dien-1-yl)methyl pivalate 
(6-17). To a stirred solution of iPr2NH (6.79 mL, 48 mmol) in anhydrous THF (80 mL), 
nBuLi (18 mL, 2.5 M in hexane, 45 mmol) was added dropwise at –20 °C. After stirring for 
20 min at this temperature, the LDA solution was cooled to a temperature between –85 and –
90 °C, before (1-allyl-4-oxocyclohex-2-en-1-yl)methyl pivalate (6-16) (7.25 g, 29 mmol) in 
THF (35 mL) was added during 0.5 h at a temperature between –80 and –90 °C. The mixture 
was stirred at –80 °C for 1 h, then TBSCl (8.7 g, 58 mmol, 2 equiv) in THF (20 mL) was 
added dropwise followed by HMPA (5.25 mL, 30 mmol, 1.03 equiv). The mixture was 
allowed to warm to room temperature overnight, then diluted with water and NH4Cl solution, 
and finally extracted with petroleum ether (3 × 150 mL). The organic extracts were washed 
with saturated NaCl solution, dried with anhydrous Na2SO4, filtered, and evaporated. The 
residue was flash chromatographed (petroleum ether/ethyl acetate, 75:1 to 60:1, Rf 0.3 at 
60:1) to furnish silyl dienol ether 6-17 in 88% yield (9.3 g, 25.52 mmol) as a colorless oil. 1H 
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NMR (400 MHz, CDCl3): [ppm] = 0.12 (s, 6H, SiCH3), 0.91 (s, 9H, SiC(CH3)3), 1.20 (s, 
9H, O=CC(CH3)3), 2.12–2.25 (m, 4H, 6-H, CH2CH=CH2), 3.85 (d, J = 10.9 Hz, 1H, 
CH2OPiv), 3.93 (d, J = 10.9 Hz, 1H, CH2OPiv), 4.77 (ddd, J = 6.3, 4.6, 2.0 Hz, 1H, 5-H), 
4.99–5.08 (m, 2H, CH2CH=CH2), 5.54 (d, J = 10.1 Hz, 1H, 2-H), 5.69–5.80 (m, 1H, 
CH2CH=CH2), 5.72 (dd, J = 10.1, 2.0 Hz, 1H, 3-H). 13C NMR (100 MHz, CDCl3): [ppm] = 
–4.5 (SiCH3), 18.0 (SiC(CH3)3), 25.7 (SiC(CH3)3), 27.2 (C(CH3)3), 29.7 (C-6), 38.0 (C-1), 
39.0 (CC(CH3)3), 39.7 (CH2CH=CH2), 67.5 (CH2OPiv), 100.9 (C-5), 118.1 (CH2CH=CH2), 
126.9 (C-3), 132.6 (C-2), 134.0 (CH2CH=CH2), 147.4 (C-4), 178.3 (CC(CH3)3). HRMS 
(ESI): calcd for C21H36O3Si [M+Na]+ 387.23259, found 387.23283. 
1
5
7
O
OPiv
3
OTBS
PivOH2C
O2, Pd(OAc)2
DMSO
6-17 6-18
 
(6-Methylene-4-oxobicyclo[3.2.1]oct-2-en-1-yl)methyl pivalate (6-18). The silyl 
dienol ether 6-17 was dissolved in DMSO (550 mL). Oxygen was bubbled through the 
solution for 5 min, then the flask was connected to a balloon with O2 and heated to 45 °C. To 
this mixture a stirred solution of Pd(OAc)2 (336 mg, 1.5 mmol, 0.058 equiv) in DMSO (10 
mL) was slowly injected within 4 h via syringe pump. Then, the resulting mixture was stirred 
under an oxygen atmosphere at 45 – 50 °C for 24–30 h until complete conversion was 
observed by TLC. The mixture was cooled, diluted with Et2O (350 mL) and poured onto ice 
(1 L). The ether layer was separated using a 2 L separating funnel. The aqueous layer was 
extracted with Et2O (3 × 150 mL). The combined organic extracts were washed with saturated 
NaCl solution, dried with anhydrous Na2SO4, filtered, and evaporated. The residue was flash 
chromatographed (petroleum ether/ethyl acetate, 8:1, Rf 0.3) to yield cyclohexenone 6-18 as a 
colorless oil. Yield: 85% (5.4 g, 21.7 mmol) or 75% for two steps. 1H NMR (400 MHz, 
CDCl3): [ppm] = 1.20 (s, 9H, O=CC(CH3)3), 1.85 (ddd, J = 11.4, 5.1, 2.0 Hz, 1H, 8a-H), 
2.13 (ddd, J = 11.4, 2.1 Hz, 1H, 8b-H), 2.37 (br d, J = 15.9 Hz, 1H, 7a-H), 2.49 (dt, J = 15.9, 
2.5 Hz, 1H, 7b-H), 3.49 (br d, J = 5.1 Hz, 1H, 5-H), 4.15 (d, J = 11.1 Hz, 1H, CH2OPiv), 4.26 
(d, J = 11.1 Hz, 1H, CH2OPiv), 5.08 (br s, 1H, C=CH2), 5.29 (br s, 1H, C=CH2), 5.86 (dd, J = 
9.7, 1.5 Hz, 1H, 3-H), 7.04 (dd, J = 9.7, 2.0 Hz, 1H, 2-H). 13C NMR (100 MHz, CDCl3): 
[ppm] = 27.2 (C(CH3)3), 39.0 (CC(CH3)3), 39.4 (C-7), 42.7 (C-8), 47.0 (C-1), 58.2 (C-5), 
67.2 (CH2OPiv), 113.0 (C=CH2), 127.2 (C-3), 144.1 (C-6), 154.6 (C-2), 178.2 (C=O ester), 
198.0 (C-4). HRMS (ESI): calcd for C15H20O3 [M+Na]+ 271.13047, found 271.13044. 
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[2-(2-Methoxy-2-oxoethyl)-6-methylene-4-oxobicyclo[3.2.1]oct-1-yl]methyl pivalate 
(6-20). To a stirred solution of (6-methylene-4-oxobicyclo[3.2.1]oct-2-en-1-yl)methyl 
pivalate 6-6-18 (4.46 g, 18 mmol) and silyl ketene acetal230 6-19 (5.9 mL, 27 mmol, 1.5 equiv, 
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Aldrich) in anhydrous CH2Cl2 (180 mL) was added TiCl4 (2.37 mL, 21.6 mmol, 1.2 equiv) 
dropwise at a temperature between –85 and –90 °C. The mixture was stirred at –80 °C 
overnight, then treated with water (150 mL) and adjusted with citric acid to pH ~ 3–4. Then, 
the CH2Cl2 layer was separated and the water phase extracted with CH2Cl2 (100 mL). The 
combined CH2Cl2 extracts were washed with saturated NaCl solution, dried with anhydrous 
Na2SO4, filtered, and evaporated. The residue was flash chromatographed (petroleum 
ether/ethyl acetate, 6:1 to 4:1, Rf 0.4 at 4:1) to deliver 5.1 g (15.84 mmol, 88%) of ketoester 
6-20 as a colorless oil. 1H NMR (400 MHz, CDCl3): [ppm] = 1.21 (s, 9H, O=CC(CH3)3), 
1.75 (ddd, J = 12.4, 4.8, 1.8 Hz, 1H, 8a-H), 1.81 (br d, J = 12.4 Hz, 1H, 8b-H), 2.05 (d, J = 
15.9 Hz, 1H, 9a-H), 2.18 (dd, J = 15.9, 10.6 Hz, 1H, 7a-H), 2.47 (dd, J = 15.9, 2.2 Hz, 1H, 
7b-H), 2.59–2.67 (m, 2H, 3-H), 2.67–2.72 (m, 1H, 2-H), 2.77 (dd, J = 15.9, 7.8 Hz, 1H, 9b-
H), 3.24 (d, J = 4.8 Hz, 1H, 5-H), 3.65 (s, 3H, CO2CH3), 3.95 (d, J = 11.4 Hz, 1H, CH2OPiv), 
4.21 (d, J = 11.4 Hz, 1H, CH2OPiv), 4.98 (s, 1H, C=CH2), 5.05 (s, 1H, C=CH2). 13C NMR 
(100 MHz, CDCl3): [ppm] = 27.2 (C(CH3)3), 35.2 (C-7), 35.3 (C-8), 38.2 (C-2), 39.0 
(CC(CH3)3), 40.3 (C-9), 42.0 (C-3), 45.7 (C-1), 51.9 (CO2CH3), 59.4 (C-5), 67.7 (CH2OPiv), 
109.3 (C=CH2), 147.0 (C-6), 172.4 (CO2CH3), 178.1(tBuCO2CH2), 208.4 (C-4). HRMS 
(ESI): calcd for C18H26O5 [M+Na]+ 345.16725, found 345.16729. 
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{2-(2-Methoxy-2-oxoethyl)-6-methylene-4-(hydroxy)bicyclo[3.2.1]oct-1-yl}methyl 
pivalate (6-21). To a stirred solution of ketoester 6-20 (425 mg, 1.32 mmol) and triethylsilane 
(0.84 mL, 5.28 mmol, 4 equiv) in anhydrous CH2Cl2 (20 mL) was added TiCl4 (1.2 equiv, 
1.58 mmol, 0.175 mL) at –40 °C. After 15 min of stirring at this temperature, TLC showed 
complete reaction. Now, the reaction mixture was treated with NaHCO3 solution before the 
CH2Cl2 layer was separated. The aqueous layer was reextracted with CH2Cl2 and the 
combined CH2Cl2 extracts were washed with saturated NaCl solution, dried with anhydrous 
Na2SO4, filtered, and evaporated. The residue was flash chromatographed (petroleum 
ether/ethyl acetate, 2:1, Rf 0.35) to provide 380 mg (1.17 mmol, 89%) of hydroxy ester 6-21 
as a single isomer and a colorless oil. 1H NMR (400 MHz, CDCl3): [ppm] = 1.12–1.18 (m, 
1H, 3a-H), 1.18 (s, 9H, C(CH3)3), 1.45 (br d, J = 15.7 Hz, 1H, 8a-H), 1.81–1.89 (m, 3b-H), 
1.97 (s, OH), 2.15–2.22 (m, 1H, 8b-H), 2.03 (dd, J = 11.9, 1.8 Hz, 1H, 3b-H), 2.15–2.23 (m, 
1H, 2-H), 2.28–2.44 (m, 2H, 9-H), 2.48 (dd, 1H, J = 14.7, 3.5 Hz, 7a-H), 2.71 (br dd, 1H, J = 
4.8, 4.6 Hz, 5-H), 2.78 (dd, 1H, J =14.7, 11.1 Hz, 7b-H), 3.64 (s, 3H, CO2CH3), 3.81 (d, J = 
11.4 Hz, 1H, 1’a-H), 3.75–3.85 (m, 1H, 4-H), 4.14 (d, J = 11.4 Hz, 1H, 1’b-H), 4.82 (s, 1H, 
6’a-H), 4.88 (s, 1H, 6’b-H). 13C NMR (100 MHz, CDCl3): [ppm] = 27.2 (C(CH3)3), 28.5 (C-
3), 30.3 (C-8), 35.8 (C-2), 35.9 (C-9), 38.9 (C(CH3)3), 41.9 (C-7), 45.8 (C-1), 49.6 (C-5), 51.6 
(CO2CH3), 69.0 (C-1’), 71.8 (C-4), 106.2 (C-6’), 151.0 (C-6), 174.3 (C-10), 178.4 
((tBuCO2CH2). HRMS (ESI): calcd for C18H28O5 [M+Na]+ 347.18290, found 347.18286. 
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(2-(2-Methoxy-2-oxoethyl)-6-methylene-4-{[(methylthio)carbonothioyl]oxy}-
bicyclo[3.2.1]oct-1-yl)methyl pivalate (6-22). To a stirred solution of alcohol 6-21 (210 mg, 
0.65 mmol) in anhydrous THF (5 mL) was added NaH (80 mg, 60% in mineral oil, 2 mmol, 3 
equiv) at 0 °C. After 10 min, CS2 (0.125 mL, 2.0 mmol, 3 equiv) was added. The mixture was 
stirred for 30 min before MeI (0.126 mL, 2.0 mmol, 3 equiv) was added. The stirred mixture 
was allowed to warm to room temperature within 1 h (TLC monitoring) and treated with half-
saturated NH4Cl solution (15 mL). The mixture was extracted with petroleum ether (2 × 35 
mL). The combined organic extracts were washed with saturated NaCl solution, dried with 
anhydrous Na2SO4, filtered, and evaporated. The residue was flash chromatographed 
(petroleum ether/ethyl acetate, 20:1, Rf 0.3) to give 225 mg (0.54 mmol, 83%) of 
xanthogenate 6-22 as a yellowish oil. 1H NMR (400 MHz, CDCl3): [ppm] = 1.20 (s, 9H, 
C(CH3)3), 1.28 (dd, J = 12.1, 4.8 Hz, 1H, 3a-H), 1.76 (br d, J = 16.2 Hz, 1H, 8a-H), 1.87 (br 
d, J = 12.1 Hz, 1H, 8b-H), 2.00–2.09 (m, 3b-H), 2.30–2.39 (m, 1H, 2-H), 2.40–2.50 (m, 2H, 
9-H), 2.52–2.57 (m, 2H, 7-H), 2.54 (s, 3H, SCH3), 3.11 (br dd, 1H, J = 4.8, 4.6 Hz, 5-H), 3.63 
(s, 3H, CO2CH3), 3.87 (d, J = 11.4 Hz, 1H, 1’a-H), 4.15 (d, J = 11.4 Hz, 1H, 1’b-H), 4.93 (s, 
1H, 6’a-H), 5.03 (s, 1H, 6’b-H), 5.55 (br s, 1H, 4-H). 13C NMR (100 MHz, CDCl3): [ppm] = 
18.9 (SCH3), 27.2 (C(CH3)3), 27.7 (C-8), 29.7 (C-3), 35.5 (C-2), 35.5 (C-9), 39.0 (C(CH3)3), 
41.8 (C-7), 45.5 (C-1), 45.9 (C-5), 51.6 (CO2CH3), 68.6 (C-1’), 82.8 (C-4), 108.2 (C-6’), 
149.0 (C-6), 173.4 (C-10), 178.3 (tBuCO2CH2), 214.7 (C=S). HRMS (ESI): calcd for 
C20H30O5S2 [M+Na]+ 437.14269, found 437.14288. 
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[2-(2-Methoxy-2-oxoethyl)-5-methylenebicyclo[2.2.2]oct-1-yl]methyl pivalate (23) 
and [4-hydroxy-2-(2-methoxy-2-oxoethyl)-6-methylenebicyclo[3.2.1]oct-1-yl]methyl 
pivalate (6-24). To a stirred mixture of xanthogenate 6-22 (320 mg, 0.77 mmol), sodium 
formate (0.42 g, 6.16 mmol, 8 equiv) and sodium carbonate (408 mg, 3.81 mmol, 5 equiv) in 
DMSO (11 mL) a first batch (1.3 mL) of (Bu4N)2S2O8 (771 mg, 2.3 mmol, 3 equiv), dissolved 
in DMSO (4 mL) was injected at 45 °C. The remaining amount (2.7 mL) of the (Bu4N)2S2O8 
solution was injected slowly (during 6 h) to the stirred mixture under inert atmosphere at 45 
°C. The resulting mixture was stirred at 45 °C overnight, then cooled and diluted with ether 
and water. Usual extractive workup followed by flash chromatography (petroleum ether/ethyl 
acetate, 15:1, Rf 0.3) afforded 90 mg (0.29 mmol, 38%) of the desired product from the 
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deoxygenative rearrangement, namely [2-(2-methoxy-2-oxoethyl)-5-
methylenebicyclo[2.2.2]oct-1-yl]methyl pivalate (6-23), which is 82% pure by NMR. It is 
contaminated with the [3.2.1] skeletal isomer 6-24, which could not be separated. In addition, 
the product of hydrolysis of the xanthate ester, [4-hydroxy-2-(2-methoxy-2-oxoethyl)-6-
methylenebicyclo[3.2.1]oct-1-yl]methyl pivalate (40 mg, 0.12 mmol) was recovered. Thus, 
the yield based on recovered starting material (brsm) was adjusted to be 47%. Running this 
reaction in DMF, as described in the original paper,220 afforded only 26% of product 6-23. 
Attempts to generate this product under standard conditions, as described in the Nicolaou 
paper,204a (AIBN, Bu3SnH) were unsuccessful with no conversion of starting xanthate ester. 
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[2-(2-Methoxy-2-oxoethyl)-5-methylenebicyclo[2.2.2]oct-1-yl]methyl pivalate (6-
23). 
Two-step procedure. A solution of ketoester 6-20 (240 mg, 0.745 mmol) and tosyl 
hydrazone (186 mg, 1.0 mmol, 1.34 equiv) in MeOH (10 mL) was refluxed under inert 
atmosphere for 5 h. Then the solvent was evaporated and the residue subjected to flash 
chromatography (petroleum ether/ethyl acetate, 2:1, Rf 0.25) to afford 359 mg (0.73 mmol, 98 
%) of hydrazone 6-25. HRMS (ESI): calcd for C25H34N2O6S [M+Na]+ 513.20298, found 
513.20284. 
Obtained hydrazone 6-25 (300 mg, 0.61 mmol), ZnCl2 (136 mg, 1.0 mmol, 1.64 equiv) 
and NaCNBH3 (100 mg, 1.56 mmol, 2.56 equiv) in MeOH (10 mL) were heated to 60 °C 
under inert atmosphere for 3 h. The reaction vessel was cooled to room temperature and 
treated with 0.5 M NaOH solution (10 mL) and saturated NaCl solution (10 mL). The mixture 
was extracted with petroleum ether (3 × 25 mL). The combined organic extracts were dried 
over Na2SO4, filtered, and evaporated. The residue was flash chromatographed (petroleum 
ether/ethyl acetate, 15:1, Rf 0.3) to provide 110 mg (0.37 mmol, 60%) of [2-(2-methoxy-2-
oxoethyl)-5-methylenebicyclo[2.2.2]oct-1-yl]methyl pivalate (6-23), which is 92% pure 
according to 1H NMR. 
One-pot procedure. Ketone 6-20 (0.84 g, 2.6 mmol) and TsNHNH2 (0.632 g, 3.4 
mmol, 1.3 equiv) in MeOH (40 mL) were heated to 60 °C for 5 h. After being cooled to room 
temperature to the mixture were added ZnCl2 (0.565 g, 4.16 mmol, 1.6 equiv) and NaCNBH3 
(400 mg, 6.24 mmol, 2.4 equiv). The mixture was heated to 60 °C for 3 h under inert 
atmosphere. Isolation of the product was done as descibed before to furnish 430 mg (1.4 
mmol, 54%) of the desired rearranged and deoxygenated product 6-23.  
1H NMR (400 MHz, CDCl3): [ppm] = 1.18–125 (m, 1H, 8a-H), 1.19 (s, 9H, C(CH3)3), 
1.20–1.27 (m, 1H, 3a-H), 1.43–1.52 (m, 1H, 3b-H), 1.58–1.65 (m, 2H, 7ab-H), 1.88–1.96 (m, 
1H, 8b-H), 2.13–2.24 (m, 4H, 2,4,6a,9a-H), 2.26–2.35 (m, 1H, 9a-H), 2.36–2.46 (m, 1H, 6b-
H), 3.54 (s, 3H, CO2CH3), 3.68 (d, J = 11.4 Hz, 1H, 1’a-H), 3.81 (d, J = 11.4 Hz, 1H, 1’b-H), 
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4.62 (dd, J = 1.8, 2.0 Hz, 1H, 5’a-H), 4.75 (dd, J = 2.0, 2.0 Hz, 1H, 5’b-H). 13C NMR (100 
MHz, CDCl3): [ppm] = 22.7 (C-3), 25.9 (C-7), 27.2 (C(CH3)3), 33.7 (C-2), 33.9 (C-8), 35.7 
(C-4), 36.1 (C-1), 36.8 (C-6), 39.0(C(CH3)3), 39.2 (C-9), 51.5 (CO2CH3), 68.7 (C-1’), 105.8 
(C-5’), 149.9 (C-5), 173.4 (C-10), 178.3 (tBuCO2CH2). HRMS (ESI): calcd for C18H28O4 
[M+Na]+ 331.18798, found 331.18777. 
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1-[1-(Hydroxymethyl)-5-methylenebicyclo[2.2.2]oct-2-yl]propan-2-ol (6-27). To a 
stirred mixture of diester 6-23 (616 mg, 2.0 mmol) and HCl·NH(OMe)Me (1.2 g, 12 mmol, 6 
equiv) in CH2Cl2 (15 mL) a toluene solution of Me3Al (5 mL, 2 M, 10 mmol, 5 equiv) was 
injected within 1 h (via syringe pump) at –10 °C. The resulting solution was stirred at 0 °C 
overnight. The reaction was quenched by slow injection of water (1 mL), and the mixture was 
poured into a solution of Rochelle’s salt (50 g in 120 mL of water). This mixture was 
vigorously stirred for 2 h and then extracted with CH2Cl2 (3 × 30 mL). The combined CH2Cl2 
extracts were washed with saturated NaCl solution, dried with anhydrous Na2SO4, filtered, 
and evaporated to dryness to give the crude Weinreb amide.  
To a solution of the Weinreb amide (Rf 0.3, petroleum ether/ethyl acetate, 4:1) in Et2O 
(12 mL) was added slowly MeLi (7.5 mL, 1.6 M solution in Et2O, 12 mmol, 6 equiv) at –80 
°C. Then the mixture was warmed to –30 °C overnight, and carefully treated with water (5 
mL). The mixture was diluted with half-saturated NH4Cl solution (25 mL) and extracted with 
Et2O (3 × 30 mL). The combined organic layers were washed with saturated NaCl solution 
(20 mL), dried with Na2SO4, filtered, and concentrated in vacuo. The crude product was 
purified by flash chromatography (petroleum ether/ethyl acetate, 4:1, Rf 0.3) to afford 397 mg 
(1.92 mmol, 96%) of hemiketal 6-26 as colorless crystals (m.p. 115 °C, lit.204a 115-117 °C). 
HRMS (ESI): calcd for C14H22O2Na [M+Na+MeOH-H2O]+ 245.15120, found 245.15122. 
The obtained hemiketal 6-26 (397 mg, 1.92 mmol) was dissolved in anhydrous Et2O (30 
mL) and LiAlH4 (73 mg, 1.92 mmol, 1 equiv) was added at –80 °C. The resulting mixture 
was stirred at 0 °C for 2–3 h and the reaction quenched with a few drops of water. The 
mixture was poured into a solution of Rochelle’s salt (30 g) in water (100 mL) and vigorously 
stirred for 2 h before being extracted with Et2O (3 × 50 mL). The ether layers were washed 
with saturated NaCl solution, dried with Na2SO4, filtered, and evaporated. Crude diol 6-27 
was purified by flash chromatography (Rf 0.2, petroleum ether/EtOAc, 1:1) to separate the 
undesired [3.2.1]-isomer, which is less polar (Rf 0.25, petroleum ether/EtOAc, 1:1) to provide 
pure 6-27 (354 mg, 1.7 mmol, 85% yield, for 3 steps) as colorless crystals (m.p. 85–94 °C). 
1H NMR (400 MHz, CDCl3): [ppm] = 1.02–1.15 (m, 1H), 1.17, 1.19 (d, J = 6.3 Hz, 3H, 
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Me), 1.22–1.26 (m, 1H), 1.32–1.49 (m, 2H), 1.52–1.75 (m, 4H), 2.03–2.13 (m, 1H), 2.17–
2.22 (m, 1H), 2.33 (br s, 2H, OH), 2.38–2.50 (m, 1H), 3.11, 3.20 (d, 1H, J = 11.4 Hz, 1’a-H), 
3.48, 3.52 (d, 1H, J = 11.4 Hz, 1’b-H), 3.81–3.98 (m, 1H, 10-H), 4.62 (br s, 5’a-H), 4.75 (br s, 
1H, 5’b-H). 13C NMR (100 MHz, CDCl3): [ppm] = 22.8 (CH2), 22.9 (CH3), 23.0 (CH2), 
25.1 (CH3), 26.2 (CH2), 26.3 (CH2), 31.6 (CH), 31.8 (CH), 34.9 (CH2), 35.8(CH2), 36.3 (CH), 
36.4 (CH), 37.5 (C-1), 37.7 (C-1), 39.2 (CH2), 39.1 (CH2), 41.4 (CH2), 41.5 (CH2), 65.9 (C-
10), 66.7 (C-10), 67.6 (C-1’), 68.2(C-1’), 105.0 (C-5’), 105.1 (C-5’), 151.4 (C-5), 151.6 (C-
5). HRMS (ESI): calcd for C13H22O2 [M+Na]+ 233.15120, found 245.15110. 
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3-Methylene-1,2,3,4,8,8a-hexahydro-7H-2,4a-ethanonaphthalen-7-one (6-3).  
a) Ketoaldehyde 6-28. To a stirred solution of oxalyl chloride (0.5 mL, 5.8 mmol, 5.8 
equiv) in CH2Cl2 (7 mL) DMSO (0.64 mL, 9.0 mmol, 9 equiv) was added dropwise at –80 °C. 
After 0.5 h a solution of diol 6-27 (210 mg, 1.0 mmol) in CH2Cl2 (7 mL) was injected during 
20 min. The resulting mixture was stirred for 3 h at –80 °C before Et3N (1.6 mL) was added at 
this temperature. After 2 h the reaction was quenched with a half-saturated NH4Cl solution, 
then water was added and the organic layer separated. The aqueous layer was extracted with 
CH2Cl2 and the combined extracts were washed with saturated NaCl solution, dried with 
anhydrous Na2SO4, filtered, and evaporated. Flash chromatography of the residue (petroleum 
ether/ ethyl acetate 6:1, Rf 0.3) provided ketoaldehyde 6-28 in 65% yield (135 mg, 0.65 
mmol). Another product, which is the more polar mixture of unreacted hemiketal, was 
recovered by reduction with LiAlH4 (20 mg) in Et2O (5 mL) to furnish 24 mg (0.11 mmol) of 
diol 6-27. Thus, the yield of ketoaldehyde 6-28 brsm amounts to 73%. 1H NMR (400 MHz, 
CDCl3): [ppm] = 1.12 (ddd, J = 13.3, 5.3, 2.7 Hz, 1H, CH2), 1.50–1.65 (m, 3H, CH2), 1.75–
1.83 (m, 2H, CH2), 2.02–2.10 (m, 1H, CH2), 2.10 (s, 3 H), 2.22–2.29 (m, 2H), 2.35 (dd, J = 
17.9, 10.4 Hz, 1H), 2.44–2.53 (m, 3H), 4.71 (dd, J = 2.0, 1.5 Hz, 1H, 5’a-H), 4.83 (dd, J = 
2.3, 1.5 Hz, 1H, 5’b-H), 9.40 (s, 1H, CH=O). 13C NMR (100 MHz, CDCl3): [ppm] = 20.2 
(CH2), 25.5 (CH2), 30.3 (CH3), 31.2 (CH), 34.4 (CH2), 36.0 (CH), 36.4 (CH2), 47.4 (C-9), 
48.4 (C-1), 107.1 (C-5’), 147.5 (C-5), 205.3 (C-1’), 207.4 (C-10). HRMS (ESI): calcd for 
C13H18O2 [M+Na]+ 229.11990, found 229.12005. 
b) Tricyclic enone 6-3. The obtained ketoaldehyde 6-28 (135 mg, 0.65 mmol) was 
dissolved in EtOH (27 mL) and solid NaOH (170 mg, 4.25 mmol, 6.5 equiv) was added at 20 
°C. The mixture was stirred at this temperature for 20 h, then concentrated. The residue was 
dissolved in ether (60 mL) and washed with 1 N aqueous HCl (2 × 20 mL), saturated aqueous 
NaHCO3 solution (25 mL), and brine (25 mL). The combined water washes were reextracted 
with Et2O and the combined organic extracts were then dried over anhydrous Na2SO4, 
filtered, and concentrated. Purification of the residue by flash column chromatography 
(petroleum ether/ ethyl acetate 10:1, Rf 0.3) afforded enone 6-3 (108 mg, 0.57 mmol, 87 % 
yield) as a colorless oil. 1H NMR (400 MHz, CDCl3): [ppm] = 1.18 (ddd, J = 12.6, 7.6, 1.5 
Hz, 1H, CH2), 1.45–1.53 (m, 1H, CH2), 1.66–1.80 (m, 3H), 1.94–2.02 (m, 1H), 2.05–2.17 (m, 
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2H), 2.28–2.32 (m, 1H), 2.30 (dd, J = 16.7, 13.4 Hz, 1H), 2.38–2.47 (m, 2H), 4.67 (dd, J = 
2.3, 1.8 Hz, 1H, 3’a-H), 4.81 (dd, J = 2.5, 1.8 Hz, 1H, 3’b-H), 5.85 (dd, J = 10.1, 0.8 Hz, 1H, 
6-H), 6.54 (d, J = 10.1 Hz, 1H, 5-H). 13C NMR (100 MHz, CDCl3): [ppm] = 24.5 (CH2), 
26.4 (CH2), 34.9 (CH2), 35.4 (CH), 35.5 (C-4a), 36.0 (CH), 40.8 (CH2), 41.6 (CH2), 106.9 (C-
3’), 127.7 (C-6), 148.9 (C-3), 156.7 (C-5), 200.1 (C-7). HRMS (ESI): calcd for C13H16O 
[M+Na]+ 211.10934, found 211.10936. 
O
O
CHO
O
O
Pd2(dba)3·CHCl3
(Z)-6-13 (+)-6-14
O
O
O
(S,S)-Trost ligand
6-29
 
Asymmetric allylic alkylation, synthesis of (+)-6-14. Pd2(dba)3·CHCl3 (13 mg, 0.0125 
mmol, 2.5 mol% of Pd) and (S,S)-Trost ligand 6-29 (25.1 mg, 0.03 mmol, 3 mol%) were 
stirred in dry degassed THF (5 mL) at 20 °C under nitrogen for 0.5 h to form an orange 
solution. This solution was cooled to –20 °C and added dropwise to a cold (–20 °C) solution 
of (Z)-6-13 (280 mg, 1.0 mmol) in THF (5 mL) and stirred at this temperature for 48 h. When 
the reaction was finished (TLC-monitoring) one drop of Me2S was added to poison the 
palladium catalyst, and then the solvent was evaporated under reduced pressure. The residue 
was purified by flash chromatography (petroleum ether/ethyl acetate, 10:1, Rf 0.3) to give (+)-
6-14 as a colorless oil (225 mg, 95%), []D = +83.7 (c = 2.0, CH2Cl2). The ee of (+)-6-14 was 
determined by chiral GC (column 977, 28 m × 0.25 mm, 30% 6-TBDMS-2,3-diacetyl -
cyclodextrin in PS 086. Temperature program: 80 °C, 2 min isothermal, then 4 ° min–1 up to 
190 °C, Pi 60 kPa H2. A typical chromatogram is shown below.  
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7. Selected NMR spectra for important compounds. 
Additional spectra are included in the supporting information of the published papers 
from this work and are available via internet at http://pubs.acs.org and 
http://www.angewandte.org. 
202  Experimental Section 
O
O
CH2OHHOH2C
1-10  
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
Chloroform-d
 
 
Chloroform-d
19.18
34.67
35.84
36.01
40.09
43.57
58.77
64.02
109.25  
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)  
 
Chloroform-d
19.15
32.75
35.33
35.69
36.75
43.61
49.44
63.54
63.96
109.33
126.77
128.05
129.14
138.61  
204  Experimental Section 
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)  
18.28
32.97
35.93
36.16
39.79
42.36
42.79
42.86
49.79
55.62
74.80
111.32
111.98
117.40
129.51
152.52
159.92  
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
 
Chloroform-d
17.87
32.16
33.85
35.14
39.06
39.67
40.57
47.88
55.22
74.37
110.87
111.67
116.84
119.81
122.74
128.74
129.23
139.22
151.57
155.09
159.55
 
N
OH
MeO
H
N O
Ph
1-17
206  Experimental Section 
10 9 8 7 6 5 4 3 2 1 0
ppm
TMS
 
Chloroform-d
198.37
143.39
139.97
139.61
132.85
131.90
129.35
128.82
127.54
126.95
125.46
77.31
77.00
76.68
39.20
29.40
23.24
 
14
3.
39
13
9.
97
13
9.
61
13
2.
85
13
1.
90
12
9.
35
12
8.
82
12
7.
54
12
6.
95
12
5.
46
 
 
O
2-7a
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
ppm
Chloroform-d
 
 
Chloroform-d
29.08
32.07
55.23
62.24
99.54
104.14
129.61
130.26
130.82
135.06
139.49
160.78  
 
OH
OMe
OMe1 4
6
2'
4'
3-7
208  Experimental Section 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5
ppm
 
Chloroform-d
6.32
32.70
33.32
55.27
99.64
104.19
129.39
130.75
131.73
133.17
139.40
160.83
 
I
OMe
OMe1 4
6
2'
4'
3-8
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10 9 8 7 6 5 4 3 2 1 0
ppm
Chloroform-d
0.
02
0.
91
 
 
Chloroform-d
-4.91
-4.67
18.11
24.37
25.74
32.63
36.49
55.25
71.40
99.55
104.16
129.63
130.31
130.70
130.87
135.17
139.51
159.96
160.83
193.57  
OMe
OMe
2'
4'
8 10
3-12c
O
O
H
Si
Me
Me
1
2
4
210  Experimental Section 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
ppm
Chloroform-d
 
Chloroform-d
19.61
20.33
27.29
32.97
33.25
33.51
43.24
43.99
48.08
55.24
55.42
68.40
73.57
76.69
77.00
77.20
77.32
96.67
99.64
124.74
127.46
127.65
129.65
129.86
133.78
134.18
134.78
136.16
136.33
150.03
157.45
162.26  
HO
H
TBDPSO
H
HH
MeO
OMe
3-13
1
4 5
6a 6b 7
9
10a
11
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10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
ppm
Chloroform-d
 
 
Chloroform-d
-5.18
-4.15
18.09
20.54
25.87
33.08
33.15
33.87
40.08
43.21
51.38
55.23
67.07
98.73
108.12
125.86
133.94
141.67
160.59
205.89
 
CHO
H
H
TBSO
OMe
OMe
3-14c
1
3
5
4a6
8
2'
4'
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Chloroform-d
 
Chloroform-d
15.55
20.19
28.38
30.89
32.65
33.87
35.57
41.98
46.60
47.69
55.25
71.11
79.15
97.67
106.92
127.03
134.66
148.44
156.40
160.49  
 
H
H
HO
H
NHBoc
Me
3-17
OMe
OMe
14
161
2
5
10
Experimental Section   213 
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
ppm  
3.5 3.0 2.5 2.0 1.5 1.0
ppm
6.15 4.05 2.952.031.08 1.08 1.071.06 1.061.02 1.01
 
 
Chloroform-d
16.60
27.63
28.13
33.21
39.03
39.61
40.51
41.71
44.01
55.27
58.29
97.36
106.27
127.38
130.63
148.90
160.83  
 
H
H
N
H
Me
OMe
OMe
14
16
1
2
5
10
4 12
3-18 (epi-dimethyl-symbioimine)
214  Experimental Section 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
ppm
Chloroform-d
 
Chloroform-d
16.18
20.97
30.01
30.74
31.34
35.97
37.08
44.19
46.27
55.32
78.45
97.66
106.54
125.94
132.29
146.78
160.87
174.90
 
3-16
H
H
O
H
O
Me
OMe
OMe
14
16
1
2
5
10
12
Experimental Section   215 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
ppm
Chloroform-d
 
 
Chloroform-d
-5.10
-3.58
18.24
20.54
25.90
32.41
33.69
34.35
35.27
37.75
43.59
55.24
55.49
67.14
95.44
104.53
114.95
120.55
125.05
127.05
134.49
141.18
155.44
159.71
 
H
H
TBSO
OMe
OMe
HH
3-20
1
3
4
9
5
8
11
14
16
216  Experimental Section 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
ppm
Chloroform-d
 
Chloroform-d
-5.31
-3.53
18.24
20.51
25.87
33.40
33.99
34.76
41.08
41.27
44.47
55.22
61.67
67.03
98.36
108.22
127.30
133.75
144.25
160.55
 
H
H
TBSO
OH
H
OMe
OMe
1
2
3
4a
6
8
2'
4'
3-15a
Experimental Section   217 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
ppm
Chloroform-d
 
Chloroform-d
-5.42
-3.49
17.63
18.11
20.20
25.76
32.93
33.74
35.04
36.90
42.25
44.66
55.27
66.45
99.03
108.50
119.62
126.71
133.28
141.78
160.46  
H
H
TBSO
CN
H
OMe
OMe
1
2
3
9
7
4 14
16
5
11
12
3-23
218  Experimental Section 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
Chloroform-d
 
Chloroform-d
18.23
26.41
26.82
35.04
35.55
36.06
38.34
45.80
55.27
74.55
98.30
108.17
127.91
134.05
141.25
160.53
174.52
 
H
H
O
H
OMe
OMe
1
2
3
9
7
4 14
16
5
11
12
3-25
O
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
ppm
Chloroform-d
 
 
Chloroform-d
14.92
20.23
26.00
33.18
34.11
34.93
40.67
40.84
45.56
55.30
65.99
98.85
109.11
122.46
127.68
131.89
142.88
160.56
 
H
H
HO
CN
H
OMe
OMe
1
3
9
7
4 14
16
5
11
12
3-28
Me
19
220  Experimental Section 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
ppm
Chloroform-d
 
 
Chloroform-d
13.02
19.77
27.69
28.30
36.46
39.16
44.68
45.73
55.28
72.25
98.05
108.87
129.73
133.57
141.59
160.53
177.58
 
H
H
O
H
OMe
OMe
1
3
9
7
4 14
16
5
11
12
3-26
O
Me
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
ppm
Chloroform-d
 
Chloroform-d
21.19
23.46
28.73
36.51
36.85
37.93
42.27
55.33
97.73
104.80
115.92
118.87
125.12
129.94
131.98
134.06
137.51
157.69
159.12
 
H
CN
MeO
OMe
H1
3
4
4a
4b
6
8
8a
9
11
10a10
3-3112
222  Experimental Section 
10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
ppm
DMSO-d6
water
 
DMSO-d6
25.40
25.83
31.13
36.66
40.69
41.82
45.02
45.49
48.34
100.84
107.93
128.99
132.21
142.03
157.74
170.76  
 
H
H
N
H
OH
OH
1
3
9
7
4 14
16
5
11
12
3-33
Experimental Section   223 
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
ppm
Chloroform-d
 
Chloroform-d
13.03
24.79
27.63
32.57
38.87
42.63
43.75
45.12
50.10
55.35
99.11
108.71
122.93
129.38
129.85
142.36
160.73
211.68  
  
H
H
O
CN
H
OMe
OMe
1
3
9
7
4 14
16
5
11
12
3-34
Me
224  Experimental Section 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
ppm
Chloroform-d
 
Chloroform-d
16.35
23.25
26.98
31.71
34.57
39.24
43.14
45.19
46.87
55.30
63.83
64.03
98.34
107.42
110.68
123.58
128.67
133.54
144.00
160.88
 
H
Me
H
OMe
OMe
1
3
97
4 14
16
5
11
12
3-35
OO
NC 19
Experimental Section   225 
10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
ppm
DMSO-d6
water
 
DMSO-d6
16.58
25.37
27.51
31.34
36.77
39.97
42.47
43.90
56.17
100.79
108.45
129.90
131.34
141.87
157.77
170.04  
H
H
N
H
OH
OH
1
3
9
7
4 14
16
5
11
12
Me
3-37
226  Experimental Section 
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
DMSO-d6
 
15.58
24.39
26.20
29.77
33.49
40.33
41.10
41.49
41.71
49.95
106.00
111.84
112.83
129.60
130.47
139.92
154.13
157.33
187.38
 
H
H
N
H
SO3-
OH
1
3
9
7
4 14
16
5
11
12
H Me
symbioimine (3-1)
Experimental Section   227 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
ppm
Chloroform-d
 
Chloroform-d
166.62
150.78
119.72
69.38
61.06
60.34
43.74
39.75
26.62
25.92
19.78
18.28
14.20
-5.38
 
 
OTBSMe
CO2Et
OH 4-7
228  Experimental Section 
10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
Chloroform-d
 
Chloroform-d
202.18
166.44
150.64
120.07
69.70
60.37
51.40
44.32
25.77
24.41
19.87
18.08
14.19
-4.34
-4.99
 
OMe
CO2Et
OTBS
4
6
8
9
4-8
Experimental Section   229 
10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
Chloroform-d
 
Chloroform-d
195.11
166.48
152.85
150.83
140.33
119.94
69.73
60.37
44.33
36.70
29.08
25.76
19.67
18.07
14.19
9.37
-4.32
-4.99
 
Me
CO2Et
OTBS
CHO
Me
4
6 911
12
4-10
230  Experimental Section 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
Chloroform-d
 
Chloroform-d
172.76
160.12
143.74
138.03
121.98
107.96
98.17
67.83
59.65
55.12
46.83
44.36
42.36
40.20
38.63
36.38
26.91
25.84
22.35
21.15
18.06
14.03
-4.18
-5.50
 
OMe
OMe
Me
Me
CO2Et
H
H
1
2'
4'
4a
3
8
6
9
10
11
4-13
TBSO
Experimental Section   231 
8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
Chloroform-d
 
Chloroform-d
160.48
144.82
138.04
123.46
108.31
98.09
67.58
61.95
55.21
44.27
42.55
41.09
40.74
39.01
37.72
26.84
25.86
22.32
21.18
18.22
-3.58
-5.35
 
OMe
OMe
Me
Me
H
H
OH
8
2
1
6 4a
2'
4'
4
8a
9
10
11
TBSO
4-13a
232  Experimental Section 
8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
Chloroform-d
 
Chloroform-d
160.41
142.41
137.78
122.90
119.74
108.60
98.76
67.14
55.30
44.43
42.27
41.96
38.55
38.04
36.83
26.65
25.77
22.11
21.05
18.13
17.92
-3.50
-5.43
 
OMe
OMe
Me
Me
H
H
N1
2
4
7
11
12 13
15
18
20
21
4-14
TBSO
Experimental Section   233 
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0
Chemical Shift (ppm)
Chloroform-d
 
Chloroform-d
211.36
160.71
143.01
135.06
125.28
123.01
108.71
98.90
55.38
50.65
49.90
46.40
43.64
38.76
38.48
35.61
24.85
22.36
20.82
13.20
 
OMe
OMe
Me
Me
H
H
H
N
Me
O
1
2
4
6
8
20
21
19
11
12
16
18
4-3b
234  Experimental Section 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0
ppm
Chloroform-d
 
Chloroform-d
17.51
19.08
21.95
26.77
29.99
36.94
40.65
43.09
44.39
44.87
48.15
55.32
64.31
64.49
97.98
106.86
110.88
123.26
123.43
139.70
144.48
160.93
 
12
3.
26
12
3.
43
 
OMe
OMe
Me
Me
H
H
NC
H
Me
OO
1
2
6
8
20
21
19
11
12
16
18
22
4-15
Experimental Section   235 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0
ppm
Chloroform-d
 
Chloroform-d
171.91
160.13
143.02
137.15
125.32
108.95
97.58
57.14
55.17
45.92
45.35
44.64
43.03
39.67
37.84
32.85
27.61
22.41
20.99
16.91
 
OMe
OMe
Me
Me
H
H
Me
H
N
4-16
1
2
4
6
8
20
21
19
11
12
16
18
236  Experimental Section 
10 9 8 7 6 5 4 3 2 1 0
ppm
DMSO-d6
 
DMSO-d6
169.76
157.72
142.32
136.06
125.61
108.45
100.70
56.43
45.36
44.66
44.08
42.36
39.19
37.30
32.36
27.63
22.38
20.80
16.64
 DMSO-d6
39
.1
9
 
OH
OH
Me
Me
H
H
Me
H
N
1
2
4
6
8
20
21
19
11
12
16
18
4-17
Experimental Section   237 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0
ppm
Methanol-d4
Methanol-d4
 
Methanol-d4
190.91
158.95
154.40
142.29
137.62
126.36
115.55
114.94
108.51
51.83
45.91
43.23
43.20
41.76
37.38
34.00
33.90
27.75
22.05
21.08
16.20
 
OSO3–
OH
Me
Me
H
H
Me
H
N
H
Neosymbioimine (4-1)
1
2
4
6
8
20
21
19
11
12
16
18
238  Experimental Section 
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
Chloroform-d
Chloroform-d
24.67
25.74
26.17
30.25
34.92
39.66
44.75
61.21
66.82
102.57
135.88
137.52
210.59  
Experimental Section   239 
 
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
Chemical Shift (ppm)
Chloroform-d
 
 
Chloroform-d
0.46
24.06
25.79
29.40
29.45
29.64
29.90
30.17
38.47
38.79
44.00
44.82
46.66
55.68
66.85
73.10
74.87
102.75
218.37  
240  Experimental Section 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
Chemical Shift (ppm)
Chloroform-d
 
Chloroform-d
25.78
26.92
28.57
30.84
32.70
36.25
42.19
46.02
49.62
55.46
66.83
79.11
102.56
214.13  
O
O
O
HO
Me 5-14
Experimental Section   241 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
Chloroform-d
 
 
Chloroform-d
15.24
21.63
25.75
28.38
30.74
32.42
35.89
43.40
45.46
48.48
55.86
65.82
66.78
66.85
78.73
79.32
102.18
127.97
129.61
133.86
144.62
204.56
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
Chemical Shift (ppm)
Chloroform-d
 
Chloroform-d
22.44
25.56
25.79
30.47
42.61
44.43
47.29
52.95
57.94
66.88
83.79
86.99
102.42
209.68  
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O
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6
3
2
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Chloroform-d
19.04
25.58
27.70
28.03
29.88
30.00
38.34
39.32
45.45
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118.25
133.83
176.17
202.14
208.67  
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Chloroform-d
23.78
30.86
31.50
33.43
33.83
37.96
42.24
64.65
109.72
118.71
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157.59
199.35  
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7
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
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Chloroform-d
23.78
31.36
35.06
42.07
44.57
46.18
58.59
64.64
109.48
112.01
126.63
145.38
158.08
198.58  
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
Chemical Shift (ppm)
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Chloroform-d
35.22
36.37
38.95
41.12
43.43
43.94
44.96
59.78
109.29
147.03
207.97
209.32  
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O
O
O
O
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8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
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Chloroform-d
18.99
20.97
27.65
27.77
69.52
74.97
103.26
118.74
120.02
130.64
141.49
151.94
177.39
188.10  
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O
O
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3
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10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
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Chloroform-d
18.98
24.25
25.75
27.66
36.92
60.22
75.06
102.44
119.44
131.95
178.14
195.80
200.74  
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6-18
O
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1
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7  
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
Chloroform-d
 
Chloroform-d
27.16
38.96
39.35
42.66
46.95
58.23
67.72
112.98
127.18
144.13
154.56
178.22
198.04  
250  Experimental Section 
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
Chloroform-d
 
Chloroform-d
27.15
35.32
38.20
38.96
40.27
41.96
45.68
51.85
59.41
67.68
109.31
146.98
172.43
178.14
208.37  
Experimental Section   251 
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5
8
2
9
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
Chemical Shift (ppm)
Chloroform-d
 
Chloroform-d
22.70
25.87
27.17
33.69
33.90
35.73
36.13
36.78
38.95
39.22
51.51
68.65
105.78
149.92
173.38
178.32  
252  Experimental Section 
6-27HO
1
5
8
2 9 Me
OH
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
Chloroform-d
 
Chloroform-d
22.75
22.89
23.02
26.22
26.28
31.58
31.75
34.90
35.83
36.32
36.36
37.72
39.14
41.46
65.89
66.68
67.63
68.21
105.05
151.36
151.56  
Experimental Section   253 
6-28 O
1
5
8
2
9
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10 9 8 7 6 5 4 3 2 1
Chemical Shift (ppm)
Chloroform-d
 
Chloroform-d
20.18
25.49
30.33
31.20
34.36
35.98
36.40
47.38
48.35
107.13
147.49
205.25
207.38
254  Experimental Section 
6-3
4a
3
10
8a 8 O
5
1
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
Chemical Shift (ppm)
Chloroform-d
 
Chloroform-d
24.48
26.36
34.86
35.46
36.00
40.84
41.61
106.86
127.73
148.87
156.67
200.07  
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